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The work described in this thesis details the development of new classes of metallated 
carbenoids to be used in the homologation of boronic esters. 2-Phenyl-azetidinium ylide 239b, 
which could be generated in situ by deprotonation of 2-phenylazetidinium triflate 211, reacted 
with boronic esters to give, after ring-opening 1,2-metallate rearrangement, γ-dimethylamino 
tertiary boronic esters (Scheme A). The process proved to be not stereospecific, owing to the 
configurational instability of the generated intermediated ylide, which presumably exists in 
equilibrium with the open chain carbene species. Further functional group transformations of 
the generated γ-dimethylamino tertiary boronic esters, including protodeboronation and 
Zweifel olefination, gave access to a range of substituted 3-aryl-1-aminopropanes, which 
represent a pivotal structural motif among biologically active compounds. 
 
Scheme A. Synthesis of 3-aryl-1-aminopropane derivatives by lithiation−borylation−ring-opening of azetidinium 
ions. 
The use of enantioenriched α-sulfinyl benzoates as precursors to lithium and magnesium 
carbenoids for the stereoselective reagent-controlled homologation of boronic esters has also 
been developed (Scheme B). α-Sulfinyl benzoates could be synthesised in very high 
enantiopurity from racemic lithiated benzoates by transmetalation to the corresponding 
magnesiated benzoates followed by electrophilic trapping with enantiomerically pure 
Andersen’s sulfinate. Alternatively, the α-sulfinyl benzoates could be prepared by alkylation 
of methylene α-sulfinyl benzoate 256. The carbenoid precursors were subsequently employed 
in the homologation of boronic esters, a process that proved to be efficient using either t-BuLi 
or i-PrMgClLiCl to trigger the sulfoxide−metal exchange, giving the homologated products in 
high yield and excellent stereofidelity. Three iterative homologations, without intervening 
chromatographic purification, could also be performed with similar levels of efficiency, 





Scheme B. Stereoselective iterative homologations of boronic esters with α-sulfinyl benzoates. 
The development of one-, two- and three-carbon building blocks for the homologation of 
boronic esters enabling the introduction of diverse functional groups has also been investigated. 
In particular, (2-bromovinyl)trimethylsilane allowed the two-carbon homologation of boronic 
esters under Zweifel olefination conditions, leading to the introduction of a C−C double bond 
(Scheme C). Subsequent borodesilylation returned the boronic ester group, essential for further 
iterative homologations to take place. 
 
Scheme C. Zweifel olefination of boronic esters with (2-bromovinyl)trimethylsilane. 
Finally, alkoxyallenes were successfully employed as three-carbon carbenoid precursors for 
the homologation of boronic esters, leading to the introduction of terminal and internal enones 
(Scheme D). This methodology will be further developed and applied to the total synthesis of 
10-deoxymethinolide. 
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Organoboron compounds have found widespread use in organic synthesis due to the possibility 
of transforming them into a variety of useful functionalities (see § 1.7). Since the seminal work 
of Herbert C. Brown on the hydroboration of alkenes,1-3 an increasing number of protocols 
have been developed for converting organoboranes into different functional groups. The main 
drawback of using boranes, which contain a boron centre linked to three carbon substituents 
(Figure 1.1), is that they are normally air and moisture sensitive, and are therefore difficult to 
manipulate. In contrast, boronic esters, where the boron centre is connected to one carbon 
substituent and two oxygen substituents, are known to possess increased stability. This is due 
to the π-donation of electron density from the oxygen lone pairs into the empty p-orbital on 
boron, making the boron atom less electrophilic and therefore less prone to undergo 
decomposition.  
 
Figure 1.1. Comparison between boranes and boronic esters. 
A variety of different methodologies have been developed to synthesise enantioenriched 
secondary and tertiary boronic esters, thus demonstrating the importance of these classes of 
compounds in modern organic synthesis.4 
The following chapter will describe the methods available to homologate organoboron 
compounds through the generation of a new C−C bond. Alternative stereospecific 
transformations of the generated secondary and tertiary enantioenriched boronic esters will also 
be briefly discussed. 
1.1. Homologation of Organoboron Compounds 
The homologation of organoboron compounds is a useful method to convert the carbon−boron 
bond into a variety of different bonds, usually with high levels of stereocontrol. These 
transformations normally take place through an initial nucleophilic attack to the empty p-orbital 
on the sp2 hybridised boron atom, resulting in the formation of a boronate complex bearing a 
formal negative charge on the boron atom.5 One of the substituents on the boron atom can then 
2 
undergo a 1,2-rearrangement to an adjacent electrophilic atom bearing a suitable leaving group 
to generate a new organoboron species (Scheme 1.1).5 
 
Scheme 1.1. Boronate complex formation and 1,2-metallate rearrangement upon reaction of boron species and 
organometals. 
In order for this process to take place, a rotation about the C–B bond must occur to align the 
migrating group on boron antiperiplanar to the leaving group on the acceptor atom, allowing 
the σ orbital of the C−B bond of the migrating group to overlap with the σ* orbital of the 
C−leaving group bond. The migration proceeds through a concertated mechanism, thus 
explaining the inversion of configuration at the migrating terminus (Scheme 1.2).6 
 
Scheme 1.2. Orbital overlap in 1,2-metallate rearrangement of boronate complexes. 
In particular, when a carbon nucleophile bearing a leaving group is employed in the sequence, 
a new C−C bond is formed. The species usually employed for this purpose are metal 
carbenoids, which, similarly to carbenes, possess the necessary nucleophilic component 
(carbon atom) as well as the required electrophilic part (leaving group). 
High levels of stereoselectivity can be imparted to the process by either substrate control or 
reagent control.7 In the first approach, pioneered by Matteson in 1980,8 a prochiral carbenoid 
is reacted with a chiral organoboron to generate a new diastereomeric organoboron after 
1,2-metallate rearrangement; the chiral auxiliary on the organoboron eventually controls all the 
subsequent transformations, thus ensuring high levels of diastereoselectivity (Scheme 1.3). 
 
Scheme 1.3. Substrate-controlled approach to the homologation of boronic esters. 
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In a complementary reagent-controlled approach, a chiral carbenoid is reacted with an 
organoboron reagent to generate an initial boronate complex bearing an already stereodefined 
migratory terminus, eventually evolving to the homologated product; the enantioselectivity is 
in this case determined exclusively by the chirality of the carbenoid (Scheme 1.4). 
 
Scheme 1.4. Reagent-controlled approach to the homologation of boronic esters. 
1.2. Matteson Homologation 
Matteson and co-workers developed a method for the homologation of boronic esters 
possessing C2-symmetrical chiral diols based on a key 1,2-metallate rearrangement of an 
intermediate boronate complex.8-11 The general mechanism of the process is outlined in 
Scheme 1.5. (Dichloromethyl)lithium, generated in situ from dichloromethane and 
n-butyllithium at −100 °C, undergoes nucleophilic addition to an enantiopure boronic ester 1 
to form boronate complex 2. Upon warming the reaction to room temperature, the alkyl or aryl 
group (R) on boron migrates to the dihalomethyl carbon, with displacement of a chloride, to 
afford one-carbon homologated boronic ester 3.  
 
Scheme 1.5. General mechanism of the Matteson homologation. 
High levels of stereoselection are observed during the 1,2-metallate rearrangement due to the 
presence of the chiral ligand on boron, and it was found that Lewis acidic ZnCl2 was essential 
to ensure high diastereoselectivity.12 Corey and co-workers proposed that the coordination of 
the metal cation to both the departing chloride and one of the oxygens of the boronic ester 
moiety leads to the stabilisation of only one of the four possible transition states (Scheme 1.6).13 
Using ab initio calculations, Midland and co-workers proposed a rational explanation for the 
observed stereoselectivity, showing that the lowest energy transition state (4a≠) is the one in 
which the metal is complexed to the less sterically hindered oxygen atom and with the 
nonparticipating chlorine atom placed anti to the metal.14 From this favoured transition state, 
1,2-metallate rearrangement affords exclusively boronic ester 3. 
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Scheme 1.6. Possible transition state structures in the Matteson homologation. 
The generated α-chloro boronic ester 3 can be further reacted with a Grignard reagent at low 
temperature to form a second boronate complex 5; this undergoes a similar 1,2-metallate 
rearrangement to yield boronic ester 6. Stereospecific oxidation using H2O2/NaOH finally 
affords enantiopure secondary alcohol 7 (Scheme 1.7).10 
 
Scheme 1.7. Homologation and oxidation of α-halo boronic esters.  
The potential of this homologation was demonstrated by Matteson and co-workers by its 
application to the stereoselective synthesis of various natural products, such as insect 
pheromones stegobinone 8,12, 15 japonilure 916 and serricornin 1017 (Figure 1.2). 
 
Figure 1.2. Examples of natural products synthesised through Matteson homologation. 
Despite its power, the Matteson homologation still suffers from some disadvantages. In some 
cases, diastereomeric boronic esters show different behaviour when reacted with an 
organometallic reagent. For instance, when boronic ester 3 was reacted with a Grignard 
reagent, the expected homologated boronic ester was generated via intermediate boronate 
CHAPTER ONE 
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complex 5 (Scheme 1.8). On the contrary, when diastereomeric boronic ester epi-3 was reacted 
under the same reaction conditions only borinic ester 11 was isolated.18 Boronate complex 
epi-5 was presumably formed in the process, but in this case the less sterically hindered 
conformation is the one keeping R1 anti to R2, whilst one of the oxygen atoms of the boronic 
ester is placed anti to the chlorine leaving group. The species is therefore prone to undergo 
O-migration rather than C-migration to give the expanded ring 11. 
 
Scheme 1.8. Matteson homologation on diastereomeric boronic esters. 
A second limitation of the methodology is that in some cases it is necessary to invert the 
stereochemistry of the diol in order to synthesise opposite stereoisomers. In practice, a 
three-step sequence must be performed, with the cleavage of the diol after the first 
homologation reaction to access the free boronic acid. This can be subsequently recondensed 
with the appropriate diol to generate the boronic ester of opposite stereochemistry, which can 
then be involved in the second homologation. 
Finally, although Matteson homologations have been successfully applied to the synthesis of 
enantiomerically enriched secondary alcohols, much less success has been obtained in the 
synthesis of enantioenriched tertiary alcohols, as lower and less predictable levels of 
diastereoselectivity were observed.19 
1.3. Homologation of Boranes by Chiral Sulfur Ylides 
Aggarwal and co-workers showed the possibility of employing chiral sulfur ylides in the 
stereospecific reagent-controlled homologation of organoboranes.20 Sulfur ylide 13 
(Scheme 1.9), generated in situ by deprotonation of the corresponding sulfonium salt 12 with 
LiHMDS, undergoes nucleophilic addition to organoborane 14 to generate boronate 
complex 15. After 1,2-metallate rearrangement, in which the sulfide acts as the leaving group, 
the homologated product 16 was isolated and subsequently converted into the corresponding 
alcohol 17 or amine 18. 
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Scheme 1.9. Homologation of boranes using sulfonium salt 12. 
The process can be rendered asymmetric by using chiral sulfonium salt 19 in the sequence to 
give the corresponding alcohols and amines in good yield and excellent enantioselectivities 
(Table 1.1).20 
Table 1.1. Homologation of boranes using chiral sulfonium salt 19. 
 
Entry R R1 X % Yield % ee 
1 n-Bu H OH 70 95 
2 n-Bu H NH2 72 97 
3 Et H OH 73 96 
4 Et H NH2 68 97 
5 Ph Me OH 87 95 
6 Ph Cl NH2 68 96 
 
The high enantioselectivity observed is determined by the favoured sulfur ylide 
conformation 20b, in which the α-aromatic substituent is oriented away from the adjacent 
bridging methylene hydrogens, thus making the Si-face less accessible; nucleophilic attack 




Scheme 1.10. Enantioselective control for the homologation of boranes with sulfonium salt 19. 
An important limitation of the methodology is that it only works efficiently with aryl 
substituted sulfur ylides, whilst low enantioselectivity was observed with non-stabilised alkyl- 
and silyl-substituted ylides.22 Furthermore, only organoboranes can be employed in the process 
as sulfur ylides do not react with less electrophilic boronic esters due to the increasing barrier 
to migration of the corresponding “ate” complexes.6, 21 
1.4. Homologation of Boronic Esters by Chiral Carbenoids Generated by 
Sulfoxide−Metal Exchange 
1.4.1. The Sulfoxide−Metal Exchange Reaction in the Synthesis of Chiral Metal 
Carbenoids 
The sulfoxide−metal exchange reaction occurs when a sulfoxide 23 is reacted with an 
organometallic reagent, either an organolithium or organomagnesium, to generate a new 
sulfoxide 24. In this process, the nucleophilic group on the organometallic reagent replaces one 
of the ligands on the sulfoxide; a new organometallic species 25 is also generated from the 
ligand which has departed from the original sulfoxide (Scheme 1.11).23 The ligand displaced 
from the initial sulfoxide departs as an anion and is therefore the group with the lower pKa.
24 
The reaction has been shown to proceed with inversion of configuration at the sulfur centre.25 
 
Scheme 1.11. Sulfoxide−metal exchange reaction. 
The most plausible mechanism involves either a pentacoordinate SN2-like transition state 26, 
or a pentacoordinate intermediate 27 (Scheme 1.12). In the latter case it must be assumed that 
Berry pseudorotation does not occur to justify the observed transfer of chiral information.24, 26 
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Scheme 1.12. Possible transition state/intermediate for the sulfoxide−metal exchange reaction. 
An alternative pathway, which is known to operate in a few limited cases with loss of the chiral 
information,26 involves the formation of an achiral sulfine intermediate (Scheme 1.13). 
 
Scheme 1.13. Postulated sulfine intermediate pathway for the sulfoxide−metal exchange reaction. 
Hoffmann and co-workers have shown that α-chlorosulfoxides can be used as precursors to 
chiral carbenoids, which can be further reacted in stereoselective processes (Scheme 1.14).27-
28 Sulfoxide 28 was treated with EtMgBr in a sulfoxide−magnesium exchange reaction to 
generate Grignard reagent Mg-29 together with the sulfoxide by-product 30. The Grignard 
reagent Mg-29 was subsequently trapped with benzaldehyde to afford chlorohydrin 31, which 
was eventually converted into epoxide 32 in order to determine the ee (93%). This value gives 
an indication of the ee of the intermediate carbenoid, thus suggesting its configurational 
stability at low temperature. Similarly, the generated chiral carbenoid was trapped with 
α-aminomethylbenzotriazole 33 to give the corresponding product 34 in moderate yield and 





Scheme 1.14. Synthesis of epoxide 32 and tertiary amine 34 using chiral carbenoid Mg-29. 
The authors further investigated the limits of the configurational stability of α-chloroalkyl 
Grignard reagent Mg-29, which was generated by treatment of sulfoxide 28 with various 
Grignard reagents; after trapping with benzaldehyde and subsequent ring-closure, epoxide 32 
was isolated.28 The results of the study are summarised in Table 1.2. 
Table 1.2. Results for configurational stability of Mg-24 using various Grignard reagents. 
 
Entry Grignard Temperature (°C) Time (min) % Yield 32 % ee 32 
1 EtMgBr −50 15 70 64 
2 EtMgCl −50 15 69 89 
3 i-Pr2Mg −50 15 83 92 
4 EtMgBr −40 15 58 17 
5 i-Pr2Mg −50 60 56 93 
6 i-Pr2Mg −20 15 48 91 
7 
i-Pr2Mg + 1 equiv 
MgBr2 
−50 15 84 88 
8 
i-Pr2Mg + 1 equiv 
MgI2 




It was found that racemisation already occurred at −50 °C and that the extent of racemisation 
was highly dependent on the nature of the Grignard reagent employed; racemisation was higher 
with EtMgBr and minimal with i-Pr2Mg (Table 1.2, entries 1 and 3, respectively). Racemisation 
with EtMgBr was found to be almost complete at −40 °C after only 15 minutes (Table 1.2, 
entry 4), while the carbenoid generated with i-Pr2Mg proved to be configurationally stable at 
temperatures ranging up to −20 °C (Table 1.2, entry 6), upon which temperature decomposition 
occurred. However, the presence of salts, such as MgBr2 and MgI2, was found to be detrimental 
and led to rapid racemisation (Table 1.2, entries 7 and 8). The most likely mechanism for the 
observed racemisation is a nucleophilic substitution at the α-chloroalkyl Grignard reagent 
Mg-29 by external halide ions present in the reaction mixture (Scheme 1.15).28 
 
Scheme 1.15. Proposed mechanism for the racemisation of Mg-29 via halide exchange . 
1.4.2. Homologation of Boronic Esters by α-Chloroalkylmetal Chiral Carbenoids 
Blakemore and co-workers demonstrated that Hoffmann-type chiral magnesium 
carbenoids Mg-29, generated by sulfoxide−magnesium exchange, could be employed in the 
“Stereospecific Reagent-Controlled Homologation (StReCH)” of boronic esters to give, after 
in situ oxidation, secondary alcohols 37 (Scheme 1.16).29-30 Despite the viability of the 
methodology, the homologated alcohols were isolated in moderate yield and with modest 
stereochemical fidelity. It was subsequently found that the corresponding lithium carbenoids 
Li-29, generated by sulfoxide−lithium exchange, were able to homologate different boronic 
esters to afford the products in better yield and higher stereospecificity.29-30 
 
Scheme 1.16. Asymmetric homologation of boronic esters using α-halogen sulfoxides.  
α-Chloroalkyllithium Li-39 was generated by treatment of the corresponding 
α-chlorosulfoxide 38 using an organolithium, with the best results obtained using either n-BuLi 
in THF or t-BuLi in toluene (Scheme 1.17).30 Due to the enhanced chemical and 
configurational lability of α-haloalkyllithiums compared to the corresponding 
α-haloalkylmagnesiums, in situ conditions (i.e. generation of the carbenoid in the presence of 
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the boronic ester) must be adopted. Reaction of carbenoid Li-39 with a pinacol or 
neopentylglycol boronic ester led to the formation of “ate” complex 40, which, upon warming 
to a higher temperature, underwent 1,2-metallate rearrangement to give homologated boronic 
ester 41. This could then be converted into the corresponding alcohol 42 by stereospecific 
oxidation with H2O2/NaOH. Moderate substrate scope was observed for the process in terms 
of boronic esters employed, while the scope of the chiral metal carbenoids was found to be 
limited to primary aliphatic sulfoxides, with secondary sulfoxides being unable to afford the 
homologated products.30 
 
Scheme 1.17. Mechanism for the asymmetric homologation of boronic esters using chiral α-halogen lithium 
carbenoids and selected products of the reaction. 
Blakemore and co-workers further extended this methodology to the iterative stereospecific 
homologation of boronic esters using enantioenriched metal carbenoids (Scheme 1.18).30 
Boronic ester 43 was reacted with α-chloroalkyl carbenoid Li-44, generated via 
sulfoxide−lithium exchange from the corresponding sulfoxide 35, to give a one-carbon 
homologated boronic ester; this was subsequently reacted with chloromethyllithium (generated 
in situ by treatment of chloroiodomethane with n-BuLi) in a Matteson chain extension reaction. 
One final homologation of the resulting boronic ester with lithium carbenoid Li-44, followed 
by oxidation, afforded alcohol 45. Judicious selection of the enantiomer of the sulfoxide 
employed in the first and last homologation cycles eventually allowed the synthesis of all four 
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stereoisomers of alcohol 45. In all the cases the homologated alcohols were isolated in very 
high enantiopurity, although with only moderate diastereoselectivity.  
 
 
Scheme 1.18. Stereospecific iterative homologation of boronic ester 43 using lithium carbenoid Li-44. 
Blakemore and co-workers also studied the possibility of applying their iterative stereospecific 
reagent-controlled homologation of boronic esters to the synthesis of (−)-Epibatidine 46, an 
analgesic alkaloid that acts as an activator of nicotinic acetylcholine receptors (nAChRs).31-33 
The target was envisioned to come from acyclic precursor 48, which could be synthesised 
through two consecutive StReCh iterations of boronic ester 50 with chiral lithium carbenoid 





Scheme 1.19. Proposed retrosynthetic analysis of (−)-Epibatidine 46. 
To address the synthesis of dioxolane-substituted chloroalkyllithium Li-49 via sulfoxide−metal 
exchange, the appropriate α-chlorosulfoxide precursor 54 was prepared from the corresponding 
sulfide 5134 through a Jackson−Ellman−Bolm catalytic enantioselective sulfoxidation36-38. This 
afforded sulfoxide 53 in excellent enantioselectivity (Scheme 1.20). Subsequent Yamakawa 
chlorination39 gave α-chlorosulfoxide syn-H-54, which was isolated in very high enantiopurity 
(>99% ee) after recrystallisation. Anti-H-54 and anti-D-54 were also prepared by epimerisation 
of syn-H-54 followed by trapping with MeOH or CD3OD.
34 
 
Scheme 1.20. Synthesis of α-chloro sulfoxides anti-H and anti-D-54 through Jackson−Ellman−Bolm oxidation 
followed by Yamakawa chlorination. 
α-Chlorosulfoxide syn-H-54 was then treated with PhLi at −78 °C for 10 minutes, followed by 
quenching with CD3OD. However, no expected deuterated α-chlorosulfoxide HD-56 was 
detected (Scheme 1.21). What they observed instead was the formation of deuterated 
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α-chlorosulfoxides syn and anti-D-54, along with non-deuterated alkyl chloride HH-56 and the 
expected by-product 55.34-35 
 
Scheme 1.21. Sulfoxide−lithium exchange – deuteration studies on α-chlorosulfoxide syn-H-54. 
This result indicated that the putative lithium−sulfoxide exchange took place to generate 
lithium carbenoid Li-49, but this was immediately quenched by an internal proton source, 
presumably the acidic α-proton on the sulfoxide precursor syn-H-54. This led to the generation 
of the observed alkyl chloride HH-56 together with α-lithiated sulfoxide Li-54, which was 
eventually deuterated upon quenching with CD3OD to give D-54
 (Scheme 1.22).34-35 
 
Scheme 1.22. Proposed mechanism for the formation of D-54 and HH-56. 
The undesired deprotonation of α-chlorosulfoxide syn-H-54 under reaction conditions was 
minimised by exploiting a primary kinetic isotope effect. Deuterated α-chlorosulfoxide 
anti-D-54 was in fact revealed to be a superior carbenoid precursor than its nonlabeled 
analogue when involved in a sulfoxide−lithium exchange/deuteration sequence, due to the 
increased bond strength of the C−D bond over the C−H bond, although some deprotonation 
was still observed (Scheme 1.23).34-35 
 
Scheme 1.23. Sulfoxide−lithium exchange – deuteration studies on deuterated α-chloro sulfoxide anti-D-54. 
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Anti-D-54 was then employed in the iterative homologation of boronic ester 50 
(Scheme 1.24).35 A first cycle of StReCh gave one-carbon homologated boronic ester (R)-D-57 
in moderate yield (53%), but perfect stereofidelity (99%). The subsequent StReCh of boronate 
(R)-D-56 with either enantiomer of chlorosulfoxide anti-D-54 finally gave, after oxidation, the 
two diastereoisomers of alcohol DD-58. In both cases, the diastereoselectivity of the process 
was found to be moderate (d.r. = 90:10), but the major diastereoisomer was isolated in high 
enantiopurity (98% ee). The sequence could also be performed in one-pot, avoiding the 
isolation and purification of intermediate boronic ester (R)-D-57.35 
 
Scheme 1.24. One-pot, double StReCH cycle from boronic ester 50. 
1.5. Homologation of Boronic Esters by Lithiated Carbenoids 
1.5.1. Hoppe Lithiated Carbamates 
The first asymmetric deprotonation of primary O-alkyl carbamates 61 was reported by Hoppe 
and co-workers in 1990.40 The required carbamate substrates, easily accessible by reacting the 
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corresponding alcohols 59 with carbamoyl chloride41 under the addition of pyridine42 or other 
bases43-44, can be deprotonated using lithium bases, such as n- or sec-buthyllithium (n-BuLi, 
s-BuLi), in the presence of a stoichiometric amount of diamine. Trapping of the generated 
lithiated intermediate Li-61 with an electrophile gives the corresponding substitued 
carbamates 62 in good yield (Scheme 1.25). The carbamate group can be eventually removed 
to give access to the corresponding secondary alcohols 63. 
 
Scheme 1.25. Deprotonation of Hoppe's carbamates and subsequent trapping with electrophiles. 
In this process, the presence of the electron-withdrawing carbamate group is fundamental to 
enable the deprotonation step, as it allows the formation of a pre-lithiation complex by bringing 
the reactive groups into proximity (complex-induced proximity effect – CIPE).45-46 
Additionally, coordination of the carbonyl group to the lithium atom allows the stabilisation of 
the lithiated intermediate. 
Hoppe and co-workers employed primarily three types of carbamate groups (Figure 1.3): 
diisopropyl carbamate (Cb), which can be removed only by reduction with LiAlH4 or 
DIBAL-H in excess, and oxazolidine carbamates (Cby, Cbx), which can be more readily 




Figure 1.3. Carbamate groups employed by Hoppe and co-workers. 
The presence of the diamine is essential in the process as it helps the stabilisation of the lithiated 
carbamate intermediate through the chelation of the nitrogen atoms with lithium. When 
N,N,N’,N’-tetramethylethylenediamine (TMEDA, 64, Figure 1.4) is employed the racemic 
product is obtained. However, a stereoselective deprotonation can be performed using chiral 
diamine (−)-sparteine (65, Figure 1.4), a natural occurring alkaloid; in this case, the generated 
intermediate organolithium is configurationally stable at −78 °C and can be trapped by an 
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electrophile with retention of configuration to afford the corresponding products with very high 
levels of enantioselectivity.40 
 
Figure 1.4. Diamines employed for the deprotonation of carbamates. 
Deprotonation of primary alkyl carbamates 66 is normally conducted in Et2O and is complete 
within 5 hours (Table 1.3). It has been shown that a range of different electrophiles can be used 
to trap the generated lithium carbenoid Li-66 and the corresponding products 67 are isolated in 
good yield and, in the case of asymmetric deprotonation, high enantioselectivities. 
Table 1.3. Examples of deprotonation of alkyl carbamates followed by trapping with electrophiles. 
 
R E−X Diamine % Yield % ee 
Me Me3SiCl TMEDA 70 
_ 
Me CO2 (−)-sparteine 75 >95 
Me Me3SnCl (−)-sparteine 73 >95 
Hex MeI (−)-sparteine 81 96 
 
Würthwein and Hoppe reported their study on the enantioselective deprotonation of O-alkyl 
carbamates in the presence of (−)-sparteine using quantum chemical DFT calculations. They 
outlined the preferred abstraction of the pro-S proton of the carbamate instead of the pro-R 
proton.48 In the case of ethyl carbamate, calculations showed that the structure of the transition 
state in which the pro-S proton is involved in the hydrogen transfer is lower in energy than the 
three other possible transition states by 2.75 kcal/mol.48 This data is in good agreement with 
the experimentally observed enantioselectivity of 99:1 in favour of the pro-S lithium compound 
after trapping with a suitable electrophile (a process that is known to occur with complete 
retention of configuration). At this stage of the reaction, considering the strong Li-methylene 
interaction, it is assumed that the lithiated carbamate is configurationally stable at −78 °C, so 
no equilibration due to epimerisation occurs. The reaction is therefore under kinetic control 
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and this explains why the lithium compound obtained is not the thermodynamically favoured 
product.48 
Despite (−)-sparteine being commercially available, it has recently become very difficult to 
access. Its enantiomer, (+)-sparteine 68, is also natural occurring and can be sourced 
commercially, although in the past it was difficult to access from natural sources. For this 
reason, O’Brien and co-workers have developed a series of (+)-sparteine surrogates 
(Figure 1.5) that can be readily prepared in three steps from (−)-cytisine, itself extracted from 
Laburnum anagyoides seeds.49  
 
Figure 1.5. The (+)-sparteine surrogates. 
N-Methyl diamine 69 and N-CD3-substituted diamine 74 were in particular found to be the 
optimum (+)-sparteine surrogates, giving the highest yields and enantioselectivites (up to 
95:5 e.r.) in the conversion of O-alkyl carbamate 76 into α-stannylated carbamate 77 
(Table 1.4). 
Table 1.4. Lithiation–trapping of O-alkyl carbamate 76 with different diamines. 
 
Diamine % Yield e.r. (R:S) 
(−)-sparteine 73 1:99 
69 84 95:5 
74 82 96:4 
75 68 96:4 
70 64 95:5 
71 72  91:9 
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Another important class of lithiated carbamates studied by Hoppe and co-workers are O-benzyl 
carbamates, first reported in 1990.50 The main difference from the previously described O-alkyl 
carbamates is that the generated carbanion is now stabilised by the presence of the aromatic 
ring, thus increasing the tendency to form solvent-separated ion pairs. In the case of primary 
benzylic carbamates, this process facilitates the migration of the lithium cation from one face 
of the carbanion to the other, eventually causing racemisation (Scheme 1.26). 
 
Scheme 1.26. Proposed mechanism for racemisation of benzylic lithiated derivatives. 
The situation is different in the case of secondary benzyl carbamates as the presence of the 
alkyl group destabilises the generated carbanion, thus preventing the migration of the lithium 
cation from one enantiotopic face of the carbanion to the other. The result is that the 
intermediate is configurationally stable at −78 °C. Chiral secondary benzyl carbamates can 
therefore be used to produce new quaternary centres with high enantioselectivity, as shown in 
the example in Scheme 1.27.51 
 
Scheme 1.27. Deprotonation of an enantiomerically enriched secondary carbamate. 
Reaction of lithiated secondary benzyl carbamates with several different electrophiles proceeds 
with either complete retention or complete inversion of stereochemistry (Table 1.5). 
.  
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Table 1.5. Electrophiles reacting with lithiated carbamates with inversion or retention of configuration. 
 
E−X Course % Yield % ee 
Me3SiCl inversion 94 96 
Me3SnCl inversion 92 >95 
MeOC(O)Cl inversion 90 85 
MeC(O)CN inversion 43 92 
MeOC(O)OMe retention 85 94 
HC(O)OMe retention 60 >95 
PhC(O)OMe retention 95 >95 
 
A possible explanation relies on the nature of the lithiated intermediate Li-78, in which the 
carbanion centre possesses more s character (between sp2 and sp3) than in non-benzylic 
carbamates due to the overlap of orbitals from the aryl ring. The carbon atom is thus flattened, 
but not completely planar, and this causes a build-up of electron density at the bottom face. 
The electrophile can approach the carbanion antarafacially, avoiding the steric hindrance by 
the complexed cation, or suprafacially, when a favourable interaction with the lithium cation 
can be established (Scheme 1.28). Electrophiles with an energetically low LUMO, but without 
any good complexing groups for the lithium cation (such as acid chlorides, cyanides or stannyl 
chlorides) would undergo an antarafacial attack. However, electrophiles with a higher energy 
LUMO and possessing an electron-donating group able to pre-complex lithium (such as esters, 




Scheme 1.28. Proposed mechanism for retention or inversion reactivity. Y = heteroatom with substituents. 
As aforementioned, lithiated primary benzyl carbamates are instead configurationally labile 
and quickly racemise even at low temperatures, so that the chiral information of the 
enantioenriched carbenoid is significantly reduced or completely lost during the deprotonation 
process. 
To overcome this problem, Hoppe and co-workers have developed a methodology to synthesise 
highly enantioenriched α-substituted benzyl alcohols 80 by generating epimeric complexes of 
lithiated secondary benzyl carbamates using chiral diamine ligands.52 Optimal results were 
obtained using chiral bis(oxazoline) ligand 81 as the diamine (Table 1.6). s-BuLi was used to 
deprotonate the carbamate in the presence of the chiral ligand and the experiments showed that, 
contrary to what happens when (−)-sparteine is used, enantiotopic differentiation by the chiral 
bis(oxazoline) in the deprotonation step is poor and both the intermediate diastereoisomers are 
initially generated. With prolonged reaction times, the epimeric complex-ion pairs equilibrate 
to generate one diastereoisomer almost exclusively. This is because a dynamic thermodynamic 
resolution takes place after the deprotonation step, eventually allowing high enantioselectivity. 
The preferentially formed diastereoisomer can then be trapped with different electrophiles to 
yield highly enantioenriched substituted benzylic carbamates.52 
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Table 1.6. Use of bis(oxazoline) ligand 81 for the lithiation of primary benzylic carbamates. 
 
E−X % Yield  % ee Product configuration 
Bu3SnCl 88 98 S 
Me3SiCl 98 98 S 
MeI 98 96 S 
CO2 99 95 R 
 
1.5.2. Lithiation−Borylation with Primary Carbamates 
Hoppe and co-workers developed a new method for the synthesis of enantioenriched secondary 
alcohols employing alkyl carbamates.53 They showed that chiral lithiated carbamate Li-76 
could undergo stereoretentive electrophilic trapping with B(Oi-Pr)3; subsequent in situ 
transesterification gave the corresponding α-carbamoyloxy-alkylboronate 82. Treatment of 82 
with a Grignard reagent at −78 °C afforded intermediate boronate complex 83, which, upon 
warming to room temperature, underwent a stereospecific 1,2-metallate rearrangement, with 
the R’ substituent migrating with inversion of configuration at the chiral centre. Stereoretentive 
in situ oxidation of the resulting secondary alkyl boronate 84 gave the corresponding secondary 




Scheme 1.29. 1,2-Metallate rearrangement from secondary boronic ester developed by Hoppe. 
Aggarwal and co-workers developed this methodology further and found that Hoppe-type 
lithiated carbamates can be directly reacted with boranes or boronic esters to form “ate” 
complex intermediates 87. After stereospecific 1,2-metallate rearrangement and in situ 
oxidation, secondary alcohols 89 were isolated in good yield and high enantioselectivity 
(Table 1.7).54 As aforementioned, the carbamate group is essential to enable the deprotonation 
process; additionally, it acts as a leaving group, allowing the 1,2-metallate rearrangement. 
Table 1.7. Lithiation−borylation reaction with Hoppe-type carbamates. 
 
R1 R2 (R3)2 % Yield e.r. 
Ph(CH2)2 Et Et 91 98:2 
Ph(CH2)2 n-Hex 9-BBN 90 98:2 
Ph(CH2)2 Ph 9-BBN 94 97:3 
Me2C=CH(CH2)2 Ph pinacol 73 98:2 
TBSO(CH2)2C(Me)2CH2 Ph pinacol 64 98:2 
i-Pr Ph pinacol 70 98:2 
Me Ph pinacol 70  97:3 
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The scope of this methodology proved to be very broad and a wide variety of primary alkyl 
carbamates, as well as aryl and alkyl substituted boranes and boronic esters, could be employed 
in the process (Table 1.7). The main difference between these two boron species is that the 
1,2-metallate rearrangement is much slower with boronic esters than with boranes, and 
sometimes it requires the use of Lewis acidic MgBr2 in Et2O at reflux; on the contrary, the 
rearrangement of the “ate” complexes derived from boranes begins at −40 °C without using 
any additive. 
Aggarwal and co-workers showed that the lithiation−borylation methodology can also be 
performed in an iterative fashion by reacting the boronic ester obtained after the first 
homologation with a second lithiated carbamate (Scheme 1.30).54 Carbamate 76 was therefore 
lithiated with s-BuLi in the presence of (−)-sparteine and the corresponding lithiated 
intermediate (R)-Li-76 was trapped with ethyl pinacol boronic ester to afford the desired 
boronic ester intermediate (S)-90. The subsequent reaction of boronic ester (S)-90 with lithiated 
carbamate (S)-Li-91 gave, after in situ oxidation, alcohol (S,R)-92 as a 96:4 mixture of 
diastereoisomers with >98:2 e.r. When O’Brien’s sparteine surrogate (+)-69 was used to 
generate lithiated carbenoid (R)-Li-76, epimeric alcohol (S,S)-92 was obtained in equally high 
d.r. and e.r.54 The process could also be repeated using lithiated carbamate (S)-Li-76 to form 
intermediate boronic ester (R)-90; further homologation using both (R)-Li-91 and (S)-Li-91 
gave the epimeric alcohols (R,S)-92 and (R,R)-92 in high d.r. and e.r. These high values of 
enantio- and diastereoselectivity clearly show that the stereochemical outcome of the second 
homologation reaction is not influenced by the stereochemistry of the boronic ester employed 




Scheme 1.30. Iterative homologation reaction of boronic esters (S)-90 and (R)-90. 
In 2009, Aggarwal and co-workers demonstrated the application of this iterative homologation 
methodology to the total synthesis of the insect pheromone (+)-Faranal (Scheme 1.31).55 Vinyl 
iodide 93 was synthesised in four steps from propyne and subsequently subjected to a 
lithium−iodide exchange reaction triggered by t-BuLi. Trapping of the generated organolithium 
with chloromethyl boronate 94 gave allylic boronic ester 95 in 53% yield. Two iterative 
lithiation−borylation reactions using lithiated ethyl carbamate Li-(S)-91 afforded boronic 
ester 97, which was subsequently subjected, without isolation, to a sequence of Zweifel 
olefination, hydroboration and oxidation to give alcohol 99 in 69% yield and 96:4 d.r. The 
whole iterative sequence could also be performed without purification of any of the 
intermediates, with the final alcohol 99 being isolated in 40% yield and d.r. of 94:6. Final 
oxidation using PDC proceeded in 76% yield to afford (+)-Faranal.55 
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Scheme 1.31. Total Synthesis of (+)-Faranal. 
1.5.3. Lithiation−Borylation with Secondary Carbamates 
Aggarwal and co-workers further extended the lithiation−borylation methodology to the 
synthesis of enantiomerically enriched tertiary alcohols.56 While the extensive work over the 
last half century has made the enantioselective synthesis of secondary alcohols relatively 
easy,57-58 the asymmetric synthesis of compounds containing quaternary stereogenic centres, 
such as tertiary alcohols59-61 is still challenging. Tertiary alcohols are generally synthesised by 
addition of an organometallic reagent to a ketone (Scheme 1.32). It is possible to make this 
process enantioselective by using chiral ligands.62-64 However, the asymmetric induction is 
generally quite low as the process relies upon the steric difference between the substituents 
either side of the carbonyl group. 
 
Scheme 1.32. Formation of tertiary alcohols via addition of organometallic reagents to ketones. 
Work within the Aggarwal group has developed an innovative methodology for the synthesis 
of quaternary stereocentres by extending the use of the 1,2-metallate rearrangement of boronate 
complexes to secondary benzylic carbamates.56 The stereospecific reaction of a chiral lithium 
CHAPTER ONE 
27 
carbenoid, bearing both an aryl and an alkyl substituent, with a boron species gives a chiral 
“ate” complex. Subsequent stereospecific 1,2-metallate rearrangement, followed by oxidative 
work up, affords the desired tertiary alcohol. As chirality is transferred through the 
lithiation−borylation reaction, the final compound can be obtained with high levels of 
enantiospecificity. Both boranes and a broad range of boronic esters could be employed in this 
reaction. It is noteworthy that the process occurs with almost complete inversion of 
stereochemistry when boranes are employed, while complete retention of stereochemistry is 
observed in the case of boronic esters. This can be rationalised considering the complexation 
of the lithium atom to the metallated carbamate by the oxygen atom on the boronic ester, which 
causes the addition to take place on the same face as the metal. On the other hand, when a 
borane is employed, this kind of complexation cannot take place and the addition occurs on the 
face opposite to the metal, where the electron density is significantly higher, leading to 
inversion of configuration (Scheme 1.33).50-51 The remarkable consequence is that it is possible 
to prepare both the enantiomers of a single tertiary alcohol starting from the same substrate 
simply using a different boron reagent. The enantiomerically enriched secondary alcohols 
necessary to synthesise the starting carbamates can be easily prepared by Noyori transfer 
hydrogenation65 with e.r. values of up to 99:1. 
 
Scheme 1.33. Lithiation–borylation of secondary benzylic carbamates leading to tertiary alcohols. 
The substrate scope has been widely investigated using a broad range of alkyl, cyclopropyl, 
vinyl, allyl, aryl and heterocyclic boronic esters and different types of secondary alcohols 
bearing both electron-rich and electron-deficient aromatics, with excellent results in terms of 
enantiospecificity in all cases (Table 1.8).56 
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Table 1.8. Experimental data of lithiation–borylation of secondary benzylic carbamates. 
 
Ar (e.r. carbamate) R (R')2 % Yield 100 e.r. (S:R) 
Ph (99:1) Et Et2 91 99:1 
Ph (99:1) Et pinacol 95 1:99 
Ph (99:1) vinyl pinacol 75 2:98 
Ph (99:1) p-Cl-C6H4- pinacol 92 99:1 
p-MeO-C6H4- (98:2) Et pinacol 97 2:98 
p-Cl-C6H4- (98:2) Et pinacol 92  4:96 
 
In some examples, with more sterically hindered carbamates bearing electron-withdrawing 
substituents on the aromatic ring, a small erosion of the enantiospecificity was observed. The 
postulated mechanism explaining this loss of stereochemical information is depicted in 
Scheme 1.34.66 The formation of boron “ate” complex 102 is shown to be a reversible process 
at −78 °C, with its dissociation regenerating lithiated carbamate Li-101 and the starting boronic 
ester. When the reaction mixture is warmed to higher temperatures, lithiated carbamate Li-101 
can racemise before recombination with the boronic ester, therefore resulting in the observed 
lowered enantiomeric excess of the homologated product. 
 
Scheme 1.34. Postulated mechanism for the erosion of enantiospecificity in the homologation boronic esters by 
lithiated secondary benzylic carbamates. 
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A solution to this problem was found to be the addition of a more reactive electrophile after 
boronate complex formation. By doing this, any lithiated carbamate Li-101 present in the 
reaction mixture can be quenched before recombination with the starting boronic ester, 
therefore preventing racemisation of tertiary boronic ester 103. After careful screening of 
different electrophiles, MeOH was found to effectively fulfil the requirements and could be 
used in conjunction with MgBr2 (usually added as a solution in MeOH) with the dual purpose 
of accelerating the rate of 1,2-metallate rearrangement and quenching the lithiated carbenoid 
Li-101. These conditions were applied to a broad range of benzylic secondary carbamates and 
varying sterically hindered pinacol boronic esters with the corresponding homologated tertiary 
boronic esters being isolated in high yield and excellent ee of 99% (Table 1.9).66 
Table 1.9. Highly enantiospecific homologation of secondary carbamates with MgBr2MeOH. 
 
Entry R R1 R2  % Yield 103 (% ee) 
1 H Me c-Hex 87 (99) 
2 H Et i-Pr 74 (99) 
3 4-Cl Me Et 91 (99) 
4 4-F Me i-Pr 88 (99) 
5 2-Me Me Ph 64 (99) 
6 2-MeO Me i-Pr 79 (99) 
 
1.5.4. Lithiation−Borylation with Benzoate Esters 
One limitation of the lithiation−borylation of carbamates is that some boronic esters are very 
slow to undergo the 1,2-metallate rearrangement, requiring the addition of Lewis acidic 
additives to avoid the formation of the homologated products in low yield. In order to solve 
this problem, alternative leaving groups have been explored and it was found that the use of 
hindered alkyl 2,4,6-triisopropylbenzoates, instead of carbamates, allowed for a remarkably 
faster 1,2-metallate rearrangement.67 Deprotonation of primary 2,4,6-triisopropylbenzoates 
with s-BuLi in the presence of TMEDA had initially been reported by Beak and co-workers.68-
70 More recently, Hammerschmidt and co-workers showed that the lithiated species generated 
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from the corresponding α-stannyl benzoates (by selective tin−lithium exchange) are 
configurationally stable at −78 °C.71 In 2010, Aggarwal and co-workers reported the first 
enantioselective deprotonation of primary 2,4,6-triisopropylbenzoates, followed by trapping 
with boronic esters, to give, after 1,2-metallate rearrangement, the corresponding homologated 
products. The enhanced leaving group ability of the TIB group with respect to the carbamate 
group allowed for a remarkable improvement in the rate of the migration process and the 
products could be isolated in higher yields.67 The enantioselectivity of this process was similar 
to when using the corresponding carbamates (Table 1.10). 
Table 1.10. Comparison between TIB esters and carbamates in the homologation of boronic esters. 
 
Entry Carbenoid R1 Conditionsa % Yield e.r. 
1 Cb Me B 50 95:5 
2 TIB Me C 76 96:4 
3 Cb c-Pr A 71 98:2 
4 TIB c-Pr C 86 96:4 
5 Cb (CH2)2COOt-Bu B
b 35 93:7 
6 TIB (CH2)2COOt-Bu A 63 96:4 
7 Cb (CH2)2CN B 0 n.d. 
8 TIB (CH2)2CN A 46 97:3 
9 Cb Ph B 88 99:1 
10 TIB Ph C 79 96:4 
a Conditions: A: 16 h, reflux; B: MgBr2Et2O (2.0 equiv), 16 h, reflux; C: 2 h, reflux. b 5 days, reflux. 
Although this methodology could be applied to primary and secondary benzylic carbamates 
and benzoates, simple non-activated secondary dialkyl carbenoids still represent a challenge. 
The α-oxy proton is not sufficiently acidic to be removed by a strong base, as reported by both 
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Hoppe40 and Beak.70 Aggarwal and co-workers recently found conditions to perform the 
deprotonation of these challenging substrates to access, after borylation and 1,2-metallate 
rearrangement, enantioenriched tertiary alkylboronic esters.72 This was achieved by 
performing the lithiation of unactivated chiral benzoates 105 with s-BuLi in the presence of a 
large excess of TMEDA (6.0 equiv) and using CPME as the solvent; the generated chiral 
lithium carbenoid was subsequently reacted with a range of different boronic species 
(Scheme 1.35). Neopentyl glycol boronic esters proved to be superior to the corresponding 
pinacol boronic esters and boranes, giving the corresponding homologated products in good 
yield and complete enantiospecificity. Remarkably, this protocol provides access to a broad 
range of enantiopure tertiary alcohols which would be otherwise difficult to synthesise using 
alternative methods. 
 
Scheme 1.35. Lithiation−borylation with dialkyl-substituted TIB esters. a MeOH (2.0 equiv) was added after “ate” 
complex formation; b TMSCl (6.0 equiv) was added after “ate” complex formation. 
The analogous dialkyl tertiary carbamates could not be deprotonated under these conditions, 
thus demonstrating the superior ability of the benzoate group to promote lithiation. 
1.5.5. Assembly-line Synthesis 
Recent work within the Aggarwal group has further extended the lithiation–borylation 
methodology to allow for the one-pot iterative homologation of boronic esters. This can be 
compared to a molecular assembly line in which successive groups are added to a growing 
chain under reagent control of the relative and absolute stereochemistry (Scheme 1.36).73 
Enantioenriched stannanes (R)-109 and (S)-109 were synthesised by asymmetric deprotonation 
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of ethyl tri-isopropylbenzoate 108 with s-BuLi/(−)-sparteine or sBuLi/(+)-sparteine, followed 
by trapping with Me3SnCl, and their e.r. could be increased to 99.9:0.1 by recrystallisation. 
Stannane (S)-109 was readily converted into the required lithiated benzoate Li-108a by 
retentive tin−lithium exchange, using n-BuLi at −78 °C. The generated lithium carbenoid was 
then trapped with an aryl boronic ester to form the corresponding “ate” complex 110 which, 
upon warming to higher temperature, underwent stereospecific 1,2-metallate rearrangement. 
At this point, the reaction mixture was filtered to remove the insoluble lithium salt of 
2,4,6-triisopropylbenzoate to give crude homologated boronic ester 111, which was directly 
employed in a subsequent homologation. The process was repeated iteratively for a total of 
nine homologations, with an aqueous work-up being performed after every third homologation, 
to yield boronic ester 112 as a single diastereoisomer and a single enantiomer, demonstrating 
the high enantiospecificity of each homologation reaction.73 By judicious selection of the 
enantiomers of stannane 109 employed in the sequence it was possible to prepare three different 
isomers of the final compound, the all-syn 112, the all-anti 113 and the alternating syn-anti 114, 
which were shown to adopt different conformations in solution. 
 
Scheme 1.36. Iterative assembly-line synthesis. 
The described iterative homologation of boronic esters was applied to the synthesis of different 
natural products,55, 74-77 demonstrating its high chemical and manpower efficiency.  
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For this iterative homologation of boronic esters to be possible three key criteria must be 
fulfilled: 
• the generated metal carbenoid must possess a good leaving group, promoting a fast 
1,2-metallate rearrangement and reducing reversibility that would eventually cause 
under-homologation. 
• the generated metal carbenoid must be chemically and configurationally stable at low 
temperature and decompose at a lower temperature than the one required for 
1,2-metallate rearrangement in order to avoid over-homologation. 
• the metal carbenoid must be generated with very high e.r. (generally >99:1) to avoid 
the formation of diastereoisomers when iterative homologations are performed. 
The importance of this last criteria is depicted in Scheme 1.37. If a metal carbenoid with an 
e.r. of 95:5 is used in the homologation of a boronic ester, assuming that the reaction occurs 
with full transfer of stereochemical information, the generated boronic ester will have an e.r. 
of 95:5. A second homologation with the same carbenoid (e.r. = 95:5) will give a major and a 
minor diastereoisomer (d.r. = 91:1) together with the corresponding enantiomers. In particular, 
the major diastereoisomer will show an increased e.r. of 99.7:0.3, as the majority of the 
undesired minor enantiomer of the starting boronic ester is converted to a different 
diastereoisomer. This amplification of enantioenrichement is better known as the Horeau 
principle.78-79 It is clear that a highly enantioenriched carbenoid must be employed in an 
iterative process in order to avoid the formation of unwanted minor diastereoisomers, which 
would eventually lower the yield of the process and reduce the purity of the desired product. 
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Scheme 1.37. Demonstration of the Horeau principle and diastereoisomers formation in the iterative 
homologation of boronic esters. 
1.6. Homologation of Boronic Esters by α-Alkoxymetal Chiral Carbenoids 
Peter O’Brien and co-workers showed that α-alkoxy sulfoxides can also be employed in the 
homologation of boronic esters.80 In particular, α-sulfinyl carbamate anti-115 was selected as 
suitable precursor for the necessary metal carbenoid, and it was efficiently synthesised from 
carbamate 76 by asymmetric deprotonation in the presence of chiral diamine (R,R)-116, 
followed by trapping with commercially available Andersen’s sulfinate 117 (Scheme 1.38). 
 
Scheme 1.38. Synthetic route to enantiomerically enriched α-sulfinyl carbamate anti-115. 
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Anti-115 was subsequently converted into the corresponding α-metallated carbenoid M-76 
through a selective sulfoxide–metal exchange employing either i-PrMgCl at room temperature 
or n-BuLi at −78 °C for only 1 minute. α-Metallated carbenoid M-76 was then immediately 
trapped with i-BuBpin to generate “ate” complex 118, which, after 1,2-metallate rearrangement 
and stereospecific oxidation, afforded one-carbon homologated alcohol 120 (Scheme 1.39). 
The product was isolated in both cases in good yield. However, while a complete transfer of 
stereochemical information was observed in the process initiated by n-BuLi, a small loss of 
enantiopurity was recorded when the Grignard reagent was employed. 
 
Scheme 1.39. Homologation of boronic esters using metal carbamate M-76 generated through sulfoxide–metal 
exchange. 
1.7. Alternative Transformations of Boronic Esters 
The boronic ester moiety can be converted into a variety of different functional groups 
(Scheme 1.40).81-82 Most of these transformations proceed through the initial formation of a 




Scheme 1.40. Overview of the possible stereospecific transformations of enantioenriched tertiary boronic 
esters. 
1.7.1. Carbon−heteroatom bond formation 
The most common and versatile transformation of the C−B bond is its oxidation to give the 
corresponding alcohol in high yield and complete stereospecificity. This conversion is 
normally achieved using basic hydrogen peroxide,56 as originally reported by Brown and 
co-workers for the oxidation of boranes.83 The reaction proceeds through the initial attack of 
the peroxide anion to the empty p-orbital on boron to generate intermediate “ate” complex 121. 
Subsequent 1,2-migration of the carbon substituent on boron onto the adjacent oxygen atom, 
with departure of the hydroxyl group, affords, after hydrolysis, alcohol 123 with complete 
retention of configuration (Scheme 1.41). Alternative oxidising agents that have been 
employed in the same transformation are sodium perborate,84 oxone85 and trimethylamine 
N-oxide.86 
 
Scheme 1.41. Mechanism of the oxidation of boronic esters with basic hydrogen peroxide. 
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Morken and co-workers reported conditions to convert enantioenriched secondary boronic 
esters into the corresponding amines using methoxyamine and n-BuLi.87 The generated N-Boc 
protected amines 125 were isolated in good yield and with very high levels of stereospecificity 
(Scheme 1.42A). Tertiary boronic esters were found to be unreactive under these conditions. 
Aggarwal and co-workers subsequently reported the stereospecific conversion of chiral tertiary 
boronic esters into amines in a two steps procedure via intermediate trifluoroborate salt 127,88 
synthesised in quantitative yield by treatment with KHF2 in MeOH.
89 Reaction with SiCl4 
generates dichloroborane 12890 that, upon treatment with an organic azide,91 is converted into 
tertiary amine 131 with complete retention of stereochemistry (Scheme 1.42B). 
 
Scheme 1.42. Conversion of secondary and tertiary boronic esters into amines. 
Aggarwal and co-workers also reported the stereospecific transformation of the C−B bond of 
tertiary boronic esters into a C−halogen bond (Scheme 1.43A).92 This was achieved through 
the initial formation of nucleophilic boronate complex 133, followed by reaction with halogens 
(I2, Br2, Cl2) to form a new C−halogen bond in a stereospecific fashion. In this case, the 
products are obtained with inversion of configuration at the carbon centre. More recently, the 
range of halogens that can be introduced using this methodology was further expanded and the 
stereospecific fluorination of tertiary boronic esters was developed (Scheme 1.43B).93 In this 
process, boronate complex 133 was reacted with Selectfluor II in acetonitrile to give 
alkylfluoride 135 in good yield. Importantly, the addition of styrene was found to be 
fundamental to ensure the complete enantiospecifity of the process. 
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Scheme 1.43. Stereospecific halogenation of tertiary boronic esters. 
1.7.2. Carbon−hydrogen bond formation 
Protodeboronation of tertiary boronic esters could also be performed stereospecifically to 
generate useful tertiary alkyl stereocentres.94 In particular, diarylalkyl boronic ester could be 
protodeboronated by reaction with CsF and H2O in dioxane at 30 °C to afford compound 137 
in excellent yield and es (Scheme 1.44A). Although aryl dialkyl boronic esters were found to 
be inert under these conditions, treatment with the more reactive TBAF3H2O in n-pentane at 
45 °C afforded protodeboronated products 139 in equally good yield and es (Scheme 1.44B). 
Both the described conditions delivered the corresponding products with complete retention of 
stereochemistry. 
 
Scheme 1.44. Protodeboronation of tertiary boronic esters. 
The proposed mechanism for the TBAF3H2O mediated protodeboronation of tertiary boronic 
esters is shown in Scheme 1.45. Hydrogen bonding between the generated boronate complex 
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and a molecule of H2O favours the delivery of the proton on the same side of the boron atom, 
therefore ensuring high levels of stereoretention. 
 
Scheme 1.45. Proposed mechanism for the TBAF mediated protodeboronation of tertiary boronic esters. 
1.7.3. Carbon−carbon bond formation 
A growing area of interest concerns the possibility of further homologating boronic esters to 
generate a new C−C bond. The Matteson homologation, giving primary alcohols after in situ 
oxidation, and the lithiation−borylation of TIB esters or carbamates fall into this category and 
have already been discussed in § 1.2 and 1.5, respectively. 
Chiral boronic esters can also be converted into the corresponding alkenes in a stereospecific 
fashion. This transformation was originally reported by Zweifel and co-workers in 1967.95 
They found that the addition of iodine to vinyl borane 140 in the presence of NaOH gave 
alkene 143 in 75% yield and as a single Z isomer. The mechanism of this transformation is 
depicted in Scheme 1.46A. After the initial formation of iodonium ion 141, an alkyl group on 
boron undergoes stereospecific 1,2-migration to give iodo-borane 142; a base-mediated 
deboronoiodination eventually affords cis-alkene 143. Evans and co-workers subsequently 
showed that the process can also be performed employing a boronic ester and a vinyllithium to 




Scheme 1.46. Examples of Zweifel olefination on boranes and boronic esters. 
Aggarwal and co-workers further extended the scope of this methodology and reported the 
conversion of enantioenriched tertiary boronic esters into the corresponding terminal alkenes 
using 4 equivalents of vinylmagnesium bromide (Scheme 1.47A).97 The reaction was found to 
proceed via intermediate boronate complex 149, which, upon addition of iodine and 
NaOMe/MeOH, gave alkene 150 in 79% yield and 100% es. It was also discovered that the use 
of ethoxy vinyllithium in the same process allowed the isolation of the corresponding methyl 
ketone 151 (Scheme 1.47B).72, 97 
 
Scheme 1.47. Functionalisation of tertiary boronic esters via Zweifel olefination. 
In the mechanism depicted in Scheme 1.46A, iodo-borane 142 undergoes anti-elimination to 
afford exclusively cis-alkene 143. Aggarwal and co-workers recently found that when boronate 
complex 152 is treated with PhSeCl as the electrophile in the place of I2, β-selenoboronate 153 
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was formed. Chemoselective oxidation using m-CPBA gave selenoxide 154, which allowed a 
syn-elimination to take place to afford trans-alkene 155 as a single isomer (Scheme 1.48).98 
These two protocols show the power of this methodology, offering stereodivergent access to 
both the alkene isomers. 
 
Scheme 1.48. E-Selective Zweifel olefination using PhSeCl. 
An extension of this methodology was subsequently developed in the Aggarwal group, 
providing access to terminal alkynes starting from enantioenriched boronic esters.99 In the case 
of secondary boronic esters, this can be achieved by formation of a boronate complex using 
lithiated vinylbromide (generated in situ by treatment with LDA at −95 °C), followed by 
addition of I2 in MeOH, to give bromo-alkene 157; TBAF-mediated elimination gives the 
desired alkyne in good yield and complete enantiospecificity (Scheme 1.49A). Vinyl 
carbamate 160 was found to be a superior reagent for the alkynylation of enantioenriched 
tertiary boronic esters, with intermediate carbamate 161 undergoing smooth elimination by 
treatment with t-BuLi to afford alkyne 162 in excellent yield and es (Scheme 1.49B). 
 
Scheme 1.49. Stereospecific alkynylation of secondary and tertiary boronic esters. 
Enantioenriched secondary and tertiary boronic esters have also been employed in 
Suzuki−Miyaura reactions. In particular, Crudden and co-workers showed the first 
stereospecific Pd-catalysed cross-coupling reaction of secondary benzylic100-101 and 
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dibenzylic102 boronic esters with aryl iodides to give the corresponding coupled products in 
good yield and high levels of enantiospecificity. Both of these processes occur with retention 
of configuration, although Liao and co-workers subsequently showed that the corresponding 
trifluoroborate salts undergo this reaction with inversion of configuration.103 In 2014, Biscoe 
and co-workers published the first example of enantiospecific Suzuki−Miyaura reaction of an 
unactivated dialkyl trifluoroborate salt with chlorobenzene, yielding the desired product in high 
es.104 
An important development was recently achieved by Aggarwal and co-workers in the 
transition-metal-free coupling reaction of enantioenriched boronic esters with aromatics 
(Scheme 1.50).105-106 In this approach, boronate complex 164, generated by addition of lithiated 
furan to boronic ester 163, is activated by NBS; facile 1,2-metallate rearrangement can 
therefore occur to generate intermediate 165, which, upon addition of a nucleophile, 
rearomatises to yield desired coupled product 166 in a completely enantiospecific fashion. 
Remarkably, the process can also be applied to enantioenriched tertiary boronic esters, which 
are normally very challenging substrates to couple with more traditional transition-metal 
mediated coupling reactions, while furan could be substituted by a range of different 
electron-rich aromatics. The scope of the aromatic partner was subsequently extended to 
include substituted N-heteroaromatics107 and phenols.108 
 
Scheme 1.50. Transition-metal-free coupling reaction of boronic esters with furan. 
More recently, it was found that also aromatics lacking functional groups reactive towards an 
activator can be employed in similar cross-coupling reactions.109 To this purpose, lithiated 
chromium arene 168 was reacted with boronic ester 167 to generate “ate” complex 169 
(Scheme 1.51). Upon addition of iodine, oxidation occurred at the chromium centre, to give 
complex 170; this made the aromatic ring sufficiently electron-withdrawing to undergo smooth 
1,2-metallate rearrangement affording anion 171. Subsequent methanol-mediated elimination 
of the boronic ester moiety gave chromium complex 172, which could be easily converted into 
the desired coupled product by further oxidation. The process was found to applicable to a wide 
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range of different substituted arenes and secondary boronic esters, with the corresponding 
products isolated as single regioisomers in very good yield and complete enantiospecificity. 
 
Scheme 1.51. Proposed mechanism for the enantiospecific coupling of boronic esters with chromium arene 
complexes. 
1.8. Conclusions 
Lithiation−borylation has been shown to be a valuable and powerful method to homologate 
chiral boronic esters. This methodology has been applied to the synthesis of complex molecules 
containing several contiguous tertiary and quaternary stereocentres as well as important natural 
and biologically active products. Many developments have been achieved in the past few years 
designed to improve the reaction and to extend the scope of the process. 
The work described in this thesis aims at further improving the boundaries of this methodology, 
focusing in particular on three main projects: the use of azetidinium ions in 
lithiation−borylation reactions to synthesise 3-aryl-1aminopropane derivatives (see § 2); the 
use of α-sulfinyl benzoates as precursors to the necessary metallated carbenoids to be employed 
in stereospecific iterative homologation of boronic esters (see § 3); the possibility of 
introducing carbonyl, C−C double bonds and enone functionalities through a building-block 
based iterative assembly line synthesis approach (see § 4). 
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2. Synthesis of 3-Aryl-1-Aminopropane Derivatives by 
Lithiation−Borylation−Ring-Opening of Azetidinium Ions 
Parts of the work described in this chapter have been adapted from the following 
communication article: 
Casoni, G., Myers, E. L., Aggarwal, V. K., Synthesis 2016, 48, 3241−3253. 
2.1. Introduction and Project Aims 
The 3-aryl-1-aminopropane motif constitutes the basic core of a number of biologically active 
molecules and drug candidates (Figure 2.1);110 bedaquiline, a potent antituberculosis 
marketed-drug, is probably the most noteworthy and structurally complex molecule belonging 
to this class of compounds.111 
 
Figure 2.1. Marketed drugs containing the 3-aryl-1-aminopropane unit. 
To date, there is a number of methods available to introduce the 3-aryl-1-aminopropane unit. 
Among these, the nucleophilic addition of aryl metal reagents to β-aminoketones giving the 
corresponding 3-arylaminoalcohols has been broadly applied to the synthesis of biologically 
active compounds.112-113 3,3-Diarylpropylamines are instead commonly accessed by 
nucleophilic substitution of the corresponding 3,3-diarylpropylhalides.114-116 However, the 
high number of steps usually required to synthesise the necessary starting halides and the low 
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overall yields, together with the lack of atom economy and the toxic nature of many of the alkyl 
halides employed, has stimulated interest in discovering new methodologies for the synthesis 
of these useful motifs. Botteghi and co-workers showed that the 3,3-diarylpropylamine motif 
could be efficiently introduced through a rhodium-catalysed hydroformylation of readily 
accessible 1,1-diarylalkenes followed by reductive amination (Scheme 2.1A).117 A few years 
later, a one-pot rhodium-catalysed hydroaminomethylation of 1,1-diarylalkenes to give the 
corresponding 3,3-diphenylpropylamines was successfully developed by Eilbracht118 and 
Beller119-120 (Scheme 2.1B). In 2009, Williams and co-workers published a novel route to 
3-aryl-1-aminopropane derivatives based on a key ruthenium-catalysed N-alkylation of amines 
with alcohols (Scheme 2.1C) and this methodology was successfully applied to the synthesis 
of various pharmaceuticals.121 More recently, a new synthetic methodology to access 
3-arylpropylamines was developed by Correia and co-workers using a Heck-Matsuda arylation 
as the key step (Scheme 2.1D).122 
 
Scheme 2.1. Comparison of literature known methods to introduce the 3-aryl-1-aminopropane motif. 
Aiming to discover a new strategy to introduce this privileged motif, we sought to synthesise 
a range of different substituted 3-aryl-1-aminopropanes through C−B functionalisation of the 
corresponding γ-dimethylamino tertiary boronic esters, which we envisioned could be accessed 
through a lithiation−borylation reaction, as depicted in Scheme 2.2.  
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However, initial investigation revealed that benzylic amino carbamates are not suitable 
precursors for this type of transformation. In fact, when secondary amino carbamate 174 was 
subjected to a lithiation borylation reaction with ethyl pinacol boronic ester, followed by in situ 
oxidation, tertiary alcohol 175 could not be obtained (Scheme 2.2A). Interestingly, subjecting 
amino carbamate 174 to the same conditions, but using triethylborane, provided tertiary 
alcohol 175 in 60% yield. (Scheme 2.2B).i This can be rationalised considering the reduced 
electrophilicity of boronic esters compared to boranes: the lithiated carbamate, stabilised by 
intramolecular chelation, is presumably not reactive enough to attack the boronic ester. Another 
possible explanation is that the increased steric hindrance of the boronic ester compared to the 
corresponding borane prevents the formation of boronate complex 176.  
 
Scheme 2.2. Lithiation−borylation of carbamate 174 using EtBpin and Et3B. 
An alternative way to achieve the synthesis of substituted γ-dimethylamino tertiary boronic 
esters 181 through lithiation−borylation would be using azetidinium ions 177 as the starting 
materials (Scheme 2.3). Specifically, deprotonation of azetidinium ion 177 would generate the 
corresponding lithiated carbenoid 178, which, upon reaction with a boronic ester, could lead to 
the formation of zwitterionic boronate complex 180. Subsequent 1,2-metallate rearrangement, 
promoting the ring opening of the azetidinium, would finally afford γ-amino tertiary boronic 
ester 181. Ideally, the process would be stereospecific. For this to be possible, lithiated 
carbenoid 178, generated by deprotonation of enantiomerically enriched azetidinium ion 177, 
must be configurationally stable at low temperature, meaning that it must stay in the 
                                                 
i Initial results on the lithiation−borylation of carbamate 174 were obtained by Dr. B. Partridge. 
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lithium-carbenoid stabilised form 178 rather than the ylidic form 179. Trapping with boronic 
esters and subsequent 1,2-metallate rearrangement, processes that are usually stereospecific, 
would lead to the formation of enantioenriched γ-amino tertiary boronic ester 181. 
 
Scheme 2.3. Proposed lithiation−borylation of azetidinium ion 177 with boronic esters. 
Previous work within the Aggarwal group showed that such ring-opening lithiation−borylation 
reactions can be successfully performed with terminal epoxides 182 (Scheme 2.4).123 These 
compounds can in fact be deprotonated using LiTMP and the generated lithiated epoxide can 
be trapped in situ with a boronic ester 183 to give boronate complex 184. Subsequent 
stereospecific 1,2-metallate rearrangement, followed by oxidation, affords syn-1,2-diols 186 as 
single diastereoisomers. The complete diastereoselectivity observed supports the proposed 
mechanism depicted in Scheme 2.4, where initial deprotonation occurs trans to the R 
substituent on the epoxide. 
 
Scheme 2.4. Lithiation−borylation of terminal epoxides with boronic esters. 
When enantioenriched (R)-butenoxide was reacted with ethyl pinacol boronic ester under these 
conditions, β-silyloxy boronic ester 188 was isolated, after in situ trapping with TESOTf, in 
good yield and excellent e.r. (Scheme 2.5A). This intermediate was subsequently further 
elaborated; in particular, a second homologation with lithiated epoxide Li-187 gave access to 
substituted triols bearing four contiguous strereocentres with complete diastereocontrol. 
In the case of styrene oxide 190, deprotonation was shown to occur in the position adjacent to 
the phenyl group. Trapping with different electrophiles at low temperature provided the 
corresponding styrene oxide derivatives with complete retention of stereochemistry.124-125 
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When this substrate was employed in the lithiation−borylation sequence, the in situ trapping of 
the generated β-alkoxy boronate intermediate with TESOTf was necessary to both prevent 
undesired boron-Wittig elimination and facilitate the 1,2-metallate rearrangement 
(Scheme 2.5B). The reaction proved to be stereospecific when performed at low temperatures 
(−98 °C) in Et2O and using less sterically hindered neopentylglycol boronic esters.  
 
Scheme 2.5. Enantiospecific synthesis of 1,3-diols through lithiation−borylation of epoxides. 
In a similar process, terminal N-Boc protected aziridines 194 were lithiated with LiTMP and 
in situ trapped with different boronic esters to give, after stereospecific 1,2-metallate 
rearrangement and oxidation, substituted syn-β-amino alcohols in a diastereospecific fashion 
(Scheme 2.6A).126 When enantiopure aziridine 198 was employed in the sequence, the 
corresponding amino alcohol 200 was isolated in 90% yield and 99% ee, thus demonstrating 
the configurational stability of the generated lithium carbenoid (Scheme 2.6B). 
 
Scheme 2.6. Lithiation−borylation of terminal N-Boc aziridines with boronic esters. 
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Unfortunately, the application of the lithiation−borylation sequence to the higher ring-size 
homologue N-Boc 2-phenylazetidine 201, that is known to undergo regioselective lithiation at 
the α position when treated with a strong base,127 met with failure (Scheme 2.7)ii.  
 
Scheme 2.7. Unsuccessful lithiation−borylation of N-Boc azetidine 201. 
Presumably, the 1,2-metallate rearrangement is too slow to allow the ring opening of the 
azetidine. In this sense, we reasoned that the corresponding azetidinium ions might be more 
reactive, since the presence of a positive charge on nitrogen would facilitate the ring-opening 
1,2-metallate rearrangement step. Even if previous studies within our group revealed that 
ammonium ylides have rather poor leaving group characteristics,128 azetidinium ylides 
represent a special class, since the driving force of the process would be the ring strain release. 
Couty and David have recently showed that cyano-substituted azetidinium ion 202 can be 
deprotonated with LiHMDS to form ylide 203; this intermediate could be subsequently trapped 
in situ with different electrophiles (Scheme 2.8). When ketones or aldehydes were employed, 
the generated intermediate alkoxide underwent intramolecular substitution to afford amino 
epoxides 204.129 Similarly, when acrylates were used as the electrophiles, the corresponding 
functionalised cyclopropanes 205 were accessed.130 Finally, primary halides were also found 
to react with ylide 203, to give, after Hofmann elimination, the corresponding substituted 
alkenes 206.131 
                                                 




Scheme 2.8. Reactivity of azetidinium ylide 203 with different electrophiles. 
The work of Couty and David showed that stabilised cyano-substituted ylide 203 is 
configurationally unstable within seconds even at cryogenic temperature. However, no data 
was reported about the configurational stability of less stabilised ylides, such as 
phenyl-substituted ylide 178.  
With this background, we decided to investigate the synthesis of γ-amino tertiary boronic esters 
through the lithiation−borylation of phenyl-substituted azetidinium ion 177 and to test the 
viability of a stereospecific version of the process. 
2.2. Results and Discussion 
2.2.1. Synthesis of the Starting Material and Optimisation of the Lithiation−Borylation 
Reaction 
We first embarked on the synthesis of azetidinium triflate 211, that was achieved in four steps 
starting from commercially available 3-chloro-1-propiophenone (Scheme 2.9). Reduction of 
the ketone gave 3-chloro-1-phenyl propanol 207,132 that was subsequently converted into the 
corresponding dichloride 208 by reaction with SOCl2.
127 Crude 208 was then involved in a 
ring-closing double displacement reaction by treatment with methylamine to afford 
azetidine 210 in 50% yield over the two-steps.127 The relatively low yield observed was due to 
a competing elimination process in the chlorination step, leading to the formation of chloro 
alkene 209 in considerable amounts (~20%). Final N-alkylation of azetidine 210 with methyl 




Scheme 2.9. Synthesis of phenyl-substituted azetidinium triflate 211. 
To probe the feasibility of the methodology, we attempted the generation of the corresponding 
azetidinium ylide from azetidinium triflate 211 by treatment with LiHMDS (1.7 equiv) in THF 
at −78 °C in the presence of ethyl pinacol boronic ester 212, conditions analogous to those 
previously reported by Couty and David.130 In situ trapping conditions were necessary to 
prevent decomposition of the generated ylide, which is known to be chemically unstable even 
at cryogenic temperatures. In fact, attempts to pre-form the ylide by treatment of azetidinium 
salt 211 with the base for only 10 minutes at −78 °C, followed by trapping with the boronic 
ester, only resulted in decomposition of the starting material. Upon warming the reaction 
mixture, generated under in situ conditions, to room temperature, 1,2-metallate rearrangement 
gave γ-dimethylamino tertiary boronic ester 213a, which was isolated in 41% yield after 
chromatography on silica gel (Table 2.1, entry 1). Encouraged by this initial good result, we 
sought to optimise the process and find reaction conditions that gave improved yields. Attempts 
to perform the reaction at higher temperatures (−20 °C) resulted in only traces of the desired 
product (Table 2.1, entry 2). Warming the reaction mixture to reflux in order to favour the 
1,2-metallate rearrangement or increasing the amount of base to 3.0 equivalents also led to 
disappointing results (Table 2.1, entry 3−4). Other non-nucleophilic bases were screened, 
among which KHMDS and LiTMP gave reduced yields (Table 2.1, entry 5−6); however, when 
LDA was used, desired tertiary boronic ester 213a could be isolated in 57% yield (Table 2.1, 
entry 7). Further investigation showed that the addition of 2.0 equivalents of LDA gave the 
optimal result, with boronic ester 213a being isolated in 69% yield after column 
chromatography (Table 2.1, entry 10). 
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Table 2.1. Optimisation of the lithiation−borylation reaction of azetidinium triflate 211. 
 
Entry Base Equiv base T (°C) % Yield 
1 LiHMDS 1.7 −78 41b 
2 LiHMDS 1.7 −20 <5b 
3c LiHMDS 1.7 −78 23d 
4 LiHMDS 3.0 −78 33d 
5 KHMDS 1.7 −78 26d 
6 LiTMP 1.7 −78 26d 
7 LDA 1.7 −78 57b 
8 LDA 1.2 −78 16d 
9 LDA 1.5 _78 43d 
10 LDA 2.0 −78 69b 
11 LDA 3.0 −78 58d 
a Reactions were performed using 0.2 mmol of 211; b yield of isolated material; c after stirring the reaction 
mixture at −78 °C (1 h), the mixture was heated to reflux; d yield determined by 1H NMR analysis of the crude 
mixture in the presence of 2,4-dimethoxybenzene as internal standard. 
2.2.2. Substrate Scope 
Having identified optimum conditions for the lithiation−borylation reaction we sought to 
explore the scope of the methodology, employing a range of different boronic esters (212a-g) 
(Scheme 2.10). Primary (212a-d) and secondary (212e-f) alkyl boronic esters were found to 
work well in the process, giving the corresponding γ-dimethylamino tertiary boronic 
esters 213a-f in moderate to good yield. Allylic boronic ester 212g was also tolerated in the 




Scheme 2.10. Scope of the alkyl boronic ester for the lithiation−borylation of 211. 
Aryl boronic esters were found to be more challenging substrates. When phenyl pinacol 
boronic ester 212h was used under the optimised conditions, a mixture of the expected tertiary 
boronic ester 213h and protodeboronated derivative 214 was isolated 213h:214 = 80:20), the 
two species being inseparable on silica gel (Scheme 2.11). 
 
Scheme 2.11. Lithiation−borylation of 211 and boronic ester 212h leading to a mixture of desired product 213h 
and protodeboronated compound 214. 
A plausible mechanism for the observed protodeboronation of 213h is depicted in 
Scheme 2.12. Desired tertiary boronic ester 213h is initially generated under the reaction 
conditions. Subsequent interaction between the dimethylamino group and the boron centre 
present on the molecule leads to the formation of a second boron “ate” complex 215. Breaking 
of the C−B bond affords biaryl anion 216, which is eventually converted into protodeboronated 
product 214. The high stabilisation of dibenzylic anion 216 makes the process extremely facile 
when aromatic boronic esters are employed, while no protodeboronation was observed with 
alkyl boronic esters. The complexation of the boronic ester with the proximal dimethylamino 
group appears to play a key role in this process, since similar boronic esters missing this amino 
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functionality do not undergo protodeboronation so promptly.56, 133 Alternatively, boronate 
complex 215 could be directly trapped by water to afford, after cleavage of the N−B bond, 
protodeboronated product 214. 
 
Scheme 2.12. Proposed mechanism for the protodeboronation of boronic ester 213h. 
Pleasingly, it was found that protodeboronation could be prevented by oxidising the unstable 
tertiary boronic esters 213i-j in situ, prior to work-up, to afford the corresponding tertiary 
alcohols 217i-j in good yields (Scheme 2.13). Electron-rich boronic ester 212k was well 
tolerated in the process and gave the corresponding stable boronic ester 213k in 75% yield with 
no protodeboronation observed, due to the presence of the electron-donor substituent making 
the intermediate dibenzylic anion less stable. 
 
Scheme 2.13. Scope of the aryl boronic ester for the lithiation−borylation of 211. a Isolation of the tertiary 
boronic ester was not possible due to protodeboronation; in situ oxidation using aqueous H2O2/NaOH allowed 
the isolation of the corresponding tertiary alcohol; b the in situ oxidation was performed at 0 °C; c the in situ 
oxidation was performed at −40 °C. 134 
In line with the mechanism proposed in Scheme 2.12, when p-chlorophenyl pinacol boronic 
ester 212l was employed, the generated tertiary boronic ester was found to undergo extremely 
facile protodeboronation. Considering that γ-amino diarylmethines are found in many 
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biologically active molecules (Figure 2.1), we sought to find conditions to transform the tertiary 
boronic ester into the protodeboronated derivative directly.  
We therefore decided to apply our previously reported conditions for the protodeboronation of 
diarylalkyl boronic esters. Upon lithiation−borylation of 211 and 212l, the reaction mixture 
was warmed to room temperature and CsF (1.5 equiv) was added, immediately followed by 
H2O (1.1 equiv). Pleasingly, these conditions allowed the isolation of protodeboronated 
compound 218l in 71% yield after chromatographic purification, with no trace of tertiary 
boronic ester left (Scheme 2.14). 
 
Scheme 2.14. Lithiation−borylation of azetidinium triflate 211 and boronic ester 212l with in situ 
protodeboronation. 
Vinyl boronic esters also proved to be challenging substrates for this transformation. When 
boronic ester 212m was employed in the lithiation−borylation sequence, the expected 
product 213m was not formed and unreacted starting material 212m could be reisolated 
(Scheme 2.15). Since vinyl substituents are known to be poor migrating groups, MgBr2Et2O 
was added to the reaction mixture in order to increase the rate of 1,2-metallate rearrangement.54 
This led to full conversion of the boronate complex, but the only species that could be isolated 
after column chromatography was alkene 219, although in low yield. This product could be 
accounted for by the generation of tertiary boronic ester 213m, which underwent 




Scheme 2.15. Lithiation−borylation of azetidinium 211 and alkenyl boronic ester 212m. 
The low yield of isolated 219 might be explained considering the presence of acidic protons 
adjacent to the NBoc group on boronic ester 212m, which might have also undergone 
deprotonation. Vinyl boronic ester 212n, bearing no acidic protons, was therefore tested in the 
process; 1,2-metallate rearrangement was in this case performed at room temperature without 
any additive (Scheme 2.16). As before, expected tertiary boronic ester 213n was not detected. 
However, cyclopropane 220 was isolated in 24% yield after column chromatography, therefore 
suggesting the formation of an intermediate carbene (for mechanistic discussion see § 2.2.4, 
Scheme 2.29). 
 
Scheme 2.16. Lithiation−borylation of azetidinium 211 and alkenyl boronic ester 212n. 
Boronic esters 212o-u were also tested in the lithiation−borylation sequence, but were found 
to be unreactive under these conditions (Scheme 2.17). In all the cases, the starting boronic 
esters 212o-u were recovered and decomposition of azetidinium triflate 211 was observed, the 
high instability of the generated ylide therefore representing the limitation of this process. In 
particular, when more sterically hindered boronic esters, such as 212o-r, were used, the 
formation of the boronate complex was probably more difficult, and the generated ylide 
decomposed before reacting. In the case of boronic esters bearing poor migrating groups, such 
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as 212s-u, the boronate complex might have initially formed, but the difficult 1,2-metallate 
rearrangement might have made the process reversible, leading to the regeneration of the 
starting boronic esters together with decomposition of the ylide. 
 
Scheme 2.17. Boronic esters that failed to undergo lithiation−borylation with azetidinium salt 211. 
2.2.3. Alternative Transformations of Tertiary Boronic Esters  
To further demonstrate the synthetic utility of the generated tertiary boronic esters 213, we 
sought to convert the C−B bond of 213a into a variety of different functionalities. 
As already discussed for substrates 213j-k, 213a could be oxidised in situ using a mixture of 
H2O2/NaOH to afford tertiary alcohol 217a in 58% yield (Scheme 2.18). Other oxidising 
conditions were also tested (NaBO34H2O, NaBO34H2O/CH3COOH
135, oxone/acetone136, 
TMANO2H2O
86), but were found to be less effective and led to partial oxidation of the tertiary 
amine group. 
 
Scheme 2.18. Lithiation-borylation of azetidinium 211 and boronic ester 212a with in situ oxidation. 
Zweifel olefination of tertiary boronic ester 213a was also attempted to convert the C−B bond 
into a terminal alkene (see § 1.7.3). When 213a was reacted under previously optimised 
Zweifel olefination conditions using 4.0 equivalents of vinylmagnesium bromide,97 only traces 
 
58 
of desired alkene 221a could be observed. However, the use of 5 equivalents of vinyllithium, 
freshly prepared by addition of n-BuLi to tetravinyl stannane, gave, after addition of iodine and 
NaOMe in MeOH, desired terminal alkene 221a, which could be isolated in 52% yield after 
column chromatography (Scheme 2.19). 
 
Scheme 2.19. Zweifel olefination of tertiary boronic ester 213a. 
As already mentioned, protodeboronation of dibenzylic tertiary boronic ester 213l proved to be 
extremely facile and was achieved using CsF and H2O.
94 Following the procedure previously 
reported by Aggarwal and co-workers, protodeboronation of aryl dialkyl boronic ester 213a 
was instead carried out using TBAF3H2O as a more reactive fluoride source (Scheme 2.20). 
Under these conditions, protodeboronated product 218a was isolated in 73% yield after column 
chromatography. 
 
Scheme 2.20. Protodeboronation of tertiary boronic ester 213a. 
We were also interested in transforming tertiary boronic ester 213a into the corresponding 
trifluoroborate salt 222a. Interestingly, the reaction of 213a with KHF2 in MeOH under 
previously reported conditions,89 gave a mixture of expected trifluoroborate salt 222a and 
intramolecularly complexed difluoroborane 223a in 2:1 ratio and 82% overall yield, as 
confirmed by both 1H and 19F NMR (Scheme 2.21). Difluoroborane 223a must have been 
generated by spontaneous intramolecular ligand exchange with the proximal tertiary amine, 
similar to what had previously been observed by Luisi and Florio.137 Pleasingly, heating the 
mixture at reflux in CH3CN resulted in the complete conversion into difluoroborane 223a, that 




Scheme 2.21. Attempted conversion of tertiary boronic ester 213a into trifluoroborate salt 222a. 
Matteson homologation of boronic ester 213a was finally attempted (see § 1.2). The in situ 
generation of chloromethyllithium from chlorobromomethane and n-BuLi at −78 °C, followed 
by oxidation with H2O2/NaOH did not lead to the formation of desired alcohol 224a and only 
starting boronic ester 213a was reisolated (Scheme 2.22A). Using the more reactive 
chloroiodomethane as the carbenoid precursor at lower temperature (−95 °C) or adding 
BF3Et2O as an activator did not give improved results and no expected product 224a could be 
detected. A possible explanation is that the coordination of the pendant tertiary amine to boron 
deactivates the boronic ester, therefore inhibiting its reactivity with chloromethyllithium. 
Chloromethyllithium is known to be highly chemically unstable with respect to decomposition 
even at very low temperature,138-139 and immediate trapping is necessary to prevent its 
decomposition. Attempts to use dichloromethyllithium, generated in situ by deprotonation of 
CH2Cl2 by LDA at −42 °C,15 also met with failure and desired aldehyde 225a was not detected 
(Scheme 2.22B). 
 
Scheme 2.22. Attempted Matteson homologation of tertiary boronic ester 213a. 
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2.2.4. Mechanistic Studies 
We then sought to study the mechanism of the transformation and in particular we were 
interested in investigating whether the release of ring-strain is key for the 1,2-metallate 
rearrangement to occur. Thus, we prepared the higher ring-size homologous pyrrolidinium 
triflate 227 and reacted it under previously optimised conditions for the 
lithiation−borylation−ring-opening of azetidinium salts. Triflate 227 was easily synthesised in 
three steps from commercially available 2-phenylpyrrolidine, that was subjected to reductive 
alkylation to give 1-methyl-2-phenylpyrrolidine 226 in 72% yield;140 subsequent alkylation 
with MeOTf gave desired pyrrolidinium triflate 227 quantitatively (Scheme 2.23).  
 
Scheme 2.23. Synthesis of pyrrolidinium triflate 227. 
A solution of pyrrolidinium salt 227 and ethyl pinacol boronic ester 212a in THF was treated 
with LDA at −78 °C (Scheme 2.24). After warming the reaction mixture to room temperature, 
no expected tertiary boronic ester 228a was observed; however, 1,2,3,4,7,8-
hexahydroazocine 229 was initially isolated in 48% yield, but it was found to rapidly isomerise 
to give the corresponding benzo-fused 1,2,3,4,5,8-hexahydroazocine 230. 
 
Scheme 2.24. Lithiation−borylation of pyrrolidinium 227 and boronic ester 212a. 
Azocine 229 is presumably formed through a Sommelet−Hauser rearrangement (Scheme 2.25). 
Benzylic ylide 231 is initially generated; subsequent proton transfer affords methylenic 




Scheme 2.25. Competing Sommelet−Hauser rearrangement of pyrrolidinium ylide 231. 
This result suggests that the trapping of the generated benzylic ylide 231 with the boronic ester 
might be slower than the Sommelet−Hauser rearrangement. Alternatively, benzylic ylide 231 
is initially trapped by ethyl pinacol boronic ester, but the 1,2-metallate rearrangement is too 
slow and the boronate complex fragments to give back ylide 231 and the boronic ester. In this 
scenario, the release of ring-strain seems to be an essential factor for the success of the 
1,2-metallate rearrangement of azetidinium triflate 211. 
We then turned our attention towards the configurational stability of the azetidinium ylide 
generated form enantioenriched azetidinium triflate (R)-211. (S)-3-Chloro-phenyl-1-propanol 
(S)-207 was initially synthesised through the asymmetric reduction of commercially available 
3-chloropropiophenone with PhSiH3 in the presence of a copper salt (CuOAc22H2O) and 
chiral ligand (S)-P-Phos 233 (Scheme 2.26).142 Under these conditions, alcohol (S)-207 was 
isolated in 74% yield and 94% ee. 
 
Scheme 2.26. Copper-catalysed asymmetric reduction of 2-chloropropiophenone. 
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Enantioenriched azetidinium ion (R)-211 was then obtained from alcohol (S)-207 through the 
usual ring-closing double displacement reaction of intermediate dichloride 208127 followed by 
N-alkylation (Scheme 2.27). 
 
Scheme 2.27. Synthesis of enantioenriched azetidinium triflate (R)-211. 
The absolute configuration of azetidine (R)-211 was assigned assuming that the reaction with 
SOCl2 occurred with retention of configuration,
143 while the subsequent cyclisation step 
occurred with inversion of configuration. The slight erosion in ee might derive from partial 
racemisation in the reaction with SOCl2 owing to a possible SN2 mechanism (Scheme 2.28, 
pathway B) competing with the predominant SNi mechanism (Scheme 2.28, pathway A). 
Additionally, partial conversion of intimate ion-pair 237a to solvent-separated ion pair 237b 
would generate a planar cationic intermediate, eventually leading to racemic dichloride 208. 
 
Scheme 2.28. Proposed mechanism of the chlorination of secondary alcohols with SOCl2 through a SNi pathway 
(A) occurring with retention or through a SN2 pathway (B) occurring with inversion. 
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A mixture of azetidinium salt (R)-211 and ethyl pinacol boronic ester 212a in THF was then 
subjected to lithiation−borylation conditions using LiHMDS as the base; unfortunately, tertiary 
alcohol (R)-217a isolated after in situ oxidation was found to be racemic, therefore revealing 
the configurational instability of the generated ylide (Table 2.2, entry 1). 
Table 2.2. Investigation of the enantiospecificity of the lithiation−borylation−oxidation reaction of (R)-211.a 
 
Entry Boronic ester X Base  Solvent % Yield % ee 
1 Et-Bpin F3CSO3− LiHMDS THF 27 0 
2 Et-Bpin F9C4SO3− LiHMDS TBME 37 0 
3 Et-Bneop F9C4SO3− LiHMDS TBME 26 0 
4 Et-Bpin F9C4SO3− LDA TBME n.d. 0 
a Reactions were performed using 0.3 mmol of azetidinium salt; n.d. = not determined. 
This lack of configurational stability exhibited by azetidinium ion (R)-211 can be explained 
considering the presence of a positive charge on the adjacent nitrogen atom that increases the 
stability of the carbanionic centre. Lithium stabilised ylide 239a would therefore dissociate to 
form solvent-separated ion pair 239b, which, if pyramidilised, undergoes rapid inversion, with 
migration of the lithium cation from one enantiotopic face to the other, leading to the formation 
of enantiomeric ylide ent-239 (Scheme 2.29). The process could also occur via ring-opened 
intermediate carbene 240. 
 
Scheme 2.29. Possible mechanism of racemisation of ylide 239. 
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Solvent-mediated dissociation of lithium-stabilised anions is known to be favoured in 
coordinating solvents.144 We therefore reasoned that the use of a less-coordinating solvent than 
THF would increase the configurational stability of ylide 239. The 
lithiation−borylation−oxidation sequence was therefore performed in TBME. In this case, the 
corresponding nonaflate salt of (R)-238, simply accessed by counter-anion exchange using 
potassium nonaflate, was employed, since it was found to possess increased solubility in TBME 
than the corresponding triflate. Unfortunately, the process failed to give improved results and 
alcohol 217a was isolated as the racemate (Table 2.2, entry 2). The very poor solubility of 
azetidinium salts (R)-211 and (R)-238 in most of the common organic solvents limited our 
choice and attempts of performing the reaction in even less-coordinating solvents, such as 
toluene or hexane, met with failure. The use of LDA in the place of LiHMDS as the base or 
the use of the less sterically hindered neopentylglycol boronic ester (EtBneop) also failed to 
induce enantioselection and only racemic alcohol 217a was isolated (Table 2.2, entries 3−4).  
Evidence for the configurational instability of lithium stabilised ylide 239 was thus revealed in 
both coordinating and less coordinating solvents, such as TBME. This suggests that 
racemisation occurs through the formation of a solvent-separated ion pair, that undergoes 
subsequent inversion through pyramidilisation or via formation of an intermediate carbene 
(Scheme 2.29); a cooperation of the two mechanisms is also not excluded. The process is 
therefore difficult to avoid, especially considering the poor solubility of azetidinium salts in 
less polar solvents. Moreover, the formation of intermediate carbene 240 was supported by the 
formation of cyclopropane 220 when the lithiation−borylation−oxidation sequence was 
performed using boronic ester 212n (see § 2.2.2, Scheme 2.16). In this case, the rate of the 
1,2-metallate rearrangement is too slow and the boronate complex dissociates to give a putative 
intermediate carbene, which can subsequently react with the alkene moiety on 212n. 
2.3. Conclusions 
The lithiation−borylation−ring-opening of 2-phenyl azetidinium salt 211 has been efficiently 
developed. Ylide 239 was generated in situ by deprotonation of azetidinium salt 211 with LDA 
and immediately trapped with different pinacol boronic esters to give acyclic γ-dimethylamino 
tertiary boronic esters 213 in moderate to good yield (Scheme 2.30). This transformation is 
believed to occur through the initial formation of a zwitterionic boronate complex, which, upon 
warming to higher temperature, undergoes a ring-opening 1,2-metallate rearrangement. The 




Scheme 2.30. Synthesis of 3-aryl-1-aminopropane derivatives through lithiation−borylation−ring-opening of 
azetidinium ions. 
The reaction shows good scope (Scheme 2.31). Various primary and secondary alkyl boronic 
ester could be successfully employed, therefore providing access to different substituted 
3-aryl-1-aminopropane derivatives, a structural motif that can be found in many important 
bioactive molecules. Aromatic boronic esters were also found to work well in the process, but 
the generated tertiary boronic esters were found to be unstable and underwent fast 
protodeboronation under reaction conditions. However, in situ oxidation with H2O2/NaOH 
allowed the isolation of the corresponding tertiary alcohols in good yield. Some limitations in 
the scope of this reaction have also been highlighted. In particular, the use of more sterically 
hindered boronic esters only resulted in the decomposition of the generated ylide, the boronate 
complex formation presumably being too slow. Similarly, slower migrating groups attached to 
boron led to a reversible boronate complex formation, eventually resulting in the 
decomposition of the ylide. 
 
Scheme 2.31. Substrate scope of the boronic esters for the lithiation−borylation of azetidinium triflate 211. 
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Several transformations of the resulting tertiary boronic esters have also been performed, 
including protodeboronation and Zweifel olefination (Scheme 2.32). Attempts to convert 
tertiary boronic ester 213a into the corresponding trifluoroborate salt led instead to the isolation 
of intramolecularly complexed difluoroborane. 
 
Scheme 2.32. Different transformations of tertiary boronic ester 213a. 
In situ formed azetidinium ylides proved to be configurationally unstable, presumably due to 
the formation of a solvent-separated ion pair, highly favourable in coordinating solvents. The 
ylide would therefore rapidly interconvert, through either pyramidilisation or via a ring-open 
carbene species. The intermediacy of a carbene was supported by the isolation of a cyclopropyl 




3. Stereoselective Iterative Homologations of Boronic Esters 
With α-Sulfinyl Benzoates 
Parts of the work described in this chapter have been adapted from the following article: 
Casoni, G., Kucukdisli, M., Fordham, J. M., Burns, M., Myers, E. L., Aggarwal, V. K., 
J. Am. Chem. Soc. 2017, 139, 11877−11886. 
This project was conducted in collaboration with Dr. M. Kucukdisli and J. M. Fordham; 
their contributions to the project are highlighted within this chapter using footnotes and are 
included to provide a complete picture of the work.  
3.1. Introduction and Project Aims 
In nature, many enantioenriched substituted linear molecules, a small selection of which is 
depicted in Figure 3.1, possess an important biological profile and play a major role in 
improving and sustaining our standard of life. Despite their great potential, they still represent 
a tiny minority of the vast libraries of small molecules selected to be screened as potential drug 
candidates, with 2D heterocyclic small molecules still being the preferred choice. It is 
recognised that there is a great need to supplement these libraries by introducing more 
stereochemically rich 3D molecules.145 The reason why these molecules are poorly represented 
is that they are difficult to synthesise in stereochemically pure form and in large quantities. To 
address this problem, we planned to develop an automated solution-phase method with inline 
purification that would potentially allow non-experts to prepare libraries of molecules bearing 
linear chains of carbon atoms where each atom can contain a substituent of any absolute and 
relative orientation. These carbon chains will be grown one carbon at a time by sequential 
addition of a readily available carbenoid precursor, which would be non-toxic and bench stable. 
Once generated in situ, the metallated carbenoid would be linked to the growing chain through 
a metalation−borylation reaction. The required carbenoid precursor must meet several criteria 
to make this automated process possible. First, it has to contain a group that can be rapidly and 
stereospecifically transformed into a reactive metal group; second, it has to contain a suitable 
leaving group; third, it must be synthesised in very high levels of enantiopurity to avoid the 




Figure 3.1. Enantioenriched substituted linear molecules possessing biological activity. 
Aggarwal and co-workers have demonstrated that enantioenriched α-stannyl benzoates are 
excellent precursors to the α-lithiated benzoates necessary to perform iterative homologations 
of boronic esters, and substituted linear chains of carbon atoms could be accessed as single 
enantio- and diastereoisomers with very high levels of efficiency.73 Unfortunately, α-stannyl 
benzoates possess a number of negative attributes that make their use undesirable. First, they 
are synthesised from highly toxic reagents, they are relatively toxic themselves and they give 
rise to toxic by-products when employed in lithiation−borylation reactions. Moreover, to be 
synthesised in very high levels of enantiopurity, they require the use of (+) and (−)-sparteine, 
the supply of which has decreased to the extent where they have become extremely expensive. 
Finally, only the methyl-substituted carbenoid precursors are crystalline, which means it is 
difficult to prepare other derivatives in highly enantiopure form. As an alternative, inspired by 
the α-chloro sulfoxides prepared by Blakemore and co-workers (see § 1.4.2),29-30 we sought to 
employ substituted α-sulfinyl benzoates as precursors to α-metallated carbenoids, which were 
attractive owing to their relative non-toxicity when compared to the corresponding α-stannyl 
derivatives. Moreover, moving from the chloride to the triisopropyl benzoate leaving group 
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would avoid the side-reactions that were often observed in Blakemore’s homologation 
protocol. 
The first objective of this project is to prepare a range of different substituted α-sulfinyl 
benzoates. As aforementioned, the required carbenoid precursors must be generated in very 
high levels of enantiopurity and, ideally, without using any chiral diamine. 
With the necessary α-sulfinyl benzoates 241 in hand, the efficiency with which they undergo 
sulfoxide−metal exchange will be investigated (Scheme 3.1). The α-metallated carbenoid 242 
will be generated by treatment with different organolithium reagents (n-BuLi, s-BuLi, t-BuLi) 
and Grignard reagents (i-PrMgCl, i-PrMgClLiCl) under various conditions (solvent, 
concentration, temperature, stoichiometry). Trapping of the generated metallated benzoate 242 
with different boronic esters will afford, after 1,2-metallate rearrangement, the homologated 
product 243. In particular, high levels of conversion and stereospecificity are targeted.  
 
Scheme 3.1. Proposed homologation of boronic esters using metal benzoates generated by sulfoxide−metal 
exchange. 
Once the optimal conditions for effecting metalation−borylation reactions that give one-carbon 
homologated boronic esters in good yield and very high levels of enantioselectivity have been 
identified, the next objective will be to test the viability of an iterative process. This will be 
done by performing sequential homologations of boronic esters without intervening 
chromatographic purification, therefore demonstrating the possibility of rendering the protocol 
automatable. One of the most difficult parts of automating a synthetic process is the 
incorporation of a purification protocol that is sufficiently general that a wide range of products 
can be obtained in high purity. For example, the research group of Burke has recently 
developed a novel broadly applicable and fully automated method for clipping together 
N-methyliminodiacetic acid (MIDA) boronates through iterative cycles of deprotection, 
coupling and purification (Scheme 3.2).146 MIDA boronate 244 was initially deprotected to 
yield free boronic acid 245 which was subsequently engaged in a coupling reaction with 
building block 246 to generate homologated MIDA boronate 247. At this point, a general 
purification protocol was successfully implemented, exploiting the peculiar minimal mobility 
of MIDA boronates on silica gel chromatography when eluted with a mixture of MeOH/Et2O, 
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while they rapidly drop off when THF is added. A simple filtration of the crude reaction 
mixture over silica, washing with MeOH/Et2O, allows the removal of the excess of reagents 
and by-products, while the desired MIDA boronate stays temporarily loaded; switching the 
eluent to THF releases the MIDA boronate, which is sufficiently pure to undergo a second 
cycle of deprotection, coupling and purification. 
 
Scheme 3.2. Burke’s molecule-making machine. 
In the case of our proposed iterative homologation of boronic esters using α-sulfinyl benzoates, 
we suggest a novel automatable purification method relying on the difference in polarity 
between sulfoxides and boronic esters. The main steps in our envisaged automated 
metalation−borylation process would be as follows (Scheme 3.3). First, a solution of α-sulfinyl 
benzoate 250 would be cooled to a sub-zero temperature. Upon addition of an organometallic 
reagent (organolithium or Grignard reagent), α-metallo benzoate 254 would form within 
minutes, together with sulfoxide by-product 253. After addition of boronic ester 249, which 
would be the limiting reagent, an “ate” complex would be generated; then, upon warming to 
higher temperature, the boronate complex would undergo 1,2-metallate rearrangement to give 
homologated boronic ester 251. By simply filtering the crude reaction mixture through a plug 
of silica gel and washing with a sufficiently non-polar eluent should allow desired boronic 
ester 251 to be eluted, while the excess of starting material 253 and by-product 252 would stay 
loaded on the silica gel. The excess of metallated benzoate 254 would instead decompose upon 
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warming to room temperature. Without any further manipulation or purification, boronic 
ester 251 could be introduced into a second cycle of metalation−borylation with another 
α-sulfinyl benzoate to elongate the chain by a further carbon atom, and this cycle will be 
repeated until the target molecule is eventually generated.  
 
Scheme 3.3. Proposed automated iterative homologations of boronic esters with inline purification. 
With the chemistry element of the plan complete, the long-term aim of this project is the design 
and realisation of an apparatus (glassware, syringe pumps, solvent pumps, cooling devices) 
able to perform iterative metalation−borylation reactions with inline purification and with the 
least amount of user manipulations, so that non-experts in application-based scientific fields 
will be able to grow complex linear molecules by themselves. 
3.2. Results and Discussion 
3.2.1. Synthesis of Enantioenriched α-Sulfinyl Benzoates 
We first concentrated our efforts towards the synthesis of highly enantioenriched α-sulfinyl 
benzoates to be used as precursors for chiral metal carbenoids. We initially approached the 
synthesis of benzoate 255a using the strategy shown in Scheme 3.4. Chiral sulfoxide 258 could 
be generated from commercially available Andersen’s sulfinate 117 by displacement of 
mentholate with a nucleophilic methyl source. Subsequent chlorination of 258 would afford 
enantioenriched α-chlorosulfoxide 257, which would then undergo an SN2 reaction with 
triisopropyl benzoic acid to give intermediate sulfoxide 256. Finally, an alkylation reaction in 
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the position alpha to the sulfinyl group would afford both diastereoisomers of chiral α-sulfinyl 
benzoate 255a.  
 
Scheme 3.4. Proposed retrosynthetic analysis of α-sulfinyl benzoate 255. 
Andersen’s sulfinate 117 was reacted with MeMgBr to give sulfoxide 258 in excellent yield 
and e.r. (Scheme 3.5). Following a procedure initially described by Yamakawa and co-workers, 
sulfoxide 258 was then chlorinated by treatment with NCS in the presence of K2CO3
147 to 
afford α-chlorosulfoxide 257 in 74% yield and 91:9 e.r. Subsequent recrystallisation gave 
access to enantiomerically pure α-chlorosulfoxide 257. 
 
Scheme 3.5. Synthesis of enantiomerically enriched α-chloro sulfoxide 257. 
The chlorination reaction was shown to occur with inversion of configuration at sulfur and, in 
the case of further substitution at the alpha position, it was shown to be partially 
diastereoselective, with preference for the formation of the syn diastereoisomer.35 Furthermore, 
the presence of insoluble K2CO3 was found to be critical to suppress racemisation, although it 
dramatically slowed down the reaction rate (5 days for full conversion compared to 1−2 h in 
the absence of K2CO3). The proposed mechanism for the Yamakawa chlorination is depicted 
in Scheme 3.6.35 Initial chlorination of sulfoxide 259 with NCS generates intermediate 260, 
which is subsequently deprotonated by the base to give sulfur ylide 261. Subsequent 
1,2-electrophilic rearrangement affords α-chlorosulfoxide 263 via contact ion pair 262. A 
rehybridisation process during the addition of chloride to thioxocarbenium ion 262 accounts 
for the inversion of configuration at sulfur. The syn diastereoselectivity is justified by the fact 
that intermediate 260 sits in the favoured conformation 260a to minimise gauche interactions 
between the R and the aryl group; limited rotation about the alpha C−S bond in the ylide leads 
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to the formation of the minor anti diastereoisomer. The partial racemisation observed under 
reaction conditions is presumably caused by either solvent separation of contact ion pair 262 
or the intervention of a radical pathway for the 1,2-rearrangement. 
 
Scheme 3.6. Mechanism of the Yamakawa chlorination proposed by Blakemore. 
Despite the formation of the desired product in high enantiopurity, the Yamakawa chlorination 
still suffers from some drawbacks, such as the long reaction time and the need for 
recrystallisation to enhance the enantiopurity of 257, eventually leading to a relatively low 
isolated yield. The viability of a different chlorination method was therefore tested. 
In 2014, Baran and co-workers proposed a new method for the chlorination of arenes and 
heteroarenes based on the use of a novel guanidine-based chlorinating agent, CBMG or 
Palau’Chlor 264.148 The methodology was shown to be compatible with a variety of differently 
substituted arenes and heteroarenes, but also conjugated π-systems, sulphonamides and silyl 
enol ethers, using a mild, operationally simple and safe procedure (Scheme 3.7A). A new 
practical electrophilic halogenation of arenes and heteroarenes was also proposed by Gustafson 
and co-workers in 2015.149 The methodology, which was found to efficiently halogenate a 
broad variety of aromatics under mild conditions, made use of N-halosuccinimides in the 
presence of phosphine sulfides as catalysts (Scheme 3.7B). In the same year, Yamamoto and 
co-workers proposed a similar methodology for the selective halogenation of different 
aromatics and heteroaromatics using N-halosuccinimides in the presence of an aniline catalyst, 





Scheme 3.7. Examples of electrophilic halogenation reactions of arenes and heteroarenes. 
All of these three methodologies were tested for the α-chlorination of sulfoxide 258 and we 
were pleased to isolate desired α-chlorosulfoxide 257 in good yield in all the cases. 
Unfortunately, none of the methodologies were able to provide stereocontrol and sulfoxide 257 




Scheme 3.8. Attempted enantiospecific chlorination of sulfoxide 258. 
Considering the crucial role played by K2CO3 in inducing enantioselectivity in the Yamakawa 
chlorination, we attempted to use it as an additive in the methodologies described above. 
Addition of K2CO3 to the aniline-catalysed chlorination reaction of sulfoxide 258 completely 
shut down any reactivity, and no desired product could be detected (Scheme 3.9). Presumably 
the base simply abstracted the acidic proton of aniline 265 generating anionic species 266 
which is no longer catalytically active. 
 





Performing the phosphine sulfide-catalysed chlorination of sulfoxide 258 in the presence of 
K2CO3 allowed the isolation of α-chlorosulfoxide 257 in 73% yield (Scheme 3.10). 
Unfortunately, no stereoinduction was observed and the product was found to be racemic. 
 
Scheme 3.10. Attempted enantioselective chlorination of sulfoxide 258 with triphosphine sulfide catalyst and 
K2CO3. 
Provided that the Yamakawa chlorination was the only successful method to access 
α-chlorosulfoxide 257 in high enantiopurity, we turned our attention towards the next step of 
the synthesis, which was the introduction of the benzoate group. To this aim, 
α-chlorosulfoxide 257 was coupled with the preformed potassium salt of 
2,4,6-triisopropylbenzoic acid to afford,  after heating the reaction mixture at 100 °C for 3 days, 
α-sulfinyl benzoate (R)-256 in excellent yield and e.r. (Scheme 3.11). Pleasingly, it was found 
that α-sulfinyl benzoate (R)-256 could be obtained in comparable yield and e.r. by heating the 
reaction mixture in the microwave for only 6 hours. 
 
Scheme 3.11. Synthesis of enantiomerically enriched α-sulfinyl benzoate (R)-256. 
With access to sulfoxide (R)-256, the next step was performing an alkylation reaction alpha to 
the sulfinyl group. Previous attempts to perform this alkylation on a similar substrate revealed 
that the deprotonation of α-sulfinyl benzoate 267 must be performed in the presence of the 
electrophile (i.e. in situ conditions) to avoid the decomposition of the generated metallated 
species.iii When the alkylation of sulfoxide 267 was attempted using MeI as the alkylating agent 
and LDA as the base, desired products syn and anti-268 were obtained with a d.r. of 42:58, 
along with unreacted starting material 267 and double alkylated product 269 (Scheme 3.12). 
Although the two diastereoisomers syn-268 and anti-268 could be separated by 
                                                 
iii Initial results on the alkylation of α-sulfinyl benzoate 267 were obtained by Dr. M. Burns. 
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chromatography on silica gel, they co-eluted with starting benzoate 267 and double alkylated 
product 269, respectively. 
 
Scheme 3.12. Attempted alkylation of sulfoxide 267 using LDA. 
It was eventually found that the use of a weaker and more hindered base, such as LiHMDS, 
was beneficial in preventing double alkylation. Alkylation of sulfoxide 267 with MeI, under in 
situ conditions, using LiHMDS as the base, allowed the isolation of the desired products syn 
and anti-268 in 79% overall yield with a d.r. of 48:52 (syn-268:anti-268, Scheme 3.13).iv 
 
Scheme 3.13. Alkylation of sulfoxide 267 using LiHMDS. 
Unfortunately, these conditions were found to be unsuitable for the TIB substrate (R)-256. 
When α-sulfinyl benzoate (R)-256 was alkylated with MeI under in situ conditions, using 
LiHMDS as the base, desired diastereoisomers syn-255a and anti-255a were isolated in 16% 
and 33% yield respectively, along with a considerable amount of dialkylated product 270 
(Scheme 3.14). 
                                                 





Scheme 3.14. Attempted alkylation of sulfoxide (R)-256 using LHMDS. 
Further optimisation revealed that the formation of the anion prior to the addition of MeI (i.e. ex 
situ conditions) was beneficial, leading to an increased yield (83% overall, determined by 1H 
NMR, 25:75 syn:anti) and suppressed the undesired dialkylation process (Table 3.1, entry 1). 
Interestingly, the use of KHMDS and NaHMDS as the base with MeI as the alkylating agent, 
led to improved results compared to LiHMDS and the desired products syn-255a and anti-255a 
were obtained in good yield and d.r., the syn diastereoisomer syn-255a being the major species, 
with no trace of the double alkylated product 270 (Table 3.1, entries 2−3). However, when 
conditions reported in Table 3.1, entry 3 were used on a moderately large scale (7.7 mmol), 
desired sulfoxides syn-255a and anti-255a were formed in increased yield (98% overall), but 
decreased diastereoselectivity now in favour of the anti diastereoisomer anti-255 (Table 3.1, 
entry 4). This difference in the observed d.r. can be rationalised by considering that the 
generated diastereomeric sulfoxides syn and anti-255a undergo epimerisation under the 
reaction conditions, the extent of the process being dependent on the scale, the base and the 
alkylating agent employed (see 3.2.3). 
Table 3.1. Results for the alkylation of sulfoxide (R)-256 using different bases. 
 
Entry Base R−X % Yield syn-255aa % Yield anti-255aa syn:antib 
1c LiHMDS MeI 20 63 12:88 
2 KHMDS MeI 48 19 83:17 
3 NaHMDS MeI 52 23 80:20 
4d NaHMDS MeI 43e 56e 43:57 
a Yield determined by 1H NMR analysis of the crude reaction mixture using 1,4-dimethoxybenzene as the internal 
standard; b d.r. values determined by 1H NMR analysis of the crude reaction mixture; c anion formed prior to the 
addition of the methylating agent; d reaction performed on a 7.7 mmol scale; e yield of isolated products. 
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With conditions to achieve the methylation of sulfoxide (R)-256, we sought to test the 
generality of the methodology and use other alkylating agents to access different substituted 
α-sulfinyl benzoates. To this aim, we initially targeted allyl-substituted sulfoxide 255b. 
Deprotonation of methylene sulfoxide (R)-256 with NaHMDS and trapping of the generated 
anion with allyl iodide under in situ conditions resulted in a large amount of unreacted starting 
material and only traces of the desired diastereomeric products syn-255b and anti-255b were 
observed (Scheme 3.15). The use of different alkylating agents, such as allyl bromide or allyl 
chloride did not give a better result and no desired products could be isolated. 
 
Scheme 3.15. Attempted synthesis of α-sulfinyl benzoates syn and anti-255b by alkylation. 
It was eventually found that purification of allyl iodide prior to use by washing with aqueous 
Na2S2O3 to remove any trace of I2, was essential for the success of the reaction. Optimisation 
of the reaction conditions revealed that a careful choice of the base was important for the 
formation of sulfoxide 255b, with LiHMDS giving the best result (Table 3.2, entry 3), while 
NaHMDS, KHMDS and LDA failed to provide any product (Table 3.2, entries 1−2 and 4). The 
conditions reported in entry 3 were found to be scalable (Table 3.2, entries 5−6) and when the 
process was performed on 3.8 mmol of starting benzoate (R)-256, desired sulfoxides syn and 




Table 3.2. Results for the alkylation of sulfoxide (R)-256 using allyl iodide. 
 
Entry Base % Yield syn-255ba % Yield anti-255ba syn:antib 
1 NaHMDS 0 0 n.d. 
2 KHMDS 0 0 n.d. 
3 LiHMDS n.d. 46c n.d. 
4 LDA 0 0 n.d. 
5d LiHMDS 12 70 15:85 
6e LiHMDS 12  74 14:86 
a Yields of isolated products; b d.r. values determined by 1H NMR analysis of the crude reaction mixture; c yield 
determined by 1H NMR analysis of the crude reaction mixture using 1,4-dimethoxybenzene as the internal 
standard; d reaction performed on a 0.75 mmol scale; e reaction performed on a 3.8 mmol scale; n.d. = not 
determined. 
The e.r. of synthesised sulfoxides syn-255b and anti-255b was found to be 98:2, thus indicating 
a slight erosion in the enantiospecificity of the process, considering that starting sulfoxide 
(R)-256 had an e.r. greater than 99:1. This partial lack of enantiospecificity can be rationalised 
considering the mechanism depicted in Scheme 3.16A. The sulfur lone pair on benzoate 
(R)-256 initially reacts with allyl iodide to give intermediate 271; this is subsequently 
deprotonated by the base to give ylide 272, which is in resonance with sulfine 273. At this 
point, a 2,3-sigmatropic rearrangement occurs to give sulfoxides ent-syn-255b and 
ent-anti-255b, bearing the opposite configuration at the sulfur centre than starting sulfoxide 
(R)-256. This pathway is mechanistically similar to the one operating in the case of optically 
active allylic sulfoxide 274, where a concerted intramolecular α,γ-shift of the allyl group 
between the sulfoxide oxygen and the sulfur centre via optically inactive allyl sulfenate 275 




Scheme 3.16. Proposed mechanism accounting for the lack of enantiospecificity in the alkylation of 
sulfoxide (R)-256 with allyl iodide. 
The synthesis of enantioenriched sulfoxides syn and anti-255b highlighted the limitations of 
this methodology. The reaction conditions optimised for the alkylation of benzoate (R)-256 
with MeI proved not to be general, and further optimisation was necessary when allyl iodide 
was employed as the alkylating agent. Additionally, the e.r. of sulfoxides syn and anti-255b 
was found to be reduced due to a competing racemisation pathway. These drawbacks, together 
with the high number of steps and the long reaction times required to make benzoate (R)-256, 
prompted us to seek a shorter and more attractive method to access different substituted 
enantioenriched α-sulfinyl benzoates. 
3.2.2. Synthesis of Enantioenriched α-Sulfinyl Benzoates by Sulfinylation 
O’Brien and co-workers showed that enantiomerically enriched α-sulfinyl carbamates syn-115 
and anti-115 could be synthesised from the corresponding carbamate 76.80 They found that 
treatment of racemic lithiated carbamate Li-76 with commercially available and enantiopure 
Andersen’s sulfinate 117, gave desired carbamates syn and anti-115 in good yield, but with 
only moderate levels of enantiospecificity (Table 3.3, entry 1). 
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Table 3.3. O’Brien’s synthetic route to enantiomerically enriched α-sulfinyl carbamates syn and anti-115. 
This erosion in the enantiospecificity was unexpected, since organometallic reagents are known 
to react with enantioenriched sulfinate esters with inversion of configuration at the sulfur 
centre.153 The origin of this competing racemisation pathway was presumed to be a sulfinyl 
transfer reaction of lithiated carbamates (R)-Li-76 and (S)-Li-76 and the early generated 
sulfoxides syn-115 and anti-115, eventually leading to the formation of products derived from 
a double-inversion pathway (Scheme 3.17). 
 
Entry Diamine % Yield anti-115 (e.r.) % Yield syn-115 (e.r.) 
1 TMEDA 23 (83:17) 32 (91:9) 
2 (−)-sparteine 53 (99:1) 0.2 (n.d.) 
3 (+)-sp surr 7 (87:13) 45 (99:1) 
4 (R,R)-116 56 (99:1) 14 (93:7) 




Scheme 3.17. Postulated mechanism for the observed racemisation of α-sulfinyl carbamates syn and anti-115. 
O’Brien and co-workers overcame this problem by employing a chiral diamine, either sparteine 
or 1,2-diaminocyclohexane derivative 116, in the deprotonation step; after trapping of the 
generated enantioenriched lithiated carbenoid with Andersen’s sulfinate 117, the major 
diastereoisomer of carbamate 115 was isolated with very high levels of enantiopurity 
(Table 3.3, entries 2−5). 
Preliminary studies showed that this racemisation pathway was also occurring in the 
sulfinylation of benzoate 108a (Scheme 3.18).v Diastereomeric sulfoxides ent-syn and 
ent-anti-255a, which could be separated by chromatography on silica gel, were in fact isolated 
in 88:12 and 87:13 e.r., respectively. Increasing the number of equivalents of sulfinate 117 did 
not lead to improved e.r. values, which contradicted the competing sulfinylation pathway 
described above. 
                                                 




Scheme 3.18. Synthesis of α-sulfinyl benzoates ent-syn and ent-anti-255a though the sulfinylation of lithiated 
precursor Li-108a with Andersen's sulfinate 117. 
As mentioned previously, we sought to find a strategy to synthesise substituted α-sulfinyl 
benzoates that did not make us reliant on the use of chiral diamines. We therefore reasoned that 
employing a more tempered nucleophile than Li-108a, such as magnesiated carbenoid 
Mg-108a, would still allow the sulfinyl transfer reaction with Andersen’s sulfinate 117, but at 
the same time would prevent the proposed double inversion pathway. To test this, lithiated 
benzoate Li-108a was initially formed by treatment of benzoate 108a with s-BuLi in the 
presence of TMEDA and subsequently transmetalated to the corresponding magnesiated 
carbenoid Mg-108a by addition of MgBr2Et2O; trapping with Andersen’s sulfinate 117 
afforded sulfoxides ent-syn and ent-anti-255a in good yield (Scheme 3.19). Pleasingly, the 
process was shown to occur with very high levels of enantiospecificity and the diastereoisomers 
ent-syn and ent-anti-255a were isolated in near-perfect levels of enantiopurity. 
 
Scheme 3.19. Synthesis of α-sulfinyl benzoates ent-syn and ent-anti-255a through the sulfinylation of 
magnesiated precursor Mg-108a with Andersen's sulfinate 117. 
These conditions were subsequently applied to the synthesis of a range of enantiopure 
α-sulfinyl benzoates (Scheme 3.20). Different substituents could be successfully introduced, 
including alkyl chains of varying steric hindrance (255c-e) and versatile functionalities, such 
as alkene ent-255b and ketal 255g. Remarkably, both diastereoisomers could be obtained in 
good yield and with excellent levels of enantiopurity in all the cases, thus providing rapid 





Scheme 3.20.vi Synthesis of α-sulfinyl benzoates 255b-g through the sulfinylation of magnesiated precursors 
with Andersen's sulfinate 117. a Diastereoisomers were not separable by column chromatography and yields 
were determined based on 1H NMR analysis. A portion of the mixture was purified by reverse-phase HPLC to 
obtain analytically pure syn and anti-255d. 
The relative and absolute configuration of the obtained α-sulfinyl benzoates was determined 
by comparing chiral HPLC traces of the products obtained from the sulfinylation reaction of 
(a) racemic magnesiated benzoate and racemic sulfinate reagent (mixture of all the four 
diastereoisomers), (b) racemic magnesiated benzoate and enantiopure Andersen’s reagent 
(mixture of two diastereoisomers, epimeric at the carbon centre) and (c) enantioenriched 
magnesiated benzoate and racemic sulfinate reagent (mixture of two diastereoisomers, 
epimeric at the sulfur centre; see § 5.6.8). 
A few benzoates were found to be not compatible with these reaction conditions. For instance, 
vinyl substituted α-sulfinyl benzoates could not be accessed through this route. In fact, 
lithiation and transmetalation of TIB ester 108h, followed by trapping with Andersen’s 
sulfinate 117, did not lead to the formation of diastereomeric sulfoxides syn and anti-255h, 
although 1H NMR analysis of the crude reaction mixture showed complete consumption of 
starting material 108h (Scheme 3.21).vii 
                                                 
vi Where indicated (*), the experimental work discussed in this chapter was conducted by Dr. M. Kucukdisli. 




Scheme 3.21. Attempted lithiation/transmetalation/sulfinylation of benzoate 108h. 
In this case, the expected desired products syn and anti-255h were presumed to have formed 
under the reaction conditions; however, vinyl substituted sulfoxides are known to undergo 
rapid decomposition via a Mislow−Evans rearrangement (Scheme 3.22).152 
 
Scheme 3.22. Mechanism of the Mislow-Evans rearrangement of allylic sulfoxides. 
The synthesis of aryl substituted α-sulfinyl benzoates was also found to be problematic. In 
particular, lithiation/transmetalation followed by sulfinylation of benzylic TIB esters 108i-j 
gave a diastereomeric mixture of desired benzylic sulfoxides syn and anti-255i-j. However, 
these were found to be inseparable by chromatography on silica gel (Scheme 3.23).viii The high 
instability of these compounds in acetonitrile made any attempt of purification by 
reverse-phase HPLC ineffective, with the consequence that enantio- and diastereopure aryl 
substituted α-sulfinyl benzoates could not be accessed using this protocol. 
 
Scheme 3.23. Lithiation/transmetalation/sulfinylation of benzoates 255i-j. 
                                                 
viii Lithiation/transmetalation/trapping of benzoates 108i-j was conducted by Dr. M. Kucukdisli. 
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3.2.3. Base-Mediated Epimerisation of α-Sulfinyl Benzoates 
In many cases, standard flash chromatography was sufficient to separate mixtures of syn and 
anti diastereomers. Diastereomeric pairs showed differences in retention factors (Rf values) of 
up to 0.2, the anti diastereoisomer always proving to be the more polar. However, in some 
cases, separation of the diastereoisomers was more challenging; for example, the 
isopropyl-substituted benzoates, syn and anti-255d, could only be separated using preparative 
HPLC. For this reason, we investigated the base-mediated epimerisation of a diastereomeric 
mixture of α-sulfinyl benzoates ent-syn and ent-anti-255a, under both kinetic and 
thermodynamic conditions; in this way, we were hoping to enrich the mixture heavily towards 
one diastereomer, thereby facilitating chromatographic separation. The Knochel−Hauser base, 
TMPMgCl∙LiCl, was found to be the optimal reagent to affect the deprotonation, LiHMDS and 
NaHMDS being ineffective and LDA leading to complete decomposition. A 50:50 mixture of 
ent-syn and ent-anti-255a in THF was exposed to TMPMgCl∙LiCl at −78 °C for 30 minutes 
followed by quenching with excess i-PrOH at the same temperature; the process resulted in a 
mixture more enriched in the syn diastereomer (ent-syn-255a: ent-anti-255a = 72:28; Table 3.4, 
entry 1). 
Table 3.4. Optimisation of reaction conditions for the epimerisation of α-sulfinyl benzoate 255a. 
 
Entry Base Proton source syn:antia 
1 TMPMgCl∙LiCl i-PrOH 72:28 
2 TMPMgCl∙LiCl Meldrum’s acid 80:20 
3 TMPMgCl∙LiCl CH3NO2 78:22 
4 TMPMgCl∙LiCl indene 86:14 
5 t-BuOK t-BuOH 53:47 
6 dimsyl sodium DMSO 55:45 
Reactions were performed on 0.05 mmol scale; a d.r. values were measured by 1H NMR analysis of the crude 
reaction mixture. 
The origin of the selectivity for the syn diastereomer presumably arises from the favoured 
approach of the proton source from the less hindered Re face of the carbanion centre presented 
by the more thermodynamically stable conformer, that is, the one that places the large OTIB 




Scheme 3.24. Rationale for the observed preferential formation of the syn diastereoisomer ent-syn-255a. 
The minor anti isomer was presumably formed through the approach of the proton source from 
the Si face of this conformer, whose steric hindrance would be mitigated by a favourable 
interaction between the magnesium ion and the oxygen atom of the proton source. We therefore 
decided to explore other proton sources where such an interaction might be diminished or 
absent. Indeed, the use of less coordinating proton sources proved to be beneficial, with indene 
exhibiting the highest d.r. value (ent-syn-255a: ent-anti-255a = 86:14; Table 3.4, entry 4). We 
also tested epimerisation under conditions that would be expected to permit equilibration of 
the mixture, namely, KOt-Bu/t-BuOH and dimsyl sodium/DMSO; however, resulting mixtures 
were only very slightly enriched in favour of the syn diastereomer (Table 3.4, entries 5−6).  
Unfortunately, when we subjected a mixture of the isopropyl-substituted benzoates, syn and 
anti-255d, to the optimised conditions (TMPMgCl∙LiCl, THF, −78 °C; indene), the d.r. value 
did not change, suggesting that deprotonation did not occur, presumably owing to the increased 
steric hindrance. 
3.2.4. Homologation of Boronic Esters with α-Sulfinyl Benzoates 
With a range of enantiopure α-sulfinyl benzoates in hand, we were prompt to test their 
efficiency as precursors to metal carbenoids, generated by sulfoxide−metal exchange, for the 
homologation of boronic esters. Optimisation of the sulfoxide−metal exchange/borylation 
sequence was carried out using enantioenriched α-sulfinyl benzoate anti-255a and boronic 
ester 43. Since the work of Blakemore and co-workers showed that lithium carbenoids, 
generated from α-chloro sulfoxides, gave significantly improved results in the homologation 
of boronic esters compared to the corresponding magnesium carbenoids, we initially 
investigated the use of organolithium reagents to trigger the exchange. Conditions reported by 
O’Brien,80 i.e. treatment of a solution of anti-255a in THF with n-BuLi at −78 °C for only one 
minute, followed by the addition of boronic ester 43 (ex situ conditions), were met with failure 
and no desired homologated boronic ester 276 could be detected (Scheme 3.25). This is 
presumably due to the chemical instability of the generated lithium carbenoid under reaction 
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conditions; the same lithium carbenoid generated by tin−lithium exchange from the 
corresponding α-stannyl benzoate is known to be stable for hours at cryogenic temperatures,73 
suggesting that the alkyl-aryl sulfoxide by-product generated by sulfoxide−lithium exchange 
was responsible for the observed instability. 
 
Scheme 3.25. Attempted homologation of boronic ester 43 with sulfoxide anti-255a under ex situ conditions. 
However, adding n-BuLi to a mixture of anti-255a and boronic ester 43  in THF at −78 °C (in 
situ conditions) and stirring the reaction mixture at that temperature for 30 minutes before 
warming to room temperature, allowed the isolation of desired homologated product 276 in 
54% yield (Scheme 3.26). Remarkably, the sulfoxide−lithium exchange was sufficiently rapid 
to prevent the reaction of n-BuLi with the boronic ester; additionally, trapping of the generated 
lithium carbenoid with the boronic ester proved to be faster than other undesired side-reactions. 
Aryl-alkyl sulfoxide by-product 277 was also isolated, although in moderate 40% yield. 
Unexpectedly, ethyl TIB 108a was obtained in significant 22% yield. 
 
Scheme 3.26. Homologation of boronic ester 43 with sulfoxide anti-255a under in situ conditions.  
Ethyl TIB 108a is presumably generated under reaction conditions due to the presence of the 
relatively acidic sulfoxide by-product 277, which could act as an internal proton source and 
quench the generated lithium carbenoid Li-108a (Scheme 3.27). 
 
Scheme 3.27. Plausible mechanism for the formation of ethyl TIB 108a under reaction conditions when n-BuLi 
is employed. 
Not surprisingly, the use of t-BuLi under the same reaction conditions gave a slightly improved 
result, with boronic ester 276 being isolated in 59% yield. However, some ethyl benzoate 108a 
was still formed, suggesting that ortho-protons on sulfoxide by-product 278 are still sufficiently 
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acidic to quench the generated lithium carbenoid (Scheme 3.28). Another possibility is that 
lithium carbenoid Li-108a promoted the elimination of isobutene from sulfoxide 278, leading 
to the formation of ethyl TIB 108a and sulfine 279.154 
 
Scheme 3.28. Plausible mechanism for the formation of ethyl TIB 108a under reaction conditions when t-BuLi is 
employed. 
This operating pathway was subsequently confirmed by the trapping experiment showed in 
Scheme 3.29.ix A solution of t-BuLi in THF was treated with a solution of sulfoxide anti-255a 
in THF at −78 °C for 30 minutes (reverse-addition protocol), followed by a quench with 
CD3OD. Analysis of the 
1H NMR recorded on the crude reaction mixture using an internal 
standard revealed that sulfoxide by-product D-278 was formed in 29% yield with full 
deuterium incorporation, therefore demonstrating its ability to act as an internal proton source 
quenching the generated lithium carbenoid.155 
 
Scheme 3.29. CD3OD-trapping experiment of lithiated benzoate Li-108a. 
Further exploration of the reaction conditions revealed that the use of solvents other than THF, 
such as Et2O, TBME, CPME or PhMe, resulted in a lower product to starting material ratio, as 
determined by GCMS analysis (Table 3.5, entries 2−5). Using t-BuLi (2.0 equiv) and anti-255a 
(1.05 equiv), with boronic ester 43 being the limiting reagent, proved to be the optimal 
                                                 
ix The CD3OD-trapping experiment was conducted by Dr. M. Kucukdisli. 
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stoichiometry to affect the process; these conditions gave complete conversion of starting 
boronic ester 43 (276:43 >99:1, as determined by GCMS analysis), with homologated 
product 276 isolated in 78% yield and excellent e.r. (99:1, 99% es, Table 3.5, entry 8). 
Table 3.5. Optimisation of the reaction conditions for the homologation of boronic ester 43 using lithium 
carbenoids derived from α-sulfinyl benzoates. 
 
Entry Equiv anti-255a Equiv t-BuLi Solvent 276:43a 
1 1.5 1.4 THF 92:8 
2 1.5 1.4 Et2O 20:80 
3 1.5 1.4 TBME 58:42 
4 1.5 1.4 CPME 28:72 
5 1.5 1.4 PhMe 55:45 
6 1.5 2.0 THF 96:4 
7 1.2 2.0 THF 97:3 
8 1.05 2.0 THF >99:1 
Reactions were performed on 0.1 mmol scale. TBME = tert-butyl methyl ether; CPME = cyclopentyl methyl ether. 
a Determined by GCMS analysis of the crude reaction mixture. 
The extra equivalent of t-BuLi is presumably needed as a sacrificial base quenching deleterious 
internal proton sources, such as the already mentioned ortho-protons of aryl-alkyl sulfoxide 
by-product 278 (Scheme 3.30, pathway b), the α-proton of starting sulfoxide anti-255a 
(Scheme 3.30, pathway c) and adventitious moisture.156 The low yield of isolated sulfoxide 278 
might also suggest that base-mediated decomposition affording sulfenic acid 279 and isobutene 




Scheme 3.30. Possible reaction pathways in the homologation of boronic ester 43 with lithium carbenoid 
Li-108a. 
With the aim of identifying milder reaction conditions that would tolerate sensitive functional 
groups, we also investigated the possibility of homologating boronic ester 43 using in situ 
generated magnesium carbenoids, which are known to be more chemically and 
configurationally stable than the corresponding lithium carbenoids.29, 80, 157 Preliminary studies 
indicated that the use of i-PrMgCl to trigger the putative sulfoxide−magnesium exchange of 
α-sulfinyl benzoate 280, followed by trapping of the generated carbenoid with boronic ester 43, 
resulted in an inseparable mixture of homologated boronic ester rac-276 and over-homologated 
boronic ester 282 (Scheme 3.31).x In situ generated magnesium carbenoid Mg-281 was 
presumably stable at the temperature where the 1,2-metallate rearrangement of the boronate 
complex occurs, with the consequence that desired boronic ester rac-276 underwent further 
homologation with the metal carbenoid to form 282. In contrast, lithium carbenoids are known 
to decompose at temperatures above −40 °C.73 
                                                 
x Initial results on the homologation of boronic ester 43 using α-sulfinyl benzoate 280 and i-PrMgCl were obtained 




Scheme 3.31. Homologation of boronic ester 43 with magnesium carbenoid Mg-281 generated with i-PrMgCl. 
Knochel and co-workers showed that the presence of Lewis acidic lithium chloride in the 
reaction mixture is able to complex the generated magnesium carbenoid, reducing its stability 
and thus increasing its reactivity.158-159 We therefore decided to test the use of turbo Grignard 
reagent i-PrMgClLiCl to trigger the sulfoxide−magnesium exchange. Pre-formation of 
magnesium carbenoid Mg-108a by treatment of sulfoxide anti-255a in CH2Cl2 at −78 °C, 
followed by trapping with boronic ester 43 (ex situ conditions), gave improved results, leading 
to complete conversion of starting boronic ester 43 to the desired one-carbon-homologated 
product 276, with no trace of any higher homologous detected (Scheme 3.32).  
 
Scheme 3.32. Homologation of boronic ester 43 with magnesium carbenoid Mg-108a generated with turbo 
Grignard reagent i-PrMgClLiCl under ex situ conditions. 
A similar result was obtained when the reaction was performed under in situ conditions, i.e. by 
addition of the turbo Grignard reagent to a mixture of sulfoxide anti-255a and boronic ester 43. 
In this case, homologated boronic ester 276 was isolated in 76% yield and excellent 




Scheme 3.33. Homologation of boronic ester 43 with magnesium carbenoid Mg-108a generated with turbo 
Grignard reagent i-PrMgClLiCl under in situ conditions. 
With optimal conditions to homologate boronic esters using both lithium and magnesium 
carbenoids, we were prompt to screen the scope of this reaction. Boronic ester 283 was 
therefore homologated with a range of different substituted α-sulfinyl benzoates 255a-g using 
both t-BuLi in THF (Conditions A) and i-PrMgClLiCl in CH2Cl2 (Conditions B, 
Scheme 3.34). Sulfoxides 255a-c,f, bearing non-branched substituents, were found to perform 
well in the process, giving homologated products 284a-c,f in good yields and excellent levels 
of enantiospecificity under both sets of reaction conditions, with the use of the lithium 
carbenoid giving slightly improved results. Not surprisingly, when α-sulfinyl benzoate 255d 
bearing a more sterically hindered substituent was employed, appreciable amounts of 
homologated boronic ester 284d could only be obtained through the generation of the more 
reactive lithium carbenoid, that gave homologated product 284d in 54% yield and 95:5 e.r. 
(97% es). The insertion of magnesium carbenoids into C−B bonds of boronic esters is 
presumably much more sensitive to steric hindrance than the corresponding lithium carbenoids, 
with the consequence that branched-substituted magnesium carbenoids are not sufficiently 




Scheme 3.34.xi Scope of α-sulfinyl benzoates for the homologation of boronic ester 283 using t-BuLi and 
i-PrMgClLiCl. Conditions A: 255 (1.05 equiv), 283 (1.0 equiv) and t-BuLi (2.0 equiv) in THF. Conditions B: 255 
(1.3 equiv), 283 (1.0 equiv) and i-PrMgClLiCl (1.2 equiv) in CH2Cl2. Conditions C: addition of 255 (1.3 equiv) to 
t-BuLi (2.0 equiv) and PMDTA (N,N,N’,N’’,N’’-pentamethyldiethylenetriamine, 2.0 equiv), then addition of 283 
(1.0 equiv). Reaction performed on a 0.2 mmol scale. Yields are based on isolated products. The e.r. values were 
determined by chiral HPLC analysis of the corresponding alcohols. 
When tert-butyl substituted sulfoxide 255e was employed, no desired homologated boronic 
ester 284e was observed under either set of reaction conditions. Detection of considerable 
quantities of neopentyl benzoate 108e indicated that quenching of the generated carbenoid by 
an internal proton source was the predominant pathway (Scheme 3.35). A plausible explanation 
is that the boronate complex formation is in this case slower than normal owing to the increased 
steric hindrance. Pleasingly, desired homologated product could be isolated in good yield using 
a reverse-addition protocol, where α-sulfinyl benzoate 255e was added to a solution of t-BuLi 
in Et2O in the presence of N,N,N',N'',N''-pentamethyldiethylenetriamine (PMDTA), followed 
by the addition of the boronic ester (Scheme 3.34, Conditions C). The relatively low yield for 
                                                 
xi Where indicated (*), the experimental work discussed in this chapter was conducted by Dr. M. Kucukdisli. 
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isolated boronic ester 284e suggests that in the case of sterically hindered benzoate 255e either 
the sulfoxide−lithium exchange or the boronate complex formation (or both the processes) are 
slower than expected, so that quenching of the generated lithiated species Li-108e by the acidic 
α-proton on the carbenoid precursor 255e is a competing pathway. 
 
Scheme 3.35. Competing quenching of the in situ generated lithium carbenoid in the homologation of boronic 
ester 283 with sulfoxide anti-255e. 
Unexpectedly, homologated product 284e was isolated in moderate enantiospecificity 
(77% es). The two possible scenarios that account for this lack of enantiospecificity when 
sulfoxide 255e was employed are shown in Scheme 3.36. One possibility is that neopentyl 
benzoate 108e, generated by quenching of enantioenriched lithium carbenoid Li-108e by an 
internal proton source, undergoes deprotonation in the presence of a combination of t-BuLi and 
PMDTA to give racemic lithiated species rac-Li-108e (Scheme 3.36A). Alternatively, since 
the sulfoxide−lithium exchange is slower in this case, an α-deprotonation/reprotonation process 
could compete, eventually leading to a diastereomeric mixture of syn and anti-255e undergoing 




Scheme 3.36. Possible mechanisms for the observed lack of enantiospecificity in the homologation of boronic 
ester 283 with sulfoxide anti-255e. 
The scope of the boronic ester component was also briefly explored (Scheme 3.37). Boronic 
esters bearing sensitive functional groups, such as tert-butyl ester (285a) or azido (285b) 
groups, could only be successfully homologated with sulfoxide 255a by reaction with the 
corresponding magnesium carbenoid, to give boronic esters 286aa and 286ab, respectively. 
This is not surprising, considering the high reactivity of organolithiums towards these 
functional groups, therefore preventing the formation of the desired boronate complex. 
Magnesium carbenoids were also found to be superior reagents for the homologation of vinyl 
and aryl boronic esters (285c-d), while when the lithium carbenoid was employed, although 
the expected products were isolated, the yields were significantly reduced. Finally, more 
sterically hindered boronic ester 285e was also successfully homologated with sulfoxide 255a. 
In this case, better results were obtained using the more reactive lithium carbenoid that allowed 




Scheme 3.37.xii Homologation of boronic esters with α-sulfinyl benzoate 255a using t-BuLi and i-PrMgClLiCl. 
Conditions A: 255a (1.05 equiv), 285 (1.0 equiv) and t-BuLi (2.0 equiv) in THF. Conditions B: 255a (1.3 equiv), 285 
(1.0 equiv) and i-PrMgClLiCl (1.2 equiv) in CH2Cl2. Reaction performed on a 0.2 mmol scale. Yields are based on 
isolated products. The e.r. values were determined by chiral HPLC analysis of the corresponding alcohols. The 
d.r. values were determined by 13C NMR analysis; a ent-anti-255a was used. 
3.2.5. Synthesis of Enantioenriched α-Sulfinyl Benzoates by Alkylation 
Compared to tin−lithium exchange, sulfoxide−metal exchange is extremely fast; this has been 
shown by the fact that the metal carbenoid could be generated under in situ conditions, 
indicating that the exchange occurs more rapidly than the reaction of the organolithium with 
the boronic ester. This means that sensitive functional groups, that would normally be reactive 
towards organometals, could potentially be tolerated in the process, thus marking a substantial 
advance in the lithiation−borylation methodology. However, the protocol described for the 
synthesis of enantioenriched α-sulfinyl benzoates nullifies this potential, since the strong base 
necessary for the initial deprotonation of benzoates is not compatible with the presence of 
sensitive functional groups. We therefore decided to explore a different strategy to access 
substituted α-sulfinyl benzoates. 
We have already shown that methylene sulfoxide 256 can be deprotonated at the alpha position 
using relatively weak bases, such as LDA and LiHMDS, and subsequently trapped with methyl 
                                                 
xii Where indicated, the experimental work discussed in this chapter was conducted by Dr. M. Kucukdisli (*) and 
J. M. Fordham (†). 
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iodide or allyl iodide (see § 3.2.1). We wondered if general conditions to alkylate sulfoxide 256 
could be developed in order to introduce a range of different functional groups. Unfortunately, 
the conditions to perform this alkylation reaction were found to be highly dependent on the 
electrophile employed and extensive optimisation was required to achieve the synthesis of a 
variety of substituted α-sulfinyl benzoates (Scheme 3.38). In particular, very reactive 
electrophiles were found to be fundamental to ensure the success of the process, with triflates 
generally performing better than the corresponding halides. With less reactive electrophiles, 
trapping of the in situ generated anion became in fact too slow and decomposition pathways 
became evident. For instance, ethyl substituted benzoate 255c could only be accessed by 
treatment of a solution of sulfoxide rac-256 and EtOTf (1.1 equiv) in THF with NaHMDS 
(1.05 equiv), while EtBr, EtI and EtOMs failed to provide the desired product. Under these 
conditions, a separable mixture of syn and anti-255c was isolated in 58% yield 
(syn-255c:anti-255c ca. 2:1). The same protocol was also found to be successful when butyl 
triflate was used as the alkylating agent to give α-sulfinyl benzoates syn and anti-255p in 56% 
overall yield (syn-255p:anti-255p ca. 1:1). Benzoate 255q, bearing an ester-terminated pentyl 
substituent, was also obtained employing the corresponding triflate under the same reaction 
conditions. Alkylation of sulfoxide (S)-256 using commercially available 1-chloro-3-iodo 
propane as the electrophile proved to be more challenging. LDA, LiTMP and NaHMDS failed 
to provide desired sulfoxides syn and anti-255n and only decomposition of the in situ generated 
anion was observed. Addition of AgOTf to favour the alkylation step by precipitating AgI did 
not give improved results. However, performing the alkylation reaction using LDA as the base 
in the presence of hexamethylphosphoramide (HMPA) as an activator resulted in the formation 
of desired sulfoxides syn and anti-255n, with anti-255n being the major product. 
Further optimisation allowed the synthesis of α-sulfinyl benzoates 255k-m,o,r. Remarkably, 
sensitive functional groups, such as azido (255o) and trifluoromethyl groups (255r) could be 
successfully installed together with other useful substituents (255k-m) which would have not 




Scheme 3.38.xiii Optimal reaction conditions for the alkylation of α-sulfinyl benzoate 256 with a range of 
electrophiles. a Prepared from rac-256; b prepared from (S)-256; c in the presence of HMPA. 
As aforementioned, the diastereoselectivity of these alkylation reactions was highly variable 
and difficult to predict. In general, we noticed that the generation of lithium carbenoids resulted 
in preferential formation of the anti diastereoisomer, while the use of magnesium bases gave 
the syn diastereoisomer as the major product. In contrast, poor diastereocontrol was observed 
when sodium bases were employed. This seems to suggest that the coordination of the metal 
centre to the electrophile plays a key role in determining the diastereoselectivity of the process, 
as well as its influence on the aggregation state of the generated carbanion.160 
                                                 
xiii Where indicated, the experimental work discussed in this chapter was conducted by Dr. M. Kucukdisli (*) and 
J. M. Fordham (†). 
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A variety of other electrophiles were also tested in the process, such as Togni reagents I and II, 
Umemoto reagent and the Eschenmoser’s salt, but were found to be unable to afford the 
corresponding alkylated α-sulfinyl benzoates, with decomposition of the generated lithium 
carbenoid becoming apparent in most of the cases.xiv 
3.2.6. Homologation of Boronic Esters with Functional Group-Rich α-Sulfinyl 
Benzoates 
α-Sulfinyl benzoates 255k-r were subsequently tested as precursors to lithium (t-BuLi) and 
magnesium (i-PrMgClLiCl) carbenoids in the homologation of boronic ester 283 
(Scheme 3.39). Unsurprisingly, better results in terms of both yields and enantiospecificity 
were obtained through the generation of the less reactive magnesium carbenoids. In the case of 
azidopropyl and ester-terminated pentyl substituted sulfoxides 255o and 255q, no product 
could be isolated when t-BuLi was employed; however, the use of milder reaction conditions 
using i-PrMgClLiCl gave access to homologated products 284o-q in good yield and excellent 
stereospecificity. 
                                                 
xiv Alkylation of methylene sulfoxide 256 using Togni reagents I and II, Umemoto reagent and Eschenmoser’s 




Scheme 3.39.xv Homologation of boronic esters with lithium or magnesium carbenoids derived from α-sulfinyl 
benzoates, as prepared through the alkylation of α-sulfinyl benzoate (R)-256 or (S)-256. Conditions A: 255a 
(1.05 equiv) and t-BuLi (2.0 equiv) in THF. Conditions B: 255a (1.3 equiv) and i-PrMgCl·LiCl (1.2 equiv) in CH2Cl2. 
Reactions performed on a 0.2 mmol scale. Yields are based on isolated product. The e.r. values were determined 
through chiral HPLC analysis of the corresponding alcohols. a Boronic ester oxidised to the corresponding alcohol 
prior to isolation; b magnesium carbenoid formed prior to the addition of the boronic ester.  
3.2.7. Synthesis of Fully Substituted α-Sulfinyl Benzoates  
We next embarked on the synthesis of fully substituted α-sulfinyl benzoates, that, if used in the 
homologation of boronic esters, would afford useful enantioenriched tertiary boronic esters.xvi 
Alkylation of methyl-substituted sulfoxide 255a with benzyl iodide using LDA as the base 
afforded fully substituted sulfoxide 287aa in 77% yield (Table 3.6, entry 2). As previously 
                                                 
xv Where indicated, the experimental work discussed in this chapter was conducted by Dr. M. Kucukdisli (*) and 
J. M. Fordham (†). 
xvi The synthesis of fully substituted α-sulfinyl benzoates was conducted by Dr. M. Kucukdisli. 
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observed, the use of a very reactive electrophile was found to be essential (Table 3.6, 
entries 1−2). 
Table 3.6.  Synthesis of disubstituted α-sulfinyl benzoates through alkylation of monosubstituted derivatives. 
 
Entry R1 R2 X Product d.r.a % Yield 
1 CH3 PhCH2 Br 287aa >95:5 10 
2 CH3 PhCH2 I 287aa >95:5 77 
3 CH3 CH2=CHCH2 I 287ab >95:5 76 
4 CH3 CH3CH2 OTf 287ac 60:40 38 
5 CH3 CH3CH2 I – – – 
6 CH2=CHCH2 CH3 I 287ab 80:20 n.d. 
7 PhCH2CH2 CH3 I 287ad 92:8 59 
Reaction conditions: benzoate 255a (1.0 equiv), R2-X (1.5 equiv), LDA (1.8 equiv) in THF, −78 °C. a Determined by 
1H NMR analysis. 
Importantly, α-sulfinyl benzoate 287aa was obtained in very high diastereoselectivity (>95:5), 
with the major diastereoisomer being the one placing the benzoate group opposite to the oxygen 
atom of the sulfinyl group. The use of either the syn or the anti diastereoisomer of the starting 
sulfoxide 255a led to the formation of the same major product, therefore suggesting the 
intermediacy of a common carbanionic species.161 A plausible mechanism accounting for the 
observed diastereoselectivity is shown in Scheme 3.40. The carbanion generated by 
deprotonation of sulfoxide 255a exists as two different conformers; only the more 
thermodynamically stable, which is the one displaying the large benzoate substituent on the 
same side of the lone pair on the sulfur centre, is involved in the subsequent trapping step. The 
electrophile then approaches the carbanion from the re face, which is not hindered by the 
presence of the oxygen atom on the sulfinyl group.162 Furthermore, the attack of the 
electrophile from the re face leads to an increase in the dihedral angle between the R substituent 
on the carbanionic carbon centre and the p-tolyl group on the vicinal sulfur centre, while the 
approach from the more hindered si face would reduce this angle, which would increase the 
strain. This model can also account for the low diastereoselectivity observed in the case of the 
alkylation of methylene sulfoxide 256. In this case, the absence of a substituent on the 
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carbanionic centre brings no such strain when the electrophile approaches from the si face. 
Furthermore, a deprotonation/reprotonation process at the alpha position might also be 
operating under reaction conditions, which would also lead to poor diastereocontrol (see § 3.2.1 
and 3.2.3). 
 
Scheme 3.40. Proposed model rationalising the observed diastereoselectivity observed in the alkylation of 
α-sulfinyl benzoates. 
Sulfoxide 255a was also alkylated using allyl iodide as the electrophile to access 
sulfoxide 287ab in 76% yield and perfect diastereoselecivity (Table 3.6, entry 3). 
Unfortunately, alkylation of sulfoxide 255a using smaller electrophiles, such as methyl iodide 
and ethyl triflate, gave inferior results, with the corresponding fully substituted α-sulfinyl 
benzoates being isolated as inseparable mixtures of diastereoisomers (Table 3.6, entries 5−7). 
It might be postulated that the smaller size of the incoming electrophile leads to a reduced facial 
selectivity, with the si face also becoming accessible. Additionally, in the case of ethyl triflate, 
coordination of the triflate group to the lithium counter anion might direct the attack of the 
electrophile from the more hindered face of the favoured conformer.160 
3.2.8. Synthesis of Enantioenriched Tertiary Boronic Esters 
Diastereo- and enantiopure fully substituted α-sulfinyl benzoates 287aa and 287ab were 
subsequently tested in the homologation of boronic esters to access α-tertiary boronic esters 
(Scheme 3.41).xvii Unsurprisingly, homologation of boronic ester 283 with sulfoxide 287aa 
failed under both sets of the previously described conditions for the generation of the lithium 
and magnesium carbenoids. Similarly to the case of tert-butyl substituted sulfoxide 255e, the 
sulfoxide−metal exchange for sulfoxide 287aa is significantly slower owing to increased steric 
                                                 




hindrance, with the consequence that the t-BuLi attacks the boronic ester to produce an 
ineffective boronate complex. When the reverse-addition protocol developed for the 
homologation of boronic esters using sulfoxide 255e (addition of the sulfoxide to a solution of 
t-BuLi in Et2O in the presence of PMDTA at −78 °C, followed by addition of the boronic ester, 
see § 3.2.4) was applied, we were pleased to isolate, after oxidation, desired homologated 
product 288a in 57% yield and 99% es. The same conditions were subsequently applied to the 
homologation of boronic ester 43 with sulfoxide 287ab, to give homologated alcohol 288b in 
good yield and similar levels of enantiospecificity, in contrast with the result obtained with 
tert-butyl substituted sulfoxide 255e, where the corresponding homologated product was 
isolated in lower e.r. (see § 3.2.4) This is consistent with the mechanism depicted in 
Scheme 3.40, suggesting that the observed lack of enantiospecificity is due to a base-mediated 
epimerisation at the alpha position of sulfoxide 255e under reaction conditions. 
 
Scheme 3.41. Homologation of boronic esters with disubstituted α-sulfinyl benzoates. Conditions: addition of 
benzoate 287 (1.3 equiv) to a solution of t-BuLi (2.0−2.3 equiv) and PMDTA (2.0−2.3 equiv) in Et2O, then boronic 
ester (1.0 equiv). a The boronic ester was oxidised to the corresponding alcohol prior to isolation. 
3.2.9. Iterative Homologation of Boronic Esters Using α-Sulfinyl Benzoates 
Having shown that substituted α-sulfinyl benzoates can be efficiently employed to homologate 
boronic esters, we sought to investigate the possibility of performing several iterative 
homologations. In particular, we wished to avoid chromatographic purification after each step, 
hoping that a simple filtration through a plug of silica gel would be sufficient to remove the 
highly polar side-products generated in each iteration. We initially planned to subject phenethyl 
pinacol boronic ester 43 to two consecutive homologations using allyl-substituted benzoate 
syn-255b followed by a third homologation with methyl-substituted benzoate ent-syn-255a; 
this three-pot process would eventually afford, after final oxidation, triple homologated 
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alcohol 289 (Table 3.7).xviii As expected, boronic ester 43 could be efficiently homologated 
using either lithium or magnesium carbenoids generated in situ from sulfoxide syn-255b. 
GCMS analysis of the crude reaction mixture showed very high ratios of desired product to 
starting material 43 in both cases (99:1 and 98:2 respectively, Table 3.7, entries 1−2). The 
second homologation process proved to be more challenging and low product to starting 
material ratio was observed by GCMS analysis (26:74, Table 3.7, entry 2) when the magnesium 
carbenoid was employed. The increased steric hindrance around the boron centre presumably 
decreased the rate for the formation of the intermediate boronate complex to an extent that 
internal quenching of the carbenoid became the privileged pathway. Pleasingly, the more 
reactive lithium carbenoid was found to give improved results, with high product to starting 
material ratios determined by GCMS analysis (96:4, Table 3.7, entry 1). The third iteration was 
conducted using the lithium carbenoid generated from methyl-substituted benzoate 
ent-syn-255a. However, low product to starting material ratio was observed by GCMS analysis 
when standard optimal conditions were applied (60:40, Table 3.7, entry 1), and alcohol 289 
was isolated in only 29% yield over the four steps (65% yield per iteration, Table 3.7, entry 1). 
Further optimisation revealed that using an excess of both α-sulfinyl benzoate ent-syn-255a 
(1.5 equiv) and t-BuLi (3.0 equiv) gave an improved product to starting material ratio observed 
by GCMS analysis (85:15, Table 3.7, entry 3), with the targeted triple homologated alcohol 289 
isolated in 41% yield and >95:5 d.r. (75% yield per iteration, Table 3.7, entry 3).  
Table 3.7. Iterative homologation of boronic esters using α-sulfinyl benzoates. 
 
Entry Conditions 1st P:SM 2nd P:SM 3rd P:SM % Yield 289 d.r. 
1 A 98:2 96:4 60:40 29 >95:5 
2 B 99:1 26:74 − − − 
3 A’ 98:2 96:4 85:15 41 >95:5 
Conditions A: boronic ester (1.0 equiv), sulfoxide (1.05 equiv) and t-BuLi (2.0 equiv) in THF (in situ conditions). 
Conditions B: boronic ester (1.0 equiv), sulfoxide (1.3 equiv) and i-PrMgClLiCl (1.2 equiv) in CH2Cl2 (in situ 
conditions). Conditions A’: boronic ester (1.0 equiv), sulfoxide (1.5 equiv) and t-BuLi (3.0 equiv) in THF (in situ 
conditions). The first two homologations were carried out on a 1.0 mmol scale and the third on a 0.33 mmol 
scale. The oxidation step was performed using NaBO34H2O. Product to starting material ratios were determined 
                                                 
xviii The iterative homologations of boronic ester 43 using α-sulfinyl benzoates were conducted by J. M. Fordham. 
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by GCMS analysis of the crude reaction mixtures. Yields reported are those of alcohol 289 isolated by column 
chromatography (over the four steps). Diastereomeric ratios were determined by 13C NMR analysis. 
The efficiency of the third homologation could be further improved using methyl substituted 
α-stannyl benzoate (S)-109 as the carbenoid precursor. Treatment of a solution of benzoate 
(S)-109 (1.35 equiv) with n-BuLi (1.3 equiv), followed by addition of double homologated 
boronic ester 290 allowed the isolation of alcohol 289 in 52% yield and as a single 
diastereoisomer (80% yield per iteration, Scheme 3.42). The high product to starting material 
ratio observed by GCMS analysis when the required lithium carbenoid was generated from 
α-stannyl benzoate is an indication of the impact of the acidity of monosubstituted α-sulfinyl 
benzoates in the homologation of sterically hindered boronic esters, where the internal 
quenching of the generated lithium carbenoid competes with the formation of the required 
boronate complex (see § 3.2.4). 
 
Scheme 3.42. Homologation of boronic ester 290 using α-stannyl benzoate (S)-109. Reaction conditions: (S)-109 
(1.35 equiv) and n-BuLi (1.3 equiv) in Et2O, then boronic ester 290 (1.0 equiv). The oxidation step was performed 
using NaBO34H2O (10 equiv) in THF/H2O (3:2). Diastereomeric ratios were determined by 13C NMR analysis. 
To further demonstrate the relevance of steric hindrance on these type of iterative homologation 
processes, we embarked in the synthesis of alcohol 291, which required a similar protocol to 
the one applied to access alcohol 289, but with the incorporation of a Matteson homologation 
between the second and the third iteration (Scheme 3.43). The alleviation of the steric 
encumbrance around the boron centre through the introduction of a methylene unit led to a 
higher product to starting material ratio observed by GCMS analysis and desired alcohol 291 
was isolated in 37% yield over the five steps (82% yield per iteration), thus providing an 




Scheme 3.43. Iterative homologation of boronic ester 290 using sulfinyl benzoate ent-syn-255a with an 
intervening Matteson homologation. Reaction conditions: boronic ester 290 (1.0 equiv), bromochloromethane 
(3.0 equiv) and n-BuLi (2.5 equiv) in Et2O; ent-syn-255a (1.1 equiv) and t-BuLi (2.0 equiv) in THF (in situ 
conditions). The oxidation step was performed using NaBO34H2O (10 equiv) in THF/H2O (3:2). Diastereomeric 
ratios were determined by 13C NMR analysis. 
3.3. Conclusions 
The results reported demonstrate that α-sulfinyl benzoates can be successfully employed in the 
homologation of boronic esters to introduce a variety of different functional groups 
(Scheme 3.44). The required metal carbenoid is generated through a selective sulfoxide−metal 
exchange using either organolithium or organomagnesium reagents. 
 
Scheme 3.44. Stereospecific homologation of boronic esters using α-sulfinyl benzoates as the carbenoid 
precursors. 
α-Sulfinyl benzoates 255 were efficiently synthesised in good yields and very high levels of 
enantiopurity from the corresponding racemic lithiated benzoates. Importantly, these 
compounds were accessed without using sparteine, which is currently difficult to source 
commercially. Extensive optimisation of the reaction conditions revealed that transmetalation 
to the corresponding magnesiated benzoate was essential to prevent racemisation in the 
subsequent electrophilic trapping with enantiomerically pure Andersen’s sulfinate, as 
previously observed by O’Brien and co-workers. High levels of enantiospecificity could be 
achieved for both the syn and anti diastereoisomers of a range of α-sulfinyl benzoates 255 




Scheme 3.45. Synthesis of enantioenriched α-sulfinyl benzoates 255 via sulfinylation of benzoates 108. 
Alternatively, α-sulfinyl benzoates could be prepared by alkylation of methylene α-sulfinyl 
benzoate 256, which could be deprotonated using relatively weak bases, such as LDA or 
LiHMDS (Scheme 3.46A). The advantage of this second approach is that sensitive functional 
groups, that would be reactive towards strong lithium bases, can be successfully introduced. 
Fully substituted α-sulfinyl benzoates 287aa-ab were also synthesised through this alkylation 
protocol, providing the desired substrates with very high levels of and enantio- and 
diastereoselectivity (>95:5) (Scheme 3.46B). 
 
Scheme 3.46. Synthesis of enantioenriched α-sulfinyl benzoates via alkylation. 
Optimal reaction conditions have been developed to convert these building blocks into the 
corresponding lithium (t-BuLi in THF) and magnesium (i-PrMgClLiCl in CH2Cl2) carbenoids 
to allow the homologation of different pinacol boronic esters. In situ conditions (generation of 
the metal carbenoid in the presence of the boronic ester) were found to be essential for the 
generation of the lithium carbenoid owing to the instability of this species under reaction 
conditions. In particular, internal quenching of the generated carbenoid was found to compete 
with the formation of the desired boronate complex, thus inhibiting the conversion of the 
starting boronic ester into the desired homologated product. Magnesium carbenoids proved to 
be more stable and were allowed to be formed prior to the addition of the boronic ester, 
although generation under in situ conditions were ultimately found to give optimal results. 
Homologation of boronic esters proceeded smoothly to give the corresponding one-carbon 
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extended products in generally good yields and with excellent levels of enantiospecificity. 
Remarkably, the use of magnesium carbenoids allowed carbon chains to be grown with the 
incorporation of sensitive functional groups, such as alkyl/aryl halides, azides and esters; the 
use of lithium carbenoids, which are less sensitive to steric hindrance, allowed sterically 
encumbered carbon–carbon bonds to be forged. Fully substituted α-sulfinyl benzoates gave 
access to versatile enantioenriched tertiary boronic esters. 
We have also shown that this class of carbenoid precursors can be used in three- and four-step 
iterative homologation processes, without intervening column chromatography, to give 
contiguously substituted carbon chains with very high levels of enantio- and 
diastereoselectivity, therefore showing the potential of this methodology to be automated. 
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4. Building Block-Based Approach for the Iterative Installation 
of Functional Groups Containing Double Bonds 
4.1. Introduction and Project Aims 
The development of synthetic methodologies allowing the stereoselective formation of new 
carbon−carbon bonds in an iterative fashion, under complete reagent control, represents an 
important progression that will herald a new era for automated synthesis.146, 163 The iterative 
homologation of boronic esters through lithiation−borylation reactions, enabling the growth of 
chains of carbon atoms with complete control of stereochemistry at each carbon centre, 
independent of the presence of pre-existing stereocentres, is part of this group of reactions and 
is therefore particularly attractive. In this case, automation is made possible by the development 
of appropriate enantiomerically enriched chiral carbenoids to be used as building blocks in 
each iteration. 
Aggarwal and co-workers have already described an efficient building-block based strategy to 
access linear molecules containing contiguous substituted stereocentres through the iterative 
homologation of boronic esters using enantioenriched α-stannyl benzoates as carbenoid 
precursors.73 This methodology allowed the synthesis of linear molecules bearing 10 sequential 
methyl substituents with excellent levels of enantiospecificity; the relative stereochemistry 
could be modulated by changing the stereochemistry of the building-block employed in each 
step (see § 1.5.5). The power of this methodology relies on the fact that no additional 
manipulations, such as functional group interconversions or protections, need to be performed 
between each iteration. Alternation of this iterative synthetic strategy with the Matteson 
homologation, which is based on the use of chloromethyllithium as the carbenoid precursor 
(see § 1.2), allowed the efficient total synthesis of two important polydeoxypropionates, 




Scheme 4.1. Iterative assembly line-synthesis for the total synthesis of polydeoxypropionate natural products, 
(+)-kalkitoxin and (+)-hydroxyphthioceranic acid. 
More recently, this methodology has been further expanded, and a new class of building blocks 
has been developed to allow the introduction of oxygen functionalities, therefore providing 
access to more complex structural motifs.164 This was achieved through the use of 
enantioenriched α-chloromethyl silanes (R) and (S)-292 as the carbenoid precursors; 
deprotonation with s-BuLi at −78 °C, followed by trapping with boronic esters, gave, after 
stereospecific 1,2-metallate rearrangement, the corresponding homologated α-silyl boronic 
esters 294 in high yield and excellent diastereoselectivity (Scheme 4.2). The silyl group acts a 
masked oxygen functionality, that can eventually be unmasked by oxidative cleavage of the 
silicon−carbon bond. 
 
Scheme 4.2. Stereoselective homologation of boronic esters with α-lithiated chloromethyl silane 292. 
An iterative homologation protocol was also successfully developed by subjecting α-silyl 
boronic ester 294 to a further homologation with lithiated benzoate (R)-Li-108a, generated in 
situ from α-stannyl benzoate (S)-109. Beforehand, cleavage of the sterically encumbered 
pyrrolidine group using photoredox catalysis was performed to access the corresponding 
methoxysilane 295; coordination of the nitrogen atom to the boron centre was in fact found to 
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reduce the reactivity of intermediate 294, thus inhibiting boronate complex formation. 
Homologation of 295 with lithiated carbenoid (S)-Li-108a proceeded smoothly to give boronic 
ester 296, which was subsequently further homologated with α-chloromethyl silane (R)-Li-292 
in excellent yield and d.r.; photoredox cleavage of the aminomethyl group, followed by another 
homologation with lithiated benzoate (S)-Li-108a afforded boronic ester 298 in 59% yield and 
>95:5 d.r. Modified Tamao oxidation of the silyloxy groups using urea-H2O2 complex finally 
gave access to diol 299 (Scheme 4.3). Importantly, each set of double 
homologation/photoredox cleavage was conducted with only one chromatographic 
purification. 
 
Scheme 4.3. Iterative assembly line synthesis for the construction of polypropionates. 
Other diastereoisomers of diol 299 could also be accessed by careful selection of the chiral 
building blocks employed in each iteration; after final Tamao oxidation, all the targeted polyols 
were obtained in similarly good yield and >95:5 d.r., therefore demonstrating the absence of 
any matched/mismatched effects.165  
One important outcome of this methodology is that it provides rapid access to polypropionates, 
carbon chains containing alternating methyl and hydroxy groups, which are common repeating 
motifs found in many polyketide structures. Polyketides are an important class of complex 
molecules displaying various biological activities, and they represent the basic chemical 
skeleton of many potent pharmaceutical agents, such as antibiotics, immunosuppressants, 
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antifungal and anticancer drugs.166-168 In nature, the biosynthesis of polyketides involves a 
series of iterative reactions catalysed by different enzymes belonging to the family of 
polyketide synthases (PKSs). In particular, a simple thioester starting unit undergoes sequential 
chain extensions, reductions and dehydrations using appropriate 2-, 3- and 4-carbon building 
blocks (Scheme 4.4).169 
 
Scheme 4.4. Nature's synthesis of polyketides; DH = dehydratase; ER = enoyl reductase; KS = ketosynthase; 
KR = ketoreductase. 
Aggarwal’s assembly-line synthesis aims to emulate this biosynthetic pathway performed by 
nature by constructing substituted chains of carbon atoms through a series of stereocontrolled 
iterative homologations of boronic esters using various building blocks. However, the current 
methodology only allows the introduction of methyl and hydroxyl substituents, while building 
blocks allowing the introduction of other functional groups have not been developed yet. This 
would be beneficial given the remarkable structural diversity of polyketides. 
 For example, carbonyls, C−C double bonds and enones can be identified as ubiquitous 




Figure 4.1. Examples of polyketide structures containing carbonyl, double bond and enone functionalities. 
The aim of this project is the development of simple 1-, 2- and 3-carbon building blocks to be 
used in the homologation of boronic esters, allowing the introduction of these functionalities. 
The combination of these new building blocks with the ones previously developed will enable 
the transformation of simple boronic esters into linear chains of carbon atoms bearing a variety 
of different functional groups, therefore extending the boundaries of the assembly-line 
methodology with the possibility of creating even more diversity. 
The introduction of a carbonyl group through the homologation of boronic esters requires the 
development of an appropriate 1-carbon building block. Specifically, carbonyl groups must be 
introduced as masked functionalities, since they are not compatible with the conditions required 
for lithiation−borylation reactions. Homologation of boronic esters with a suitable building 
block 300 would therefore generate intermediate boronic ester 301, which could then undergo 
further homologations with different building blocks; a final functional group interconversion 




Scheme 4.5. Development of a 1-carbon building block allowing the homologation of boronic esters with the 
introduction of a masked carbonyl functionality. 
The required building block should therefore fulfil the following criteria: first, it must be 
possible to rapidly convert it into a reactive lithium carbenoid, by either deprotonation or 
lithium/halogen exchange; second, the carbenoid carbon must be attached to both a suitable 
leaving group, to allow the 1,2-metallate rearrangement, and a functional group, stable under 
lithiation borylation reaction conditions, acting as a masked ketone (Scheme 4.6). The most 
common way of masking a carbonyl functionality is using the corresponding ketal, a functional 
group that is known to be stable under various reaction conditions and can be easily removed 
by treatment with acid. Thioketals can also be used as protected carbonyl groups, although they 
are more stable to hydrolysis under acidic conditions than the corresponding ketals, thus 
requiring harsher methods for their removal, such as the use of oxidising agents or mercury 
salts. However, the acidity of 1,3-dithianes makes this carbonyl masking group particularly 
attractive, since the corresponding readily accessible anion, if attached to a suitable leaving 
group, could be employed in lithiation−borylation reactions. Hemiaminal thioethers will also 
be considered as potential masking groups for the targeted carbonyl functionality. 
Alternatively, a C−C double bond could be introduced as a masking carbonyl group, that could 
be eventually converted into a ketone by simple ozonolysis followed by reductive work-up. 
Another possibility would be developing a building block that allows the insertion of a 
thioether functionality, that would release the required ketone in a three-step process, involving 
an initial oxidation to the corresponding sulfoxide, followed by Pummerer rearrangement and 
hydrolysis of the resulting α-acyloxy-thioether. All these potential strategies will be considered 





Scheme 4.6. Possible masking groups for carbonyl functionalities. 
A 2-carbon building block is required for the introduction of double bonds through the 
homologation of boronic esters. In this case, there is no need to mask the targeted functionality, 
since it is known that alkenes are well tolerated in lithiation−borylation reactions. In 2012, Breit 
and co-workers reported a novel methodology to convert alkenes into primary and secondary 
alkylmagnesium reagents through sequential hydroboration and boron−magnesium exchange 
(Scheme 4.7A).170 The generated alkylmagnesium species were successfully trapped with a 
variety of carbon electrophiles to generate new C−C bonds using a simple and efficient 
protocol. Interestingly, alkylmagnesium intermediate 303, generated from the corresponding 
pinacol boronic ester 302, could also be successfully employed in a palladium catalysed 
Kumada cross-coupling reaction with β-bromostyrene to give coupled product 304 in excellent 
91% yield (Scheme 4.7B). This methodology was subsequently applied to the total synthesis 
of epothilone D, a polyketide studied as potential cancer drug.171 In one of the key steps, 
alkylboronic ester 306, obtained by catalytic hydroboration of alkene 305, was subjected to 
boron−magnesium exchange, using 1,4-di(chloromagnesium)butane, to give the corresponding 
alkylmagnesium intermediate; this was subsequently used in a Negishi cross-coupling reaction 
with vinyl bromide 307 to afford vinyl boronic ester 308 (Scheme 4.7C). The process thus 
allowed a 2-carbon homologation of starting boronic ester 306 with the introduction of a C−C 
double bond; more importantly, the cross-coupling reaction enabled the reintroduction of the 




Scheme 4.7. Breit's synthesis of alkylmagnesium reagents through hydroboration and boron−magnesium 
exchange. 
Although the process is reported to work with secondary boronic esters,170 no example was 
reported that made use of enantioenriched substrates. In particular, we were concerned about 
the configurational stability of the generated alkylmagnesium species at the temperature 
required for the boron−magnesium exchange; this made us hesitant about adopting this 
methodology and prompted us to seek new protocols. 
A powerful method to convert enantioenriched secondary and tertiary boronic esters into 
terminal and internal alkenes using vinyl metals is the Zweifel olefination, which is known to 
proceed with very high levels of stereoselectivity (see § 1.7.3). It was reasoned that the 
introduction, on the vinyl metal partner, of a suitable substituent that could be eventually 
converted into a boron group would effectively enable a 2-carbon homologation of boronic 
esters, maintaining the boronate group, with the introduction of a double bond (Scheme 4.8). 
One of the aims of this project is the design and synthesis of an appropriate 2-carbon alkenyl 
building block 309 bearing one substituent (Y), that can be rapidly converted into an 
organolithium; and a second one (X), that is stable under the homologation reaction conditions, 
but would allow the reintroduction of the boronic ester functionality. Once identified, the 




Scheme 4.8. Proposed homologation of boronic esters with introduction of C−C double bonds through Zweifel 
olefination. 
Finally, a 3-carbon building block will also be developed to enable the introduction of enone 
functionalities. As mentioned before, the carbonyl group must be introduced in a masked form 
due to its instability under the typical homologation reaction conditions and released only at 
the end of the assembly-line synthesis process.  
A building block that could be suitable for this protocol is alkene 310 (Scheme 4.9). An 
appropriate leaving group (Y) must be identified to allow the formation of a sufficiently stable 
lithium carbenoid that, upon reaction with a boronic ester, would undergo 1,2-metallate 
rearrangement to give homologated product 311; subsequent oxidation and protection of the 
generated alcohol would finally give intermediate 312. The vinyl substituent (X) must also be 
carefully chosen to make the reintroduction of the boronic ester group possible, so that further 
iterative homologations, using different building blocks, could elongate the carbon chain. Final 
deprotection and oxidation of the generated hydroxyl group will liberate the required enone 
functionality. 
 
Scheme 4.9. Proposed homologation of boronic esters with introduction of enone functionalities using alkenyl 
building block 310. 
Propargylic substrate 314 could also be employed in a similar process (Scheme 4.10). In this 
case, the intermediate 3-carbon homologated vinyl boronic ester 317, bearing a protected 
oxygen functionality, would be accessed through hydroboration of the terminal alkyne.xix 
                                                 





Scheme 4.10. Proposed homologation of boronic esters with introduction of enone functionalities using 
propargyl building block 314. 
A different approach would involve the use of alkoxyallenes as 3-carbon building blocks for 
the homologation of boronic esters. In this case, a modified Zweifel olefination protocol, using 
the lithiated alkoxyallene in the place of a vinyl metal, would allow the conversion of boronic 
esters into terminal enones (Scheme 4.11). This methodology will be investigated and, if 
successful, further extended to allow the use of this new type of building block in an iterative 
fashion through the reintroduction of the boronic ester functionality. 
 
Scheme 4.11. Proposed homologation of boronic esters with introduction of enone functionalities using 
alkoxyallene 318. 
4.2. Results and Discussion 
4.2.1. Development of a 1-C Building Block for the Introduction of Masked Carbonyl 
Functionalities through the Homologation of Boronic Esters 
Initial investigations focused on the development of a building block to homologate boronic 
esters with the introduction of a thioketal group as a masked carbonyl functionality. 
2-Chloro-1,3-dithiane 323 was at first selected as a suitable carbenoid precursor, since 
deprotonation would readily occur at the 2 position to generate lithium carbenoid Li-323; upon 
addition of a boronic ester, “ate” complex 324 would form and subsequently undergo 
1,2-metallate rearrangement to give homologated product 325 (Scheme 4.12). Further iterative 
homologations would elongate the carbon chain until the targeted carbonyl functionality is 




Scheme 4.12. Proposed homologation of boronic esters using 2-chloro-1,3-dithiane 323. 
Despite the number of protocols reported in the literature, the synthesis of 
2-chloro-1,3-dithiane 323 proved to be challenging. Treatment of a solution of 1,3-dithiane in 
anhydrous CH2Cl2 with NCS at 0 °C for 40 min, followed by stirring the reaction mixture at 
room temperature for 2 h,172 resulted in complete conversion of starting material, but no desired 
product was detected (Table 4.1, entry 1). Using different solvents, such as DCE or toluene, or 
recrystallising NCS prior to use did not give improved results and chlorinated product 323 
could not be obtained (Table 4.1, entries 2−5). The use of sulfuryl chloride173 or 
trichloroisocyanuric acid (TCCA) as the chlorinating agents also met with failure (Table 4.1, 
entries 6−7). 
Table 4.1. Attempted synthesis of 3-chloro-1,2-dithiane 323. 
 
Entry Chlorinating agent Solvent % Yield 
1 NCS CH2Cl2 0 
2a NCS DCE 0 
3a NCS PhMe 0 
4b NCS CH2Cl2 0 
5b NCS PhMe 0 
6c SO2Cl2 CHCl3 0 
7b,c SO2Cl2 CHCl3 0 
8 TCCA PhMe 0 
a The reaction mixture was stirred at room temperature for only 20 min; b NCS was freshly recrystallised from 
H2O before use; c SO2Cl2 was added at −30 °C. 
In all the cases, a major species was detected by 1H NMR, recorded on the crude reaction 
mixture, showing a diagnostic signal at 10.13 ppm, indicative of the presence of an aldehyde 
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group. This suggested that desired product 323 was initially formed under reaction conditions, 
but it underwent rapid hydrolysis, presumably upon aqueous work-up, to give hydroxy 
dithiane 328, which is rapidly converted into thioformate 329 (Scheme 4.13). 
 
Scheme 4.13. Proposed mechanism for the decomposition of chlorothiane 323 to thioformate 329. 
Although other strategies could have been attempted to achieve the synthesis of 
2-chloro-1,3-dithiane 323, the high instability observed made clear that it did not possess the 
required attributes for a readily available and bench-stable carbenoid precursor. Attention was 
therefore turned towards the development of a different building block. 
Imidazolium salts were then considered as possible carbenoid precursors. It was reasoned that, 
upon deprotonation of N,N-dimethyl imidazolium salt 330, N-heterocyclic carbene 331 would 
form; reaction with a boronic ester would generate ylidic boronate complex 332, which, after 
1,2-metallate rearrangement, would afford cyclic aminal 333, bearing the targeted masked 
carbonyl functionality (Scheme 4.14). 
 
Scheme 4.14. Proposed homologation of boronic esters using imidazolium salts as carbenoid precursors. 
Curran and co-workers have shown that N-heterocyclic carbene 331, generated in situ from the 
corresponding imidaziolium iodide 330a, could be trapped with borane tetrahydrofuran 
complex to give N-heterocyclic carbene borane 334 in good yield (Scheme 4.15).174 
 
Scheme 4.15. Curran's synthesis of N-heterocyclic carbene borane 334. 
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Conditions reported by Curran and co-workers were thus applied and in situ generated 
N-heterocyclic carbene 331 was trapped with phenethyl pinacol boronic ester 43. Although 
analysis of the reaction mixture by 11B NMR spectroscopy revealed full boronate complex 
formation (δ = 6.2 ppm), no desired aminal 336 was detected after warming the reaction 
mixture to higher temperatures, and only starting boronic ester 43 was recovered 
(Scheme 4.16). This suggested that the desired 1,2-metallate rearrangement was not occurring, 
and ylide 335 was instead reversing to regenerate starting material 43. 
 
Scheme 4.16. Attempted homologation of boronic ester 43 using imidazolium salt 330a. 
It was considered that in situ activation of the generated boronate complex, instead of 
preforming the N-heterocyclic carbene, could have been beneficial in promoting the desired 
1,2-metallate rearrangement. To prove this, commercially available benzothiazole was 
deprotonated with n-BuLi to give lithiated intermediate Li-337, which, upon addition of 
phenethyl pinacol boronic ester 43, was fully converted into boronate complex 338, as 
confirmed by in situ 11B NMR spectroscopy analysis (δ = 5.8 ppm, Scheme 4.17). It was 
thought that N-activation of boronate complex 338 using 2,2,2-trichloroethyl chloroformate 
(Troc-Cl),107 would trigger the 1,2-migration, leading to dearomatised thioaminal 340. 
However, similar to what was observed for ylide 335, the desired 1,2-metallate rearrangement 
did not occur under these conditions, and only starting boronic ester 43 was reisolated, thus 




Scheme 4.17. Attempted homologation of boronic ester 43 using benzothiazole. 
The use of ClCO2CMe2CCl3 (Me2Troc-Cl) as the N-activator, which proved to be superior to 
Troc-Cl in inducing the 1,2-metallate rearrangement of boronate complexes generated from 
N-benzyl amines,175 also met with failure, and desired thioaminal 340 could not be formed. 
With the aim of reducing the steric hindrance around the boron centre and making the 
1,2-metallate rearrangement more favourable, thiazole was employed in place of benzothiazole 
in the same process (Scheme 4.18). As expected, 11B NMR spectroscopy showed full boronate 
complex formation (δ = 5.9 ppm); however, upon addition of Troc-Cl, the desired 
1,2-migration did not occur and only boronic ester 43 was recovered. 
 
Scheme 4.18. Attempted homologation of boronic ester 43 using thiazole. 
1-Methylimidazole was also tested as a potential carbenoid precursor for the homologation of 
boronic ester 43, hoping that the increased electronegativity of nitrogen compared to sulfur 
would make the migrating terminus more electron deficient, thus promoting the desired 
1,2-migration (Scheme 4.19). However, this was not the case and generation of boronate 




Scheme 4.19. Attempted homologation of boronic ester 43 using 1-methylimidazole. 
An alternative approach to the homologation of boronic esters with the introduction of a 
masked carbonyl functionality is using the DCME reaction.176-177 Brown and co-workers 
showed that α,α-dichloromethyl methyl ether (DCME) can be reversibly deprotonated with 
sterically hindered bases, such as lithium tert-butoxide or LiOC(Et)3, to form a lithium 
carbenoid; addition to borinic esters leads to the formation of boronate complex 349, that 
undergoes two subsequent 1,2-migrations to give intermediate α-chloroboronate 350; oxidation 
with basic hydrogen peroxide gives access to ketone 351 (Scheme 4.20). 
 
Scheme 4.20. Brown's conversion of borinic esters into ketones using α,α-dichloromethyl methyl ether. 
It was postulated that employing a boronic ester in the place of borinic esters in a similar 
process would give access, after a single 1,2-metallate rearrangement, to homologated 
intermediate 353; addition of a methoxide base would eventually form desired ketal 354 
(Scheme 4.21).  
 
Scheme 4.21. Proposed homologation of boronic esters using DCME as the carbenoid precursor. 
Generation of the lithium carbenoid by treatment of a solution of DCME in Et2O with LiOt-Bu 
at −78 °C in the presence of phenethyl pinacol boronic ester 43 (in situ conditions), followed 
by warming the reaction mixture to room temperature, resulted in only unreacted starting 
boronic ester 43 (Table 4.2, entry 1). The presence of a permanent boronate complex in the 
11B NMR spectrum recorded on the reaction mixture (δ = 4.9 ppm) suggested that the formation 
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of the required boronate complex was slow, owing to the decreased electrophilicity and the 
increased steric hindrance of boronic esters if compared to the corresponding borinic esters; 
the base could therefore react with the boron centre, leading to an improductive boronate 
complex. However, attempts to pre-form the lithium carbenoid before adding the boronic ester 
(ex situ conditions) did not give improved results and only unreacted starting material 43 was 
reisolated, thus confirming the low rate of boronate complex formation (Table 4.2, entry 2). 
Using THF as the solvent or LDA as a non-nucleophilic base also met with failure (Table 4.2, 
entries 3−4). 
Table 4.2. Attempted homologation of boronic ester 43 using DCME. 
 
Entry Base Solvent  Conditions % Yield 357 
1 LiOt-Bu Et2O in situ 0 
2 LiOt-Bu Et2O ex situ 0 
3 LiOt-Bu THF in situ 0 
4 LDA Et2O in situ 0 
It was concluded that the lithium carbenoid generated in situ by deprotonation of DCME was 
not sufficiently reactive to attack the boron centre of boronic esters. A different class of 
building blocks to introduce masked carbonyl functionalities was therefore explored.  
Efforts were then focused on the use of N,N-dimethylformamide (DMF) as the carbenoid 
precursor. It is in fact known that DMF can be deprotonated by LDA at low temperature to 
generate lithiated carbonyl intermediate Li-358.178 It was argued that trapping of the generated 
lithiated species with a boronic ester would afford boronate complex 359, that, upon addition 
of an activating agent, would undergo 1,2-metallate rearrangement to give desired hemiaminal 




Scheme 4.22. Proposed homologation of boronic esters using DMF as the carbenoid precursor. 
To test this possibility, a solution of DMF (1.1 equiv) and phenethyl pinacol boronic ester in 
THF was treated with freshly prepared LDA at −78 °C (Table 4.3, entry 1).179 However, after 
stirring the reaction mixture for 5 h at that temperature, in situ 11B NMR spectroscopy revealed 
incomplete boronate complex formation; addition of TMSCl as the activating agent, followed 
by warming the reaction mixture to room temperature overnight, did not lead to the formation 
of desired product 362 and only unreacted boronic ester 43 was reisolated. Modified conditions 
reported by Senanayake and co-workers (use of excess of DMF −3.1 equiv− in toluene)180 
initially gave more promising results, with full boronate complex formation observed on the 
11B NMR spectrum recorded on the reaction mixture (δ = 8.6 ppm); however, despite testing 
various activating agents to promote the 1,2-metallate rearrangement, homologated 
product 362 was never observed, with boronic ester 43 being the main species observed by 
1H NMR analysis of the crude reaction mixture (Table 4.3, entries 2−5). This indicated that the 
1,2-rearrangement was too slow and the boronate complex formation was reversible. 
Table 4.3. Attempted homologation of boronic ester 43 using DMF. 
 
Entry Conditions Activator % Yield 362 
1 A TMS-Cl 0 
2 B TMS-Cl 0 
3 B Troc-Cl 0 
4 B TES-OTf 0 
5 B Tf2O 0 
Reaction conditions: conditions A, 43 (1.0 equiv), DMF (1.1 equiv) and LDA (1.1 equiv) in THF at −78 °C for 5 h; 
conditions B, 43 (1.0 equiv), DMF (3.1 equiv) and LDA (3.1 equiv) in PhMe at −78 °C for 1 h.  
In 2014, Bode and co-workers reported the synthesis of thioamide derivative 363 by 
deprotonation of N,N-dimethyl thioformamide at −110 °C181 in the presence of B(OMe)3, 
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followed by treatment with aqueous KF.182 Subsequent S-alkylation with ethyl iodide gave 
imidate 364 in good yield (Scheme 4.23). 
 
Scheme 4.23. Bode's synthesis of imidate 364. 
These conditions were tested for the homologation of boronic ester 43 (Scheme 4.24). Despite 
in situ 11B NMR spectroscopy revealing full boronate complex formation (δ = 6.1 ppm), no 
desired thioaminal 366 could be detected after addition of ethyl iodide and only starting boronic 
ester 43 was recovered. 
 
Scheme 4.24. Attempted homologation of boronic ester 43 using N,N-dimethyl thioformamide. 
The use of less sterically hindered and more reactive activating agents than ethyl iodide, such 
as methyl iodide and methyl triflate, also met with failure and thioaminal 366 could not be 
accessed. 
Due to the difficulties encountered in finding a suitable building block able to homologate 
boronic esters with the introduction of a ketal-type substituent as a masked carbonyl 
functionality, attention was turned towards a different masking group. In particular, terminal 
C−C double bonds can be easily converted into ketones by ozonolysis followed by reductive 
work-up. It was therefore reasoned that homologation of boronic esters using a building block 
allowing the introduction of α,α-disubstituted C−C double bonds would provide rapid access 
to vinyl boronic esters 367; subsequent homologations using various building blocks would 
elongate the linear chain of substituted carbon atoms before final manipulations would release 




Scheme 4.25. Proposed homologation of boronic esters with the introduction of terminal double bonds as 
masked carbonyl functionalities. 
Soderquist and co-workers demonstrated that α-methoxyvinyllithium (LiAMV) Li-368 can be 
used to homologate alkyl borinic esters (Scheme 4.26).183 In this process, initially generated 
boronate complex 369 undergoes a BCl3-mediated alkyl group migration to produce vinyl 
borinate 370, which is eventually converted into the corresponding methyl ketones 371 by 
oxidation with basic hydrogen peroxide. 
 
Scheme 4.26. Soderquist’s homologation of borinic esters using LiAMV Li-368. 
The use of boronic esters in an analogous process is unprecedented; it was reasoned that, if 
boronic esters were reactive under these conditions, versatile vinyl boronates could be rapidly 
accessed and employed in further iterative homologations. To test this possibility, 
α-ethoxyvinyllithium Li-372 was generated in situ by treatment of a solution of vinyl ethyl 
ether in THF with t-BuLi at −78 °C and subsequently trapped with phenethyl pinacol boronic 
ester 43 to give boronate complex 373, as confirmed by 11B NMR spectroscopy (δ = 4.4 ppm,  
Scheme 4.27). At this point, a solvent exchange to CH2Cl2 was performed, followed by addition 
of a solution of BCl3 in CH2Cl2 at −78 °C; the resulting reaction mixture was stirred for 30 min 
at −78 °C and then warmed to room temperature for 2 h to allow the 1,2-metallate 
rearrangement/elimination sequence. However, the fraction isolated after purification of the 
crude reaction mixture by chromatography on silica gel was found to be a mixture of desired 
vinyl boronic ester 374, isomerised product 375 and starting material 43 in 5:3:2 ratio, as 
determined by 1H NMR analysis. A yield of 16% could therefore be calculated for isolated 374, 
while isomerised alkene 375 accounted for an 8% yield. Isomerisation was suggested to happen 
under the reaction conditions, presumably favoured by the combination of Lewis acidic BCl3 





Scheme 4.27. Attempted homologation of boronic ester 43 using α-ethoxyvinyllithium Li-372 and BCl3. 
Attempt to prevent the undesired isomerisation side-reaction by using milder TMS-OTf to 
promote the 1,2-migration/elimination step met with failure, leading to the recovery of only 
unreacted starting boronic ester 43. The use of SiCl4 as the promoter gave an analogous result 
to the one obtained using BCl3, the two Lewis acidic species presumably behaving in a similar 
fashion in the process. Conditions reported by Ingleson and co-workers for the electrophilic 
borylation of arenes and heteroarenes were also tested (Scheme 4.28).185-186 In this case, the 
active borylating agent was pre-formed in situ by treatment of BCl3 in CH2Cl2 with 2,6-lutidine 
in the presence of AlCl3. However, no desired vinyl boronate 374 was formed under these 
conditions and only unreacted starting material 43 was reisolated. 
 
Scheme 4.28. Attempted homologation of boronic ester 43 using α-ethoxyvinyllithium Li-372 and preactivated 
BCl3. 
It was argued that, if the generated vinyllithium was attached to a sufficiently good leaving 
group, the desired 1,2-metallate rearrangement could occur without the need to activate the 
alkene moiety. To prove this, commercially available vinyl bromide, which undergoes 
lithiation by treatment with LDA at low temperature,187-188 was selected as suitable carbenoid 
precursor (Table 4.4). However, deprotonation of vinyl bromide at −78 °C in the presence of 
phenethyl pinacol boronic ester 43 only resulted in incomplete boronate complex formation 
after stirring the reaction mixture at −78 °C for 4 h, as shown by in situ 11B NMR analysis 
(δ = 5.6 ppm). Subsequent addition of MgBr2MeOH to promote the desired 1,2-migration, 
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followed by warming the reaction mixture to room temperature, gave a mixture of required 
vinyl boronic ester 374 and starting material 43 in a 40:60 ratio, as revealed by GCMS analysis 
(Table 4.4, entry 1). Performing the deprotonation step at −95 °C to prevent decomposition of 
the unstable 1,1-lithiobromoethene188 only led to a moderate improvement, with a 374:43 ratio 
of 54:46, determined by GCMS analysis (Table 4.4, entry 1). 
Table 4.4. Attempted homologation of boronic ester 43 using vinyl bromide. 
 
Entry Temperature 374:43a 
1 −78 °C 40:60 
2 −95 °C 54:46 
a Determined by GCMS analysis. 
Since the main problem of the reaction was the high instability of the generated lithiated 
intermediate, we turned our attention towards the possibility of enhancing the stability of the 
carbenoid with respect to decomposition, in order to allow complete boronate complex 
formation. To this aim, vinyl carbamate 160, which can be lithiated with LDA at −78 °C,99 was 
tested as suitable building block for the homologation of boronic ester 43 (Scheme 4.29). 
Generation of lithiated carbamate Li-160 in the presence of 43 gave full conversion to boronate 
complex 377, as determined by 11B NMR analysis of the reaction mixture (δ = 5.1 ppm). Owing 
to the diminished leaving group ability of the carbamate with respect to the bromide, addition 
of TMSCl as an additive was necessary to promote the desired 1,2-metallate rearrangement. 
However, no required vinyl boronic ester 374 was generated under these conditions and 
1H NMR analysis of the crude reaction mixture revealed the presence of starting boronic 
ester 43 together with unreacted carbamate 160. This suggests that the 1,2-migration process 
was too slow to occur and the boronate complex reversed back to reform both the starting 
materials. 
 
Scheme 4.29. Attempted homologation of boronic ester 43 using vinyl carbamate 160. 
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With the aim of reducing the steric hindrance around the boron centre and facilitate the desired 
1,2-metallate rearrangement, N,N-dimethylvinyl carbamate 378 was readily synthesised by 
deprotonation of THF with n-BuLi, followed by trapping with commercially available 
dimethylcarbamyl chloride (Scheme 4.30).189 
 
Scheme 4.30. Synthesis of N,N-dimethylvinyl carbamate 378. 
As expected, treatment of a solution of vinyl cabamate 378 and phenethyl pinacol boronic 
ester 43 in THF with LDA at −78 °C resulted in the complete formation of boronate 
complex 379, as confirmed by in situ 11B NMR monitoring of the reaction mixture 
(δ = 4.7 ppm, Scheme 4.31). However, addition of TMSOTf as the activator, followed by 
warming the reaction mixture to room temperature, gave only starting boronic ester 43, and no 
desired product 374 was detected. The isolation of monoprotected diol 381 in 23% yield 
suggested that the desired 1,2-metallate rearrangement was too slow and a competing 
ring-opening of the pinacol boronic ester moiety, upon activation with TMSOTf, occurred 
instead to give intermediate borinic ester 380, which was eventually hydrolysed during aqueous 
work-up. 
 
Scheme 4.31. Attempted homologation of boronic ester 43 using N,N-dimethylvinyl carbamate 378. 
Subsequent attempt of using Tf2O as a stronger activating agent also met with failure and 
desired vinyl boronate 374 could not be accessed. 
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Since the homologation of boronic esters leading to the insertion of terminal double bonds as 
masked carbonyl functionalities could not be achieved, building blocks bearing other potential 
masking groups were considered. We were specifically intrigued by the possibility of using a 
building block 382 that, if employed in a lithiation−borylation reaction with a boronic ester, 
would allow the synthesis of intermediate thioether 384; after further iterative homologations, 
oxidation of sulfide 386 to the corresponding sulfoxide 387 and subsequent Pummerer 
rearrangement would liberate the required ketone functionality 389 (Scheme 4.32). 
 
Scheme 4.32. Proposed homologation of boronic esters with the introduction of thioethers as masked carbonyl 
functionalities. 
Commercially available chloromethyl phenyl sulfide was initially selected as a suitable 
carbenoid precursors. However, lithiation−trapping studies immediately made evident the high 
instability of the generated lithium carbenoid with respect to decomposition (Table 4.5). 
Deprotonation of chloromethyl phenyl sulfide in THF at −78 °C with s-BuLi for 1 h, followed 
by quenching with an excess of TMSCl, resulted in complete decomposition of the generated 
lithiated species (Table 4.5, entry 1); the use of LDA as the base did not give a better result in 
either THF or Et2O and decomposition of the carbenoid was revealed after quenching the 
reaction mixture with CD3OD (Table 4.5, entries 2−3). Performing the deprotonation with LDA 
for only 5 min, before addition of CD3OD, also met with failure, and deuterated sulfide 390 
was not observed (Table 4.5, entry 4); finally, when NaHMDS was employed as the base, 
unreacted starting material was recovered after quenching with CD3OD, indicating that the 




Table 4.5. Attempted lithiation−trapping of chloromethyl phenyl sulfide. 
 
Entry Base Solvent Time E−X % Yield 390 
1 s-BuLi THF 1 h TMSCl 0 
2 LDA THF 1 h CD3OD 0 
3 LDA Et2O 1 h CD3OD 0 
4 LDA THF 5 min CD3OD 0 
5 NaHMDS THF 5 min CD3OD 0 
 
Despite the unpromising outset, the homologation of boronic ester 43 with chloromethyl phenyl 
sulfide was attempted, with the hope that an in situ trapping of the generated lithium carbenoid 
would be sufficiently fast to prevent decomposition (Scheme 4.33). However, deprotonation of 
chloromethyl phenyl sulfide with LDA in the presence of 43 did not lead to the formation of 
boronate complex 391, as confirmed by in situ 11B NMR monitoring of the reaction mixture, 
therefore suggesting that the lithiated species decomposed before being trapped by the boronic 
ester. 
 
Scheme 4.33. Attempted homologation of boronic ester 43 using chloromethyl phenyl sulfide. 
In an attempt to generate a more stable lithium carbenoid with respect to decomposition, 
sulfide-substituted TIB benzoate 393 was readily synthesised from the corresponding chloride 
(Scheme 4.34). 
 
Scheme 4.34. Synthesis of sulfide-substituted benzoate 393. 
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Initial lithiation−deuteration studies on benzoate 393, using either s-BuLi in Et2O or LDA in 
THF, revealed the high instability of the corresponding lithiated carbenoid, which was found 
to decompose at −78 °C in only 15 min (Scheme 4.35). 
 
Scheme 4.35. Lithiation−deuteration studies on benzoate 393. 
In situ trapping of the generated lithiated benzoate with phenethyl pinacol boronic ester 43 was 
therefore attempted. Pleasingly, treatment of a solution of thioether 393 (1.2 equiv) in Et2O 
with LDA (1.5 equiv) at −78 °C for 1 h, followed by warming the reaction mixture to room 
temperature, gave the desired homologated boronic ester 392, together with starting 
material 43, in an 85:15 ratio, as determined by GCMS analysis (Table 4.6, entry 1). Increasing 
the amount of LDA employed to 2.0 equiv only led to a partial improvement, with the product 
to starting material ratio determined by GCMS analysis being 392:43 = 90:10 (Table 4.6, 
entry 2). Finally, using an excess of both carbenoid precursor 393 (2.0 equiv) and base 
(2.0 equiv) gave complete consumption of starting material, thus proving the high instability 
of the generated lithium carbenoid with respect to decomposition (Table 4.6, entry 3). 
Disappointingly, homologated boronic ester 392 was never isolated in high yield after 
purification by column chromatography, the species presumably being unstable on silica gel. 
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Table 4.6. Homologation of boronic ester 43 with benzoate 393. 
 
Entry Equiv 393 Equiv LDA 392:43a % Yield 392 
1 1.2 1.5 85:15 29 
2 1.2 2.0 90:10 n.d. 
3 2.0 2.0 100:0 45 
a Determined by GCMS analysis; n.d. = not determined. 
The instability of boronic ester 392 on silica gel was attributed to the presence of the α-thioether 
group. It was therefore decided to use crude boronic ester 392 in a subsequent homologation 
with lithiated carbenoid (R)-Li-108a, generated in situ from α-stannyl benzoate (R)-109; the 
process would form β-sulfide boronic ester 395, which was hoped to be more stable than its 
precursor 392 on silica gel (Scheme 4.36). However, generation of lithiated benzoate 
(R)-Li-108a by lithium−halogen exchange, followed by addition of a solution of crude boronic 
ester 392 in Et2O, gave moderate levels of conversion of starting material 392, and desired 
homologated product 395 was isolated as a mixture of diastereoisomers (d.r. = 1:1) in only 
26% yield over the two steps. Under-homologated boronic ester 392 was also reisolated in 28% 
yield, indicating either incomplete or reversible boronate complex formation.  
 
Scheme 4.36. Attempted homologation of crude α-thioboronic ester 392 with (R)-Li-108a. 
GCMS analysis of the crude reaction mixture revealed the formation of sulfide 398 as a 
side-product, although the species was not isolated. This suggested that a fragmentation 
pathway of boronate complex 396, leading to stabilised anion 398, competed with the desired 




Scheme 4.37. Fragmentation of boronate complex 396 competing with the desired 1,2-metallate 
rearrangement. 
α-Phenylthio boronic ester 392 was therefore shown not to be a suitable substrate for 
lithiation−borylation reactions. Additionally, homologation of boronic ester 43 with 
benzoate 393 proved to be not always reproducible, giving variable levels of conversion of 
starting material 43, as determined by GCMS analysis. These observations, together with the 
high number of steps necessary for the final release of the targeted carbonyl functionality, made 
us hesitant about further attempts to optimise the process. New types of building blocks for the 
homologation of boronic esters leading to the introduction of masked ketones were to be 
therefore considered in the future.  
4.2.2. Development of a 2-C Building Block for the Introduction of C−C Double Bonds 
through the Homologation of Boronic Esters  
The development of a two-carbon building block enabling the homologation of boronic esters 
leading to the introduction of C−C double bonds began with exploring the possibility of using 
a Zweifel olefination reaction. As aforementioned, the required carbenoid precursor must bear 
a group that can be readily converted into an organolithium; additionally, a functional group, 
stable under the reaction conditions and able to be eventually transformed into a boronic ester, 
is necessary to make subsequent iterations possible. Commercially available 
(2-bromovinyl)trimethylsilane was initially selected as a suitable building block 
(Scheme 4.38). Lithium−halogen exchange was successfully achieved by treatment of a 
solution of (2-bromovinyl)trimethylsilane in Et2O with t-BuLi at −78 °C for 45 min; a solution 
of boronic ester 43 in Et2O was subsequently added and the complete boronate complex 
formation was confirmed by in situ 11B NMR analysis (δ = 5.5 ppm).  Addition of a solution 
of I2 in MeOH at 0 °C, followed by warming the reaction mixture to room temperature, allowed 
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the 1,2-metallate rearrangement/elimination process to take place, to give, after purification by 
chromatography on silica gel, alkene 400 in 62% yield and as a single Z-isomer. 
 
Scheme 4.38. Zweifel olefination of boronic ester 43 with (2-bromovinyl)trimethylsilane. 
Prompted by the successful olefination of boronic ester 43, we were willing to test the 
subsequent borodesilylation of alkene (Z)-400 to give vinylboronate (Z)-401. To this aim, 
conditions reported for the ipso-borodesilylation of alkenylsilanes were applied 
(Scheme 4.39).190-192 Treatment of a solution of alkene (Z)-400 in CH2Cl2 with BCl3 at low 
temperature, followed by esterification with pinacol, afforded the desired alkenyl boronate 
(Z)-401 in 62% yield after chromatographic purification. 
 
Scheme 4.39. ipso-Borodesilylation of vinylsilane (Z)-400. 
With an efficient protocol to homologate boronic esters leading to the introduction of a 
disubstituted C−C double bond in hand, the next step was exploring the possibility of applying 
the same methodology to introduce trisubstitued alkenes. In particular, we were interested in 
the introduction of methyl substituents, since isopropenyl units are ubiquitous in polyketide 
structures. To this aim, literature known methyl-substituted iodoalkene 403 was identified as a 
suitable building block and readily accessed by hydrostannylation of commercially available 
1-(trimethylsilyl)propyne, followed by iodination (Scheme 4.40).193 
 
Scheme 4.40. Synthesis of iodoalkene 403. 
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Phenethyl pinacol boronic ester 43 was initially subjected to a Zweifel olefination reaction with 
alkene 403 using the reaction conditions that had previously allowed the introduction of a 
disubstituted double bond (Scheme 4.41). Iodine−lithium exchange, followed by addition 
of 43, resulted in full boronate complex formation, as determined by 11B NMR analysis of the 
reaction mixture (δ = 6.9 ppm); a subsequent iodine-mediated 1,2-metallate 
rearrangement/elimination sequence afforded trisubstitued alkene 405 in 70% yield after 
purification by column chromatography. Surprisingly, the isolated product was found to be a 
mixture of geometric isomers in a 1.4:1 ratio, as determined by 1H NMR analysis. 
 
Scheme 4.41. Iodine-mediated Zweifel olefination of boronic ester 43 using alkene 403 leading to a mixture of 
geometric isomers. 
The Zweifel olefination was known to be a stereospecific process, leading to the selective 
formation of a single geometric isomer through anti-elimination of the intermediate 
β-iodoboronic ester (see § 1.7.3). The possible scenario accounting for the observed diminished 
stereospecificity in the case of alkene 403 is depicted in Scheme 4.42. One possibility is that a 
cis-elimination of intermediate β-iodoboronic ester 407 competes with the favoured 
anti-elimination, therefore leading to the formation of the opposite geometric isomer; this 
pathway is nevertheless unlikely, since a cis-elimination process would require an eclipsed 
synperiplanar transition state, which is less favoured that the corresponding staggered 
antiperiplanar transition state. Another possibility is that an SN2 reaction occurs at the C−I 
bond, due to presence of iodide ions in solution, eventually leading to inversion of 
configuration at the carbon centre; the generated intermediate 411 would then undergo the 
expected anti-elimination to give alkene (E)-405. Finally, isomerisation of the initially 





Scheme 4.42. Possible mechanisms accounting for the diminished stereoselectivity observed in the Zweifel 
olefination of boronic ester 43 with alkene 403. 
It was argued that the use of a different electrophile, other than iodine, to induce the 
1,2-metallate rearrangement/elimination sequence would overcome the observed diminished 
selectivity. Aggarwal and co-workers have recently developed a protocol for the 
stereodivergent Zweifel olefination of boronic esters with vinyl halides using PhSeCl 
(Scheme 4.43).98 In this process, initially generated boronate complex 412 undergoes 
selenation by addition of PhSeCl to give intermediate 413, which, after 1,2-metallate 
rearrangement, affords β-selenoboronic ester 414; subsequent addition of a solution of NaOMe 
in MeOH triggers an anti-elimination process to give homologated alkene 415 as a single 
geometric isomer. Alternatively, intermediate β-selenoboronic ester 414 can be oxidised by 
m-CPBA to afford selenoxide 416; attack of the selenoxide 416 onto the boron centre results 




Scheme 4.43. Aggarwal's stereodivergent Zweifel olefination of boronic esters using PhSeCl. 
Both sets of reaction conditions were tested in the Zweifel olefination of boronic ester 43 
(Scheme 4.44). However, the expected trisubstituted alkene 405 was not formed and only 
starting boronic ester 43 could be reisolated, despite in situ 11B NMR monitoring of the reaction 
mixture showed full boronate complex formation (δ = 5.8 ppm). 
 
Scheme 4.44. Stereodivergent Zweifel olefination of boronic ester 43 with trisubstituted alkene 403. 
Since silyl-substituted alkenes had never been employed in selenium-mediated Zweifel 
olefination reactions before, the protocol was tested on disubstituted 
(2-bromovinyl)trimethylsilane, reasoning that the reduced steric hindrance on the vinylhalide 
compared to alkene 403 would make the process more facile (Scheme 4.45). In this case, the 
application of the previously described conditions to accomplish the stereodivergent Zweifel 
olefination of boronic ester 43 gave access to both the geometric isomers of alkene 400; 
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however, despite full boronate complex formation was confirmed by in situ 11B NMR 
spectroscopy (δ = 5.4 ppm), low product to starting material ratio was observed by GCMS 
analysis of the crude reaction mixture. 
 
Scheme 4.45. Stereodivergent Zweifel olefination of boronic ester 43 with (2-bromovinyl)trimethylsilane. 
The considerable amount of starting boronic ester 43 recovered suggested the operation of a 
mechanism competing with the desired 1,2-metallate rearrangement/elimination pathway 
(Scheme 4.46). Specifically, breaking (or lengthening) of the C−Se bond could lead to the 
formation of intermediate 419, with the forming (or partially forming) carbocation stabilised 
by the presence of the silicon group in the β position; subsequent elimination of the TMS group 
would generate β-seleno boronate complex 420, which would be either protonated upon 
aqueous work-up to give vinyl selenide 421 and starting boronic ester 43 or would eliminate 
the selenide to form acetylene. Alternatively, further reaction of intermediate 420 with PhSeCl 




Scheme 4.46. Possible competing elimination pathway accounting for the recovery of starting material 43 in the 
Zweifel olefination reaction using PhSeCl. 
With the knowledge that PhSeCl was not a suitable electrophile to accomplish the Zweifel 
olefination of boronic ester 43 using trisubstituted alkene 403, other experiments were 
conducted, with the aim of identifying new reaction conditions ensuring high stereoselectivity 
(Table 4.7). Addition of I2 and NaOMe in THF, thus avoiding the use of MeOH, shut down 
any reactivity of the boronate complex and no desired product 405 was observed (Table 4.7, 
entry 1). Not surprisingly, reducing the equivalents of I2 (1.05 equiv) and performing the 
1,2-metallate rearrangement/elimination step at −78 °C instead of 0 °C, gave only moderate 
product to starting material ratio (405:43 = 74:26, as determined by GCMS analysis), but an 
increased isomeric ratio of 3.5:1, therefore suggesting that the presence of iodide ions in the 
reaction mixture might have an effect on the observed low stereoselectivity (Table 4.7, entry 2). 
However, the use of NIS in the place of I2, to reduce the amount of iodide ions in solution, gave 
a similar result, with a 67:33 product to starting material ratio observed by GCMS analysis and 
an isomeric ratio of 1.8:1 (Table 4.7, entry 3). Finally, iodine monochloride (ICl) was tested as 
the electrophile (Table 4.7, entries 4−5). The addition of ICl as a solution in MeOH:CH2Cl2 
(4:1 v/v) resulted in a moderate product to starting material ratio of 80:20, determined by 
GCMS analysis, and an isomeric ratio of 2.3:1; attempts to avoid the use of MeOH by adding 
ICl as a solution in pure CH2Cl2 was detrimental and a low product to starting material ratio 
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was observed (405:43 = 20:80, determined by GCMS analysis) as well as low stereoselectivity 
(1:1 isomeric ratio, determined by 1H NMR analysis). 
Table 4.7. Zweifel olefination of boronic ester 43 with trisubstitued alkene 403 using various electrophiles. 
 
Entry Electrophile (equiv) 405:43a isomeric ratiob 
1c I2 (2.2 equiv) − − 
2 I2 (1.05 equiv) 74:26 3.5:1 
3 NIS (1.2 equiv) 67:33 1.8:1 
4 ICl (1.3 equiv) 80:20 2.3:1 
5d ICl (1.3 equiv) 20:80 1:1 
a Determined by GCMS analysis of the crude reaction mixture; b determined by 1H NMR analysis of the crude 
reaction mixture; c I2 and NaOMe were added in THF instead of MeOH at 0 °C; d ICI was added as a solution in 
CH2Cl2. 
The experiments conducted were not sufficient to determine the origin of the observed lack of 
stereoselectivity in the Zweifel olefination of boronic ester 43 with trisubstituted alkene 403. 
The increased isomeric ratio obtained when only one equivalent of I2 was employed or when 
NIS was used as the electrophile suggests that the iodide ions present in the reaction mixture 
might play a role in inducing the observed diminished stereoselectivity; this would presumably 
happen through an SN2 process occurring at the C−I bond in the intermediate β-iodoboronic 
ester leading to inversion of configuration (Scheme 4.42). This pathway is however difficult to 
prevent, due to the generation of LiI as the by-product of the initial lithium−iodine exchange 
reaction. Another possibility is that elongation of the C−I bond allows a partial positive charge 
to build up at the tertiary centre, further stabilised by the β-silicon effect, and this allows a 
syn-migration process to occur (Scheme 4.47). This operating pathway is similar to the one 
postulated to explain the low diastereoselectivity observed in the trapping of vinyl boronate 
complexes with PhSeCl to give β-selenoboronic esters.194 In that case, the undesired competing 
mechanism was found to be solvent-dependent and could be suppressed by performing the 




Scheme 4.47. Postulated non-diastereoselective trapping of boronate complex 399 accounting for the observed 
reduced stereospecificity in the Zweifel olefination of boronic ester 43. 
Further experiments will be therefore conducted in order to confirm the occurrence of these 
operating pathways. Alternative methodologies to introduce C−C double bonds through the 
homologation of boronic esters will be also considered. 
4.2.3. Development of a 3-C Building Block for the Introduction of Enone 
Functionalities through the Homologation of Boronic Esters 
Initial investigations on the development of a 3-carbon building block enabling the introduction 
of a masked enone functionality focused on the possibility of employing a carbenoid precursor 
having the required C−C double bond pre-installed. In particular, attention was turned towards 
allylic benzoate 426, which, if subjected to lithiation−borylation reaction conditions with a 
boronic ester, would give access to homologated product 427 (Scheme 4.48). Subsequent 
oxidation of the boronic ester moiety, followed by protection of the generated alcohol with a 
suitable protecting group, would yield vinyl silane 428. ipso-Borodesilylation would eventually 
reintroduce the boronate group, thus making other iterative homologations possible; final 





Scheme 4.48. Proposed homologation of boronic esters using benzoate 426 leading to the introduction of an 
enone functionality. 
Required benzoate 426 was readily accessed from the corresponding commercially available 
alcohol 432 through a Mitsunobu reaction (Scheme 4.49). 
 
Scheme 4.49. Synthesis of allylic benzoate 426. 
Aggarwal and co-workers showed that secondary allylic carbamates can successfully undergo 
lithiation−borylation reactions with various boronic esters, displaying excellent α-selectivity in 
the boronate complex formation step.195 However, no data was reported on the homologation 
of boronic esters using primary allylic TIB esters. 
A lithiation−deuteration study of benzoate 426 was conducted and it showed that deprotonation 
by treatment of a solution of 426 in Et2O with s-BuLi in the presence of TMEDA was complete 
in only 10 min (Scheme 4.50). However, an unidentified side-product was visible on the 1H 
NMR recorded on the crude reaction mixture, suggesting partial instability of the generated 
lithium carbenoid with respect to decomposition. 
 
Scheme 4.50. Lithiation−deuteration study on benzoate 426. 
Unfortunately, when benzoate 426 was employed for the homologation of boronic ester 43, no 
desired product 433 was observed, and unreacted starting material 43 could instead be 




Scheme 4.51. Attempted homologation of boronic ester 43 using benzoate 426. 
This result suggested that the generated lithium carbenoid Li-426 was trapped by boronic 
ester 43 in a reversible fashion, and the rapid dissociation of the boronate complex regenerated 
starting material 43 together with stabilised anion 434, which presumably underwent 
decomposition under the reaction conditions (Scheme 4.52). 
 
Scheme 4.52. Reversible boronate complex formation in the homologation of boronic ester 43 with 
benzoate 426. 
With the knowledge that benzoate 426 could not be used as a suitable building block to 
homologate boronic esters, attention was turned towards a different class of carbenoid 
precursors. Specifically, we were intrigued about the possibility of using alkoxyallenes, which 
are known to be versatile building blocks in organic synthesis,196-197 in a Zweifel olefination 
reaction to allow the three-carbon homologation of boronates. Alkoxyallenes 318 undergo 
selective deprotonation at C-1 by treatment with n-BuLi to form lithiated intermediate Li-318, 
which can subsequently react with a variety of different electrophiles to access C-1 substituted 
derivatives 436 (Scheme 4.53).198 Interestingly, when lithiated intermediate Li-318 was 
transmetalated with a less electropositive metal, such as magnesium or titanium, the 





Scheme 4.53. C-1 deprotonation of alkoxyallenes followed by electrophilic trapping. 
It was reasoned that trapping of a suitable lithiated alkoxyallene Li-318 with a boronic ester 
would give access to boronate complex 319; upon addition of I2 and NaOMe, a rapid 
1,2-metallate rearrangement would occur, followed by elimination, to afford substituted 
alkoxyallene 321, which can be regarded as a terminal α,β-unsaturated carbonyl compound 
(Scheme 4.54). 
 
Scheme 4.54. Proposed homologation of boronic esters lithiated alkoxyallene Li-318. 
To prove this possibility, benzyloxyallene 318a was initially identified as a suitable starting 
material and could be accessed in a straightforward manner by base-promoted isomerisation of 
commercially available benzyl propargyl ether (Scheme 4.55).200 The benzyl derivative was 
selected owing to its low volatility, making the purification more facile; despite the presence 




Scheme 4.55. Synthesis of benzyloxyallene 318a. 
Lithiation−deuteration studies were conducted in order to optimise the deprotonation 
conditions (Table 4.8). It was found that full deuterium incorporation was achieved after 
treatment of a solution of allene 318a in Et2O with n-BuLi at −42 °C for 30 min, plus additional 
10 min at 0 °C, followed by quenching the reaction mixture with an excess of CD3OD. 
Table 4.8. Lithiation−deuteration studies on allene 318a. 
 
Entry Temperature  Time % Da 
1 −78 °C 30 min 53 
2 −78 °C 1 h 79 
3 −42 °C + 0 °C 30 min + 10 min 100 
a Determined by 1H NMR analysis. 
With optimal conditions to deprotonate benzyloxyallene 318a in hand, the next step was testing 
the 3-carbon homologation of phenethyl pinacol boronic ester 43 (Scheme 4.56). Trapping of 
the in situ generated lithiated allene Li-318a with boronic ester 43 resulted in complete 
boronate complex formation, as confirmed by 11B NMR analysis of the reaction mixture 
(δ = 3.2 ppm); however, after I2-mediated 1,2-metallate rearrangement, followed by 
elimination, desired substituted allene 440a was not observed and purification by flash column 





Scheme 4.56. Homologation of boronic ester 43 with alkoxyallene 318a. 
The formation of vinyl iodide 442a suggested that desired derivatised allene 440a was initially 
formed under reaction conditions, but it immediately reacted with the excess of I2 to form 
iodonium ion 443; a subsequent MeOH-promoted ring-opening of intermediate 443 afforded 
ketal 442a (Scheme 4.57). The same mechanistic pathway operating on the excess of starting 
allene 318a gave access to acetal 441a. 
 
Scheme 4.57. Proposed mechanism for the formation of side-products 441a and 442a. 
In order to prevent the undesired further reactivity of generated allene 440a, the sequence was 
repeated without excess of I2 (Scheme 4.58). The reaction proceeded smoothly to form desired 
product 440a in 73% yield, as determined by 1H NMR analysis of the crude reaction mixture 
using 1,4-dimethoxybenzene as the internal standard. Unfortunately, allene 440a was found to 





Scheme 4.58. Homologation of boronic ester 43 with alkoxyallene 318a using no excess of I2. 
To facilitate the isolation process, an acidic wash of a solution of crude allene 440a was 
performed to promote its conversion to terminal enone 443 (Scheme 4.59). Pleasingly, these 
conditions allowed the isolation of desired product 443 in 44% yield after purification by flash 
column chromatography. 
 
Scheme 4.59. Homologation of boronic ester 43 with alkoxyallene 318a followed by acidic work-up. 
Surprisingly, boronic ester 444a was also isolated in 19% yield. This suggested that, when the 
amount of I2 in solution is not sufficiently high, boronate complex 439 can undergo a 
proton-mediated 1,2-metallate rearrangement to give alkene 444a (Scheme 4.60).201 
 
Scheme 4.60. Proposed mechanism for the formation of side-product 444a. 
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It was reasoned that this reactivity of the generated boronate complex with a proton source 
could be exploited to achieve a more efficient synthesis of terminal enones, which would be 
readily accessed by simple oxidation of boronic ester 444 (Scheme 4.61). 
 
Scheme 4.61. Proposed conversion of boronate complex 439 to enone 443. 
The conversion of boronic ester 444 to terminal enone 443 through a proton-mediated 
1,2-metallate rearrangement was therefore attempted (Scheme 4.62). In this case, 
methoxyallene 318b was used as the carbenoid precursor (vide infra). After generating the 
intermediate boronate complex using previously described conditions, excess MeOH was 
added at 0 °C and the reaction mixture was allowed to warm to room temperature over 2 h to 
give expected alkene 444b; subsequent oxidation of crude boronic ester 444b using 
NaBO34H2O afforded enone 443 in 58% yield after purification by column chromatography.  
 
Scheme 4.62. Conversion of boronic ester 43 to enone 443 using methoxyallene 318b. 
With an efficient methodology to perform a 3-carbon homologation of boronic esters leading 
to the formation of terminal α,β-unsaturated carbonyl compounds, attention was turned towards 
the possibility of reintroducing the boronate group at the end of the process, in order to enable 
subsequent iterative homologations. Specifically, side-product 442a generated in the reaction 
of boronic ester 43 with lithiated allene Li-318a using excess of I2 looked particularly 
attractive. It was reasoned that, upon elimination of HI, ketal 442 could be readily converted 
into alkyne 447; subsequent hydroboration would lead to the formation of vinyl boronic 




Scheme 4.63. Proposed 3-carbon homologation of boronic ester 43 leading to the formation of vinyl 
boronate 448 containing a masked enone functionality. 
To test this possibility, boronic ester 43 was subjected to Zweifel olefination conditions using 
allene 318a in the presence of excess of I2 (Scheme 4.64). These conditions allowed the 
formation of vinyl iodide 442a, which was isolated in 64% yield after purification by column 
chromatography. 
 
Scheme 4.64. Homologation of boronic ester 43 with benzyloxyallene 318a using excess of I2 to form vinyl 
iodide 442a. 
Subsequent dehydroiodination proceeded smoothly by treatment of a solution of vinyl 
iodide 442a in DMF with TBAF3H2O to give alkyne 447a in 90% yield after chromatographic 
purification (Scheme 4.65).76 
 
Scheme 4.65. Dehydroiodination of vinyl iodide 442a with TBAF4H2O. 
To avoid the formation of stereocentres, that would complicate the assembly-line sequence 
leading to the formation of diastereoisomers, methoxyallene 318b was synthesised from 
commercially available methyl propargyl ether and subsequently employed in the 
homologation of boronic ester 43 (Scheme 4.66). In this case, vinyl iodide 442a was isolated 





Scheme 4.66. Homologation of boronic ester 43 with methoxyallene 318b using excess of I2 to form vinyl 
iodide 442b. 
4.3. Conclusions and Future Work 
The development of one, two and three-carbon building blocks for the homologation of boronic 
esters leading to the introduction of useful functional groups has been addressed (Scheme 4.67). 
In particular, attention focused on the possibility of inserting carbonyl, alkene and enone 
functionalities; these groups are in fact found to be prominent in numerous polyketide natural 
products, many of which possess important biological profiles. The use of these building blocks 
in the Aggarwal’s iterative assembly-line synthesis, combined with the ones previously 
developed within the group, will allow the construction of diversified substituted linear chains 
of carbon atoms, thus giving potential rapid access to a variety of natural products. 
 
Scheme 4.67. Development of new building blocks for the homologation of boronic esters leading to the 
introduction of diverse functional groups. 
A one-carbon building block to homologate boronic esters leading to the introduction of a 
masked carbonyl functionality has not been developed yet. Different carbenoid precursors were 
tested as potential homologating agents, enabling the introduction of various masked ketone 
groups, but they were all found to be unable to afford the desired product (Scheme 4.68). In 
most of the cases, the main obstacle proved to be the reversible formation of the intermediate 
boronate complex, which, instead of undergoing the desired 1,2-metallate rearrangement, 




Scheme 4.68. Building blocks tested for the homologation of boronic esters leading to the introduction of 
masked carbonyl functionalities. 
Thioether-substituted benzoate 393 could successfully homologate phenethyl pinacol boronic 
ester 43, allowing the introduction of phenyl sulfide as a masked carbonyl group 
(Scheme 4.69). The relatively low yield of isolated 392 is due to its instability on silica gel.  
 
Scheme 4.69. Homologation of boronic ester 43 with thioether-substituted benzoate 393. 
Unfortunately, the reaction was found to be not reproducible, with variable amounts of 
recovered starting material 43 observed by GCMS analysis. This, together with the difficulties 
encountered in the attempts to employ homologated boronic ester 392 in a subsequent iteration, 
prompted us to seek a new and more efficient method to insert masked carbonyl groups through 
the homologation of boronic esters. 
In particular, Matteson and co-workers showed that CH2Cl2 can be used as a carbenoid 
precursor in the homologation of boronic esters.202 In this process, (dichloromethyl)lithium 
Li-449 is generated in situ by deprotonation of CH2Cl2 with n-BuLi at −100 °C and 
subsequently trapped with a boronic ester to form boronate complex 450; 1,2-metallate 
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rearrangement affords α-chloro boronic ester 451, which is eventually converted into α-alkoxy 
boronic ester 452 by reaction with alkoxide ions (Scheme 4.70). 
 
Scheme 4.70. Matteson's homologation of boronic esters using CH2Cl2 as the carbenoid precursor. 
This methodology could be optimised and subsequently employed in the iterative 
homologation of boronic esters to introduce protected alcohols as masked carbonyl 
functionalities. The alkoxide ion will be carefully chosen in order to allow the selective 
deprotection of the alcohol at the end of the iterative sequence; final oxidation will unmask the 
targeted ketone group. 
The development of a 2-carbon building block enabling the homologation of boronic esters 
with the introduction of C−C double bonds has also been addressed. It was found that 
(trimethylsilyl)vinyllithium, readily accessed from commercially available 
(2-bromovinyl)trimethylsilane by lithium/halogen exchange, could be successfully employed 
in the Zweifel olefination of boronic ester 43 to give the corresponding substituted vinyl 
silane (Z)-400 in good yield (Scheme 4.71). Subsequent borodesilylation allowed the 
reintroduction of the boronic ester moiety, thus enabling further iterative homologations. 
 
Scheme 4.71. Zweifel olefination of boronic ester 43 with (2-bromovinyl)trimethylsilane and subsequent 
borodesilylation. 
The scope of this process will be probed and a variety of boronic esters, bearing substituents 
of varying steric hindrance, will be employed in order to define the strenghts and limitations 
of the methodology. 
Unfortunately, the protocol was found to be not applicable to the introduction of trisubstitued 
double bonds, as when alkene 403 was employed as the carbenoid precursor in the same 
process, the expected homologated vinyl silane 405, although obtained in good yield, was 




Scheme 4.72. Zweifel olefination of boronic ester 43 using trisubstituted alkene 403 giving vinyl silane 405 as a 
mixture of geometric isomers. 
The origin of the observed reduced stereospecificty is still not clear. A possible explanation is 
that the iodide ions present in the reaction mixture cause an SN2 reaction to occur at the C−I 
bond on the generated intermediate β-iodoboronic ester, leading to inversion of configuration. 
Alternatively, a syn-elimination pathway, favoured by the stabilisation of the building positive 
charge by the silicon group in the β position, might be competing with the expected 
anti-elimination, thus leading to the formation of both the geometric isomers.  
Experiments will be conducted in order to provide further insight into these speculated 
mechanisms. The Zweifel olefination of boronic ester 43 will be therefore attempted under 
iodide-free conditions using vinyl stannane 402 as the starting building block, which would 
generate the required vinyllithium by tin−lithium exchange (Scheme 4.73). The isomeric ratio 
of trisubstituted alkene 405 will be carefully measured in order to determine the role of iodide 
ions in decreasing the stereoselectivity of the process. 
 
Scheme 4.73. Proposed Zweifel olefination of boronic ester 43 under iodide-free conditions using vinyl 
stannane 402. 
Additionally, the Zweifel olefination of boronic ester 43 with vinyl iodide 403 will be 
performed in a mixture of THF:trifluoroethanol194 to determine whether the observed 
diminished stereoselectivity originates in a non-diastereoselective trapping of the generated 
boronate complex with iodine. Finally, the possibility of an isomerisation of trisubstituted 
alkene 405 occurring under the reaction conditions will be addressed. 
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Alternative methods for the introduction of trisubstituted C−C double bonds through the 
homologation of boronic esters will also be tested. Hattori and co-workers have recently 
reported a novel electrophilic borylation of terminal alkenes using BBr3 in the presence of 
2,6-disubstituted pyridines (Scheme 4.74).203 A variety of alkenes and heteroarenes could be 
borylated to give the corresponding vinyl boronic esters in good yield. Importantly, 
α,α-dialkylethylenes were also successfully employed in the process and the corresponding 
trisubstituted alkenes were formed in good yield, although lower E/Z selectivity was observed. 
 
Scheme 4.74. Hattori's electrophilic borylation of terminal alkenes with BBr3. 
This methodology could be applied to homologate boronic esters to introduce trisubstituted 
C−C double bonds. Specifically, Zweifel olefination of boronic esters with vinyllithium Li-456 
would afford terminal alkene 457, which, if subjected to electrophilic borylation, would be 
converted into desired vinyl boronic ester 458 (Scheme 4.75). 
 
Scheme 4.75. Proposed conversion of boronic esters into trisubstituted vinyl boronates via electrophilic 
borylation. 
Alternatively, the stereo- and regiocontrolled methylboration of terminal alkynes recently 
developed by Aggarwal and co-workers could be used to convert boronic esters into 
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trisubstituted vinyl boronates. In this process, terminal alkyne 459 is initially converted into 
the corresponding alane 460 through a Cp2ZrCl2-catalysed Negishi carboalumination using 
AlMe3; subsequent in situ transmetalation of vinyl alane 460 with i-PrOBpin affords the desired 
vinyl boronate 461 in generally good yield and excellent levels of stereo- and regioselectivity 
(Scheme 4.72). 
 
Scheme 4.76. Aggarwal's methylboration of terminal alkynes. 
The conversion of boronic esters into terminal alkynes 459 using the conditions developed by 
Aggarwal and co-workers99 would give rapid access to the substrate required for the described 
methylboration, which would afford the targeted trisubstituted vinyl boronates (Scheme 4.77). 
 
Scheme 4.77. Proposed conversion of boronic esters into trisubstituted vinyl boronates via methylboration. 
Finally, the 3-carbon homologation of boronic esters allowing the introduction of a masked 
enone functionality has been examined. Initial investigation showed that allylic benzoate 426 
was not a suitable building block to achieve this transformation. In fact, when boronic ester 43 
was subjected to lithiation/borylation conditions, no desired homologated product 433 was 




Scheme 4.78. Failed homologation of boronic ester 43 using benzoate 426. 
Pleasingly, lithiated alkoxyallenes were found to efficiently react with pinacol boronic esters 
under Zweifel olefination reaction conditions. In particular, lithiation of alkoxyallenes 318, 
followed by trapping with boronic ester 43, resulted in the complete formation of boronate 
complex 439 (Scheme 4.79). Upon addition of a proton source, vinyl boronic ester 444 was 
accessed; subsequent oxidation using NaBO34H2O afforded terminal enone 443 in good yield. 
Alternatively, treatment of boronate complex 439 with a solution of I2 in MeOH yielded 
ketal 442, which was then subjected to dehydroiodination to give terminal alkyne 447; 
subsequent hydroboration will afford the targeted homologated boronic ester 448 containing a 
masked enone functionality. 
 
Scheme 4.79. 3-Carbon homologation of boronic esters using lithiated alkoxyallenes. 
The scope of this protocol will be examined by employing different substituted boronic esters, 
and the corresponding homologated products, containing terminal or internal masked 
α,β-unsaturated carbonyl functionalities, will be isolated. The methodology will be also applied 
to the total synthesis of 10-deoxymethynolide 462, the 12-membered aglycon of the macrolide 
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polyketide 10-deoxymethymycin 463, which displays potent antibiotic activity against 
gram-positive bacteria (Figure 4.2).204  
 
Figure 4.2. Structures of 10-deoxymethynolide 462 and 10-deoxymethymycin 463. 
To date, only two total syntheses of 10-deoxymethynolide 462 have been reported. In 1998, 
Pilli and co-workers reported the first synthesis of 10-deoxymethynolide 462 in 17 steps and 
12% overall yield using an intramolecular Nozaki-Hiyama-Kishi (NHK) reaction to form the 
key macrolactone.205 Ten years later, Kang and co-workers achieved the synthesis of the same 
target molecule in 13 steps (LLS) and 11% overall yield; key steps in the synthesis involved 
an asymmetric aldol reaction, a Yamaguchi esterification and ring-closing metathesis for the 
final cyclisation.206  
A concise and efficient synthesis of 10-deoxymethynolide 462 is envisaged using the 
Aggarwal’s assembly line synthesis protocol (Scheme 4.80). In particular, advanced 
intermediate 464 could be accessed through eight iterative homologations starting from boronic 
ester 465 employing various building blocks, including the recently developed lithiated 
methoxyallene to introduce the necessary masked enone functionality. Final functional group 








Parts of this section have been adapted from the following articles: 
Casoni, G., Myers, E. L., Aggarwal, V. K., Synthesis 2016, 48, 3241−3253. 
Casoni, G., Kucukdisli, M., Fordham, J. M., Burns, M., Myers, E. L., Aggarwal, V. K., 
J. Am. Chem. Soc. 2017, 139, 11877−11886. 
5.1. General Experimental 
All air- and water-sensitive reactions were carried out in oven-dried or flame-dried glassware 
under a N2 atmosphere using standard Schlenk techniques. Microwave reactions were 
performed in a Biotage Initiatio EXP EU microwave synthesiser. Analytical TLC was 
performed on aluminium backed plates pre-coated (0.25 mm) with Merck Silica Gel 60 F254. 
Compounds were visualised by exposure to UV-light or stained using KMnO4, p-anisaldehyde 
or phosphomolybdic acid (PMA) followed by heating. Flash column chromatography was 
performed using Sigma Aldrich silica gel 60 (40-63 μm) or prepacked column (SNAP Ultra 
columns 10 g, 25 g, 100 g) with automated system (Biotage® IsoleraTM One 3.0). All mixed 
solvent eluents are reported as v/v solutions. 1H, 13C, 11B and 19F Nuclear Magnetic Resonance 
(NMR) spectra were acquired at various field strengths as indicated using JEOL ECS 300, 
JEOL ECS 400, Varian 400 and Bruker 400 spectrometers. 1H and 13C NMR spectra were 
referenced internally to the residual non-deuterated solvent signal. 1H and 13C NMR coupling 
constants are reported in Hertz (Hz). Coupling constants are reported as follows: s = singlet, 
br. s = broad singlet, d = doublet, t = triplet, q = quartet, quint = quintet, sext = sextet, 
sept = septet, m = multiplet, dd = doublet of doublet, etc. Assignment of signals in 1H and 13C 
spectra was performed using COSY, DEPT, HMQC and HMBC experiments where 
appropriate. 13C signals adjacent to boron are generally not observed due to quadrupolar 
relaxation. 11B NMR spectra were measured using Norell S-200-QTZ quartz tubes at 128 MHz 
with complete proton decoupling. 19F NMR spectra were recorded at 376 MHz. High resolution 
mass spectra were recorded on Bruker Daltonics MicroTOF II by using Electron Spray 
Ionisation (ESI). GC-MS was performed on an Agilent 6890 apparatus. All IR data were 
obtained on a Perkin-Elmer Spectrum One FT-IR spectrometer. Optical rotations were 
measured on a Bellingham and Stanley Ltd. ADP220 polarimeter. Melting point ranges were 
determined with a Kofler hot-stage microscope apparatus and are reported uncorrected. 
Enantiomeric excess of boronic esters was determined after oxidation to the corresponding 
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alcohols. Chiral HPLC was performed using Daicel Chiralpak IA and IB columns (4.6 mm × 
250 mm, 5 μm) fitted with the respective guard (4 mm × 10 mm) and monitored by DAD 
(Diode Array Detector) on an Agilent 1100 system equipped with HP Chemstation/OpenLab 
software using. Waters HPLC system (Waters system fluidics organiser, Waters 2545 gradient 
module, and Waters 2998 photodiode array detector) was used for preparative reverse phase 
separation. Chiral gas chromatography (Chiral GC) was performed on an Agilent 7890A using 
a Chiraldex β-DP 120 column (30m × 0.25mm × 0.25 μm) and a Chiraldex β-DM 120 column 
(30m × 0.25mm × 0.25μm). 
5.2. Materials and Reagents 
All reagents were used as received unless otherwise stated. Anhydrous Et2O, THF, CH3CN, 
toluene and CH2Cl2 were dried using a purification column composed of activated alumina. 
Anhydrous Et2O was stored over 3 Å molecular sieves. TMEDA, Et3N, HMDS and DCME 
were distilled over CaH2 and stored in a Young’s tube under N2. Diisopropylamine was dried 
over NaOH before distillation and stored in a Young’s tube under N2. Organolithiums (n-BuLi, 
s-BuLi, and t-BuLi) reagents were periodically titrated using N-benzylbenzamide.207 
i-PrMgClLiCl was titrated using I2.
208 LDA and LiHMDS solutions were freshly prepared 
from the corresponding distilled amines and n-BuLi immediately before use. Basic silica gel 




5.3. General Procedures Chapter 2 
General procedure for the lithiation/borylation of 1,1-dimethyl-2-phenylazetidin-1-ium 
trifluoromethanesulfonate 211 to give γ-dimethylamino tertiary boronic esters (GP1) 
To a solution of diisopropylamine (2.0 equiv) in anhydrous THF (2.0 M) was added n-BuLi 
(2.0 equiv) at −78 °C. After stirring for 30 min, the solution was added dropwise to a mixture 
of azetidinium salt 211 (1.0 equiv) and the boronic ester (1.2 equiv) in dry THF (0.03 M) at 
−78 °C. The reaction mixture was stirred at −78 °C for 1 h, then was allowed to warm to room 
temperature. The solvent was removed in vacuo and the crude residue was taken up with H2O 
and extracted with CH2Cl2 (3 times). The combined organic layers were dried over MgSO4 and 
the solvent was removed in vacuo to afford the crude tertiary boronic ester, which was purified 
by flash chromatography on silica gel (EtOAc:Et3N = 100:0.5) to afford the pure 
γ-dimethylamino tertiary boronic ester. 
General procedure for the lithiation/borylation of 1,1-dimethyl-2-phenylazetidin-1-ium 
trifluoromethanesulfonate 211 with in situ oxidation (GP2a) 
To a solution of diisopropylamine (2.0 equiv) in anhydrous THF (2.0 M) was added n-BuLi 
(2.0 equiv) at −78 °C. After stirring for 30 min the solution was added dropwise to a mixture 
of azetidinium salt 211 (1.0 equiv) and the boronic ester (1.2 equiv) in dry THF (0.03 M) at 
−78 °C. The reaction mixture was stirred at −78 °C for 1 h, then was allowed to warm to room 
temperature. The reaction mixture was cooled to 0 °C and a 2:1 mixture of aq. NaOH (2.0 M) 
and 30% H2O2 (3.0 mL in total) was added under vigorous stirring. The cooling bath was 
removed and the reaction mixture was stirred at room temperature for 1 h. The solvent was 
removed in vacuo and the residue was partitioned between H2O and CH2Cl2. The phases were 
separated and the aqueous layer was re-extracted with CH2Cl2 (2 times). The combined organic 
layers were washed with brine, dried over MgSO4, filtered and the solvent was removed under 
reduced pressure. The residue was purified by flash chromatography on silica gel 




General procedure for the lithiation/borylation of 1,1-dimethyl-2-phenylazetidin-1-ium 
trifluoromethanesulfonate 211 with in situ oxidation at low temperature (GP2b) 
To a solution of diisopropylamine (2.0 equiv) in anhydrous THF (2.0 M) was added n-BuLi 
(2.0 equiv) at −78 °C. After stirring for 30 min the solution was added dropwise to a mixture 
of azetidinium salt 211 (1.0 equiv) and the boronic ester (1.2 equiv) in dry THF (0.03 M) at 
−78 °C. The reaction mixture was stirred at −78 °C for 1 h, then was allowed to warm to room 
temperature. The reaction mixture was cooled to −40 °C and a 2:1 mixture of aq. NaOH (2.0 M) 
and 30% H2O2 (3.0 mL in total) was added under vigorous stirring. The cooling bath was 
removed and the reaction mixture was stirred at room temperature for 1 h. The solvent was 
removed in vacuo and the residue was partitioned between H2O and CH2Cl2. The phases were 
separated and the aqueous layer was re-extracted with CH2Cl2 (2 times). The combined organic 
layers were washed with brine, dried over MgSO4, filtered and the solvent was removed under 
reduced pressure. The residue was purified by flash chromatography on silica gel 
(EtOAc:Et3N = 100:0.5) to afford the pure tertiary alcohol. 
General procedure for the lithiation/borylation of 1,1-dimethyl-2-phenylazetidin-1-ium 
trifluoromethanesulfonate with in situ protodeboronation (GP3) 
To a solution of diisopropylamine (2.0 equiv) in anhydrous THF (2.0 M) was added n-BuLi 
(2.0 equiv) at −78 °C. After stirring for 30 min the solution was added dropwise to a mixture 
of azetidinium salt 211 (1.0 equiv) and the boronic ester (1.2 equiv) in dry THF (0.03 M) at 
−78 °C. The reaction mixture was stirred at −78 °C for 1 h and then was allowed to warm to 
room temperature. CsF (1.5 equiv) was added at room temperature, followed by H2O 
(1.1 equiv), and the reaction mixture was stirred at room temperature for 1 h. The solvent was 
removed in vacuo and the residue was partitioned between H2O and CH2Cl2. The phases were 
separated and the aqueous layer was re-extracted with CH2Cl2 (2 times). The combined organic 
layers were washed with brine, dried over MgSO4, filtered and the solvent was removed under 
reduced pressure. The residue was purified by flash chromatography on silica gel 




5.4. Single Compounds Chapter 2 
(S)-3-Chloro-1-phenylpropan-1-ol ((S)-207) 
 
Following a literature reported procedure,142 Cu(OAc)2.H2O (0.12 g, 0.60 mmol) and 
(S)-P-Phos (0.15 g, 0.20 mmol) were weighted under air and dissolved in toluene (66 mL). The 
reaction mixture was stirred at room temperature for 20 min, then a solution of phenylsilane 
(3.0 mL, 24 mmol) in toluene (32 mL) was added. The mixture was cooled to −20 °C and a 
solution of 3-chloro-1-phenylpropan-1-one (3.4 g, 20 mmol) in toluene (32 mL) was added 
under vigorous stirring. The flask was stoppered and the reaction mixture was stirred for 24 h 
at the above temperature. Upon completion, the mixture was treated with 10% HCl (130 mL) 
and the organic product was extracted with Et2O (3 × 150 mL). The combined organic layers 
were washed with H2O, dried over MgSO4, filtered and concentrated in vacuo. Purification by 
column chromatography on silica gel (hexane:EtOAc = 90:10) afforded alcohol (S)-207 (2.5 g, 
73%) as a white solid. 
[The racemate was synthesised as follows: according to a literature reported procedure,132 
NaBH4 (5.68 g, 150 mmol) was added in small portions at 0 °C to a stirred solution of 
3-chloro-1-propiophenone (8.4 g, 50 mmol) in MeOH (104 mL). The mixture was stirred at 
room temperature for 18 h and then was quenched with H2O (90 mL). The solvent was removed 
in vacuo and the residue was extracted with Et2O (3 × 50 mL). The combined organic layers 
were dried over MgSO4 and concentrated under reduced pressure to give the title compound as 
a colourless oil (8.4 g, 98% yield). The product was used in the next step without further 
purification.] 
1H NMR (CDCl3, 400 MHz) δ: 7.37–7.26 (m, 5H, Ar-H), 4.93 (dd, J1 = 11.3 Hz, J2 = 6.4 Hz, 
1H, CH-OH), 3.73 (ddd, J1 = 14.5 Hz, J2 = 10.8 Hz, J3 = 7.6 Hz, 1H, CH2-Cl), 3.55 (m, 1H, 
CH2-Cl), 2.23 (m, 1H, CH2-CH), 2.10 (m, 1H, CH2-CH), 2.03 (br. s, 1H, OH). 
13C NMR (CDCl3, 101 MHz) δ: 143.8 (Ar-C), 128.8 (2C, Ar-C), 128.1 (Ar-C), 125.9 (2C, 
Ar-C), 71.5 (CH), 41.8 (CH2), 41.6 (CH2). 
[α]24D: −23 (c 1.0, CHCl3). [Lit. value for (S): −24.1 (c 1.1 CHCl3)].209 
All analytical data matched that previously reported in the literature.132 
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Chiral HPLC: Daicel Chiralcel-IB column (25 cm), hexane:isopropanol = 98:2, 1.0 mL/min, 
room temperature, 254 nm: tR = 16.2 minutes (major), 18.1 minutes (minor), e.r. = 97:3. 
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Following a literature reported procedure,127 to a solution of (S)-3-chloro-1-phenylpropan-1-ol 
(S)-207 (3.10 g, 18.2 mmol) in dry CH2Cl2 (18 mL), a solution of SOCl2 (4.00 mL, 54.6 mmol) 
in dry CH2Cl2 (5.5 mL) was added dropwise at room temperature. After stirring for 1 h, the 
reaction mixture was poured into H2O (20 mL) and aq. NaOH (15% w/v) was added slowly to 
neutralise the excess of HCl until the pH of the solution was 7. The aqueous phase was extracted 
with CH2Cl2 (3 × 30 mL) and the combined organic layers were dried over MgSO4, filtered 
and the solvent was evaporated under reduced pressure to afford 1-phenyl-1,3-dichloropropane 
which was employed in the next step without further purification. 
To a solution of 1-phenyl-1,3-dichloropropane and Et3N (5.10 mL, 36.4 mmol) in EtOH 
(23 mL) in a sealed flask, a solution of MeNH2 (33% w/v in EtOH, 23 mL) was added at room 
temperature. The reaction mixture was heated at 70 °C for 16 h and then allowed to cool to 
ambient temperature. The solvent was removed in vacuo and HCl (2.0 M, 30 mL) was added. 
The aqueous phase was extracted with CH2Cl2 (3 × 40 mL) and subsequently basified by 
addition of aq. NaOH (15% w/v) until the pH of the solution was >12. The basic aqueous phase 
was extracted with CH2Cl2 (3 × 50 mL), the combined organic layers were dried over MgSO4, 
filtered and the solvent was removed in vacuo. The crude mixture was purified by flash column 
chromatography on silica gel (EtOAc:Et3N = 100:0.5) to afford azetidine (R)-210 (1.34 g, 50% 
over two steps) as a colourless oil. 
[The racemate was synthesised as above, replacing (S)-207 with racemic 207.]  
1H NMR (CDCl3, 400 MHz) δ: 7.38–7.30 (m, 4H, Ar-H), 7.26–7.22 (m, 1H, Ar-H), 3.87 (t, 
J = 8.4 Hz, 1H, 1-H), 3.45 (m, 1H, 3-H), 2.85 (dt, J1 = 9.6 Hz, J2 = 7.1 Hz, 1H, 3-H), 2.33 (s, 
3H, CH3), 2.26 (m, 1H, 2-H), 2.14 (quint, J = 8.9 Hz, 1H, 2-H). 
13C NMR (CDCl3, 101 MHz) δ: 143.0 (Ar-C), 128.5 (2C, Ar-C), 127.4 (Ar-C), 126.7 (2C, 
Ar-C), 71.3 (1-C), 53.1 (3-C), 44.6 (CH3), 27.0 (2-C). 
[α]24D: +105 (c 0.6, CHCl3). [Lit. value for (S): −117 (c 0.55 CHCl3)].127 
All analytical data matched that previously reported in the literature.127 
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Chiral GC: Chiraldex β-DM column, injector T = 250 °C, detector T = 300 °C, inject at 
T = 90 °C then hold constant for 40 min, He carrier gas at 1.0 mL min–1: tR = 35.1 minutes 




(R)-1,1-Dimethyl-2-phenylazetidin-1-ium trifluoromethanesulfonate ((R)-211) 
 
Following a modified literature reported procedure,130 azetidine (R)-210 (272 mg, 1.85 mmol) 
was dissolved in dry Et2O (15 mL). After cooling to 0 °C, methyl trifluoromethane sulfonate 
(440 µL, 3.89 mmol) was added. The mixture was stirred for 1 h at 0 °C, then all the volatiles 
were removed under vacuum to afford azetidinium triflate (R)-211 (575 mg, 99%) as a thick 
orange oil. 
[The racemate was synthesised as above, replacing (R)-210 with racemic 210.]  
1H NMR (CDCl3, 400 MHz) δ: 7.52–7.47 (m, 5H, Ar-H), 5.84 (dd, J1 = 10.5 Hz, J2 = 8.6 Hz, 
1H, 1-H), 4.59 (ps q, J = 9.3 Hz, 1H, 3-H) 4.07 (ps td, J1 = 10.0 Hz, J2 = 3.5 Hz, 1H, 3-H), 3.29 
(s, 3H, CH3), 3.24 (m, 1H, 2-H), 2.78 (m, 1H, 2-H), 2.59 (s, 3H, CH3). 
13C NMR (CDCl3, 101 MHz) δ: 131.9 (Ar-C), 129.9 (2C, Ar-C), 129.7 (2C, Ar-C), 128.8 
(Ar-C), 120.7 (q, 1JC−F = 320 Hz, CF3), 79.1 (1-C), 62.6 (3-C), 52.5 (CH3), 45.7 (CH3), 19.0 
(2-C). 
19F NMR (CDCl3, 376 MHz) δ: –78.3. 
IR (neat) νmax: 1465, 1254, 1223, 1152, 1028, 975, 830, 770, 756, 706 cm
‒1. 
HRMS (ESI) calculated for C11H16N (M)
+: 162.1277, found: 162.1283. 







According to general procedure GP1, diisopropylamine (561 µL, 4.00 mmol), n-BuLi (2.5 mL, 
4.0 mmol), 1,1-dimethyl-2-phenylazetidin-1-ium trifluoromethanesulfonate (211) (623 mg, 
2.00 mmol) and 2-ethyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (375 mg, 2.40 mmol) in 
anhydrous THF (35 mL) afforded, after purification by flash column chromatography on silica 
gel (EtOAc:Et3N = 100:0.5) γ-dimethylamino boronic ester 213a (438 mg, 69%) as a 
colourless oil. 
Rf: 0.23 (CH2Cl2:MeOH:Et3N = 99.5:0.5:0.5). 
1H NMR (CDCl3, 400 MHz) δ: 7.32–7.29 (m, 2H, Ar-H), 7.27–7.23 (m, 2H, Ar-H), 7.11 (tt, 
J1 = 6.8 Hz, J2 = 1.3 Hz, 1H, Ar-H), 2.20 (s, 6H, N-(CH3)2), 2.19–2.13 (m, 2H, 1-H), 2.04−1.91 
(m, 2H, 2-H), 1.91–1.75 (m, 2H, CH2-CH3), 1.20 (s, 6H, C-CH3 × 2), 1.17 (s, 6H, C-CH3 × 2), 
0.70 (t, J = 7.4 Hz, 3H, CH2-CH3). 
13C NMR (CDCl3, 101 MHz) δ: 145.5 (Ar-C), 128.1 (2C, Ar-C), 127.67 (2C, Ar-C), 125.1 
(Ar-C), 83.2 (2C, B-O-C × 2), 56.5 (1-C), 46.0 (2C, N-(CH3)2), 31.9 (2-C), 29.9 (3-C), 28.1 
(CH2-CH3), 25.0 (2C, C-CH3 × 2), 25.0 (2C, C-CH3 × 2), 9.3 (CH2-CH3). 
11B NMR (CDCl3, 128 MHz) δ: 31.8. 
IR (neat) νmax: 2973, 2936, 1460, 1370, 1350, 1308, 1260, 1143, 1031, 167, 851, 759 cm
‒1. 
HRMS (ESI) calculated for C19H33BNO2 (M+H)






According to general procedure GP1, diisopropylamine (140 µL, 1.00 mmol), n-BuLi (625 µL, 
1.00 mmol), 1,1-dimethyl-2-phenylazetidin-1-ium trifluoromethanesulfonate (211) (156 mg, 
0.500 mmol) and 4,4,5,5-tetramethyl-2-phenethyl-1,3,2-dioxaborolane (139 mg, 0.600 mmol) 
in anhydrous THF (12 mL) afforded, after purification by flash column chromatography on 
silica gel (EtOAc:Et3N = 100:0.5) γ-dimethylamino boronic ester 213b (97 mg, 50%) as a pale 
yellow solid. 
Rf: 0.24 (CH2Cl2:MeOH:Et3N = 99.5:0.5:0.5). 
1H NMR (CD3OD, 400 MHz) δ: 7.39 (d, J = 7.6 Hz, 2H, Ar-H), 7.31 (t, J = 7.5 Hz, 2H, Ar-H), 
7.23 (t, J = 7.5 Hz, 2H, Ar-H), 7.18–7.09 (m, 4H, Ar-H), 2.42–2.37 (m, 2H, 5-H), 2.30–2.26 
(m, 2H, 1-H), 2.23 (s, 6H, N-(CH3)2), 2.13–2.02 (m, 4H, 2-H + 4-H), 1.26 (s, 6H, C-CH3 × 2), 
1.25 (s, 6H, C-CH3 × 2). 
13C NMR (CD3OD, 101 MHz) δ: 146.1 (Ar-C), 144.4 (Ar-C), 129.4 (2C, Ar-C), 129.2 (2C, 
Ar-C), 129.2 (2C, Ar-C), 128.5 (2C, Ar-C), 126.7 (Ar-C), 126.5 (Ar-C), 84.7 (2C, B-O-C × 2), 
57.4 (1-C), 45.8 (2C, N-(CH3)2), 39.4 (2-C), 33.1 (5-C), 32.8 (4-C), 25.3 (4C, C-CH3 × 4); 
carbon attached to boron not observed due to quadrupolar relaxation. 
11B NMR (CD3OD, 128 MHz) δ: 31.6, 13.0. 
IR (neat) νmax: 2936, 1459, 1138, 1111, 1096, 1079, 1069, 1052, 1022, 988, 839, 757 cm
‒1. 
HRMS (ESI) calculated for C25H37BNO2 (M+H)
+: 394.2916, found: 394.2933. 






According to general procedure GP1, diisopropylamine (140 µL, 1.00 mmol), n-BuLi (625 µL, 
1.00 mmol), 1,1-dimethyl-2-phenylazetidin-1-ium trifluoromethanesulfonate (211) (156 mg, 
0.500 mmol) and 2-isobutyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (111 mg, 0.600 mmol) in 
anhydrous THF (12 mL) afforded after purification by flash column chromatography on silica 
gel (EtOAc:Et3N = 100:0.5) γ-dimethylamino boronic ester 213c (80 mg, 46%) as a colourless 
oil. 
Rf: 0.32 (EtOAc:Et3N = 100:0.5). 
1H NMR (CD3OD, 400 MHz) δ: 7.39 (d, J = 8.0 Hz, 2H, Ar-H), 7.26 (t, J = 7.6 Hz, 2H, Ar-H), 
7.12 (t, J = 7.3 Hz, 1H, Ar-H), 2.19 (s, 6H, N-(CH3)2), 2.17–1.99 (m, 4H, 1-H + 2-H), 1.77 (m, 
2H, 4-H), 1.56 (sept, J = 6.5 Hz, 1H, CH), 1.21 (s, 6H, C-CH3 × 2), 1.19 (s, 6H, C-CH3 × 2), 
0.82 (d, J = 6.7 Hz, 3H, CH-CH3), 0.78 (d, J = 6.7 Hz, 3H, CH-CH3). 
13C NMR (CD3OD, 101 MHz) δ: 146.5 (Ar-C), 129.1 (2C, Ar-C), 128.6 (2C, Ar-C), 126.3 
(Ar-C), 84.7 (2C, B-O-C x 2), 57.1 (1-C), 45.6 (2C, N-(CH3)2), 45.5 (4-C), 33.0 (2-C), 26.8 
(CH), 25.3 (2C, C-CH3 × 2), 25.2 (2C, C-CH3 × 2), 24.9 (CH-CH3), 24.6 (CH-CH3); carbon 
attached to boron not observed due to quadrupolar relaxation. 
11B NMR (CD3OD, 128 MHz) δ: 32.4, 19.2, 16.1. 
IR (neat) νmax: 2952, 1447, 1371, 1143, 701 cm
‒1. 
HRMS (ESI) calculated for C21H37BNO2 (M+H)






According to general procedure GP1, diisopropylamine (140 µL, 1.00 mmol), n-BuLi (625 µL, 
1.00 mmol), 1,1-dimethyl-2-phenylazetidin-1-ium trifluoromethanesulfonate (211) (156 mg, 
0.500 mmol) and (R)-tert-butyldimethyl(2-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-
2yl)propoxy)silane (189 mg, 0.600 mmol) in anhydrous THF (12 mL) afforded after 
purification by flash column chromatography on silica gel (EtOAc:Et3N = 100:0.5) 
γ-dimethylamino boronic ester 213d (79.5 mg, 46%, 1:1 d.r.) as a colourless oil. 
Rf: 0.30 (EtOAc:Et3N = 100:0.5). 
1H NMR (CD3OD, 400 MHz) δ: 7.39 (d, J = 7.8 Hz, 2H, Ar-H), 7.37 (d, J = 7.8 Hz, 2H, Ar-H), 
7.26 (m, 4H, Ar-H), 7.12 (t, J = 7.3 Hz, 2H, Ar-H), 3.28 (m, 2H, 6-H diast. a), 3.14 (dd, 
J1 = 9.5 Hz, J2 = 7.1 Hz, 2H, 6-H diast. b), 2.38–2.25 (m, 2H, 1-H diast. a + diast. b), 2.22 (s, 
12H, N-(CH3)2 diast. a + diast. b), 2.17–2.00 (m, 6H, 1-H diast. a + diast. b + 2-H × 2 diast. a 
+ diast. b), 1.98–1.86 (m, 2H, 5-H diast. a + diast. b), 1.67–1.47 (m, 4H, 4-H x 2 diast. a + 
diast. b), 1.25 (s, 6H, C-CH3 × 2 diast. a), 1.23 (s, 6H, C-CH3 × 2 diast. a), 1.20 (s, 6H, C-CH3 
× 2 diast. b), 1.18 (s, 6H, C-CH3 × 2 diast. b), 0.88 (s, 9H, Si-C-(CH3)3 diast. a), 0.86 (s, 9H, 
Si-C-(CH3)3 diast. b), 0.83 (d, J = 6.2 Hz, 3H, 6’-H diast. a), 0.65 (d, J = 6.6 Hz, 3H, 6’-H 
diast. b), −0.01 (s, 6H, Si-(CH3)2 diast. a), −0.03 (s, 6H, Si-(CH3)2 diast. b). 
13C NMR (CD3OD, 101 MHz) δ: 146.7 (Ar-C), 146.6 (Ar-C), 129.1 (2C, Ar-C), 129.1 (2C, 
Ar-C), 128.8 (Ar-C), 128.7 (2C, Ar-C), 128.6 (2C, Ar-C), 128.5 (Ar-C), 84.7 (4C, B-O-C × 2 
diast. a + diast. b), 70.2 (6-C diast. a), 70.2 (6-C diast. b), 57.7 (1-C diast. a), 57.2 (1-C diast. b), 
45.7 (4C, N-(CH3)2 diast. a + diast. b), 41.0 (4-C diast. a), 39.5 (4-C diast. b), 34.5 (5-C diast. a), 
34.3 (5-C diast. b), 34.0 (2-C diast. a), 32.4 (2-C diast. b), 26.5 (3C, Si-C-(CH3)3 diast. a), 26.5 
(3C, Si-C-(CH3)3 diast. b), 26.4 (2C, Si-C-CH3 diast. a + diast. b), 25.4 (2C, C-CH3 × 2 diast. a), 
25.4 (2C, C-CH3 x 2 diast. a), 25.2 (2C, C-CH3 × 2 diast. b), 25.0 (2C, C-CH3 × 2 diast. b), 
19.1 (7-C diast. a), 19.1 (7-C diast. b), –6.1 (2C, Si-CH3 diast. a), –5.2 (2C, Si-CH3, diast. b); 
carbon attached to boron not observed due to quadrupolar relaxation. 
 
176 
11B NMR (CD3OD, 128 MHz) δ: 32.8, 15.4. 
IR (neat) νmax: 2954, 2929, 1253, 1143, 1083, 834, 774, 700 cm
‒1. 
HRMS (ESI) calculated for C27H51BNO3Si (M+H)






According to general procedure GP1, diisopropylamine (140 µL, 1.00 mmol), n-BuLi (625 µL, 
1.00 mmol), 1,1-dimethyl-2-phenylazetidin-1-ium trifluoromethanesulfonate (211) (159 mg, 
0.510 mmol) and 2-cyclohexyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (126 mg, 0.600 mmol) 
in anhydrous THF (12 mL) afforded after purification by flash column chromatography on 
silica gel (EtOAc:Et3N = 100:0.5) γ-dimethylamino boronic ester 213e (84 mg, 44%) as a 
colourless oil. 
Rf: 0.24 (CH2Cl2:MeOH:Et3N = 99.5:0.5:0.5). 
1H NMR (CD3OD, 400 MHz) δ: 7.35 (d, J = 7.5 Hz, 2H, Ar-H), 7.24 (t, J = 7.5 Hz, 2H, Ar-H), 
7.13 (t, J = 7.3 Hz, 1H, Ar-H), 2.24–2.10 (m, 2H, 3-H + c-Hex-H), 2.17 (s, 6H, N-(CH3)2), 
2.02–1.93 (m, 2H, 1-H + c-Hex-H), 1.89 (m, 1H, c-Hex-H), 1.76–1.48 (m, 5H, 
c Hex-H × 3 + 2-H × 2), 1.33 (s, 6H, C-CH3 × 2), 1.32 (s, 6H, C-CH3 × 2), 1.29–0.91 (m, 5H, 
c-Hex-H × 5). 
13C NMR (CD3OD, 101 MHz) δ: 144.8 (Ar-C), 130.2 (2C, Ar-C), 128.7 (2C, Ar-C), 126.5 
(Ar-C), 84.8 (2C, B-O-C x 2), 58.3 (1-C), 48.0 (2-C), 45.5 (2C, N-(CH3)2), 33.9 (c-Hex-C), 
31.5 (c-Hex-C), 30.2 (c-Hex-C), 28.4 (c-Hex-C), 28.2 (c-Hex-C), 28.0 (c-Hex-C), 25.7 (2C, 
C-CH3 × 2), 25.4 (2C, C-CH3 × 2); carbon attached to boron not observed due to quadrupolar 
relaxation. 
11B NMR (CD3OD, 128 MHz) δ: 33.3. 
IR (neat) νmax: 2926, 2852, 1450, 1371, 1350, 1300, 1269, 1141, 1036, 852 cm
‒1. 
HRMS (ESI) calculated for C23H39BNO2 (M+H)






According to general procedure GP1, diisopropylamine (140 µL, 1.00 mmol), n-BuLi (625 µL, 
1.00 mmol), 1,1-dimethyl-2-phenylazetidin-1-ium trifluoromethanesulfonate (211) (156 mg, 
0.500 mmol) and 2-cyclopropyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (101 mg, 
0.600 mmol) in anhydrous THF (12 mL) afforded after purification by flash column 
chromatography on silica gel (EtOAc:Et3N = 100:0.5) γ-dimethylamino boronic ester 213f 
(108 mg, 66%) as a colourless oil. 
Rf: 0.31 (EtOAc:Et3N = 100:0.5). 
1H NMR (CD3OD, 400 MHz) δ: 7.42 (dd, J1 = 7.9 Hz, J2 = 1.2 Hz, 2H, Ar-H), 7.26 (t, 
J = 7.5 Hz, 2H, Ar-H), 7.13 (t, J = 7.3 Hz, 1H, Ar-H), 2.35 (t, J = 8.2 Hz, 2H, 1-H), 2.20 (s, 
6H, N-(CH3)2), 2.01 (m, 2H, 2-H), 1.22 (s, 6H, C-CH3 × 2), 1.20 (s, 6H, C-CH3 × 2), 1.03 (m, 
1H, 4-H), 0.59–0.48 (m, 3H, 5-H/6-H), 0.32 (m, 1H, 5-H/6-H). 
13C NMR (CD3OD, 101 MHz) δ: 146.9 (Ar-C), 129.0 (2C, Ar-C), 128.9 (2C, Ar-C), 126.4 
(Ar-C), 84.7 (2C, B-O-C x 2), 57.5 (1-C), 45.5 (2C, N-(CH3)2), 36.1 (2-C), 25.2 (2C, 
C-CH3 × 2), 25.1 (2C, C-CH3 × 2), 18.1 (4-C), 4.1 (5-C/6-C), 3.4 (5-C/6-C); carbon attached 
to boron not observed due to quadrupolar relaxation. 
11B NMR (CD3OD, 128 MHz) δ: 31.7. 
IR (neat) νmax: 2976, 1371, 1306, 1142, 853, 700 cm
‒1. 
HRMS (ESI) calculated for C20H33BNO2 (M+H)






According to general procedure GP1, diisopropylamine (140 µL, 1.00 mmol), n-BuLi (625 µL, 
1.00 mmol), 1,1-dimethyl-2-phenylazetidin-1-ium trifluoromethanesulfonate (211) (155 mg, 
0.500 mmol) and 2-allyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (101 mg, 0.600 mmol) in 
anhydrous THF (12 mL) afforded after purification by flash column chromatography on silica 
gel (EtOAc:Et3N = 100:0.5) γ-dimethylamino boronic ester 213g (67 mg, 45%) as a colourless 
oil. 
Rf: 0.32 (EtOAc:Et3N = 100:0.5). 
1H NMR (CD3OD, 400 MHz) δ: 7.32–7.24 (m, 4H, Ar-H), 7.11 (ps t, J = 7.2 Hz, 1H, Ar-H), 
5.62 (tdd, J1 = 17.3 Hz, J2 = 10.2 Hz, J3 = 7.2 Hz, 1H, 5-H), 5.03 (dd, J1 = 17.1 Hz, J2 = 2.2 Hz, 
1H, 6-Htrans), 4.95 (dd, J1 = 10.2 Hz, J2 = 2.2 Hz, 1H, 6-Hcis), 2.57 (d, J = 7.2 Hz, 2H, 4-H), 
2.26–2.17 (m, 2H, 1-H), 2.19 (s, 6H, N-(CH3)2), 2.02–1.97 (m, 2H, 2-H), 1.20 (s, 6H, 
C-CH3 × 2), 1.19 (s, 6H, C-CH3 × 2). 
13C NMR (CD3OD, 101 MHz) δ: 146.0 (Ar-C), 136.9 (5-C), 129.1 (2C, Ar-C), 128.4 (2C, 
Ar-C), 126.3 (6-C), 117.3 (Ar-C), 84.6 (2C, B-O-C x 2), 56.8 (1-C), 45.8 (2C, N-(CH3)2), 40.5 
(4-C), 32.3 (2-C), 25.4 (2C, C-CH3 × 2), 25.3 (2C, C-CH3 × 2); carbon attached to boron not 
observed due to quadrupolar relaxation. 
11B NMR (CD3OD, 128 MHz) δ: 30.7. 
IR (neat) νmax: 2975, 1457, 1371, 1143, 1057, 700 cm
‒1. 
HRMS (ESI) calculated for C20H33BNO2 (M+H)






According to general procedure GP1, diisopropylamine (140 µL, 1.00 mmol), n-BuLi (625 µL, 
1.00 mmol), 1,1-dimethyl-2-phenylazetidin-1-ium trifluoromethanesulfonate (211) (153 mg, 
0.500 mmol) and 2-(4-methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (141 mg, 
0.600 mmol) in anhydrous THF (12 mL) afforded after purification by flash column 
chromatography on silica gel (EtOAc:Et3N = 100:0.5) γ-dimethylamino boronic ester 213k 
(145 mg, 75%) as a yellow oil. 
Rf: 0.31 (EtOAc:Et3N = 100:0.5). 
1H NMR (CD3OD, 400 MHz) δ: 7.26–7.10 (m, 7H, Ar-H), 6.80 (d, J = 8.7 Hz, 2H, Ar-H), 
3.76 (s, 3H, O-CH3), 2.36–2.28 (m, 2H, 1-H), 2.20 (s, 6H, N-(CH3)2), 2.10 (ps t, J = 7.8 Hz, 
2H, 2-H), 1.15 (s, 6H, C-CH3 × 2), 1.14 (s, 6H, C-CH3 × 2). 
13C NMR (CD3OD, 101 MHz) δ: 159.1 (Ar-C), 147.8 (Ar-C), 139.2 (Ar-C), 131.3 (2C, Ar-C), 
130.3 (2C, Ar-C), 128.8 (2C, Ar-C), 126.5 (Ar-C), 114.3 (2C, Ar-C), 84.8 (2C, B-O-C x 2), 
58.8 (1-C), 55.6 (O-CH3), 45.4 (2C, N-(CH3)2), 35.9 (2-C), 24.9 (2C, C-CH3 × 2), 24.9 (2C, 
C-CH3 × 2); carbon attached to boron not observed due to quadrupolar relaxation. 
11B NMR (CD3OD, 128 MHz) δ: 31.5, 13.2. 
IR (neat) νmax: 2969, 1509, 1461, 1341, 1297, 1245, 1181, 1141, 1035, 852, 827 cm
‒1. 
HRMS (ESI) calculated for C24H35BNO3 (M+H)





According to general procedure GP2a, diisopropylamine (140 µL, 1.00 mmol), n-BuLi 
(625 µL, 1.00 mmol), 1,1-dimethyl-2-phenylazetidin-1-ium trifluoromethanesulfonate (211) 
(153 mg, 0.490 mmol) and 4,4,5,5-tetramethyl-2-phenyl-1,3,2-dioxaborolane (123 mg, 
0.600 mmol) in anhydrous THF (12 mL), afforded after purification by flash chromatography 
on silica gel (EtOAc:Et3N = 100:0.5) tertiary alcohol 217i (88 mg, 70%) as a white solid. 
Rf: 0.22 (CH2Cl2:MeOH:Et3N = 99:1:0.5). 
1H NMR (CDCl3, 400 MHz) δ: 7.50 (pd, J = 8.0 Hz, 4H, Ar-H), 7.32 (ps t, J = 7.4 Hz, 4H, 
Ar-H), 7.20 (ps t, J = 7.2 Hz, 2H, Ar-H), 2.42 (s, 4H, 2-H + 3-H), 2.23 (s, 6H, N-(CH3)2). 
13C NMR (CDCl3, 101 MHz) δ: 148.1 (2C, Ar-C), 128.0 (4C, Ar-C), 126.3 (2C, Ar-C), 125.8 
(4C, Ar-C), 79.2 (1-C), 56.3 (3-C), 45.1 (2C, N-(CH3)2), 36.0 (2-C). 
IR (neat) νmax: 2830, 2783, 1446, 1204, 1064, 1019, 963, 891, 841, 1777, 751, 716 cm
‒1. 
HRMS (ESI) calculated for C17H22NO (M+H)
+: 256.1696, found: 256.1697. 






According to general procedure GP2b, diisopropylamine (140 µL, 1.00 mmol), n-BuLi 
(625 µL, 1.00 mmol), 1,1-dimethyl-2-phenylazetidin-1-ium trifluoromethanesulfonate (211) 
(156 mg, 0.500 mmol) and 4,4,5,5-tetramethyl-2-(thiophen-2-yl)-1,3,2-dioxaborolane 
(126 mg, 0.600 mmol) in anhydrous THF (12 mL), afforded after purification by flash 
chromatography on silica gel (EtOAc:Et3N = 100:0.5) tertiary alcohol 217j (64 mg, 49%) as a 
white solid. 
Rf: 0.39 (EtOAc:Et3N = 100:0.5). 
1H NMR (CDCl3, 400 MHz) δ: 7.56 (d, J = 7.4 Hz, 2H, Ar-H), 7.33 (t, J = 7.6 Hz, 2H, Ar-H), 
7.22 (t, J = 7.1 Hz, 1H, Ar-H), 7.18 (d, J = 5.0 Hz, 1H, 5-H), 6.92 (t, J = 3.6 Hz, 1H, 6-H), 6.89 
(d, J = 3.5 Hz, 1H, 7-H), 2.52 (m, 1H, 1-H), 2.47–2.30 (m, 3H, 1-H + 2-H), 2.24 (s, 6H, 
N-(CH3)2). 
13C NMR (CDCl3, 101 MHz) δ: 154.4 (4-C), 147.4 (Ar-C), 128.2 (2C, Ar-C), 126.8 (Ar-C), 
126.6 (6-C), 125.5 (2C, Ar-C), 124.3 (5-C), 122.8 (7-C), 78.5 (3-C), 56.6 (1-C), 45.2 (2C, 
N-(CH3)2), 38.1 (2-C). 
IR (neat) νmax: 2779, 1178, 1068, 847, 699 cm
‒1. 
HRMS (ESI) calculated for C15H20NOS (M+H)
+: 262.1260, found: 262.1267. 






According to general procedure GP3, diisopropylamine (120 µL, 0.876 mmol), n-BuLi 
(565 µL, 1.00 mmol), 1,1-dimethyl-2-phenylazetidin-1-ium trifluoromethanesulfonate (211) 
(137 mg, 0.438 mmol), 2-(4-chlorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (138 mg, 
0.581 mmol), CsF (99.8 mg, 0.657 mmol) and H2O (9.0 µL, 0.48 mmol) in anhydrous THF 
(8 mL), afforded after purification by flash chromatography on silica gel 
(EtOAc:Et3N = 100:0.5) protodeboronated compound 218l (85 mg, 71%) as a colourless oil. 
Rf: 0.24 (CH2Cl2:MeOH:Et3N = 99.5:0.5:0.5). 
1H NMR (CDCl3, 400 MHz) δ: 7.26–7.24 (m, 8H, Ar-H), 7.15 (m, 1H, Ar-H), 3.93 (t, 
J = 6.0 Hz, 1H, 3-H), 2.27–2.20 (m, 4H, 1-H + 2-H), 2.19 (s, 6H, N-(CH3)2). 
13C NMR (CDCl3, 101 MHz) δ: 145.5 (Ar-C), 145.0 (Ar-C), 132.9 (Ar-C), 130.4 (2C, Ar-C), 
129.6 (2C, Ar-C), 129.5 (2C, Ar-C), 128.7 (2C, Ar-C), 127.5 (Ar-C), 59.1 (1-C), 49.9 (3-C), 
45.4 (2C, N-(CH3)2), 34.0 (2-C). 
IR (neat) νmax: 2942, 2765, 1489, 1092, 1014, 821, 698 cm
‒1. 
HRMS (ESI) calculated for C17H21Cl (M+H)







According to general procedure GP1, diisopropylamine (140 µL, 1.00 mmol), n-BuLi (625 µL, 
1.00 mmol), 1,1-dimethyl-2-phenylazetidin-1-ium trifluoromethanesulfonate (211) (155 mg, 
0.500 mmol) and 4,4,5,5-tetramethyl-2-(1-phenylvinyl)-1,3,2-dioxaborolane (138 mg, 
0.600 mmol) in anhydrous THF (12 mL) afforded after purification by flash column 
chromatography on silica gel (EtOAc:Et3N = 100:0.5) cyclopropane 220 (47 mg, 24%) as a 
colourless oil. 
Rf: 0.30 (EtOAc:Et3N = 100:0.5). 
1H NMR (CD3OD, 400 MHz) δ: 7.06–6.78 (m, 10H, Ar-H), 2.54 (td, J1 = 12.4 Hz, J2 = 4.4 Hz, 
1H, 1-H), 2.32 (td, J1 = 11.5 Hz, J2 = 4.4 Hz, 1H, 1-H), 2.17 (s, 6H, N-(CH3)2), 2.20–2.10 (m, 
1H, 2-H), 1.99 (bs, 1H, 5-H), 1.87 (td, J1 = 12.3 Hz, J2 = 4.3 Hz, 1H, 2-H), 1.36 (d, J = 4.8 Hz, 
1H, 5-H), 1.26 (s, 6H, C-CH3 × 2), 1.22 (s, 6H, C-CH3 × 2). 
13C NMR (CD3OD, 101 MHz) δ: 141.4 (Ar-C), 141.3 (Ar-C), 131.4 (2C, Ar-C), 130.6 (2C, 
Ar-C), 128.6 (2C, Ar-C), 128.1 (2C, Ar-C), 126.8 (Ar-C), 125.8 (Ar-C), 85.0 (2C, B-O-C × 2), 
58.7 (1-C), 45.3 (2C, N-(CH3)2), 37.6 (3-C), 36.8 (2-C), 25.3 (2C, C-CH3 × 2), 25.2 (2C, 
C-CH3 × 2), 20.4 (5-C); carbon attached to boron not observed due to quadrupolar relaxation. 
11B NMR (CDCl3, 96 MHz) δ: 30.7, 21.1. 
IR (neat) νmax: 2976, 1599, 1448, 1372, 1144, 849, 766, 697 cm
‒1. 
HRMS (ESI) calculated for C25H35BNO2 (M+H)






According to general procedure GP2a, diisopropylamine (140 µL, 1.00 mmol), n-BuLi 
(625 µL, 1.00 mmol), 1,1-dimethyl-2-phenylazetidin-1-ium trifluoromethanesulfonate (211) 
(156 mg, 0.500 mmol) and 2-ethyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (94 mg, 
0.60 mmol) in anhydrous THF (6 mL), afforded after purification by flash chromatography on 
silica gel (CH2Cl2:MeOH:Et3N = 100:0.5:0.5) tertiary alcohol 217a (60 mg, 58%) as a white 
solid. 
Rf: 0.25 (EtOAc:Et3N = 100:1). 
1H NMR (CDCl3, 400 MHz) δ: 7.41–7.39 (m, 2H, Ar-H), 7.34–7.30 (m, 2H, Ar-H), 7.20 (ps tt, 
J1 = 8.4 Hz, J2 = 0.9 Hz, 1H, Ar-H), 2.28 (td, J1 = 12.5 Hz, J2 = 2.6 Hz, 1H, 1-H), 2.19 (m, 1H, 
1-H), 2.18 (s, 6H, N-(CH3)2), 2.08 (ddd, J1 = 14.7 Hz, J2 = 12.0 Hz, J3 = 3.12 Hz, 1H, 2-H), 
1.84–1.74 (m, 3H, CH2-CH3 + 2-H), 0.72 (t, J = 7.3 Hz, 3H, CH2-CH3). 
13C NMR (CDCl3, 101 MHz) δ: 147.0 (Ar-C), 128.0 (2C, Ar-C), 126.1 (Ar-C), 125.9 (2C, 
Ar-C), 78.2 (3-C), 56.2 (1-C), 45.2 (2C, N-(CH3)2), 37.2 (2-C), 36.7 (CH2-CH3), 7.7 
(CH2-CH3). 
IR (neat) νmax: 2936, 2823, 2781, 1464, 1445, 1174, 1042, 1024, 773, 758 cm
‒1. 
HRMS (ESI) calculated for C13H22NO (M+H)
+: 208.1696, found: 208.1702. 






Following a modified literature procedure,94 N,N-dimethyl-3-phenyl-3-(4,4,5,5-tetramethyl-
1,3,2-dioxaborolan-2yl)pentan-1-amine (213a) (64 mg, 0.20 mmol) was dissolved in dry THF 
(2 mL) and TBAF3H2O (95 mg, 0.30 mmol) was added at room temperature. The reaction 
mixture was allowed to stir at 65 °C for 2 h, then H2O (5 mL) was added. The mixture was 
partitioned between H2O and CH2Cl2 and the aqueous phase was extracted with CH2Cl2 
(2 × 5 mL). The combined organic layers were dried over MgSO4 and solvent was removed 
under reduced pressure. The crude residue was purified by flash chromatography on silica gel 
(EtOAc:Et3N = 100:0.5) to afford 218a (28 mg, 73%) as a colourless oil. 
Rf: 0.20 (EtOAc:Et3N = 100:0.5). 
1H NMR (CDCl3, 400 MHz) δ: 7.30 (m, 2H, Ar-H), 7.22–7.15 (m, 3H, Ar-H), 2.47 (sept, 
J = 5.0 Hz, 1H, 3-H), 2.21 (m, 1H, 1-H), 2.21 (s, 6H, N-(CH3)2), 2.09 (td, J1 = 10.3 Hz, 
J2 = 5.1 Hz, 1H, 1-H), 1.87 (m, 1H, 2-H), 1.80–1.65 (m, 2H, 2-H + 4-H), 1.59 (m, 1H, 4-H), 
0.78 (t, J = 7.4 Hz, 3H, 5-H). 
13C NMR (CDCl3, 101 MHz) δ: 145.4 (Ar-C), 128.4 (2C, Ar-C), 127.8 (2C, Ar-C), 126.13 
(Ar-C), 58.1 (1-C), 46.0 (3-C), 45.5 (2C, N-(CH3)2), 34.3 (2-C), 30.0 (4-C), 12.2 (5-C). 
IR (neat) νmax: 2929, 1453, 1042, 755, 700 cm
‒1. 
HRMS (ESI) calculated for C13H22N (M+H)





Following a literature procedure,210 n-BuLi (1.50 mmol, 940 µL) was added dropwise to neat 
tetravinyltin (140 µL, 0.750 mmol) at room temperature under a N2 atmosphere. The reaction 
mixture was stirred for 30 min; the white solid formed was allowed to settle and the colourless 
solution was removed by syringe under N2. The solid (vinyl lithium) was washed with dry 
pentane (3 × 1 mL), every time adding and removing the solvent by syringe under N2, then it 
was dissolved in dry THF (1 mL). N,N-Dimethyl-3-phenyl-3-(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2yl)pentan-1-amine (213a) (95 mg, 0.30 mmol) was dissolved in dry THF 
(3 mL) and the vinyl lithium solution was added dropwise at –78 °C. The reaction mixture was 
stirred for 30 min at –78 °C, then it was warmed to –42 °C and stirred for additional 20 min. 
After that time, 11B NMR analysis of the crude reaction mixture showed complete boronate 
complex formation. The solution was cooled to –78 °C and a solution of I2 (381 mg, 1.50 mmol) 
in dry MeOH (2.4 mL) was added dropwise. After stirring for 15 min at –78 °C a suspension 
of MeONa (126 mg, 3.00 mmol) in dry MeOH (1.2 mL) was added. The reaction mixture was 
allowed to warm to room temperature and stirred for 1 h, then sat. aq. Na2S2O3 (10 mL) was 
added. The layers were separated, the organic layer was washed with brine (2 × 5 mL) and the 
combined aqueous layers were extracted with CH2Cl2 (3 × 5 mL). The combined organic layers 
were dried over MgSO4 and the solvent was removed under reduced pressure. The crude 
residue was purified by flash column chromatography on silica gel (EtOAc:Et3N = 100:0.5) to 
afford alkene 221a (34 mg, 52%) as a colourless oil. 
Rf: 0.20 (EtOAc:Et3N = 100:0.5). 
1H NMR (CDCl3, 400 MHz) δ: 7.31–7.28 (m, 4H, Ar-H), 7.18 (m, 1H, Ar-H), 5.91 (dd, 
J1 = 17.7 Hz, J2 = 11.0 Hz, 1H, 4’-H), 5.20 (dd, J1 = 10.9 Hz, J2 = 1.0 Hz, 1H, 5’-Hcis), 5.11 
(dd, J1 = 17.7 Hz, J2 = 1.0 Hz, 1H, 5’-Htrans), 2.19 (s, 6H, N-(CH3)2), 2.10 (m, 2H, 1-H), 1.97 
(m, 2H, 2-H), 1.80 (qd, J1 = 13.8 Hz, J2 = 7.2 Hz, 2H, 4-H), 0.72 (t, J = 7.4 Hz, 3H, 5-C). 
13C NMR (CDCl3, 101 MHz) δ: 145.7 (Ar-C), 145.2 (4’-C), 128.2 (2C, Ar-C), 127.4 (2C, 
Ar-C), 126.0 (Ar-C), 113.2 (5’-C), 55.2 (1-C), 47.0 (3-C), 45.7 (2C, N-(CH3)2), 34.5 (2-C), 
30.3 (4-C), 8.6 (5-C). 




HRMS (ESI) calculated for C15H24N (M+H)





Following a literature reported procedure,55 to a rapidly stirred solution of N,N-dimethyl-3-
phenyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2yl)pentan-1-amine 213a (95 mg, 
0.30 mmol) in MeOH (3 mL) was added dropwise a solution of KHF2 (105 mg, 1.35 mmol) in 
H2O (700 µL) at room temperature. The resulting reaction mixture was stirred for 30 min, then 
all the volatiles were removed under reduced pressure. The residue was dissolved in a mixture 
of MeOH:H2O (1:1 v/v, 6 mL) and evaporated to dryness. This evaporation–dissolution cycle 
was repeated 6 times, after which 1H NMR analysis of an aliquot of the reaction mixture 
showed no presence of pinacol (δ = 1.14 ppm) in CD3CN. The solid residue was then triturated 
with dry acetone (5 mL); the liquid phase was carefully decanted and the residual inorganic 
salts were additionally washed with acetone (3 × 1 mL). The combined washings were collected 
and concentrated in vacuo to give a 2:1 mixture of  tetrafluoroborate salt 222a and 
azaborolidine 223a (82% overall yield). 
A portion of the mixture (45 mg) was dissolved in dry CH3CN (3 mL) and the solution was 
heated at reflux for 5 h. The reaction mixture was then filtered through a pad of SiO2 and 
washed with CH2Cl2 to give azaborolidine 223a (26 mg, 68%) as a white solid. 
Rf: 0.66 (EtOAc:Et3N = 100:0.5). 
1H NMR (CDCl3, 400 MHz) δ: 7.29 (m, 4H, Ar-H), 7.12 (m, 1H, Ar-H), 3.00 (m, 1H, 1-H), 
2.90 (m, 1H, 1-H), 2.61 (s, 3H, N-CH3), 2.39 (s, 3H, N-CH3), 2.30 (quint, J = 7.6 Hz, 1H, 2-H), 
1.89 (m, 2H, 4-H), 1.59 (quint, J = 6.9 Hz, 1H, 2-H), 0.57 (t, J = 7.2 Hz, 3H, 5-H). 
13C NMR (CDCl3, 101 MHz) δ: 147.7 (Ar-C), 137.7 (4C, Ar-C), 124.4 (Ar-C), 60.4 (1-C), 
46.8 (d, J = 9.1 Hz, N-CH3), 46.6 (d, J = 10.1 Hz, N-CH3), 30.9 (4-C), 29.6 (2-C), 9.1 (5-C); 
carbon attached to boron not observed due to quadrupolar relaxation. 
11B NMR (CDCl3, 96 MHz) δ: 7.4 (t, J = 67.4 Hz). 
19F NMR (CDCl3, 282 MHz) δ:  –152.4 (m), –157.3 (m). 
IR (neat) νmax: 2959, 2927, 1467, 1053, 950, 755, 724, 701, 658 cm
‒1. 
HRMS (ESI) calculated for C13H20BF2NNa (M+Na)





Following a literature reported procedure,140 commercially available 2-phenylpyrrolidine 
(3.40 mmol, 500 mg) was suspended in H2O (4 mL) in a microwave test tube and formic acid 
(3.70 mmol, 141 µL) and formaldehyde (35% solution in H2O, 3.70 mmol, 320 µL) were added 
at room temperature. The tube was sealed and it was heated using microwave radiation at 
150 °C for 5 min. The reaction mixture was allowed to cool to room temperature, then it was 
basified to pH 14 using aq. NaOH (2.0 M) and extracted with CH2Cl2 (3 × 10 mL). The 
combined organic layers were dried over MgSO4 and the solvent was removed in vacuo. The 
crude material was purified by Kugelrohr distillation to afford the pure tertiary amine (396 mg, 
72%) as a colourless oil. 
1H NMR (CDCl3, 400 MHz) δ: 7.36–7.29 (m, 4H, Ar-H), 7.23 (m, 1H, Ar-H), 3.24 (td, 
J1 = 9.4 Hz, J2 = 1.8 Hz, 1H, 4-H), 3.03 (t, J = 8.8 Hz, 1H, 1-H), 2.28 (q, J = 9.3 Hz, 1H, 4-H), 
2.17 (m, 1H, 2-H), 2.17 (s, 3H, CH3), 1.95 (m, 1H, 3-H), 1.78 (m, 2H, 2-H + 3-H). 
13C NMR (CDCl3, 101 MHz) δ: 143.4 (Ar-C), 128.5 (2C, Ar-C), 127.6 (2C, Ar-C), 127.1 
(Ar-C), 71.8 (1-C), 57.2 (4-C), 40.6 (CH3), 35.3 (2-C), 22.6 (3-C). 
IR (neat) νmax: 2968, 2775, 1454, 1044, 754, 699 cm
‒1. 
HRMS (ESI) calculated for C11H16N (M+H)
+: 162.1277, found: 162.1272. 
All analytical data matched that previously reported in the literature.140 
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1,1-Dimethyl-2-phenylpyrrolidin-1-ium trifluoromethanesulfonate (227) 
 
Following a modified procedure reported by Couty,130 pyrrolidine 226 (358 mg, 2.22 mmol) 
was dissolved in dry Et2O (19 mL) and trifluoromethanesulfonate (500 µL, 4.45 mmol) was 
added at 0 °C. The mixture was stirred for 1 h at room temperature, then all the volatiles were 
removed under vacuum to afford pyrrolidinium triflate 227 (721 g, >99%) as a purple oil. 
1H NMR (CDCl3, 400 MHz) δ: 7.50 (d, J = 6.6 Hz, 2H, Ar-H), 7.45 (t, J = 8.6 Hz, 3H, Ar-H), 
4.87 (dd, J1 = 11.5 Hz, J2 = 7.8 Hz, 1H, 1-H), 3.82 (t, J = 7.7 Hz, 2H, 4-H), 3.07 (s, 3H, CH3), 
2.69 (s, 3H, CH3), 2.60 (m, 1H, 2-H), 2.49 (m, 1H, 2-H), 2.31 (b quint, J = 7.1 Hz, 2H, 3-H). 
13C NMR (CDCl3, 101 MHz) δ: 131.4 (Ar-C), 130.9 (2C, Ar-C), 129.5 (2C, Ar-C), 128.4 
(Ar-C), 120.7 (q, 1JC−F = 320 Hz, CF3), 78.7 (1-C), 65.8 (4-C), 50.6 (CH3), 45.2 (CH3), 26.1 
(2-C), 19.3 (3-C). 
19F NMR (CDCl3, 376 MHz) δ:  –78.4. 
IR (neat) νmax: 2972, 1475, 1256, 1152, 754, 706, 635 cm
‒1. 
HRMS (ESI) calculated for C12H18N (M)





To a solution of diisopropylamine (140 µL, 1.00 mmol) in anhydrous THF (500 µL) was added 
n-BuLi (625 µL, 1.00 mmol) at −78 °C. After stirring for 20 min at −78 °C and 10 min at room 
temperature, the solution was added dropwise to a mixture of pyrrolidinium salt 227 (163 mg, 
0.50 mmol) and 2-ethyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (94 mg, 0.60 mmol) in dry 
THF (12 mL) at −78 °C. The reaction mixture was stirred at −78 °C for 1 h, then was allowed 
to warm to room temperature. The solvent was removed in vacuo and the crude residue was 
taken up with H2O (5 mL) and extracted with CH2Cl2 (3 × 15 mL). The combined organic 
layers were dried over MgSO4 and the solvent was removed under reduced pressure to afford 
crude 229, which was purified by flash chromatography on silica gel (EtOAc:Et3N = 100:0.5) 
to afford the pure azocine 229 (42 mg, 48%) as a colourless oil. 
1H NMR (CDCl3, 400 MHz) δ: 6.05 (d, J = 9.5 Hz, 1H, 6-H), 5.94 (dd, J1 = 9.4 Hz, J2 = 5.3 Hz, 
1H, 8-H), 5.77–5.68 (m, 3H, 4-H, 7-H, 9-H), 3.51 (br. s, 1H, 10-H), 2.70–2.46 (m, 4H, 1-H × 
2, 3-H, 11-H), 2.42 (s, 3H, CH3), 2.21 (m, 1H, 3-H), 2.04 (m, 1H, 11-H), 1.87 (m, 1H, 2-H), 
1.47 (m, 1H, 2-H). 
(Z)-2-Methyl-1,2,3,4,5,10a-hexahydrobenzo[c]azocine (229) was found to rapidly rearrange at 
room temperature to give 2-methyl-1,2,3,4,5,6-hexahydrobenzo[c]azocine (230) which could 
be fully characterised. 
 
Rf: 0.54 (EtOAc:Et3N = 100:0.5). 
1H NMR (CDCl3, 400 MHz) δ: 7.18 (m, 4H, Ar-H), 3.78 (s, 2H, 1-H), 2.85 (t, J = 5.8 Hz, 2H, 
5-H), 2.46 (t, J = 4.8 Hz, 2H, 2-H), 2.39 (s, 3H, CH3), 1.71 (quint, J = 5.8 Hz, 2H, 4-H), 1.61 
(quint, J = 5.6 Hz, 2H, 3-H). 
13C NMR (CDCl3, 101 MHz) δ: 142.1 (Ar-C), 134.5 (Ar-C), 131.0 (Ar-C), 129.6 (Ar-C), 127.8 
(Ar-C), 126.0 (Ar-C), 55.9 (1-C), 54.1 (2-C), 43.6 (CH3), 33.1 (5-C), 31.0 (4-C), 23.7 (3-C). 




HRMS (ESI) calculated for C12H18N (M+H)




5.5. General Procedures Chapter 3 
General procedure for the synthesis of syn and anti 1-(p-tolylsulfinyl) 
2,4,6-triisopropylbenzoates by transmetalation (GP4) 
To a stirred solution of 2,4,6-triisopropylbenzoate (1.0 equiv) and TMEDA (1.2−1.5 equiv) in 
anhydrous Et2O (0.3 M) was added s-BuLi (1.3 M in cyclohexane/hexane, 1.2−1.5 equiv) 
dropwise at −78 °C under N2 atmosphere. After stirring for the required time at −78 °C, a 
solution of freshly prepared MgBr2Et2O* (1.5 equiv in Et2O − 0.8 M) was added at −78 °C and 
the reaction mixture was stirred for 2 h at that temperature. At this point, a solution of 
(1R,2S,5R)-(−)-menthyl (S)-p-toluenesulfinate (1.5 equiv) in anhydrous THF (1.0 M) was 
added dropwise at −78 °C. The mixture was stirred for additional 1 h at that temperature before 
being warmed to room temperature and stirred overnight. The reaction mixture was then diluted 
with EtOAc and sat. aq. NH4Cl, the phases were separated and the aqueous phase was extracted 
with EtOAc (3 times). The combined organic layers were washed with brine, dried over MgSO4 
and the solvent was evaporated under reduced pressure. In many cases separation of the desired 
diastereoisomers from the menthol by-product was facilitated by silylation of menthol:211 to a 
solution of the crude mixture in anhydrous CH2Cl2 (0.5 M) was added Et3N (1.5 equiv). TMSCl 
(1.3 equiv) was added dropwise at room temperature, the resulting mixture was stirred for 
20 min, diluted with Et2O and washed with H2O. The organic layer was dried over MgSO4 and 
the solvent was removed under reduced pressure to give a crude residue, which was purified 
by flash silica gel column chromatography (hexane:EtOAc) to afford the syn (less polar) and 
the anti (more polar) diastereoisomers.  
The racemates were synthesised as described above but using racemic methyl 
4-methylbenzenesulfinate 466 as the starting material. 
* A solution of MgBr2Et2O was prepared as follows: Mg turnings (4.0 equiv) were charged in 
a Schlenk tube in a N2 atmosphere and anhydrous Et2O (0.8 M with respect to dibromoethane) 
was added. The solution was cooled to 0 °C and dibromoethane (1.5 equiv) was added 
dropwise. The ice bath was removed and the reflux was initiated after a few minutes. After gas 




General procedure for the synthesis of syn and anti 1-(p-tolylsulfinyl) 
2,4,6-triisopropylbenzoates by alkylation (GP5) 
(p-Tolylsulfinyl)methyl 2,4,6-triisopropylbenzoate (R) or (S)-256 (1.0 equiv) and the 
alkylating agent (1.1−2.0 equiv) in an oven dried Schlenk tube were dissolved in anhydrous 
THF (0.2 M) under a N2 atmosphere. For substrate 255n, HMPA (2.0 equiv) was added at this 
stage. The reaction mixture was cooled to −78 °C and the base (2.0 equiv) was added dropwise. 
The mixture was stirred at −78 °C for 30 min, then the cooling bath was removed and the 
solution was stirred at room temperature for 30 min. The reaction mixture was quenched with 
sat. aq. NH4Cl and diluted with EtOAc. The layers were separated and the aqueous phase was 
extracted with EtOAc (3 times). The combined organic layers were dried over MgSO4, filtered 
and concentrated in vacuo. The crude residue was purified by flash silica gel column 
chromatography (hexane:EtOAc) to give the syn (less polar) and the anti (more polar) 
diastereoisomers.  
The racemates were synthesised as described above but using racemic sulfoxide rac-256 as the 
starting material. 
General procedure for the stereocontrolled homologation of boronic esters using 
α-sulfinyl benzoates: in situ procedure using t-BuLi (GP6) 
t-BuLi (1.7 M in pentane, 2.00 equiv) was added dropwise to a mixture of sulfoxide 
(1.05−1.10 equiv) and pinacol boronic ester (1.00 equiv) in anhydrous THF (0.1 M with respect 
to the boronic ester) at −78 °C under N2 atmosphere and the resulting solution was stirred at 
this temperature for 1 h. After warming to room temperature, the reaction mixture was heated 
at 66 °C for 3 h, cooled to room temperature, diluted with Et2O and sat. aq. NH4Cl was added. 
The phases were separated and the aqueous phase was extracted with Et2O (3 times). The 
combined organic layers were dried over MgSO4, filtered and the solvent was removed under 
reduced pressure. Purification of the crude reaction mixture by flash silica gel column 
chromatography (hexane:Et2O) afforded the desired homologated boronic ester. A small 
portion of the boronic ester was oxidised to the corresponding alcohol following general 
procedures GP8 to determine the e.r. 
For substrate 255r, after stirring the reaction mixture at −78 °C for 1 h, acetic acid (1.00 equiv) 
was added to quench the excess of the reactive organolithium and the 1,2-metallate 
rearrangement was performed at room temperature for 16 h. 
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When the separation of the homologated boronic ester from the unreacted starting boronic ester 
was not possible the mixture was oxidised (see GP8) and the corresponding alcohol was 
isolated clean. 
The racemates were synthesised as described above but using the corresponding racemic 
sulfoxides as the starting materials. 
General procedure for the stereocontrolled homologation of boronic esters using 
α-sulfinyl benzoates: in situ procedure using i-PrMgClLiCl (GP7a) 
i-PrMgClLiCl (1.3 M in THF, 1.2 equiv) was added dropwise to a mixture of sulfoxide 
(1.3 equiv) and pinacol boronic ester (1.0 equiv) in anhydrous CH2Cl2 (0.1 M with respect to 
the boronic ester) at −78 °C under N2 atmosphere and the resulting solution was stirred at this 
temperature for 1 h. After being warmed to room temperature, the reaction mixture was heated 
at 40 °C for 3 h, cooled to room temperature, diluted with Et2O and sat. aq. NH4Cl was added. 
The phases were separated and the aqueous phase was extracted with Et2O (3 times). The 
combined organic layers were dried over MgSO4, filtered and the solvent was removed under 
reduced pressure. The crude mixture was purified by flash silica gel column chromatography 
(hexane:Et2O) to afford the desired homologated boronic ester. A small portion of the boronic 
ester was oxidised to the corresponding alcohol following general procedures GP8 to determine 
the e.r. 
When the separation of the homologated boronic ester from the unreacted starting boronic ester 
was not possible the mixture was oxidised (see GP8) and the corresponding alcohol was 
isolated. 
The racemates were synthesised as described above but using the corresponding racemic 
sulfoxides as the starting materials. 
General procedure for the stereocontrolled homologation of boronic esters using 
α-sulfinyl benzoates: ex situ procedure using i-PrMgClLiCl (GP7b) 
i-PrMgClLiCl (1.3 M in THF, 1.2 equiv) was added dropwise to a solution of sulfoxide 
(1.3 equiv) in anhydrous CH2Cl2 (0.13 M) at −78 °C under N2 atmosphere and the resulting 
solution was stirred at this temperature for 30 min. A solution of the pinacol boronic ester 
(1.0 equiv) in CH2Cl2 (0.5 M) was then added slowly and the resulting mixture was stirred at 
−78 °C for additional 45 min.  After being warmed to room temperature, the reaction mixture 
was heated at 40 °C for 3 h, cooled to room temperature, diluted with Et2O and sat. aq. NH4Cl 
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was added. The phases were separated and the aqueous phase was extracted with Et2O 
(3 times). The combined organic layers were dried over MgSO4, filtered and the solvent was 
removed under reduced pressure. The crude mixture was purified by flash silica gel column 
chromatography (hexane:Et2O) to afford the desired homologated boronic ester. A small 
portion of the boronic ester was oxidised to the corresponding alcohol following general 
procedures GP8 to determine the e.r. 
When the separation of the homologated boronic ester from the unreacted starting boronic ester 
was not possible the mixture was oxidised (see GP8) and the corresponding alcohol was 
isolated clean. 
The racemates were synthesised as described above but using the corresponding racemic 
sulfoxides as the starting materials. 
General procedure for the stereospecific oxidation of boronic esters using H2O2/NaOH 
(GP8) 
Pinacol boronic ester (1.0 equiv) was dissolved in THF (5.0 mL) and the solution was cooled 
to 0 °C. A solution of aq. NaOH (2.0 M) and 30% H2O2 (2/1 v/v, 3.0 mL) was added dropwise. 
The solution was stirred vigorously for 2 h at room temperature, then it was diluted with H2O 
(10 mL) and Et2O (10 mL). The layers were separated and the aqueous layer was extracted 
with Et2O (3 × 10 mL). The organic layers were combined, dried over MgSO4 and concentrated 
under reduced pressure. The crude product was purified by flash silica gel column 




5.6. Single Compounds Chapter 3 
5.6.1. Preparation of α-Sulfinyl Benzoates 
Methyl 4-methylbenzenesulfinate (466) 
 
Following a literature reported procedure,212 solid N-bromosuccinimide powder (12.6 g, 
70.8 mmol) was added in one portion to a solution of 4-methylbenzenethiol (150 mg, 
1.07 mmol) in a mixture of MeOH:CH2Cl2 (1/1 v/v, 86 mL) at 0 °C. The ice bath was removed 
and after 1 h the mixture was poured into a solution of saturated NaHCO3 (50 mL) at 0 °C. The 
biphasic mixture was transferred into a separating funnel and shaken until discoloration. The 
phases were separated and the aqueous layer was extracted with CH2Cl2 (3 × 50 mL). The 
combined organic layers were dried over MgSO4 and the solvent was removed under reduced 
pressure. The crude residue was purified by column chromatography on silica gel 
(hexane:Et2O = 90:10) to afford pure methyl sulfinate ester 466 (5.56 g, 93%) as a colourless 
oil. 
1H NMR (CDCl3, 400 MHz) δ: 7.57 (d, 2H, J = 8.2 Hz, Ar-H), 7.32 (d, J = 7.9 Hz, 2H, Ar-H), 
3.44 (s, 3H, O-CH3), 2.41 (s, 3H, CH3). 
13C NMR (CDCl3, 101 MHz) δ: 142.7 (Ar-C), 140.9 (Ar-C), 129.6 (2C, Ar-C x 2), 125.3 (2C, 
Ar-C x 2), 49.3 (O-CH3), 21.4 (CH3). 
IR (neat) νmax: 2941, 1129, 1080, 959, 812, 676, 626 cm
‒1. 







MeMgBr (3.0 M in Et2O, 9.50 mL, 28.6 mmol) was added dropwise to a solution of (−)-menthyl 
(S)-p-toluenesulfinate 117 (6.0 g, 20.4 mmol) in dry toluene (60 mL) at 0 °C. The reaction 
mixture was stirred at room temperature for 2 h, then it was quenched with sat. aq. NH4Cl 
(50 mL). The phases were separated and the aqueous phase was extracted with Et2O 
(3 × 50 mL). The combined organic phases were washed with water (50 mL), with brine 
(50 mL), dried over MgSO4 and the solvent was evaporated under reduced pressure. The crude 
residue was purified by flash column chromatography on silica gel 
(CH2Cl2:MeOH = 100:0 → 95:5) to yield sulfoxide 258 (2.35 g, 75%) as a colourless solid. 
[The racemate was synthesised as follows: a mixture of methyl p-tolyl sulfide (691 mg, 
5.00 mmol) and H2O2 (30%, 540 µL, 5.50 mmol) was heated at 60 °C for 16 h. The reaction 
mixture was cooled to room temperature and diluted with CH2Cl2 (5 mL) and H2O (5 mL). The 
phases were separated and the organic phase was washed with water (5 mL), with brine (5 mL), 
dried over MgSO4 and concentrated under reduced pressure. The crude residue was purified by 
flash column chromatography on silica gel (EtOAc) to afford methyl p-tolyl sulfoxide rac-258 
(619 mg, 80%) as a colourless solid.] 
1H NMR (CDCl3, 400 MHz) δ: 7.53 (d, J = 8.2 Hz, 2H, Ar-H), 7.32 (d, J = 8.4 Hz, 2H, Ar-H), 
2.70 (s, 3H, S-CH3), 2.41 (s, 3H, C-CH3). 
13C NMR (CDCl3, 101 MHz) δ: 142.6 (Ar-C), 141.7 (Ar-C), 130.2 (2C, Ar-C), 123.7 (2C, 
Ar-C), 44.1 (S-CH3), 21.5 (C-CH3). 
IR (neat) νmax: 3468, 2996, 1494, 1087, 1038, 1014, 952, 811, 684 cm
‒1. 
HRMS (ESI) calculated for C8H10NaOS (M+Na)
+: 177.0345, found: 177.0350. 
[α]20D: +173 (c 1.0, CHCl3). [Lit. value for (R): +150.4 (c 1.17 acetone)].
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Chiral HPLC: Daicel Chiralcel-OD-H column (25 cm), hexane:isopropanol = 92:8, 


































































Following a literature reported procedure,147 to a solution of methyl p-tolyl sulfoxide 258 
(2.00 g, 13.0 mmol) in dry CH2Cl2 (13 mL) was added K2CO3 (1.08 g, 7.78 mmol), followed 
by NCS (3.46 g, 25.9 mmol). The resulting suspension was stirred for 40 h at room temperature. 
The reaction mixture was diluted with Et2O (50 mL) and aq. NaI (4% w/v, 50 mL). The phases 
were separated and the organic phase was washed with aq. Na2S2O3 (10% w/v, 50 mL), dried 
over MgSO4 and the solvent was removed under reduced pressure. The crude residue was 
purified by flash column chromatography on silica gel (pentane:EtOAc = 75:25) to give 
sulfoxide 257 (1.79 g, 73%) as a colourless solid. Recrystallisation from AcOEt:hexane 
afforded enantiopure sulfoxide 257 (926 mg, 38%) as a colourless solid. 
[The racemate was synthesised as follows: sulfoxide rac-258 (600 mg, 3.52 mmol) was 
dissolved in dry THF (20 mL) and chloroiodomethane (515 µL, 7.05 mmol) was added. The 
solution was cooled to −78 °C and n-BuLi (1.6 M in hexane, 4.40 mL, 7.05 mmol) was added 
dropwise. The reaction mixture was stirred at −78 °C for 30 min, then NH4Cl (20 mL) was 
added. After stirring for additional 30 min at −78 °C the reaction mixture was warmed to room 
temperature and diluted with Et2O (20 mL). The phases were separated and the aqueous phase 
was extracted with Et2O (3 × 20 mL). The combined organic phases were washed with brine 
(20 mL), dried over MgSO4 and the solvent was removed under reduced pressure. The crude 
residue was purified by flash column chromatography on silica gel (pentane:EtOAc = 75:25) 
to afford sulfoxide rac-257 (363 mg, 55%) as a colourless solid.] 
1H NMR (CDCl3, 400 MHz) δ: 7.59 (d, J1 = 8.2 Hz, 2H, Ar-H), 7.36 (d, J = 8.4 Hz, 2H, Ar-H), 
4.36 (s, 2H, CH2), 2.44 (s, 3H, CH3). 
13C NMR (CDCl3, 101 MHz) δ: 142.88 (Ar-C), 137.70 (Ar-C), 130.04 (2C, Ar-C × 2), 124.83 
(2C, Ar-C × 2), 61.24 (CH2), 21.51 (CH3). 
IR (neat) νmax: 2921, 1493, 1146, 1080, 1040, 1016, 809, 738 cm
‒1. 
HRMS (ESI) calculated for C8H9ClNaOS (M+Na)
+: 210.9955, found: 210.9961. 
[α]23D: −178 (c 1.0, CHCl3). [Lit. value for (R): −239.0 (c 1.0 acetone)].147 
All analytical data matched that previously reported.215 
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Chiral HPLC: Daicel Chiralcel-IB column (25 cm), hexane:isopropanol = 90:10, 0.5 mL/min, 
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(R)-(p-Tolylsulfinyl)methyl 2,4,6-triisopropylbenzoate ((R)-256) 
 
KOH (39 mg, 0.69 mmol) was added to a solution of 2,4,6-triisopropylbenzoic acid (171 mg, 
0.689 mmol) in dry DMF (900 µL) at room temperature and the resulting mixture was stirred 
for 30 min. Chloromethyl p-tolyl sulfoxide 257 (100 mg, 0.530 mmol) was added and the 
reaction mixture was heated using microwave irradiation at 150 °C for 6 h. The solution was 
then allowed to cool to room temperature and was diluted with sat. aq. NH4Cl (3 mL) and 
EtOAc (3 mL). The phases were separated and the aqueous phase was extracted with EtOAc 
(2 × 3 mL). The combined organic phases were washed with water (3 × 3 mL), with aq. NaOH 
(1.0 M, 2 × 3 mL), washed with brine (3 × 3 mL), dried over MgSO4 and the solvent was 
removed under reduced pressure. The crude residue was purified by flash column 
chromatography on silica gel (pentane:EtOAc = 75:25) to afford sulfoxide (R)-256 (200 mg, 
94%) as a viscous colourless oil that turned into a colourless solid upon standing at room 
temperature.  
 [The racemate was synthesised as above, replacing 257 with rac-257.]  
Rf: 0.32 (pentane:EtOAc = 80:20). 
1H NMR (400 MHz, CDCl3): δ 7.64 (d, J = 8.2 Hz, 2H, Ar-H), 7.37 (d, J = 8.2 Hz, 2H, Ar-H), 
7.02 (s, 2H, Ar-H), 5.28 (d, J = 10.4 Hz, 1H, 6-H), 5.00 (d, J = 10.4 Hz, 1H, 6-H), 2.90 (sept, 
J = 7.5 Hz, 1H, 14-H), 2.90 (sept, J = 6.9 Hz, 2H, 10H), 2.44 (s, 3H, 1-H), 1.25 (d, J = 6.9 Hz, 
12H, CH3 × 4), 1.23 (d, J = 6.9 Hz, 6H, CH3 × 2). 
13C NMR (101 MHz, CDCl3): δ 169.8 (CO), 151.1 (Ar-C), 145.4 (2C, Ar-C × 2), 142.5 (Ar-C), 
137.4 (Ar-C), 130.3 (2C, Ar-C × 2), 128.6 (Ar-C), 124.8 (2C, Ar-C × 2), 121.1 (2C, Ar-C × 2), 
83.4 (6-C), 34.6 (14-C), 31.8 (2C, 10-C), 24.4 (2C, CH-CH3 × 2), 24.3 (2C, CH-CH3 × 2), 24.1 
(2C, CH-CH3 × 2), 21.6 (1-C). 
IR (neat) νmax: 2961, 1745, 1227, 1035, 816 cm
–1. 
HRMS (ESI) calculated for C24H32O3Sna (M+Na)
+: 423.1964, found 423.1974. 
M.P.: 90–92 ºC. 
[α]22D: −123 (c 0.9, CHCl3). 
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Chiral HPLC: Daicel Chiralcel-IA column (25 cm), hexane:isopropanol = 95:5, 1.0 mL/min, 
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(R)-1-((R)-p-Tolylsulfinyl)ethyl 2,4,6-triisopropylbenzoate (syn-255a) and (S)-1-((R)-p-
tolylsulfinyl)ethyl 2,4,6-triisopropylbenzoate (anti-255a) 
 
 
NaHMDS (1.0 M in THF, 8.9 mL, 8.9 mmol), was added dropwise to a solution of sulfoxide 
(R)-256 (3.1 g, 7.7 mmol) and MeI (0.53 mL, 8.5 mmol) in anhydrous THF (40 mL) at −78 °C. 
The reaction mixture was stirred for 30 min at −78 °C before being warmed to room 
temperature and then stirred for additional 30 min at this temperature. The reaction mixture 
was then diluted with sat. aq. NH4Cl (30 mL), the phases were separated and the aqueous phase 
was extracted with EtOAc (3 × 30 mL). The combined organic layers were washed with brine 
(60 mL), dried over MgSO4 and the solvent was evaporated under reduced pressure.  The crude 
residue (d.r. = 55:45) was purified by flash column chromatography (pentane:EtOAc = 90:10) 
to afford the two diastereoisomers syn-255a (less polar, 1.4 g, 44%) and anti-255a (more polar, 
1.7 g, 54%) as colourless solids. 
[The racemates were synthesised as above, replacing (R)-256 with rac-256.]   
syn-255a 
Rf: 0.29 (pentane:EtOAc = 90:10). 
1H NMR (CDCl3, 400 MHz) δ: 7.63 (d, J = 8.2 Hz, 2H, Ar-H), 7.37 (d, J = 8.0 Hz, 2H, Ar-H), 
7.04 (s, 2H, Ar-H), 5.79 (q, J = 6.4 Hz, 1H, 6-H), 2.90 (app sept, Japp = 6.8 Hz, 3H, 15-H + 
11-H), 2.44 (s, 3H, 1-H), 1.40 (d, J = 6.4 Hz, 3H, 7-H), 1.29–1.24 (m, 18H, CH3 × 6). 
13C NMR (CDCl3, 101 MHz) δ: 169.9 (CO), 150.9 (Ar-C), 145.2 (2C, Ar-C × 2), 141.7 (Ar-C), 
137.5 (Ar-C), 130.0 (2C, Ar-C × 2), 128.7 (Ar-C), 124.4 (2C, Ar-C × 2), 121.0 (2C, Ar-C × 2), 
89.0 (6-C), 34.5 (15-C), 31.6 (2C, 11-C), 24.2 (2C, CH-CH3 × 2), 24.1 (2C, CH-CH3 × 2), 23.9 
(2C, CH-CH3 × 2), 21.4 (1-C), 9.1 (7-C). 
IR (neat) νmax: 2962, 1735, 1228, 1087, 1060, 1041, 874, 811 cm
‒1. 
HRMS (ESI) calculated for C25H34NaOS (M+Na)
+: 437.2121, found: 437.2109. 
M.P.: 117−119 ºC.  
[α]23D: −43 (c 1.0, CHCl3). 
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Chiral HPLC: Daicel Chiralcel-IA column (25 cm), hexane:isopropanol = 95:5, 0.5 mL/min, 






Rf: 0.20 (pentane:EtOAc = 90:10). 
1H NMR (CDCl3, 400 MHz) δ: 7.54 (d, J = 9.0 Hz, 2H, Ar-H), 7.32 (d, J = 8.0 Hz, 2H, Ar-H), 
7.01 (s, 2H, Ar-H), 6.07 (q, J = 6.4 Hz, 1H, 6-H), 2.90 (sept, J = 6.8 Hz, 1H, 15-H), 2.78 (sept, 
J = 6.8 Hz, 2H, 11-H), 2.41 (s, 3H, 1-H), 1.39 (d, J = 6.4 Hz, 3H, 7-H), 1.26–1.24 (m, 12H, 
12-H), 1.19 (d, J = 6.0 Hz, 6H, 16-H). 
13C NMR (CDCl3, 101 MHz) δ: 169.0 (CO), 150.7 (Ar-C), 145.1 (2C, Ar-C × 2), 142.1 (Ar-C), 
136.0 (Ar-C), 129.8 (2C, Ar-C × 2), 128.8 (Ar-C), 125.6 (2C, Ar-C × 2), 120.9 (2C, Ar-C × 2), 
85.0 (6-C), 34.4 (15-C), 31.5 (2C, 11-C), 24.5 (2C, CH-CH3 × 2), 23.9 (2C, CH-CH3 × 2), 23.9 
(2C, CH-CH3 × 2), 21.4 (1-C), 13.1 (7-C). 
IR (neat) νmax: 2962, 1735, 1228, 1087, 1060, 1041, 874, 811 cm
‒1. 
HRMS (ESI) calculated for C25H34NaOS: 437.212087, found: 437.210910. 
M.P.: 95−97 ºC.           
[α]21D: −29 (c 1.0, CHCl3). 
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Chiral HPLC: Daicel Chiralcel-IB column (25 cm), hexane:isopropanol = 98:2, 0.5 mL/min, 
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(R)-1-((R)-p-Tolylsulfinyl)but-3-en-1-yl 2,4,6-triisopropylbenzoate (syn-255b) and 
(S)-1-((R)-p-tolylsulfinyl)but-3-en-1-yl 2,4,6-triisopropylbenzoate (anti-255b) 
 
To a solution of bis(trimethylsilyl)amine (0.89 mL, 4.2 mmol) in anhydrous THF (0.70 mL) 
n-BuLi (1.6 M in hexane, 2.6 mL, 4.2 mmol) was added dropwise at −78 °C. After stirring for 
20 min at 0 °C, the solution was added dropwise to a solution of sulfoxide (R)-256 (1.5 g, 
3.8 mmol) and allyl iodide (0.40 mL, 4.4 mmol) in anhydrous THF (21 mL) at −78 °C. The 
reaction mixture was stirred for 30 min at −78 °C before being warmed to room temperature 
and then stirred for additional 30 min at this temperature. The reaction mixture was then diluted 
with sat. aq. NH4Cl (20 mL), the phases were separated and the aqueous phase was extracted 
with EtOAc (3 × 20 mL). The combined organic layers were washed with brine (50 mL), dried 
over MgSO4 and the solvent was evaporated under reduced pressure. The crude residue 
(d.r. = 86:14) was purified by flash column chromatography (pentane:EtOAc = 90:10) to afford 
the syn diastereoisomer syn-255b (less polar, 205 mg, 12%) as a colourless solid and the anti 
diastereosiomer anti-255b (more polar, 1.2 g, 74%) as a dense, colourless oil. 
[The racemates were synthesised as above, replacing (R)-256 with rac-256.]    
syn-255b 
Rf: 0.21 (hexane:EtOAc = 90:10). 
1H NMR (CDCl3, 400 MHz) δ: 7.67 (d, J = 8.0 Hz, 2H, Ar-H), 7.38 (d, J = 8.0 Hz, 2H, Ar-H), 
7.04 (s, 2H, Ar-H), 5.75 (dd, J1 = 10.0 Hz, J2 = 3.0 Hz, 1H, 5-H), 5.67 (m, 1H, 7-H), 5.11–5.06 
(m, 2H, 8-H), 2.91 (app sept, Japp = 6.6 Hz, 3H, 12-H + 16-H), 2.72 (m, 1H, 6-H), 2.44 (s, 3H, 
1-H), 2.42 (m, 1H, 6-H), 1.28–1.23 (m, 18H, CH3 × 6). 
13C NMR (CDCl3, 101 MHz) δ: 170.1 (CO), 150.7 (Ar-C), 145.1 (2C, Ar-C × 2), 141.6 (Ar-C), 
137.2 (Ar-C), 131.3 (Ar-C), 130.0 (2C, Ar-C × 2), 128.7 (7-C), 124.3 (2C, Ar-C × 2), 120.9 
(2C, Ar-C × 2), 119.2 (8-C), 91.3 (5-C), 34.3 (16-C), 31.4 (6-C), 27.7 (2C, 12-C), 24.3 (2C, 
CH-CH3 × 2), 24.1 (2C, CH-CH3 × 2), 23.8 (2C, CH-CH3 × 2), 21.3 (1-C). 




HRMS (ESI) calculated for C27H36NaO3S (M+Na)
+: 463.2277, found: 463.2276. 
M.P.: 85−87 ºC.  
[α]22D: −86 (c 0.5, CHCl3). 
Chiral HPLC: (Daicel Chiralcel-IA column (25 cm), hexane:isopropanol = 95:5, 0.5 mL/min, 




Rf: 0.17 (hexane:EtOAc = 90:10). 
1H NMR (CDCl3, 400 MHz) δ: 7.55 (d, J = 8.1 Hz, 2H, Ar-H), 7.32 (d, J = 8.1 Hz, 2H, Ar-H), 
7.02 (s, 2H, Ar-H), 6.07 (dd, J1 = 8.9 Hz, J2 = 3.6 Hz, 1H, 5-H), 5.78 (m, 1H, 7-H), 5.15 (m, 
2H, 8-H), 2.90 (sept, J = 7.0 Hz, 1H, 16-H), 2.83 (sept, J = 6.7 Hz, 2H, 12-H × 2), 2.70 (m, 
1H, 6-H), 2.42 (s, 3H, 1-H), 2.08 (m, 1H, 6-H), 1.26–1.18 (m, 18H, CH3 × 6). 
13C NMR (CDCl3, 101 MHz) δ: 169.1 (CO), 150.6 (Ar-C), 145.2 (2C, Ar-C × 2), 142.1 (Ar-C), 
136.0 (Ar-C), 131.3 (Ar-C), 129.8 (2C, Ar-C × 2), 128.8 (7-C), 125.4 (2C, Ar-C × 2), 120.9 
(2C, Ar-C × 2), 119.5 (8-C), 87.2 (5-C), 34.3 (16-C), 31.8 (6-C), 31.3 (2C, 12-C), 24.4 (2C, 
CH-CH3 × 2), 24.0 (2C, CH-CH3 × 2), 23.8 (2C, CH-CH3 × 2), 21.4 (1-C). 
IR (neat) νmax: 2961, 1740, 1230, 1056, 1038, 877, 809 cm
‒1. 
HRMS (ESI) calculated for C27H36NaO3S: 463.2277, found: 463.2276. 
M.P.: 85–87 ºC.  
[α]20D: −22 (c 1.0, CHCl3). 
min12 12.5 13 13.5 14 14.5

















min12 12.5 13 13.5 14 14.5



















Chiral HPLC: (Daicel Chiralcel-IA column (25 cm), hexane:isopropanol = 95:5, 0.5 mL/min, 
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5.6.2. Preparation of Triisopropylbenzoates  
Propyl 2,4,6-triisopropylbenzoate (108c) 
 
Following a modified literature reported procedure,99 to a solution of 2,4,6-triisopropylbenzoic 
acid (5.0 g, 20 mmol) in CHCl3 (50 mL) was added a solution of NaOH (2.4 g, 60 mmol) and 
n-Bu4NHSO4 (0.55 g, 1.6 mmol) in deionised H2O (50 mL). 4-Bromo-1-butene (5.5 mL, 
60 mmol) was added to the biphasic mixture under vigorous stirring and the resulting reaction 
mixture was stirred at room temperature for 16 h. The phases were separated, the organic phase 
was dried over MgSO4, filtered and the solvent was removed under reduced pressure. The 
resulting oil was dissolved in hexane:EtOAc = 90:10 and filtered through a plug of silica. The 
solution was concentrated under reduced pressure to afford the pure benzoate (6.0 g, 99%) as 
a colourless oil. 
1H NMR (CDCl3, 400 MHz) δ: 7.01 (s, 2H, Ar-H), 4.27 (t, J = 6.7 Hz, 2H, 3-H), 2.93–2.84 
(m, 3H, CH(CH3)2 × 3), 1.77 (sest, J = 7.1 Hz, 2H, 2-H), 1.25 (d, J = 6.8 Hz, 18H, CH3 × 6), 
1.01 (t, J = 7.4 Hz, 3H, 1-H). 
13C NMR (CDCl3, 101 MHz) δ: 171.0 (CO), 150.0 (Ar-C), 144.7 (2C, Ar-C × 2), 130.7 (Ar-C), 
120.8 (2C, Ar-C × 2), 66.6 (3-C), 34.4 (CH-(CH3)2), 31.5 (2C, CH-(CH3)2 × 2), 24.1 (4C, CH3 × 
4), 24.0 (2C, CH3 × 2), 21.98 (2-C), 10.55 (1-C). 
IR (neat) νmax: 2961, 1724, 1461, 1249, 1136, 1074, 876 cm
‒1. 
HRMS (ESI) calculated for C19H30NaO2 (M+Na)
+: 313.2138, found: 313.2136. 




Isobutyl 2,4,6-triisopropylbenzoate (108d) 
 
Following a literature reported procedure,216 to a solution of i-butyl alcohol (1.6 mL, 17 mmol) 
and Et3N (1.4 mL, 10 mmol) in anhydrous PhMe (10 mL) in a sealable microwave vial 
equipped with a magnetic stirring bar was added 2,4,6-triisopropylbenzoyl chloride (2.0 g, 
7.7 mmol). The vial was sealed and the resulting reaction mixture was heated using microwave 
irradiation at 150 °C for 2 h. The reaction mixture was cooled to room temperature and filtered 
through a plug of silica washing with Et2O. The solvent was removed under reduced pressure 
and the crude reaction mixture was purified by chromatography on silica gel (petroleum 
ether:Et2O = 95:5) to afford benzoate 108d as a colourless oil (1.8 g, 75%). 
1H NMR (CDCl3, 400 MHz) δ: 7.01 (s, 2H, Ar-H), 4.08 (d, J = 6.6 Hz, 2H, 3-H), 2.86 (m, 3H, 
CH(CH3)2 × 3), 2.03 (hept, J = 6.7 Hz, 1H, 2-H), 1.24 (d, J = 6.8 Hz, 18H, CH3 × 6), 0.99 (d, 
J = 6.7 Hz, 6H, 1-H × 2). 
13C NMR (CDCl3, 101 MHz) δ: 171.1 (CO), 150.0 (Ar-C), 144.7 (2C, Ar-C × 2), 130.8 (Ar-C), 
120.81 (2C, Ar-C × 2), 71.3 (3-C), 34.4 (CH-(CH3)2), 31.5 (2C, CH-(CH3)2 × 2), 27.7 (2-C), 
24.2 (4C, CH3 × 4), 24.0 (2C, CH3 × 2), 19.3 (2C, 1-C × 2) ppm 





3-Phenylpropyl 2,4,6-triisopropylbenzoate (108f) 
 
Following a literature reported procedure,216 to a solution of 3-phenylpropan-1-ol (1.85 mL, 
13.3 mmol) and Et3N (2.23 mL, 16.0 mmol) in anhydrous PhMe (12 mL) in a sealable 
microwave vial equipped with a magnetic stirring bar was added 2,4,6-triisopropylbenzoyl 
chloride (3.2 g, 12 mmol). The vial was sealed and the resulting reaction mixture was heated 
using microwave irradiation at 150 °C for 1 h. The reaction mixture was cooled to room 
temperature and filtered through a plug of silica washing with Et2O. The solvent was removed 
under reduced pressure and the crude reaction mixture was purified by chromatography on 
silica gel (hexane:Et2O = 98:2) to afford benzoate 108f as a colourless oil (1.85 g, 42%). 
1H NMR (CDCl3, 400 MHz) δ: 7.30  (app t, Japp = 7.6 Hz, 2H, Ar-H), 7.20 (app t, J = 8.6 Hz, 
3H, Ar-H), 7.02 (s, 2H, Ar-H), 4.33 (t, J = 6.5 Hz, 2H, O-CH2), 2.88 (hept, J = 6.9 Hz, 3H, 
CH(CH3)2 × 3), 2.75 (t, J = 7.5 Hz, 2H, Ph-CH2), 2.06 (q, J = 8.5 Hz, 2H, CH2), 1.27 (d, 
J = 6.8 Hz, 12H, CH3 × 4), 1.25 (d, J = 6.8 Hz, 6H, CH3 × 2). 
13C NMR (CDCl3, 101 MHz) δ: 171.0 (CO), 150.1 (Ar-C), 144.7 (2C, Ar-C × 2), 141.1 (Ar-C), 
130.6 (Ar-C), 128.5 (2C, Ar-C × 2), 128.4 (2C, Ar-C × 2), 126.1 (Ar-C), 120.9 (2C, Ar-C × 2), 
64.3 (O-CH2), 34.4 (Ph-CH2), 32.3 (CH-(CH3)2), 31.5 (2C, CH-(CH3)2 × 2), 30.4 (CH2), 24.2 
(4C, CH3 × 4), 23.9 (2C, CH3 × 2). 






But-3-en-1-yl 2,4,6-triisopropylbenzoate (108b)  
 
To a solution of 2,4,6-triisopropylbenzoic acid (5.00 g, 20.1 mmol) in CHCl3 (50 mL) was 
added a solution of NaOH (2.42 g, 60.4 mmol) and n-Bu4NHSO4 (0.55 g, 1.6 mmol) in 
deionised H2O (50 mL). 4-Bromo-1-butene (6.13 mL, 60.4 mmol) was added to the biphasic 
mixture under vigorous stirring and the resulting reaction mixture was stirred at room 
temperature for 16 h. The phases were separated, the organic phase was dried over MgSO4, 
filtered and the solvent was removed under reduced pressure. The resulting oil was dissolved 
in pentane:EtOAc = 90:10 and filtered through a plug of silica. The solution was concentrated 
under reduced pressure to afford the pure benzoate 108b (4.93 g, 81%) as a colourless oil. 
1H NMR (CDCl3, 400 MHz) δ: 7.03 (s, 2H, Ar-H), 5.86 (m, 1H, 3-H), 5.17 (dq, J1 = 17.2 Hz, 
J2 = 1.6 Hz, 1H, 4-Htrans), 5.11 (dq, J1 = 10.3 Hz, J2 = 1.2 Hz, 1H, 4-Hcis), 4.40 (t, J = 6.8 Hz, 
2H, 1-H), 2.89 (sept, J = 6.8 Hz, 3H, CH(CH3)2 × 3), 2.52 (qt, J1 = 6.7 Hz, J2 = 1.4 Hz, 2H, 
2-H), 1.26 (d, J = 6.9 Hz, 18H, CH3 × 6). 
13C NMR (CDCl3, 101 MHz) δ: 170.8 (CO), 150.1 (Ar-C), 144.7 (2C, Ar-C × 2), 134.0 (3-C), 
130.5 (Ar-C), 120.8 (2C, Ar-C × 2), 117.3 (4-C), 64.0 (1-C), 34.4 (CH-(CH3)2), 33.1 (2-C), 
31.4 (2C, CH-(CH3)2 × 2), 24.1 (2C, CH3 × 2), 23.9 (4C, CH3 × 4).  
IR (neat) νmax: 2961, 2930, 2871, 1725, 1607, 1461, 1248, 1134, 1102, 1074, 917, 876 cm
‒1. 
HRMS (ESI) calculated for C20H31O2 (M+H)
+: 303.2319, found: 303.2319. 




3-(2-Methyl-1,3-dioxolan-2-yl)propyl 2,4,6-triisopropylbenzoate (108g) 
 
Following a modified literature reported procedure,218 to a solution of 
2,4,6-triisopropylbenzoic acid (2.00 g, 8.05 mmol) and Cs2CO3 (3.94 g, 12.1 mmol) in CH3CN 
(90 mL) was added 5-chloro-2-pentanone ethylene ketal (1.47 g, 8.90 mmol) and the resulting 
reaction mixture was stirred at 82 °C for 24 h. After cooling to room temperature, the 
precipitate was filtered off and the filtrate was concentrated under reduced pressure. The 
residue was dissolved in CHCl3 (50 mL) and washed with aq. NaHCO3 (20% w/v, 3 × 30 mL). 
The organic phases were combined, dried over MgSO4, filtered and the solvent was removed 
under reduced pressure. Purification by flash silica gel column chromatography 
(hexane:Et2O = 70:30) afforded the pure benzoate 108g (2.82 g, 93%) as a colourless oil. 
Rf: 0.33 (hexane:EtOAc = 80:20). 
1H NMR (CDCl3, 400 MHz) δ: 7.01 (s, 2H, Ar-H), 4.33 (t, J = 6.2 Hz, 2H, 1-H), 3.94 (m, 4H, 
O-CH2 × 2), 2.87 (sept, J = 6.7 Hz, 3H, CH(CH3)2 × 3), 1.89–1.81 (m, 2H, 2-H), 1.79–1.75 (m, 
2H, 3-H), 1.33 (s, 3H, 4-H), 1.25 (d, J = 6.8 Hz, 18H, CH3 × 6). 
13C NMR (CDCl3, 101 MHz) δ: 171.0 (CO), 150.0 (Ar-C), 144.7 (2C, Ar-C × 2), 130.6 (Ar-C), 
120.8 (2C, Ar-C × 2), 109.6 (O-C-O), 65.0 (1-C), 64.7 (2C, O-CH2 × 2), 35.7 (3-C), 34.4 
(CH-(CH3)2), 31.5 (2C, CH-(CH3)2 × 2), 24.1 (4C, CH3 × 4), 23.9 (2C, CH3 × 2), 23.9 (2-C), 
23.4 (4-C). 
IR (neat) νmax: 2961, 1722, 1462, 1250, 1137, 1068, 877, 754 cm
‒1. 
HRMS (ESI) calculated for C23H36NaO4 (M+Na)





5.6.3. Preparation of α-Sulfinyl Benzoates by transmetalation 
(S)-(p-Tolylsulfinyl)methyl 2,4,6-triisopropylbenzoate ((S)-256) 
 
Following GP4, methyl 2,4,6-triisopropylbenzoate (5.00 g, 19.1 mmol), TMEDA (3.71 mL, 
24.8 mmol), s-BuLi (1.30 M in cyclohexane/hexane, 19.1 mL, 24.8 mmol − lithiation time = 
30 min), Mg turnings (1.37 g, 57.2 mmol), dibromoethane (2.46 mL, 28.6 mmol) and 
(1R,2S,5R)-(−)-menthyl (S)-p-toluenesulfinate (8.15 g, 28.6 mmol) afforded after purification 
by flash column chromatography (hexane:EtOAc = 100:0 → 80:20) sulfoxide (S)-256 (5.09 g, 
67%) as a colourless solid. 
[α]24D: +134 (c 1.0, CHCl3). 
Spectral data matched that previously described in this report. 
Chiral HPLC: (Daicel Chiralcel-IA column (25 cm) with guard, hexane:isopropanol = 95:5, 
1.0 mL/min, room temperature, 210.8 nm): tR = 10.1 minutes (minor), 12.0 minutes (major), 






(S)-1-((S)-p-Tolylsulfinyl)ethyl 2,4,6-triisopropylbenzoate (ent-syn-255a) and (R)-1-((S)-
p-tolylsulfinyl)ethyl 2,4,6-triisopropylbenzoate (ent-anti-255a) 
 
Following GP4, ethyl benzoate 108a (2.45 g, 8.86 mmol), TMEDA (1.59 mL, 10.64 mmol), 
s-BuLi (1.3 M in cyclohexane/hexane, 8.18 mL, 10.6 mmol − lithiation time = 1 h), Mg turnings 
(869 mg, 36.2 mmol), dibromoethane (1.17 mL, 13.3 mmol), (1R,2S,5R)-(−)-menthyl 
(S)-p-toluenesulfinate (3.91 g, 13.3 mmol), Et3N (1.85 mL, 13.3 mmol) and TMSCl (1.46 mL, 
11.6 mmol) afforded after purification by flash column chromatography 
(hexane:EtOAc = 95:5) the syn diastereoisomer ent-syn-255a (less polar, 1.49 g, 41%) as a 
colourless solid and the anti diastereoisomer ent-anti-255a (more polar, 1.48 g, 40%) as a 
colourless solid. 
Spectral data matched that previously described in this report. 
syn-255a 
[α]24D: +86 (c 1.0, CHCl3). 
Chiral HPLC: Daicel Chiralcel-IA column (25 cm), hexane:isopropanol = 96:4, 0.5 mL/min, 







[α]21D: +30 (c 1.0, CHCl3). 
Chiral HPLC: Daicel Chiralcel-IA column (25 cm), hexane:isopropanol = 96:4, 0.5 mL/min, 







(S)-1-((S)-p-Tolylsulfinyl)propyl 2,4,6-triisopropylbenzoate (syn-255c) and (R)-1-((S)-p-
tolylsulfinyl)propyl 2,4,6-triisopropylbenzoate (anti-255c) 
 
Following GP4, propyl 2,4,6-triisopropylbenzoate (2.9 g, 10 mmol), TMEDA (1.8 mL, 
12 mmol), s-BuLi (1.30 M in cyclohexane/hexane, 9.2 mL, 12.0 mmol − lithiation time = 1 h), 
Mg turnings (972 mg, 40.0 mmol), dibromoethane (1.3 mL, 15 mmol) and 
(1R,2S,5R)-(−)-menthyl (S)-p-toluenesulfinate (4.40 g, 15.0 mmol), afforded after purification 
by flash column chromatography (hexane:EtOAc = 95:5 → 90:10) the syn diastereoisomer 
syn-255c (less polar, 1.10 g, 26%) as a colourless solid and the anti diastereoisomer anti-255c 
(more polar, 1.37 g, 32%) as a colourless oil that turned into a waxy colourless solid upon 
standing at room temperature.  
[The racemates were synthesised as above, replacing (1R,2S,5R)-(−)-menthyl 
(S)-p-toluenesulfinate with racemic sulfinate 466.]   
syn-255c 
Rf: 0.19 (hexane:EtOAc = 95:5). 
1H NMR (CDCl3, 400 MHz) δ: 7.66 (d, J = 8.0 Hz, 2H, Ar-H), 7.36 (d, J = 8.0 Hz, 2H, Ar-H), 
7.04 (s, 2H, Ar-H), 5.62 (dd, J1 = 9.8 Hz, J2 = 3.2 Hz, 1H, 5-H), 2.92 (app sest, J = 6.7 Hz, 3H, 
11-H × 2 + 15-H), 2.44 (s, 3H, 1-H), 2.01 (sept, J = 7.6 Hz, 1H, 6-H), 1.71 (m, 1H, 6-H), 1.29 
(d, J = 6.8 Hz, 6H, CH3 × 2), 1.26 (d, J = 6.9 Hz, 6H, CH3 × 2), 1.25 (d, J = 6.6 Hz, 6H, 
CH3 × 2), 0.95 (t, J = 7.4 Hz, 3H, 7-H). 
13C NMR (CDCl3, 101 MHz) δ: 170.5 (CO), 150.8 (Ar-C), 145.2 (2C, Ar-C × 2), 141.5 (Ar-C), 
137.6 (Ar-C), 130.0 (2C, Ar-C × 2), 128.9 (Ar-C), 124.4 (2C, Ar-C × 2), 121.0 (2C, Ar-C × 2), 
93.8 (5-C), 34.4 (15-C), 31.6 (2C, 11-C × 2), 24.4 (2C, CH-CH3 × 2), 24.2 (2C, CH-CH3 × 2), 
23.9 (2C, CH-CH3 × 2), 21.5 (1-C), 16.7 (6-C), 9.4 (7-C). 
IR (neat) νmax: 3675, 2988, 2972, 2901, 1394, 1057, 892 cm
‒1. 
HRMS (ESI) calculated for C26H36NaO3S (M+Na)
+: 451.2277, found: 451.2278. 
M.P.: 87−89 ºC.                                                                                                                      
 
220 
[α]22D: +92 (c 1.0, CHCl3). 
Chiral HPLC: Daicel Chiralcel-IA column (25 cm), hexane:isopropanol = 95:5, 0.5 mL/min, 




Rf: 0.16 (hexane:EtOAc = 95:5). 
1H NMR (CDCl3, 400 MHz) δ: 7.55 (d, J = 8.1 Hz, 2H, Ar-H), 7.31 (d, J = 8.0 Hz, 2H, Ar-H), 
7.02 (s, 2H, Ar-H), 5.93 (dd, J1 = 8.5 Hz, J2 = 4.1 Hz, 1H, 5-H), 2.90 (sept, J = 6.9 Hz, 1H, 
15-H), 2.84 (sept, J = 6.8 Hz, 2H, 11-H × 2), 2.41 (s, 3H, 1-H), 1.94 (m, 1H, 6-H), 1.45 (sept, 
J = 8.0 Hz, 1H, 6-H), 1.25 (d, J = 6.9 Hz, 6H, CH3 × 2), 1.25 (d, J = 6.8 Hz, 6H, CH3 × 2), 1.20 
(d, J = 6.8 Hz, 6H, CH3 × 2), 1.06 (t, J = 7.4 Hz, 3H, 7-H). 
13C NMR (CDCl3, 101 MHz) δ: 169.4 (CO), 150.6 (Ar-C), 145.1 (2C, Ar-C × 2), 142.0 (Ar C), 
136.4 (Ar-C), 129.8 (2C, Ar-C × 2), 129.0 (Ar-C), 125.5 (2C, Ar-C × 2), 121.0 (2C, Ar-C × 2), 
89.9 (5-C), 34.4 (15-C), 31.6 (2C, 11-C × 2), 24.6 (2C, CH-CH3 × 2), 24.1 (2C, CH-CH3 × 2), 
23.9 (2C, CH-CH3 × 2), 21.5 (1-C), 21.0 (6-C), 9.8 (7-C). 
IR (neat) νmax: 3675, 2968, 1742, 1231, 1065, 752 cm
‒1. 
HRMS (ESI) calculated for C26H36NaO3S (M+Na)
+: 451.2277, found: 451.2278.  




Chiral HPLC: Daicel Chiralcel-IA column (25 cm), hexane:isopropanol = 95:5, 0.5 mL/min, 






(S)-2-Methyl-1-((S)-p-tolylsulfinyl)propyl 2,4,6-triisopropylbenzoate (syn-255d) and 
(R)-2-methyl-1-((S)-p-tolylsulfinyl)propyl 2,4,6-triisopropylbenzoate (anti-255d) 
 
Following GP4, isobutyl 2,4,6-triisopropylbenzoate (0.51 g, 1.7 mmol), TMEDA (300 µL, 
2.01 mmol), s-BuLi (1.30 M in cyclohexane/hexane, 1.50 mL, 2.01 mmol − lithiation 
time = 1.5 h), Mg turnings (163 mg, 6.72 mmol), dibromoethane (220 µL, 2.52 mmol), 
(1R,2S,5R)-(−)-menthyl (S)-p-toluenesulfinate (0.74 g, 2.5 mmol), Et3N (350 µL, 2.52 mmol) 
and TMSCl (280 µL, 2.18 mmol) afforded after purification by flash column chromatography 
(hexane:EtOAc = 90:10) a 1.8:1 mixture of the syn diastereoisomer syn-255d and the anti 
diastereoisomer anti-255d (488 mg, 66% overall yield, 36:64 d.r.). A portion of the mixture 
(450 mg) was further purified by reverse phase HPLC (CH3CN:H2O = 85:15, isocratic) to 
afford the syn diastereoisomer syn-255d (less polar, 112 mg, 15%) as a colourless solid and the 
anti diastereoisomer anti-255d (more polar, 215 mg, 29%) as a thick colourless oil. 
[The racemates were synthesised as above, replacing (1R,2S,5R)-(−)-menthyl 
(S)-p-toluenesulfinate with racemic sulfinate 466.]    
syn-255d 
Rf: 0.29 (hexane:EtOAc = 90:10). 
1H NMR (CDCl3, 400 MHz) δ: 7.73 (d, J = 7.8 Hz, 2H, Ar-H), 7.35 (d, J = 7.8 Hz, 2H, Ar-H), 
7.04 (s, 2H, Ar-H), 5.72 (d, J = 4.9 Hz, 1H, 5-H), 2.94–2.81 (m, 3H, 11-H × 2 + 15-H), 2.54 
(app sest, Japp = 6.8 Hz, 1H, 6-H), 2.43 (s, 3H, 1-H), 1.26 (d, J = 6.9 Hz, 12H, CH3 × 4), 1.22 
(d, J = 6.8 Hz, 6H, CH3 × 2), 1.14 (d, J = 6.8 Hz, 3H, 7-H), 0.96 (d, J = 6.9 Hz, 3H, 7-H). 
13C NMR (CDCl3, 101 MHz) δ: 170.1 (CO), 150.7 (Ar-C), 145.2 (2C, Ar-C × 2), 141.7 (Ar-C), 
138.2 (Ar-C), 129.9 (2C, Ar-C × 2), 128.7 (Ar-C), 125.3 (2C, Ar-C × 2), 121.0 (2C, Ar-C × 2), 
95.8 (5-C), 34.4 (15-C), 31.4 (2C, 11-C × 2), 26.5 (6-C), 24.4 (2C, CH-CH3 × 2), 24.3 (2C, 
CH-CH3 × 2), 23.9 (2C, CH-CH3 × 2), 21.4 (1-C), 20.1 (7-C), 17.5 (7-C). 
IR (neat) νmax: 2961, 1729, 1236, 1060, 1042, 812 cm
‒1. 
HRMS (ESI) calculated for C27H38NaO3S (M+Na)
+: 465.2434, found: 465.2439. 
M.P.: 87−89 ºC.  
 
223 
[α]22D: +41 (c 0.9, CHCl3).                                                                                                         
Chiral HPLC: Daicel Chiralcel-IA column (25 cm), hexane:isopropanol = 95:5, 0.5 mL/min, 




Rf: 0.29 (hexane:EtOAc = 90:10). 
1H NMR (CDCl3, 400 MHz) δ: 7.66 (d, J = 8.0 Hz, 2H, Ar-H), 7.35 (d, J = 8.0 Hz, 2H, Ar-H), 
7.04 (s, 2H, Ar-H), 5.89 (d, J = 3.5 Hz, 1H, 5-H), 3.03 (sept, J = 6.7 Hz, 2H, 11-H × 2), 2.90 
(sept, J = 6.9 Hz, 1H, 15-H), 2.43 (s, 3H, 1-H), 1.95 (m, 1H, 6-H), 1.26 (d, J = 6.9 Hz, 12H, 
CH3 × 4), 1.23 (d, J = 6.8 Hz, 6H, CH3 × 2), 1.06 (app t, J = 6.4 Hz, 6H, 7-H × 2). 
13C NMR (CDCl3, 101 MHz) δ: 169.6 (CO), 150.5 (Ar-C), 145.5 (2C, Ar-C × 2), 142.3 (Ar-C), 
138.3 (Ar-C), 130.1 (2C, Ar-C × 2), 129.2 (Ar-C), 125.7 (2C, Ar-C × 2), 121.0 (2C, Ar-C × 2), 
94.5 (5-C), 34.4 (15-C), 31.3 (2C, 11-C × 2), 28.6 (6-C), 24.5 (4C, CH-CH3 × 4), 23.9 (2C, 
CH-CH3 × 2), 21.5 (1-C), 19.5 (7-C), 17.3 (7-C). 
IR (neat) νmax: 2962, 1740, 1461, 1230, 1063, 1048, 877, 810 cm
‒1. 
HRMS (ESI) calculated for C27H38NaO3S (M+Na)
+: 465.2434, found: 465.2439. 




Chiral HPLC: Daicel Chiralcel-IA column (25 cm), hexane:isopropanol = 95:5, 0.5 mL/min, 






(S)-3-Phenyl-1-((S)-p-tolylsulfinyl)propyl 2,4,6-triisopropylbenzoate (syn-255f) and 
(R)-3-phenyl-1-((S)-p-tolylsulfinyl)propyl 2,4,6-triisopropylbenzoate (anti-255f) 
 
Following GP4, 3-phenylpropyl 2,4,6-triisopropylbenzoate (1.0 g, 2.7 mmol), TMEDA 
(485 µL, 3.24 mmol), s-BuLi (1.30 M in cyclohexane/hexane, 2.50 mL, 3.24 mmol − lithiation 
time = 2 h), Mg turnings (263 mg, 10.8 mmol), dibromoethane (350 µL, 4.05 mmol), 
(1R,2S,5R)-(−)-menthyl (S)-p-toluenesulfinate (1.19 g, 4.05 mmol), Et3N (560 µL, 4.05 mmol) 
and TMSCl (450 µL, 3.51 mmol) afforded after purification by flash column chromatography 
(hexane:EtOAc = 95:5) the syn diastereoisomer syn-255f (less polar, 500 mg, 37%) as a 
colourless solid and the anti diastereoisomer anti-255f (more polar, 581 mg, 43%) as a 
colourless solid. 
[The racemates were synthesised as above, replacing (1R,2S,5R)-(−)-menthyl 
(S)-p-toluenesulfinate with racemic sulfinate 466.]   
syn-255f 
Rf: 0.29 (hexane:EtOAc = 95:5). 
1H NMR (CDCl3, 400 MHz) δ: 7.60 (d, J = 8.2 Hz, 2H, Ar-H), 7.34 (d, J = 8.0 Hz, 2H, Ar-H), 
7.21–7.15 (m, 3H, Ar-H), 7.07 (s, 2H, Ar-H), 6.94 (d, J = 6.3 Hz, 2H, Ar-H), 5.64 (dd, 
J1 = 9.7 Hz, J2 = 2.9 Hz, 1H, 5-H), 2.96 (m, 3H, 11-H × 2 + 15-H), 2.78 (m, 1H, 7-H), 2.51 (m, 
1H, 7-H), 2.45 (s, 3H, 1-H), 2.29 (m, 1H, 6-H), 1.99 (m, 1H, 6-H), 1.33–1.27 (m, 18H, 
CH3 × 6). 
13C NMR (CDCl3, 101 MHz) δ: 170.4 (CO), 150.9 (Ar-C), 145.2 (2C, Ar-C × 2), 141.5 (Ar-C), 
139.9 (Ar-C), 137.4 (Ar-C), 130.0 (2C, Ar-C × 2), 128.8 (Ar-C), 128.4 (2C, Ar-C × 2), 128.1 
(2C, Ar-C × 2), 126.2 (Ar-C), 124.2 (2C, Ar-C × 2), 121.0 (2C, Ar-C × 2), 92.0 (5-C), 34.5 
(15-C), 31.7 (2C, 11-C), 30.8 (7-C), 24.6 (6-C), 24.4 (2C, CH-CH3 × 2), 24.3 (2C, 
CH-CH3 × 2), 23.9 (2C, CH-CH3 × 2), 21.4 (1-C). 




HRMS (ESI) calculated for C32H40NaO3S (M+Na)
+: 527.2590, found: 527.2574. 
M.P.: 99−101 ºC.  
[α]22D: +123 (c 0.9, CHCl3).                                                                                                             
Chiral HPLC: Daicel Chiralcel-IA column (25 cm), hexane:isopropanol = 95:5, 0.5 mL/min, 




Rf: 0.21 (hexane:EtOAc = 95:5). 
1H NMR (CDCl3, 400 MHz) δ: 7.53 (d, J = 8.1 Hz, 2H, Ar-H), 7.31–7.26 (m, 4H, Ar-H), 7.21 
(t, J = 7.2 Hz, 1H, Ar-H), 7.09 (d, J = 7.2 Hz, 2H, Ar-H), 7.07 (s, 2H, Ar-H), 6.08 (dd, 
J1 = 8.8 Hz, J2 = 3.4 Hz, 1H, 5-H), 2.96 (app sept, J = 6.8 Hz, 3H, 11-H × 2 + 15-H), 2.78 (m, 
2H, 7-H), 2.41 (s, 3H, 1-H), 2.21 (m, 1H, 6-H), 1.71 (m, 1H, 6-H), 1.30–1.25 (m, 18H, 
CH3 × 6). 
13C NMR (CDCl3, 101 MHz) δ: 169.2 (CO), 150.8 (Ar-C), 145.2 (2C, Ar-C × 2), 142.1 (Ar-C), 
139.9 (Ar-C), 136.1 (Ar-C), 129.9 (2C, Ar-C × 2), 128.9 (Ar-C), 128.6 (2C, Ar-C × 2), 128.2 
(2C, Ar-C × 2), 126.4 (Ar-C), 125.5 (2C, Ar-C × 2), 121.0 (2C, Ar-C × 2), 87.8 (5-C), 34.4 
(15-C), 31.7 (2C, 11-C × 2), 31.6 (7-C), 29.2 (6-C), 24.7 (2C, CH-CH3 × 2), 24.1 (2C, 
CH-CH3 × 2), 23.9 (2C, CH-CH3 × 2), 21.5 (1-C). 
IR (neat) νmax: 2962, 1734, 1460, 1229, 1067, 1042, 880, 815 cm
‒1. 
HRMS (ESI) calculated for C32H40NaO3S (M+Na)
+: 527.2590, found: 527.2574. 
M.P.: 91–93 ºC.                                                                                                                         
 
227 
[α]22D: +11 (c 1.0, CHCl3). 
Chiral HPLC: Daicel Chiralcel-IA column (25 cm), hexane:isopropanol = 95:5, 0.7 mL/min, 







(S)-1-((S)-p-Tolylsulfinyl)but-3-en-1-yl 2,4,6-triisopropylbenzoate (ent-syn-255b) and 
(R)-1-((S)-p-tolylsulfinyl)but-3-en-1-yl 2,4,6-triisopropylbenzoate (ent-anti-255b) 
 
Following GP4, homoallylic benzoate 108b (700 mg, 2.31 mmol), TMEDA (417 µL, 
2.78 mmol), s-BuLi (1.35 M in cyclohexane/hexane, 2.00 mL, 2.78 mmol − lithiation 
time = 1 h), Mg turnings (225 mg, 9.24 mmol), dibromoethane (300 µL, 3.47 mmol), 
(1R,2S,5R)-(−)-menthyl (S)-p-toluenesulfinate (1.36 g, 4.62 mmol), Et3N (485 µL, 3.47 mmol) 
and TMSCl (380 µL, 3.00 mmol) afforded after purification by flash column chromatography 
(hexane:EtOAc = 95:5) the syn diastereoisomer ent-syn-255b (less polar, 285 mg, 28%) as a 
colourless solid and the anti diastereoisomer ent-anti-255b (more polar, 395 mg, 39%) as a 
dense colourless oil. 
Spectral data matched that previously described in this report.  
ent-syn-255b 
 [α]22D: +163 (c 0.3, CHCl3). 
Chiral HPLC: Daicel Chiralcel-IA column (25 cm), hexane:isopropanol = 95:5, 0.5 mL/min, 







[α]25D: +8 (c 1.0, CHCl3). 
Chiral HPLC: Daicel Chiralcel-IA column (25 cm), hexane:isopropanol = 95:5, 0.5 mL/min, 








2,4,6-triisopropylbenzoate (syn-255g) and (R)-3-(2-methyl-1,3-dioxolan-2-yl)-1-((S)-p-
tolylsulfinyl)propyl 2,4,6-triisopropylbenzoate (anti-255g) 
 
Following GP4, ketal benzoate 108g (1.45 g, 3.85 mmol), TMEDA (870 µL, 5.78 mmol), 
s-BuLi (1.30 M in cyclohexane/hexane, 4.40 mL, 5.78 mmol − lithiation time = 2 h), Mg 
turnings (374 mg, 15.5 mmol), dibromoethane (500 µL, 5.78 mmol) and 
(1R,2S,5R)-(−)-menthyl (S)-p-toluenesulfinate (1.70 g, 5.78 mmol), afforded after purification 
by flash column chromatography (hexane:EtOAc = 75:25 → 70:30) the syn diastereoisomer 
syn-255g (less polar, 367 mg, 19%) as a colourless solid and the anti diastereoisomer anti-255g 
(more polar, 659 mg, 33%) as a colourless oil that turned into a waxy colourless solid upon 
standing at room temperature.  
[The racemates were synthesised as above, replacing (1R,2S,5R)-(−)-menthyl 
(S)-p-toluenesulfinate with racemic sulfinate 466.] 
syn-255g 
Rf: 0.24 (hexane:EtOAc = 75:25). 
1H NMR (CDCl3, 400 MHz) δ: 7.66 (d, J = 8.0 Hz, 2H, Ar-H), 7.36 (d, J = 7.9 Hz, 2H, Ar-H), 
7.04 (s, 2H, Ar-H), 5.78 (dd, J1 = 10.2 Hz, J2 = 2.1 Hz, 1H, 5-H), 3.83 (m, 2H, 10-H), 3.72−3.60 
(m, 2H, 10-H), 2.99–2.88 (m, 3H, 14-H × 2 and 18-H), 2.43 (s, 3H, 1-H), 2.05 (m, 1H, 6-H), 
1.83–1.73 (m, 2H, 7-H), 1.64 (m, 1H, 6-H), 1.29 (d, J = 6.8 Hz, 6H, CH3 × 2), 1.26 (d, 
J = 6.9 Hz, 12H, CH3 × 4), 1.16 (s, 3H, 9-H). 
13C NMR (CDCl3, 101 MHz) δ: 170.4 (CO), 150.8 (Ar-C), 145.2 (2C, Ar-C × 2), 141.4 (Ar-C), 
137.6 (Ar-C), 129.9 (2C, Ar-C × 2), 128.9 (Ar-C), 124.3 (2C, Ar-C × 2), 121.0 (2C, Ar-C × 2), 
109.3 (8-C), 92.5 (5-C), 64.7 (10-C), 64.4 (10-C), 34.4 (18-C), 33.6 (7-C), 31.5 (2C, 14-C × 2), 
24.4 (2C, CH-CH3 × 2), 24.2 (2C, CH-CH3 × 2), 23.9 (9-C), 23.9 (CH-CH3), 23.9 (CH-CH3), 
21.4 (1-C), 17.6 (6-C). 




HRMS (ESI) calculated for C30H42NaO5S (M+Na)
+: 537.2645, found: 537.2641.  
M.P.: 71−73 ºC.  
[α]22D: +64 (c 0.7, CHCl3).                                                                                                         
Chiral HPLC: Daicel Chiralcel-IA column (25 cm), hexane:isopropanol = 95:5, 0.5 mL/min, 
room temperature, 210.8 nm: tR = 19.7 minutes (minor), 27.8 minutes (major), e.r. >99:1. 
 
anti-255g 
Rf: 0.18 (hexane:EtOAc = 75:25). 
1H NMR (CDCl3, 400 MHz) δ: 7.56 (d, J = 7.8 Hz, 2H, Ar-H), 7.31 (d, J = 7.9 Hz, 2H, Ar-H), 
7.01 (s, 2H, Ar-H), 6.09 (dd, J1 = 8.2 Hz, J2 = 4.2 Hz, 1H, 5-H), 3.92 (m, 2H, 10-H), 3.84 (m, 
2H, 10-H), 2.90 (sept, J = 6.9 Hz, 1H, 18-H), 2.82 (sept, J = 6.8 Hz, 2H, 14-H × 2), 2.41 (s, 
3H, 1-H), 2.04 (m, 1H, 6-H), 1.84 (m, 2H, 7-H), 1.58 (m, 1H, 6-H), 1.26–1.20 (m, 21H, 
CH3 × 6 + 9-H). 
13C NMR (CDCl3, 101 MHz) δ: 169.20 (CO), 150.6 (Ar-C), 145.1 (2C, Ar-C × 2), 142.0 
(Ar-C), 136.4 (Ar-C), 129.8 (2C, Ar-C × 2), 128.9 (Ar-C), 125.5 (2C, Ar-C × 2), 120.9 (2C, 
Ar-C × 2), 109.2 (8-C), 88.4 (5-C), 64.7 (10-C), 64.7 (10-C), 34.4 (14-C), 34.3 (7-C), 31.5 (2C, 
18-C × 2), 24.6 (2C, CH-CH3 × 2), 24.1 (2C, CH-CH3 × 2), 23.9 (CH3), 23.9 (CH3), 23.9 (CH3), 
22.5 (6-C), 21.4 (1-C). 
IR (neat) νmax: 3675, 2962, 1736, 1230, 1040, 812 cm
‒1. 
HRMS (ESI) calculated for C30H42NaO5S (M+Na)
+: 537.2645, found: 537.2641. 
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[α]22D: +47 (c 1.0, CHCl3). 
Chiral HPLC: Daicel Chiralcel-IA column (25 cm), hexane:isopropanol = 95:5, 0.5 mL/min, 








5.6.4. Preparation of Triflates 
Ethyl 6-(((trifluoromethyl)sulfonyl)oxy)hexanoate (467) 
 
To a solution of trifluoromethanesulfonic anhydride (1.2 mL, 7.4 mmol) in CH2Cl2 (10 mL) at 
−10 °C was added a solution of ethyl 6-hydroxyhexanoate (1.0 mL, 6.2 mmol) in CH2Cl2 
(2.0 mL). The reaction mixture was stirred at −10 °C for 20 min, then was warmed to room 
temperature and stirred for further 40 min. H2O (10 mL) was added, the phases were separated 
and the aqueous phase was extracted with CH2Cl2 (2 × 10 mL). The combined organic phases 
were dried over MgSO4 and the solvent was removed under reduced pressure. Filtration of the 
crude reaction mixture through a plug of SiO2 eluting with CH2Cl2 gave triflate 467 (1.24 g, 
70%) as a colourless oil. 
1H NMR (CDCl3, 400 MHz) δ: 4.53 (t, J = 6.4 Hz, 2H, 1-H), 4.12 (q, J = 7.1 Hz, 2H, 6-H), 
2.32 (t, J = 10.0 Hz, 2H, 5-H), 1.84 (m, 2H, 2-H), 1.67 (m, 2H, 4-H), 1.48 (m, 2H, 3-H), 1.25 
(t, J = 7.1 Hz, 3H, CH3). 
13C NMR (CDCl3, 101 MHz) δ: 173.5 (CO), 118.6 (q, 
1JC−F = 320 Hz, CF3), 77.2 (1-C), 60.5 
(6-C), 33.9 (5-C), 28.9 (2-C), 24.6 (4-C), 24.1 (3-C), 14.1 (CH3). 
19F NMR (CDCl3, 376 MHz) δ: –74.8. 





5.6.5. Preparation of α-Sulfinyl Benzoates by alkylation 
(R)-4-Chloro-((S)-p-tolylsulfinyl)butyl 2,4,6-triisopropylbenzoate (anti-255n) 
 
Following GP5, ((S)-p-tolylsulfinyl)methyl 2,4,6-triisopropylbenzoate (S)-256 (1.0 g, 
2.5 mmol), 1-chloro-3-iodopropane (1.0 g, 5.0 mmol), i-Pr2NH (700 µL, 5.00 mmol), n-BuLi 
(1.6 M in hexane, 3.1 mL, 5.0 mmol) and HMPA (870 µL, 5.00 mmol) afforded after 
purification by flash column chromatography (hexane:EtOAc = 90:10) the syn diastereoisomer 
syn-255n (less polar, mixed with impurity) and the anti diastereoisomer anti-255n (more polar, 
482 mg, 40%) as a colourless solid. 
[The racemate was synthesised as above, replacing (S)-256 with racemic benzoate rac-256.]   
Rf: 0.21 (hexane:EtOAc = 80:20). 
1H NMR (CDCl3, 400 MHz) δ: 7.56 (d, J = 8.0 Hz, 2H, Ar-H), 7.32 (d, J = 8.0 Hz, 2H, Ar-H), 
7.03 (s, 2H, Ar-H), 6.02 (dd, J1 = 8.4 Hz, J2 = 3.4 Hz, 1H, 5-H), 3.49 (m, 2H, 8-H), 2.91 (sept, 
J = 6.9 Hz, 1H, 16-H), 2.84 (sept, J = 6.8 Hz, 2H, 12-H × 2), 2.42 (s, 3H, 1-H), 2.06–1.90 (m, 
3H, 7-H × 2 + 6-H), 1.60 (m, 1H, 6-H), 1.26 (d, J = 6.8 Hz, 12H, CH3 × 4), 1.21 (d, J = 6.8 Hz, 
6H, CH3 × 2). 
13C NMR (CDCl3, 101 MHz) δ: 169.2 (CO), 150.8 (Ar-C), 145.2 (2C, Ar-C × 2), 142.3 (Ar-C), 
136.1 (Ar-C), 130.0 (2C, Ar-C × 2), 128.7 (Ar-C), 125.5 (2C, Ar-C × 2), 121.0 (2C, Ar-C × 2), 
87.6 (5-C), 43.8 (8-C), 34.4 (16-C), 31.6 (2C, 12-C × 2), 28.3 (7-C), 25.2 (6-C), 24.5 (2C, 
CH-CH3 × 2), 24.1 (2C, CH-CH3 × 2), 23.9 (2C, CH-CH3 × 2), 21.5 (1-C). 
IR (neat) νmax: 3675, 2965, 1741, 1229, 1073, 1040 cm
‒1. 
HRMS (ESI) calculated for C27H37ClNaO3S (M+Na)
+: 499.2044, found: 499.2044. 
M.P.: 95−97 ºC.                                                                                                                        




Chiral HPLC: Daicel Chiralcel-IA column (25 cm), hexane:isopropanol = 95:5, 0.7 mL/min, 






(R)-1-((R)-p-Tolylsulfinyl)pentyl 2,4,6-triisopropylbenzoate (syn-255p) and 
(S)-1-((R)-p-tolylsulfinyl)pentyl 2,4,6-triisopropylbenzoate (anti-255p) 
 
Following GP5, ((S)-p-tolylsulfinyl)methyl 2,4,6-triisopropylbenzoate (R)-256 (601 mg, 
1.50 mmol), butyl trifluoromethanesulfonate (260 µL, 1.65 mmol), NaHMDS (1.0 M in THF, 
1.60 mL, 1.58 mmol) afforded after purification by flash column chromatography 
(hexane:EtOAc = 95:5) the syn diastereoisomer syn-255p (less polar, 290 mg, 42%) as a 
colourless solid and the anti diastereoisomer anti-255p (more polar, 246 mg, 36%) as a 
colourless solid.  
[The racemates were synthesised as above, replacing (S)-256 with racemic benzoate rac-256.]   
syn-255p 
Rf: 0.24 (hexane:EtOAc = 95:5). 
1H NMR (CDCl3, 400 MHz) δ: 7.65 (d, J = 8.1 Hz, 2H, Ar-H), 7.37 (d, J = 8.0 Hz, 2H, Ar-H), 
7.05 (s, 2H, Ar-H), 5.67 (dd, J1 = 10.2 Hz, J2 = 2.8 Hz, 1H, 5-H), 2.93 (app sept, J = 7.0 Hz, 
3H, 13-H × 2 + 17-H), 2.44 (s, 3H, 1-H), 2.00 (m, 1H, 6-H), 1.61 (m, 1H, 6-H), 1.41 (m, 1H, 
7-H), 1.34–1.16 (m, 3H, 7-H + 8-H × 2), 1.29 (d, J = 6.8 Hz, 6H, CH3 × 2), 1.26 (d, J = 6.7 Hz, 
12H, CH3 × 4), 0.80 (t, J = 7.4 Hz, 3H, 9-H). 
13C NMR (CDCl3, 101 MHz) δ: 170.5 (CO), 150.8 (Ar-C), 145.2 (2C, Ar-C × 2), 141.5 (Ar-C), 
137.5 (Ar-C), 130.0 (2C, Ar-C × 2), 128.9 (Ar-C), 124.4 (2C, Ar-C × 2), 120.9 (2C, Ar-C × 2), 
92.5 (5-C), 34.4 (17-C), 31.6 (2C, 13-C × 2), 26.9 (7-C), 24.4 (2C, CH-CH3 × 2), 24.2 (2C, 
CH-CH3 × 2), 23.9 (CH-CH3), 23.9 (CH-CH3), 22.6 (6-C), 22.2 (8-C), 21.4 (1-C), 13.7 (9-C). 
IR (neat) νmax: 2960, 1735, 1461, 1232, 1046, 753 cm
‒1. 
HRMS (ESI) calculated for C28H40NaO3S (M+Na)
+: 479.2590, found: 479.2580. 
M.P.: 104−106 ºC.                                                                                                                     
[α]22D: −126 (c 1.3, CHCl3). 
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Chiral HPLC: Daicel Chiralcel-IA column (25 cm), hexane:isopropanol = 95:5, 0.5 mL/min, 




Rf: 0.18 (hexane:EtOAc = 95:5). 
1H NMR (CDCl3, 400 MHz) δ: 7.55 (d, J = 8.2 Hz, 2H, Ar-H), 7.31 (d, J = 8.0 Hz, 2H, Ar-H), 
7.03 (s, 2H, Ar-H), 6.00 (m, 1H, 5-H), 2.94–2.82 (m, 3H, 13-H × 2 + 17-H), 2.42 (s, 3H, 1-H), 
1.85 (m, 1H, 6-H), 1.47–1.39 (m, 3H, 6-H + 7-H × 2), 1.35–1.29 (m, 2H, 8-H), 1.25 (d, 
J = 6.9 Hz, 12H, CH3 × 4), 1.21 (d, J = 6.8 Hz, 6H, CH3 × 2), 0.85 (t, J = 7.4 Hz, 3H, 9-H). 
13C NMR (CDCl3, 101 MHz) δ: 169.3 (CO), 150.6 (Ar-C), 145.1 (2C, Ar-C × 2), 142.0 (Ar-C), 
136.5 (Ar-C), 129.8 (2C, Ar-C × 2), 129.0 (Ar-C), 125.5 (2C, Ar-C × 2), 121.0 (2C, Ar-C × 2), 
88.5 (5-C), 34.4 (17-C), 31.5 (2C, 13-C × 2), 27.3 (7-C), 27.1 (6-C), 24.6 (2C, CH-CH3 × 2), 
24.1 (2C, CH-CH3 × 2), 23.9 (CH-CH3), 23.9 (CH-CH3), 22.2 (8-C), 21.5 (1-C), 13.7 (9-C). 
IR (neat) νmax: 3675, 2968, 2901, 1736, 1394, 1230, 1066, 1044, 879 cm
‒1. 
HRMS (ESI) calculated for C28H40NaO3S (M+Na)
+: 479.2590, found: 479.2580. 
M.P.: 112−114 ºC.                                                                                                                        




Chiral HPLC: Daicel Chiralcel-IA column (25 cm), hexane:isopropanol = 95:5, 0.5 mL/min, 






(R)-7-Ethoxy-7-oxo-1-((R)-p-tolylsulfinyl)hepthyl 2,4,6-triisopropylbenzoate (syn-255q) 
and (S)-7-ethoxy-7-oxo-1-((R)-p-tolylsulfinyl)hepthyl 2,4,6-triisopropylbenzoate 
(anti-255q) 
 
Following GP5, ((S)-p-tolylsulfinyl)methyl 2,4,6-triisopropylbenzoate (R)-256 (600 mg, 
1.50 mmol), ethyl hexanoate trifluoromethanesulfonate (575 mg, 1.95 mmol) and NaHMDS 
(1.0 M in THF, 2.25 mL, 2.25 mmol) afforded after purification by flash column 
chromatography (hexane:EtOAc = 85:15) the syn diastereoisomer syn-255q (less polar, 
239 mg, 29%) as a thick colourless oil and the anti diastereoisomer anti-255q (more polar, 
217 mg, 27%) as a thick colourless oil which was found to contain 5% of syn-255q. Further 
subsequent purification by reverse phase HPLC (CH3CN:H2O = 30:70 → 85:15) afforded pure 
anti-255q, which was used for characterisation. 
[The racemates were synthesised as above, replacing (S)-256 with racemic benzoate rac-256.]   
syn-255q 
Rf: 0.18 (hexane:EtOAc = 85:15). 
1H NMR (CDCl3, 400 MHz) δ: 7.64 (d, J = 7.8 Hz, 2H, Ar-H), 7.37 (d, J = 7.6 Hz, 2H, Ar-H), 
7.04 (s, 2H, Ar-H), 5.66 (dd, J1 = 9.6 Hz, J2 = 2.2 Hz, 1H, 5-H), 4.09 (q, J = 7.0 Hz, 2H, 12-H), 
2.92 (quint, J = 6.4 Hz, 3H, 17-H × 2 + 21-H), 2.44 (s, 3H, 1-H), 2.20 (t, J = 7.4 Hz, 2H, 10-H), 
1.99 (m, 1H, 6-H), 1.64–1.41 (m, 5H, 6-H + 7-H × 2 + 9-H × 2), 1.30–1.21 (m, 23H, CH3 × 7 
+ 8-H × 2). 
13C NMR (CDCl3, 101 MHz) δ: 173.4 (Ar-CO), 170.4 (Et-CO), 150.8 (Ar-C), 145.1 (2C, 
Ar-C × 2), 141.6 (Ar-C), 137.5 (Ar-C), 130.0 (2C, Ar-C × 2), 128.8 (Ar-C), 124.3 (2C, 
Ar-C × 2), 121.0 (2C, Ar-C × 2), 92.5 (5-C), 60.2 (12-C), 34.4 (21-C), 34.0 (10-C), 31.6 (2C, 
17-C × 2), 28.6 (8-C), 24.6 (9-C), 24.5 (7-C), 24.4 (2C, CH-CH3 × 2), 24.2 (2C, CH-CH3 × 2), 
23.9 (2C, CH-CH3 × 2), 22.8 (6-C), 21.4 (1-C), 14.2 (13-C). 
IR (neat) νmax: 2960, 1731, 1461, 1233, 1044, 811 cm
‒1. 
HRMS (ESI) calculated for C32H46NaO5S (M+Na)
+: 565.2958, found: 565.2955.  
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[α]22D: −93 (c 0.7, CHCl3). 
Chiral HPLC: Daicel Chiralcel-IA column (25 cm), hexane:isopropanol = 90:10, 0.5 mL/min, 




Rf: 0.16 (hexane:EtOAc = 85:15). 
1H NMR (CDCl3, 400 MHz) δ: 7.53 (d, J = 8.0 Hz, 2H, Ar-H), 7.31 (d, J = 8.0 Hz, 2H, Ar-H), 
7.02 (s, 2H, Ar-H), 5.99 (dd, J1 = 8.5 Hz, J2 = 4.1 Hz, 1H, 5-H), 4.11 (q, J = 7.2 Hz, 2H, 12-H), 
2.90 (sept, J = 6.9 Hz, 1H, 21-H), 2.84 (sept, J = 6.8 Hz, 2H, 17-H × 2), 2.42 (s, 3H, 1-H), 2.25 
(t, J = 7.5 Hz, 2H, 10-H), 1.85 (m, 1H, 6-H), 1.56 (quint, J = 7.5 Hz, 2H, 9-H), 1.50–1.31 (m, 
5H, 6-H + 7-H × 2 + 8-H × 2), 1.26–1.20 (m, 21H, CH3 × 7). 
13C NMR (CDCl3, 101 MHz) δ: 173.4 (Ar-CO), 169.3 (1), 150.7 (Ar-C), 145.1 (2C, Ar-C × 2), 
142.1 (Ar-C), 136.3 (Ar-C), 129.9 (2C, Ar-C × 2), 128.9 (Ar-C), 125.5 (2C, Ar-C × 2), 121.0 
(2C, Ar-C × 2), 88.7 (5-C), 60.2 (12-C), 34.4 (21-C), 34.1 (10-C), 31.6 (2C, 17-C × 2), 28.7 
(8-C), 27.2 (6-C), 25.1 (7-C), 24.6 (9-C), 24.6 (2C, CH-CH3 × 2), 24.1 (2C, CH-CH3 × 2), 23.9 
(2C, CH-CH3 × 2), 21.5 (1-C), 14.2 (13-C). 
IR (neat) νmax: 2961, 1733, 1230, 1088, 1038, 810 cm
‒1. 
HRMS (ESI) calculated for C32H46NaO5S (M+Na)
+: 565.2958, found: 565.2955. 




Chiral HPLC: Daicel Chiralcel-IA column (25 cm), hexane:isopropanol = 95:5, 0.5 mL/min, 






5.6.6. Epimerisation of anti-255a to syn-255a  
Representative Procedure Using TMPMgClLiCl 
A stirred solution of a 50:50 mixture of syn- and anti-255a (20.7 mg, 0.05 mmol) in dry THF 
(0.5 mL) under N2 was treated with TMPMgClLiCl (1.0 M in THF/toluene, 0.750 mL, 0.075 
mmol) at −78 °C. The resulting mixture was stirred for 30 min at −78 °C before the proton 
source (0.50 mmol, 10 equiv) was added. The quenched reaction mixture was warmed to room 
temperature, H2O (5 mL) and Et2O (5 mL) were added, the phases were separated and the 
aqueous phase was extracted with Et2O (3 × 5 mL). The combined organic layers were dried 
over MgSO4, filtered and the solvent was removed under reduced pressure. The d.r. and the 
yield of each diastereoisomer were determined by 1H NMR using 1,4-dimethoxybenzene as the 
internal standard.   
Procedure Using KOt-Bu/t-BuOH 
A stirred solution of a 50:50 mixture of syn- and anti-255a (20.7 mg, 0.05 mmol) in dry THF 
(0.50 mL) under N2 was treated with KOt-Bu (1.0 M in t-BuOH, 0.750 mL, 0.075 mmol) at 
−78 °C. The resulting mixture was stirred for 30 min at −78 °C before it was warmed to room 
temperature. H2O (5 mL) and Et2O (5 mL) were added, the phases were separated and the 
aqueous phase was extracted with Et2O (3 × 5 mL). The combined organic layers were dried 
over MgSO4, filtered and the solvent was removed under reduced pressure. The d.r. and the 
yield of each diastereoisomer were determined by 1H NMR using 1,4-dimethoxybenzene as the 
internal standard.   
Procedure Using NaDMSO/DMSO 
NaDMSO was freshly prepared according to a modified literature procedure.220 A dry schlenk 
tube was charged with NaH (60% dispersion in mineral oil, 8.0 mg, 0.2 mmol). Pentane 
(1.0 mL) was added, the suspension was swirled for few minutes, decanted and the solvent was 
removed with a syringe. The procedure was repeated for three times to remove all the mineral 
oil, then NaH was dried under high vacuum before being suspended in dry DMSO (1.0 mL). 
The resulting suspension was heated at 60 °C for 40 minutes. Completion of the reaction was 
shown by disappearance of solid NaH and cessation of gas evolution to give a pale yellow 
solution. The flask was cooled to room temperature and a 50:50 mixture of syn- and anti-255a 
(42 mg, 0.1 mmol) in DMSO:THF (2/1 v/v, 1.0 mL in total) under N2 was added slowly. The 
resulting mixture was stirred for 1 h at room temperature before H2O (5 mL) and Et2O (5 mL) 
were added. The phases were separated and the aqueous phase was extracted with Et2O 
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(3 × 5 mL). The combined organic layers were dried over MgSO4, filtered and the solvent was 
removed under reduced pressure. The d.r. and the yield of each diastereoisomer were 




5.6.7. Homologation of Boronic Esters 
(R)-2-(4-(4-Methoxyphenyl)butan-2-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (284a) 
  
Following GP6, methyl sulfoxide ent-syn-255a (87 mg, 0.21 mmol), boronic ester 283 (52 mg, 
0.20 mmol) and t-BuLi (1.7 M in pentane, 235 µL, 0.400 mmol) afforded after purification by 
flash column chromatography (hexane:Et2O = 95:5) the homologated boronic ester 284a 
(45.4 mg, 78%) as a colourless oil. 
Following GP7a, methyl sulfoxide ent-syn-255a (108 mg, 0.260 mmol), boronic ester 283 
(52 mg, 0.20 mmol) and i-PrMgClLiCl (1.14 M in THF, 210 µL, 0.240 mmol) afforded after 
purification by flash column chromatography (hexane:Et2O = 95:5) the homologated boronic 
ester 284a (33.6 mg, 58%) as a colourless oil. 
[The racemate was synthesised as above, replacing enantioenriched α-sulfinyl benzoate 
ent-syn-255a with racemic α-sulfinyl benzoate rac-syn-255a.]   
1H NMR (CDCl3, 400 MHz) δ: 7.10 (dt, J1 = 8.7 Hz, J2 = 2.9 Hz, 2H, Ar-H), 6.81 (dt, 
J1 = 8.6 Hz, J2 = 3.0 Hz, 2H, Ar-H), 3.78 (s, 3H, O-CH3), 2.60−2.53 (m, 2H, 1-H), 1.75 (m, 
1H, 2-H), 1.56 (m, 1H, 2-H), 1.25 (s, 12H, C-CH3 × 4), 1.10−1.00 (m, 4H, 3-H + 4-H). 
13C NMR (CDCl3, 101 MHz) δ: 157.5 (Ar-C), 135.2 (Ar-C), 129.3 (2C, Ar-C × 2), 113.6 (2C, 
Ar-C × 2), 82.8 (2C, B-O-C × 2), 55.2 (O-CH3), 35.5 (1-C), 34.4 (2-C), 24.8 (2C, C-CH3 × 2), 
24.8 (2C, C-CH3 × 2), 15.4 (4-C); carbon attached to boron not observed due to quadrupolar 
relaxation. 
11B NMR (CDCl3, 128 MHz) δ: 34.3. 
IR (neat) νmax: 2977, 2931, 1612, 1512, 1463, 1380, 1370, 1314, 1243, 1142, 1112, 1038, 967, 
863, 848, 822, 687, 670, 561 cm‒1. 
HRMS (ESI) calculated for C17H27BO3 (M+H)
+: 291.2132, found: 291.2123. 
[α]23D: −19 (c 0.7, CHCl3). [Lit. value for (R):93 −8.2 (c 0.98, CHCl3); for (S):92 +7.6 (c 1.7, 
CHCl3)]. 
All analytical data matched that previously reported in the literature.92  
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Chiral HPLC: Daicel Chiralcel-IB column (25 cm), hexane:isopropanol = 95:5, 0.5 mL/min, 











Following GP6, ethyl sulfoxide syn-255c (90 mg, 0.21 mmol), boronic ester 283 (52 mg, 
0.20 mmol) and t-BuLi (1.7 M in pentane, 235 µL, 0.400 mmol) afforded after purification by 
flash column chromatography (hexane:Et2O = 95:5) the homologated boronic ester 284c 
(37.1 mg, 61%) as a colourless oil. 
Following GP7a, ethyl sulfoxide syn-255c (111 mg, 0.260 mmol), boronic ester 283 (52 mg, 
0.20 mmol) and iPrMgClLiCl (1.3 M in THF, 210 µL, 0.240 mmol) afforded after purification 
by flash column chromatography (hexane:Et2O = 95:5) the homologated boronic ester 284c 
(29.8 mg, 49%) as a colourless oil. 
[The racemate was synthesised as above, replacing enantioenriched α-sulfinyl benzoate 
syn-255c with racemic α-sulfinyl benzoate rac-syn-255c.]   
1H NMR (CDCl3, 400 MHz) δ: 7.10 (d, J = 8.6 Hz, 2H, Ar-H), 6.82 (d, J = 8.5 Hz, 2H, Ar-H), 
3.78 (s, 3H, O-CH3), 2.61–2.48 (m, 2H, 1-H), 1.72 (m, 1H, 2-H), 1.62 (m, 1H, 2-H), 1.51–1.43 
(m, 2H, 4-H), 1.27 (s, 12H, C-CH3 × 4), 0.98 (m, 1H, 3-H), 0.22 (t, J = 7.4 Hz, 3H, 5-H). 
13C NMR (CDCl3, 101 MHz) δ: 157.6 (Ar-C), 135.2 (Ar-C), 129.2 (2C, Ar-C × 2), 113.6 (2C, 
Ar-C × 2), 82.9 (2C, B-O-C × 2), 55.2 (O-CH3), 34.7 (1-C), 33.4 (2-C), 24.8 (2C, C-CH3 × 2), 
24.8 (2C, C-CH3 × 2), 24.1 (4-C), 13.6 (5-C); carbon attached to boron not observed due to 
quadrupolar relaxation. 
11B NMR (CDCl3, 128 MHz) δ: 33.6. 
IR (neat) νmax: 2976, 2927, 1511, 1371, 1313, 1244, 1142, 1038, 966, 852, 824 cm
‒1. 
HRMS (ESI) calculated for C18H29BNaO3  (M+Na)
+: 327.2105, found: 327.2099. 
[α]23D: −9 (c 0.7, CHCl3) ). [Lit. value for (R):93 −9.6 (c 1.05, CHCl3); for (S):92 +9.4 (c 1.6, 
CHCl3)]. 




Chiral HPLC: Daicel Chiralcel-IB column (25 cm), hexane:isopropanol = 97:3, 0.7 mL/min, 





























Following GP6, isopropyl sulfoxide anti-255d (93 mg, 0.21 mmol), boronic ester 283 (52 mg, 
0.20 mmol) and t-BuLi (1.7 M in pentane, 235 µL, 0.400 mmol) afforded after purification by 
flash column chromatography (hexane:Et2O = 97:3) the homologated boronic ester 284d (34.1 
mg, 54%) as a colourless solid. 
Following GP7a, isopropyl sulfoxide anti-255d (95.0 mg, 0.22 mmol), boronic ester 283 
(43.3 mg, 0.17 mmol) and i-PrMgClLiCl (1.14 M in THF, 170 µL, 0.20 mmol) afforded after 
purification by flash column chromatography (hexane:Et2O = 97:3) the homologated boronic 
ester 284d (4.00 mg, 8%) as a colourless solid. 
[The racemate was synthesised as above, replacing enantioenriched α-sulfinyl benzoate 
anti-255d with racemic α-sulfinyl benzoate rac-anti-255d.]   
Rf: 0.26 (hexane:Et2O = 97:3). 
1H NMR (CDCl3, 400 MHz) δ: 7.12 (d, J = 8.5 Hz, 2H, Ar-H), 6.82 (d, J = 8.5 Hz, 2H, Ar-H), 
3.79 (s, 3H, O-CH3), 2.58 (m, 1H, 1-H), 2.46 (m, 1H, 1-H), 1.80–1.59 (m, 3H, 2-H + 4-H), 
1.28 (s, 12H, C-CH3 × 4), 0.93 (d, J = 6.8 Hz, 6H, 5-H × 2), 0.91 (m, 1H, 3-H). 
13C NMR (CDCl3, 101 MHz) δ: 157.68 (Ar-C), 135.4 (Ar-C), 129.3 (2C, Ar-C × 2), 113.8 
(2C, Ar-C × 2), 83.0 (2C, B-O-C × 2), 55.3 (O-CH3), 35.2 (1-C), 31.8 (2-C), 29.7 (4-C), 25.2 
(2C, C-CH3 × 2), 25.0 (2C, C-CH3 × 2), 22.4 (5-C), 21.8 (5-C); carbon attached to boron not 
observed due to quadrupolar relaxation. 
11B NMR (CDCl3, 128 MHz) δ: 33.7. 
IR (neat) νmax: 2952, 2857, 1512, 1312, 1297, 1235, 1141, 1041, 874, 824, 515 cm
‒1. 
HRMS (ESI) calculated for C19H31BNaO3  (M+Na)
+: 341.2262, found: 341.2261. 
M.P.: 35–37 ºC.                                                                                                                      




Chiral HPLC: Daicel Chiralcel-IB column (25 cm), hexane:isopropanol = 90:10, 0.5 mL/min, 
room temperature, 210.8 nm: tR = 10.7 minutes (minor), 12.1 minutes (major), e.r. = 95:5 (Li), 










Following GP6, phenyl ethyl sulfoxide syn-255f (106 mg, 0.210 mmol), boronic ester 283 
(52 mg, 0.20 mmol) and t-BuLi (1.7 M in pentane, 235 µL, 0.400 mmol) afforded after 
purification by flash column chromatography (hexane:Et2O = 95:5) the homologated boronic 
ester 284f (61.7 mg, 81%) as a colourless oil. 
Following GP7a, phenyl ethyl sulfoxide syn-255f (131 mg, 0.260 mmol), boronic ester 283 
(52 mg, 0.20 mmol) and i-PrMgClLiCl (1.14 M in THF, 210 µL, 0.240 mmol) afforded after 
purification by flash column chromatography (hexane:Et2O = 95:5) the homologated boronic 
ester 284f (61.7 mg, 71%) as a colourless oil. 
[The racemate was synthesised as above, replacing enantioenriched α-sulfinyl benzoate 
syn-255f with racemic α-sulfinyl benzoate rac-syn-255f.]   
Rf: 0.31 (hexane:Et2O = 90:10). 
1H NMR (CDCl3, 400 MHz) δ: 7.30–7.26 (m, 2H, Ar-H), 7.21–7.17 (m, 3H, Ar-H), 7.11 (d, 
J = 8.6 Hz, 2H, Ar-H), 6.83 (d, J = 8.6 Hz, 2H, Ar-H), 3.80 (s, 3H, O-CH3), 2.70–2.51 (m, 4H, 
1-H + 5-H), 1.86–1.64 (m, 4H, 2-H + 4-H), 1.30 (s, 12H, C-CH3 × 4), 1.14 (m, 1H, 3-H). 
13C NMR (CDCl3, 101 MHz) δ: 157.6 (Ar-C), 143.0 (Ar-C), 135.0 (Ar-C), 129.2 (2C, 
Ar-C × 2), 128.4 (2C, Ar-C × 2), 128.2 (2C, Ar-C × 2), 125.5 (Ar-C), 113.6 (2C, Ar-C × 2), 
83.0 (2C, B-O-C × 2), 55.2 (O-CH3), 35.6 (5-C), 34.6 (1-C), 33.6 (2-C), 33.4 (4-C), 24.9 (4C, 
C-CH3 × 4); carbon attached to boron not observed due to quadrupolar relaxation. 
11B NMR (CDCl3, 128 MHz) δ: 33.5. 
IR (neat) νmax: 2977, 2926, 1511, 1379, 1316, 1243, 1142, 1037, 821 cm
‒1. 
HRMS (ESI) calculated for C24H33BNaO3 (M+Na)
+: 403.2419, found: 403.2412. 
[α]23D: −6 (c 0.5, CHCl3). 
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Chiral HPLC: Daicel Chiralcel-IB column (25 cm), hexane:isopropanol = 90:10, 0.7 mL/min, 
room temperature, 210.8 nm: tR = 13.5 minutes (minor), 15.3 minutes (major), e.r. = 98:2 (Li), 











Following GP6, allylic sulfoxide ent-syn-255b (93 mg, 0.21 mmol), boronic ester 283 (52 mg, 
0.20 mmol) and t-BuLi (1.7 M in pentane, 235 µL, 0.400 mmol) afforded after purification by 
flash column chromatography (hexane:Et2O = 95:5) the homologated boronic ester 284b 
(53.6 mg, 85%) as a colourless oil. 
Following GP7a, allylic sulfoxide ent-syn-255b (115 mg, 0.26 mmol), boronic ester 283 
(52.4 mg, 0.20 mmol) and i-PrMgClLiCl (1.14 M in THF, 210 µL, 0.24 mmol) afforded after 
purification by flash column chromatography (hexane:Et2O = 95:5) the homologated boronic 
ester 284b (43.9 mg, 69%) as a colourless oil. 
[The racemate was synthesised as above, replacing enantioenriched α-sulfinyl benzoate 
ent-syn-255b with racemic α-sulfinyl benzoate rac-ent-syn-255b.]   
1H NMR (CDCl3, 400 MHz) δ: 7.09 (dt, J1 = 8.6 Hz, J2 = 2.9 Hz, 2H, Ar-H), 6.81 (dt, J1 = 8.6 
Hz, J2 = 2.9 Hz, 2H, Ar-H), 5.80 (m, 1H, 5-H), 5.03 (dq, J1 = 17.1 Hz, J2 = 2.0 Hz, 1H, 6-Htrans), 
4.95 (dq, J1 = 10.1 Hz, J2 = 1.0 Hz, 1H, 6-Hcis), 3.78 (s, 3H, O-CH3), 2.55 (m, 2H, 1-H), 2.19 
(m, 2H, 4-H), 1.68 (m, 2H, 2-H), 1.25 (s, 12H, C-CH3 × 4), 1.13 (m, 1H, 3-H). 
13C NMR (CDCl3, 101 MHz) δ: 157.6 (Ar-C), 138.4 (5-C), 135.0 (Ar-C), 129.2 (2C, Ar-C × 2), 
114.9 (6-C), 113.7 (2C, Ar-C × 2), 83.0 (2C, B-O-C × 2), 55.2 (O-CH3), 35.4 (1-C), 34.5 (3-C), 
33.2 (2-C), 24.9 (2C, C-CH3 × 2), 24.8 (2C, C-CH3 × 2); carbon attached to boron not observed 
due to quadrupolar relaxation. 
11B NMR (CDCl3, 128 MHz) δ: 33.3. 
IR (neat) νmax: 2977, 2924, 1511, 1318, 1142, 1038, 823 cm
‒1. 
HRMS (ESI) calculated for C19H29BNaO3 (M+Na)
+: 339.2105, found: 339.2109. 
[α]23D: −16 (c 0.8, CHCl3). [Lit. Value for (R):92 +0.12 (c 1.0, CHCl3)]. 




Chiral HPLC: Daicel Chiralcel-IB column (25 cm), hexane:isopropanol = 90:10, 0.8 mL/min, 









Following GP6, ketal sulfoxide syn-255g (108 mg, 0.210 mmol), boronic ester 283 (52 mg, 
0.20 mmol) and t-BuLi (1.7 M in pentane, 235 µL, 0.400 mmol) afforded after purification by 
flash column chromatography (hexane:Et2O = 75:25) the homologated boronic ester 284g 
(54.3 mg, 70%) as a colourless oil. 
Following GP7a, ketal sulfoxide syn-255g (134 mg, 0.260 mmol), boronic ester 283 (52 mg, 
0.20 mmol) and i-PrMgClLiCl (1.14 M in THF, 210 µL, 0.240 mmol) afforded after 
purification by flash column chromatography (hexane:Et2O = 75:25) the homologated boronic 
ester 284g (48.9 mg, 63%) as a colourless oil. 
[The racemate was synthesised as above, replacing enantioenriched α-sulfinyl benzoate 
syn-255g with racemic α-sulfinyl benzoate rac-syn-255g.]   
Rf: 0.18 (hexane:Et2O = 80:20). 
1H NMR (CDCl3, 400 MHz) δ: 7.09 (d, J = 8.5 Hz, 2H, Ar-H), 6.81 (d, J = 8.5 Hz, 2H, Ar-H), 
3.95−3.87 (m, 4H, 7-H × 2), 3.77 (s, 3H, O-CH3), 2.61−2.47 (m, 2H, 1-H), 1.77−1.46 (m, 6H, 
2-H + 4-H + 5-H), 1.31 (s, 3H, 6-H), 1.25 (s, 12H, C-CH3 × 4), 1.00 (m, 1H, 3-H). 
13C NMR (CDCl3, 101 MHz) δ: 157.6 (Ar-C), 135.1 (Ar-C), 129.2 (2C, Ar-C × 2), 113.6 (2C, 
Ar-C × 2), 110.1 (O-C-O), 82.9 (2C, B-O-C × 2), 64.5 (2C, 7-C × 2), 55.2 (O-CH3), 38.3 (5-C), 
34.6 (1-C), 33.6 (2-C), 25.5 (4-C), 24.8 (2C, C-CH3 × 2), 24.8 (2C, C-CH3 × 2), 23.6 (6-C); 
carbon attached to boron not observed due to quadrupolar relaxation. 
11B NMR (CDCl3, 128 MHz) δ: 33.7. 
IR (neat) νmax: 2978, 2932, 1511, 1372, 1316, 1244, 1142, 1037, 848, 825 cm
‒1. 
HRMS (ESI) calculated for C22H35BNaO5 (M+Na)
+: 413.2474, found: 413.2475. 





Chiral HPLC: Daicel Chiralcel-IB column (25 cm), hexane:isopropanol = 95:5, 0.7 mL/min, 
room temperature, 210.8 nm: tR = 23.6 minutes (major), 25.1 minutes (minor), e.r. = 99:1 (Li), 











Following GP6, methyl sulfoxide anti-255a (87 mg, 0.21 mmol), boronic ester 285c (63 mg, 
0.20 mmol) and t-BuLi (1.7 M in pentane, 235 µL, 0.400 mmol) afforded after purification by 
flash column chromatography (hexane:Et2O = 97:3) the homologated boronic ester 286ac 
(20.8 mg, 31%) as a colourless oil. 
Following GP7a, methyl sulfoxide anti-255a (108 mg, 0.260 mmol), boronic ester 285c 
(63 mg, 0.20 mmol) and i-PrMgClLiCl (1.25 M in THF, 190 µL, 0.240 mmol) afforded after 
purification by flash column chromatography (hexane:Et2O = 97:3) the homologated boronic 
ester 286ac (49.1 mg, 73%) as a colourless oil. 
[The racemate was synthesised as above, replacing enantioenriched α-sulfinyl benzoate 
syn-255a with racemic α-sulfinyl benzoate rac-syn-255a.]   
Rf: 0.26 (hexane:Et2O = 97:3). 
1H NMR (CDCl3, 400 MHz) δ: 5.27 (t, J = 6.4 Hz, 1H, 2-H), 4.21 (d, J = 6.3 Hz, 2H, 1-H), 
1.80 (q, J = 7.3 Hz, 1H, 5-H), 1.65 (s, 3H, CH3), 1.22 (s, 12H, C-CH3 × 4), 1.09 (d, J = 7.4 Hz, 
3H, 6-H), 0.89 (s, 9H, Si-C-(CH3)3), 0.06 (s, 6H, Si-(CH3)2). 
13C NMR (CDCl3, 101 MHz) δ: 139.2 (2-C), 122.7 (3-C), 83.1 (2C, B-O-C × 2), 60.6 (1-C), 
26.0 (3C, Si-C-CH3)3), 24.7 (2C, C-CH3 × 2), 24.6 (2C, C-CH3 × 2), 18.4 (Si-C), 16.7 (4-C), 
14.1 (6-C), –5.0 (2C, Si-(CH3)2); carbon attached to boron not observed due to quadrupolar 
relaxation. 
11B NMR (CDCl3, 128 MHz) δ: 32.8. 
IR (neat) νmax: 2956, 2929, 1462, 1347, 1317, 1253, 1144, 834, 774 cm
‒1. 
HRMS (ESI) calculated for C18H37BNaO3Si (M+Na)
+: 363.2501, found: 363.2512. 





Chiral GC: Chiraldex β-DM column, injector T = 250 °C, detector T = 300 °C, inject at 
T = 70 °C for 3 min, then ramp (1 °C min–1) until 180 °C then hold for 5 min, He carrier gas at 
1.0 mL min–1: tR = 61.9 min (minor), 62.5 min (major), total analysis time 120 min; e.r. = 99:1 































































































Following GP6, methyl sulfoxide ent-anti-255a (87 mg, 0.21 mmol), 4-methoxyphenyl pinacol 
boronic ester 285d (47 mg, 0.20 mmol), and t-BuLi (1.7 M in pentane, 235 µL, 0.400 mmol) 
afforded after purification by flash column chromatography (hexane:Et2O = 95:5) the 
homologated boronic ester 286ad (23.1 mg, 44%) as a colourless oil. A solution of 
MgBr2MeOH
* (1.0 M, 300 µL, 0.300 mmol) was added prior to warm the reaction mixture to 
66 °C. 
* 1.0 M MgBr2MeOH solution was prepared in advance by adding anhydrous MeOH to solid 
MgBr2. Reaction without addition of MgBr2MeOH gave the desired homologated alcohol in 
56% yield but only 85:15 e.r. due to reversible “ate” complex formation.66 
Following GP7a, methyl sulfoxide ent-anti-255a (108 mg, 0.260 mmol), boronic ester 285d 
(47 mg, 0.20 mmol) and i-PrMgClLiCl (1.25 M in THF, 190 µL, 0.240 mmol) afforded after 
purification by flash column chromatography (hexane:Et2O = 95:5) the homologated boronic 
ester 286ad (37 mg, 71%) as a colourless oil. 
[The racemate was synthesised as above, replacing enantioenriched α-sulfinyl benzoate 
ent-anti-255a with racemic α-sulfinyl benzoate rac-ent-anti-255a.]   
Spectral data matched that previously reported.221  
1H NMR (CDCl3, 400 MHz) δ: 7.14 (d, J = 8.6 Hz, 2H, Ar-H), 6.82 (d, J = 8.6 Hz, 2H, Ar-H), 
3.78 (s, 3H, O-CH3), 2.38 (q, J = 7.6 Hz, 1H, CH-CH3), 1.30 (d, J = 7.5 Hz, 3H, CH-CH3), 
1.22 (s, 6H, C-CH3 x 2), 1.20 (s, 6H, C-CH3 x 2). 
13C NMR (CDCl3, 101 MHz) δ: 157.2 (Ar-C), 137.0 (Ar-C), 128.6 (2C, Ar-C × 2), 113.7 (2C, 
Ar-C × 2), 83.2 (2C, B-O-C × 2), 55.2 (O-CH3), 24.6 (2C, C-CH3 × 2), 24.6 (2C, C-CH3 × 2), 
17.3 (CH-CH3); carbon attached to boron not observed due to quadrupolar relaxation. 
11B NMR (CDCl3, 128 MHz) δ: 32.8. 
IR (neat) νmax: 2977, 1509, 1353, 1318, 1242, 1141, 1038, 845, 828 cm
‒1. 
HRMS (ESI) calculated for C15H24BO3 (M+H)
+: 263.1816, found: 263.1822.  
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[α]23D: −10 (c 0.1, CHCl3). [Lit. value for (R)74: −120.3 (c 1.0, CHCl3); for (S)217: +13 (c 1.0, 
CHCl3)]. 
Chiral HPLC: Daicel Chiralcel-IB column (25 cm), hexane:isopropanol = 99:1, 0.7 mL/min, 
room temperature, 210.8 nm: tR = 34.5 minutes (major), 36.0 minutes (minor), e.r. = 99:1 (Li), 







Following GP6, chloropropyl sulfoxide anti-255n (100 mg, 0.210 mmol), boronic ester 283 
(52 mg, 0.20 mmol), t-BuLi (1.7 M in pentane, 235 µL, 0.400 mmol) and acetic acid (11 µL), 
afforded after purification by flash column chromatography (hexane:Et2O = 95:5) a mixture of 
the desired homologated boronic ester and starting boronic ester 283. Following GP8, oxidation 
of the mixture using H2O2/NaOH (1/1 v/v, 1 mL) afforded after purification by flash column 
chromatography (hexane:EtOAc = 80:20) the alcohol 284n (20.3 mg, 42%) as a colourless 
solid. 
Following GP7b, chloropropyl sulfoxide anti-255n (124 mg, 0.260 mmol), boronic ester 283 
(52 mg, 0.20 mmol) and i-PrMgClLiCl (1.14 M in THF, 210 µL, 0.240 mmol) afforded after 
purification by flash column chromatography (hexane:Et2O = 95:5) a mixture of the desired 
homologated boronic ester  and starting boronic ester 283. Following GP8, oxidation of the 
mixture using H2O2/NaOH (1/1 v/v, 1 mL) afforded after purification by flash column 
chromatography (hexane:EtOAc = 80:20) the alcohol 284n (27.0 mg, 56%) as a colourless 
solid. 
[The racemate was synthesised as above, replacing enantioenriched α-sulfinyl benzoate 
anti-255n with racemic α-sulfinyl benzoate rac-anti-255n.]   
Rf: 0.16 (hexane:EtOAc = 80:20). 
1H NMR (CDCl3, 400 MHz) δ: 7.12 (d, J = 8.6 Hz, 2H, Ar-H), 6.84 (d, J = 8.6 Hz, 2H, Ar-H), 
3.79 (s, 3H, O-CH3), 3.65 (m, 1H, 3-H), 3.57 (t, J = 6.0 Hz, 2H, 6-H), 2.73 (m, 1H, 1-H), 2.63 
(m, 1H, 1-H), 1.96 (m, 1H, 5-H), 1.89–1.64 (m, 4H, 5-H + 2-H × 2 + 4-H), 1.56 (m, 1H, 4-H), 
1.48 (bs, 1H, OH). 
13C NMR (CDCl3, 101 MHz) δ: 157.8 (Ar-C), 133.8 (Ar-C), 129.3 (2C, Ar-C × 2), 113.9 (2C, 
Ar-C × 2), 70.7 (3-C), 55.3 (O-CH3), 45.2 (6-C), 39.4 (2-C), 34.6 (4-C), 31.1 (1-C), 28.8 (5-C). 
IR (neat) νmax: 3675, 2988, 2972, 2901, 1394, 1074, 1066, 1057, 892, 879 cm
‒1. 
HRMS (ESI) calculated for C13H19ClNaO2 (M+Na)
+: 265.0966, found: 265.0976. 
M.P.: 37–39 ºC. 
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[α]23D: −8 (c 0.5, CHCl3). 
Chiral HPLC: Daicel Chiralcel-IB column (25 cm), hexane:isopropanol = 95:5, 0.7 mL/min, 
room temperature, 210.8 nm: tR = 17.2 minutes (major), 18.5 minutes (minor), e.r. = 98:2 (Li), 





















Following GP6, butyl sulfoxide syn-255p (96 mg, 0.21 mmol), boronic ester 283 (52 mg, 0.20 
mmol) and t-BuLi (1.7 M in pentane, 235 µL, 0.400 mmol) afforded after purification by flash 
column chromatography (hexane:Et2O = 98:2) the homologated boronic ester 284p (43.2 mg, 
65%) as a colourless oil. 
Following GP7a, ethyl sulfoxide syn-255p (119 mg, 0.260 mmol), boronic ester 283 (52 mg, 
0.20 mmol) and i-PrMgClLiCl (1.14 M in THF, 210 µL, 0.240 mmol) afforded after 
purification by flash column chromatography (hexane:Et2O = 98:2) the homologated boronic 
ester 284p (46.2 mg, 70%) as a colourless oil. 
[The racemate was synthesised as above, replacing enantioenriched α-sulfinyl benzoate 
syn-255p with racemic α-sulfinyl benzoate rac-syn-255p.]   
Rf: 0.28 (hexane:Et2O = 98:2). 
1H NMR (CDCl3, 400 MHz) δ: 7.10 (dt, J1 = 8.6 Hz, J2 = 2.9 Hz, 2H, Ar-H), 6.81 (dt, 
J1 = 8.6 Hz, J2 = 2.9 Hz, 2H, Ar-H), 3.78 (s, 3H, O-CH3), 2.61–2.48 (m, 2H, 1-H), 1.70 (m, 
1H, 2-H), 1.62 (m, 1H, 2-H), 1.49−1.36 (m, 2H, 4-H), 1.32–1.23 (m, 4H, 5-H + 6-H), 1.26 (s, 
12H, C-CH3 × 4), 1.03 (m, 1H, 3-H), 0.88 (t, J = 7.0 Hz, 3H, 7-H). 
13C NMR (CDCl3, 101 MHz) δ: 157.6 (Ar-C), 135.3 (Ar-C), 129.2 (2C, Ar-C × 2), 113.6 (2C, 
Ar-C × 2), 82.9 (2C, B-O-C × 2), 55.2 (O-CH3), 34.7 (1-C), 33.8 (2-C), 31.5 (4-C), 30.9 (5-C), 
24.9 (2C, C-CH3 × 2), 24.8 (2C, C-CH3 × 2), 23.0 (6-C), 14.1 (7-C); carbon attached to boron 
not observed due to quadrupolar relaxation. 
11B NMR (CDCl3, 128 MHz) δ: 33.8. 
IR (neat) νmax: 2923, 2856, 1512, 1379, 1314, 1244, 1143, 1039, 967, 824 cm
‒1. 
HRMS (ESI) calculated for C20H33BNaO3 (M+Na)
+: 355.2419, found: 355.2422. 




Chiral HPLC: Daicel Chiralcel-IB column (25 cm), hexane:isopropanol = 95:5, 0.7 mL/min, 
room temperature, 210.8 nm: tR = 11.4 minutes (minor), 12.6 minutes (major), e.r. = 97:3 (Li), 










Following GP7b, ethyl sulfoxide anti-255q (71 mg, 0.13 mmol), boronic ester 283 (26 mg, 
0.10 mmol) and i-PrMgClLiCl (1.14 M in THF, 105 µL, 0.120 mmol) afforded after 
purification by flash column chromatography (hexane:Et2O = 85:15) the homologated boronic 
ester 284q (25.4 mg, 61%) as a colourless oil. 
[The racemate was synthesised as above, replacing enantioenriched α-sulfinyl benzoate 
anti-255q with racemic α-sulfinyl benzoate rac-anti-255q.]   
Rf: 0.30 (hexane:Et2O = 85:15). 
1H NMR (CDCl3, 400 MHz) δ: 7.08 (d, J = 8.6 Hz, 2H, Ar-H), 6.80 (d, J = 8.6 Hz, 2H, Ar-H), 
4.10 (q, J = 7.1 Hz, 2H, 10-H), 3.77 (s, 3H, O-CH3), 2.59–2.57 (m, 2H, 1-H), 2.26 (t, J = 7.5 Hz, 
2H, 8-H), 1.74–1.66 (m, 1H, 2-H), 1.64–1.56 (m, 3H, 2-H + 7-H), 1.47–1.36 (m, 2H, 4-H), 
1.31–1.21 (m, 19H, C-CH3 × 4, 5-H, 6-H, 10-H), 1.03 (m, 1H, 3-H). 
13C NMR (CDCl3, 101 MHz) δ: 173.9 (CO), 157.6 (Ar-C), 135.1 (Ar-C), 129.2 (2C, Ar-C × 2), 
113.6 (2C, Ar-C × 2), 82.9 (2C, B-O-C × 2), 60.1 (10-C), 55.2 (O-CH3), 34.7 (1-C), 34.3 (8-C), 
33.7 (2-C), 31.0 (4-C), 29.4 (6-C), 28.8 (5-C), 24.9 (7-C), 24.8 (2C, C-CH3 × 2), 24.8 (2C, 
C-CH3 × 2), 14.2 (11-C); carbon attached to boron not observed due to quadrupolar 
relaxation. 
11B NMR (CDCl3, 128 MHz) δ: 34.2. 
IR (neat) νmax: 2927, 1733, 1512, 1379, 1314, 1244, 1143, 1036, 967, 824 cm
‒1. 
HRMS (ESI) calculated for C24H39BNaO5 (M+Na)
+: 441.2787, found: 441.2792. 




Chiral HPLC: Daicel Chiralcel-IB column (25 cm), hexane:isopropanol = 90:10, 0.7 mL/min, 







5.6.8. Determination of the Absolute Configuration of α-Sulfinyl Benzoates 
The stereochemistry of the sulfoxide–metal exchange is well established in the literature.80 
While inversion of configuration at sulfur occurs with sulfoxide−metal exchange,153 the 
generated metal carbenoid reacts with boronic esters with retention of configuration. When 
ethyl benzoate 108a was lithiated with s-BuLi in the presence of TMEDA and trapped with 
racemic methyl tolylsulfinate 466 after transmetalation to the corresponding magnesiated 
species, all four stereoisomers were obtained (Figure 5.1A). Replacing racemic methyl 
tolylsulfinate 466 with enantiomeriacally pure Andersen’s sulfinate 117 gave two major 
stereoisomers of benzoate 255a with S-configuration at the sulfur atom (Figure 5.1B). On the 
other hand, enantioselective lithiation of ethyl benzoate 108a using (+)-sparteine in the place 
of TMEDA, followed by transmetalation and trapping of the generated magnesium carbenoid 
with racemic methyl tolylsulfinate 466 gave two major stereoisomers of benzoate 255a with 
R-configuration at the carbon centre (Figure 5.1C). The less polar compound on TLC was 
therefore identified as the syn diastereomer ent-syn-255a, while the more polar compound was 





Figure 5.1. (A): Reaction using TMEDA and racemic methyl sulfinate 466; (B) reaction using TMEDA and 
Andersen’s sulfinate 117; (C): reaction using (+)-sparteine and racemic methyl sulfinate 466. 
The same experiment using (+)-sparteine was done starting from homoallylic benzoate 108b 
and the opposite enantiomer of Andersen’s sulfinate ent-117 to generate ent-syn-255b as the 
major diastereomer (less polar) with only minor amount of ent-anti-255b (more polar). 
After comparison of the chemical shifts for the α-sulfinyl proton (1H NMR) and α-sulfinyl 
carbon (13C NMR), the trends have been used to assign the stereochemistry of sulfoxides 


















Figure 5.2. Correlation between the chemical shifts α-proton and carbon of sulfinyl benzoates and the relative 
configuration of compounds 255. 
Furthermore, four known compounds have been synthesised and the optical rotation value of 




    
[α]23D: −19 (c 0.7, CHCl3) [α]23D: −9 (c 0.7, CHCl3) [α]23D: −16 (c 0.8, CHCl3) [α]23D: +18 (c 0.8, CHCl3) 
For (R): −8.2 (c 0.98, CHCl3)93 For (R): −9.6 (c 1.05, CHCl3)93 For (R): +0.12 (c 1.05, CHCl3)92 For (R): +57 (c 1.0, CHCl3)72 








5.7. Single Compounds Chapter 4 
1,3-Dimethyl-1H-benzo[d]imidazole-3-ium iodide (330a) 
 
Following a literature reported procedure,223 benzimidazole (2.0 g, 17 mmol) was charged in a 
round-bottomed flask equipped with a condenser and aq. KOH (5.0 N, 20 mL) was added, 
followed by MeOH (10 mL). Methyl iodide (12 mL, 19 mmol) was added dropwise at room 
temperature and the resulting reaction mixture was stirred at 45 °C for 16 h. After cooling to 
room temperature, the precipitated solid was filtered and dried in vacuo to give iodide 330a 
(2.7 g, 59%). 
1H NMR (CDCl3, 400 MHz) δ: 9.66 (s, 1H, N-CH-N), 8.05 (dd, J1 = 6.3 Hz, J2 = 3.2 Hz, 2H, 
Ar-H), 7.74 (dd, J1 = 6.3 Hz, J2 = 3.2 Hz, 2H, Ar-H), 4.11 (s, 6H, CH3 × 2). 
13C NMR (CDCl3, 101 MHz) δ: 143.6 (N-CH-N), 132.1 (2C, Ar-C × 2), 126.9 (2C, Ar-C × 2), 
113.9 (2C, Ar-C × 2), 33.7 (2C, CH3 × 2). 




Vinyl dimethylcarbamate (378) 
 
Following a modified literature reported procedure,189 a solution of n-BuLi (1.6 M in hexane, 
9.4 mL, 15 mmol) in THF (12 mL) was stirred at room temperature overnight. The solution 
was cooled to 0 °C and a solution of dimethylcarbamoyl chloride (0.92 mL, 10 mmol) in 
anhydrous DMPU (11 mL) was added. The reaction mixture was stirred at room temperature 
for 4 h and then sat. aq. NH4Cl (20 mL) and Et2O (20 mL) were added. The phases were 
separated and the aqueous phase was extracted with Et2O (2 × 20 mL). The combined organic 
phases were dried over MgSO4, filtered and the solvent was removed under reduced pressure 
without heating. Purification by flash column chromatography on SiO2 (hexane:Et2O = 50:50) 
afforded cabamate 378 (495 mg, 43%) as a colourless oil. 
Rf: 0.83 (hexane:EtOAc = 50:50). 
1H NMR (CDCl3, 400 MHz) δ: 7.20 (dd, J1 = 14.0, J2 = 6.3 Hz, 1H, CH), 4.77 (dd, J1 = 14.0, 
J2 = 1.5 Hz, 1H, CH2trans), 4.43 (dd, J1 = 6.3, J2 = 1.5 Hz, 1H, CH2cis), 2.97 (s, 3H, CH3), 2.94 
(s, 3H, CH3). 
13C NMR (CDCl3, 101 MHz) δ: 153.7 (CO), 142.6 (CH), 95.0 (CH2), 36.5 (CH3), 35.9 (CH3). 
IR (neat) νmax: 2935, 1715, 1646, 1398, 1371, 1168, 1043, 759 cm
‒1. 
HRMS (ESI) calculated for C5H9NNaO2 (M+Na)




(Phenylthio)methyl 2,4,6-triisopropylbenzoate (393) 
 
Following a modified literature reported procedure,224 to a solution of 
2,4,6-triisopropylbenzoic acid (1.72 g, 6.90 mmol) and Cs2CO3 (2.3 g, 6.9 mmol) in DMF 
(11 mL) was added chloromethyl phenyl sulfide (1.0 g, 6.3 mmol) and the resulting reaction 
mixture was stirred at 85 °C for 16 h. After cooling to room temperature, the precipitate was 
filtered off and the filtrate was concentrated under reduced pressure. The residue was dissolved 
in CHCl3 (20 mL) and washed with 20% aq. NaHCO3 solution (3 × 20 mL). The organic phases 
were combined, dried over MgSO4, filtered and the solvent was removed under reduced 
pressure. Purification by flash column chromatography on SiO2 (hexane:EtOAc = 98:2) 
afforded the pure benzoate 393 (2.2 g, 94%) as a white solid. 
Rf: 0.22 (hexane:Et2O = 98:2). 
1H NMR (CDCl3, 400 MHz) δ: 7.48 (m, 2H, Ar-H), 7.35–7.16 (m, 3H, Ar-H), 6.99 (s, 2H, 
Ar-H), 5.68 (s, 2H, CH2), 2.88 (m, 3H, CH(CH3)2 × 3), 1.24 (d, J = 6.9 Hz, 6H, CH3 × 2), 1.19 
(d, J = 6.8 Hz, 12H, CH3 × 4). 
13C NMR (CDCl3, 101 MHz) δ: 170.2 (CO), 150.5 (Ar-C), 145.0 (2C, Ar-C × 2), 134.8 (Ar-C), 
129.8 (2C, Ar-C × 2), 129.4 (Ar-C), 129.1 (2C, Ar-C × 2), 127.1 (Ar-C), 120.9 (2C, Ar-C × 2), 
68.3 (CH2), 34.4 (CH-(CH3)2), 31.3 (2C, CH-(CH3)2 × 2), 24.1 (4C, CH3 × 4), 23.9 (2C, 
CH3 × 2). 
IR (neat) νmax: 2966, 1735, 1234, 1060, 1046, 748 cm
‒1. 
HRMS (ESI) calculated for C23H30NaO2S (M+Na)
+: 393.1859, found: 393.1859. 







To a solution of diisopropylamine (55 µL, 0.40 mmol) in anhydrous THF (200 µL) was added 
n-BuLi (1.6 M in hexane, 0.25 mL, 0.40 mmol) at −78 °C. After stirring for 20 min at −78 °C 
and 10 min at room temperature, the solution was added dropwise to a mixture of benzoate 393 
(148 mg, 0.400 mmol) and phenethyl pinacol boronic ester (46 mg, 0.20 mmol) in anhydrous 
THF (2 mL) at −78 °C. The resulting reaction mixture was stirred at −78 °C for 1 h, then it was 
allowed to warm to room temperature and stirred for additional 1 h. H2O (10 mL) and Et2O 
(10 mL) were sequentially added, the phases were separated and the aqueous phase was 
extracted with Et2O (2 × 10 mL). The combined organic phases were dried over MgSO4, 
filtered and the solvent was removed under reduced pressure. Purification by flash silica gel 
column chromatography (hexane:Et2O = 95:5) afforded homologated boronic ester 392 
(32 mg, 45%) as a colourless oil. 
Rf: 0.53 (hexane:CH2Cl2 = 50:50). 
1H NMR (CDCl3, 400 MHz) δ: 7.35 (m, 2H, Ar-H), 7.29–7.11 (m, 8H, Ar-H), 2.88–2.61 (m, 
3H, 1-H + 3-H), 2.03 (m, 2H, 2-H), 1.22 (d, J = 2.5 Hz, 12H, C-CH3 × 4). 
13C NMR (CDCl3, 101 MHz) δ: 141.7 (Ar-C), 136.3 (Ar-C), 130.0 (2C, Ar-C × 2), 128.6 (2C, 
Ar-C × 2), 128.5 (2C, Ar-C × 2), 128.3 (2C, Ar-C × 2), 126.0 (Ar-C), 125.8 (Ar-C), 84.0 (2C, 
B-O-C × 2), 34.7 (2-C), 32.8 (1-C), 24.7 (2C, C-CH3 × 2), 24.6 (2C, C-CH3 × 2); carbon 
attached to boron not observed due to quadrupolar relaxation. 
11B NMR (CDCl3, 128 MHz) δ: 33.3. 
IR (neat) νmax: 2976, 1455, 1367, 1330, 1141, 845, 739 cm
‒1. 
HRMS (ESI) calculated for C21H28BO2S (M+H)









Following a literature reported procedure,73 a solution of stannane (R)-109 (158 mg, 
0.360 mmol) in anhydrous Et2O (2.0 mL) was cooled to −78 °C and n-BuLi (225 µL, 
0.360 mmol) was added dropwise. The mixture was stirred at −78 °C for 1 h, then a solution of 
crude boronic ester 392 (0.3 mmol) in Et2O (1.0 mL) was added dropwise at −78 °C. After 
stirring at −78 °C for 30 min, the mixture was warmed to room temperature and heated at 35 °C 
for 16 h. H2O (10 mL) and Et2O (10 mL) were added, the phases were separated and the 
aqueous phase was extracted with Et2O (2 × 10 mL). The combined organic phases were dried 
over MgSO4, filtered and the solvent was removed in vacuo. Purification by flash column 
chromatography on silica gel (hexane:Et2O = 95:5) afforded boronic ester 395 (30 mg, 26%, 
1:1 d.r.) as a colourless oil. 
Rf: 0.42 (hexane:CH2Cl2 = 60:40). 
1H NMR (CDCl3, 400 MHz) δ: 7.48–7.43 (m, 4H, Ar-H), 7.31–7.08 (m, 16H, Ar-H), 3.33 (m, 
2H, 3-H), 2.95–2.66 (m, 4H, 1-H), 2.05–1.78 (m, 4H, 2-H), 1.47 (m, 2H, 4-H), 1.25 (d, 
J = 1.9 Hz, 24H, C-CH3 × 8), 1.14 (d, J = 7.4 Hz, 3H, CH-CH3 diast. a), 1.07 (d, J = 7.4 Hz, 
3H, CH-CH3 diast. b). 
13C NMR (CDCl3, 101 MHz) δ: 142.2 (Ar-C, diast. a), 142.1 (Ar-C, diast b), 136.3 (Ar-C, 
diast. a), 136.2 (Ar-C, diast. b), 131.9 (2C, Ar-C × 2, diast. a), 131.9 (2C, Ar-C × 2, diast. b), 
128.7 (2C, Ar-C × 2, diast. a), 128.7 (2C, Ar-C × 2, diast. b), 128.5 (2C, Ar-C × 2, diast. a), 
128.4 (2C, Ar-C × 2, diast. b), 128.3 (2C, Ar-C × 2, diast. a), 128.2 (2C, Ar-C × 2, diast. b), 
126.4 (Ar-C, diast. a), 126.4 (Ar-C, diast. b), 125.7 (Ar-C, diast. a), 125.7 (Ar-C, diast. b), 83.3 
(2C, B-O-C × 2, diast. a), 83.3 (2C, B-O-C × 2, diast. b), 52.8 (3-C, diast. a), 51.9 (3-C, diast. b), 
36.7 (2-C, diast. a), 34.9 (2-C, diast. b), 33.4 (1-C, diast. a), 33.3 (1-C, diast. b), 24.9 (2C, 
C-CH3 × 2, diast. a), 24.9 (2C, C-CH3 × 2, diast. a), 24.7 (2C, C-CH3 × 2, diast. b), 24.7 (2C, 
C-CH3 × 2, diast. b), 12.5 (CH-CH3, diast. a), 11.8 (CH-CH3, diast. b); carbon attached to 
boron not observed due to quadrupolar relaxation. 
11B NMR (CDCl3, 128 MHz) δ: 33.6. 
 
276 
IR (neat) νmax: 2976, 2930, 1454, 1379, 1318, 1141, 966, 856, 744 cm
‒1. 
HRMS (ESI) calculated for C23H31BNaO2S (M+Na)






To a solution of (2-bromovinyl)trimethylsilane (approx. 90% trans, 108 mg, 0.600 mmol) in 
anhydrous Et2O (2.0 mL) was added t-BuLi (1.7 M in pentane, 710 µL, 1.20 mmol) dropwise 
at −78 °C. The reaction mixture was stirred at −78 °C for 45 min, then a solution of phenethyl 
pinacol boronic ester 43 (70 mg, 0.30 mmol) in Et2O (0.50 mL) was added dropwise. The 
mixture for stirred at −78 °C for 30 min, warmed to 0 °C and stirred for additional 30 min. A 
solution of I2 (168 mg, 0.660 mmol) in anhydrous MeOH (2.0 mL) was added dropwise at 
0° C, the reaction mixture was stirred for 30 min at this temperature and then warmed to room 
temperature for 1 h. Sat. aq. Na2S2O3 (10 mL) and Et2O (10 mL) were sequentially added, the 
phases were separated and the aqueous phase was extracted with Et2O (2 × 10 mL). The 
combined organic phases were dried over MgSO4, filtered and the solvent was removed under 
reduced pressure. Purification by flash column chromatography on silica gel (hexane) afforded 
desired alkene (Z)-400 (38 mg, 62%, >95:5 Z:E) as a colourless oil. 
1H NMR (CDCl3, 400 MHz) δ: 7.33–7.27 (m, 2H, Ar-H), 7.23–7.16 (m, 3H, Ar-H), 6.35 (dt, 
J1 = 14.3 Hz, J2 = 7.3 Hz, 1H, 2-H), 5.54 (dt, J1 = 14.0 Hz, J2 = 1.3 Hz, 1H, 1-H), 2.70 (t, 
J = 8.4 Hz, 2H, 4-H), 2.45 (q, J = 7.3 Hz, 2H, 3-H), 0.09 (s, 9H, Si-CH3 × 3). 
13C NMR (CDCl3, 101 MHz) δ: 147.8 (2-C), 141.8 (Ar-C), 129.8 (Ar-C), 128.4 (2C, Ar-C × 2), 
128.3 (2C, Ar-C × 2), 125.8 (1-C), 36.1 (4-C), 35.5 (3-C), 0.2 (3C, CH3 × 3). 






Following a literature reported procedure,192 to a solution of (Z)-400 (0.02 g, 0.05 mmol) in 
anhydrous CH2Cl2 (2.0 mL) at −30 °C was added BCl3 (1.0 M in CH2Cl2, 400 µL, 0.400 mmol) 
dropwise. The reaction mixture was stirred at −30 °C for 5 h, then a solution of pinacol (35 mg, 
0.30 mmol) and Et3N (85 µL, 0.60 mmol) in CH2Cl2 (2.0 mL) was added and the resulting 
mixture was stirred at room temperature for 16 h. Sat. aq. Na2CO3 was added (10 mL), followed 
by Et2O (10 mL). The phases were separated and the aqueous phase was extracted with Et2O 
(2 × 10 mL). The combined organic phases were dried over MgSO4, filtered and the solvent 
was removed under reduced pressure. Purification by flash column chromatography on silica 
gel (hexane:Et2O = 98:2) afforded alkene (Z)-401 (16 mg, 62%, >95:5 Z:E) as a colourless oil. 
1H NMR (CDCl3, 400 MHz) δ: 7.31–7.15 (m, 5H, Ar-H), 6.47 (m, 1H, 2-H), 5.37 (d, 
J  = 13.4 Hz, 1H, 1-H), 2.77–2.68 (m, 4H, 4-H + 3-H), 1.26 (s, 12H, CH3 × 4). 
13C NMR (CDCl3, 101 MHz) δ: 153.9 (2-C), 142.9 (Ar-C), 128.6 (2C, Ar-C × 2), 128.3 (2C, 
Ar-C × 2), 125. 8 (Ar-C), 82.9 (2C, B-O-C × 2), 36.1 (4-C), 34.0 (3-C), 24.9 (4C, CH3 × 4); 
carbon attached to boron not observed due to quadrupolar relaxation. 
11B NMR (CDCl3, 128 MHz) δ: 28.8. 





Following a literature reported procedure,98 to a solution of (2-bromovinyl)trimethylsilane 
(approx. 90% trans, 108 mg, 0.600 mmol) in anhydrous THF (2.0 mL) was added t-BuLi (1.7 M 
in pentane, 710 µL, 1.20 mmol) dropwise at −78 °C. The reaction mixture was stirred at −78 °C 
for 45 min, then a solution of phenethyl pinacol boronic ester 40 (70 mg, 0.30 mmol) in THF 
(0.50 mL) was added dropwise. The mixture for stirred at −78 °C for 30 min, warmed to 0 °C 
and stirred for additional 30 min. A solution of PhSeCl (69 mg, 0.36 mmol) in anhydrous THF 
(0.50 mL) was added dropwise at −78° C. The reaction mixture was stirred for 30 min at this 
temperature, warmed to room temperature for 15 min and then cooled to 0 °C. A suspension 
of NaOMe (81 mg, 1.5 mmol) in MeOH (3.0 mL) was added dropwise and the mixture was 
stirred at 0 °C for 2 h. Sat. aq. Na2S2O3 (10 mL) and Et2O (10 mL) were sequentially added, 
the phases were separated and the aqueous phase was extracted with Et2O (2 × 10 mL). The 
combined organic phases were dried over MgSO4 and the solvent was removed under reduced 
pressure. Purification by chromatography on silica gel (hexane) afforded alkene (Z)-400 (25 
mg, 41%, >95:5 Z:E) as a colourless oil. 






Following a literature reported procedure,98 to a solution of (2-bromovinyl)trimethylsilane 
(approx. 90% trans, 108 mg, 0.600 mmol) in anhydrous THF (2.0 mL) was added t-BuLi (1.7 M 
in pentane, 710 µL, 1.20 mmol) dropwise at −78 °C. The reaction mixture was stirred at −78 °C 
for 45 min, and a solution of phenethyl pinacol boronic ester 43 (70 mg, 0.30 mmol) in THF 
(0.50 mL) was added dropwise. The mixture for stirred at −78 °C for 30 min, warmed to 0 °C 
and stirred for additional 30 min. A solution of PhSeCl (69 mg, 0.36 mmol) in anhydrous THF 
(0.50 mL) was added dropwise at −78° C. The reaction mixture was stirred for 30 min at 
−78° C, warmed to room temperature for 15 min and then filtered through a short plug of SiO2 
washing with Et2O. The filtrate was concentrated under reduced pressure and the residue was 
dissolved in THF (0.50 mL). A solution of m-CPBA (104 mg, 0.60 mmol) in THF (3.0 mL) 
was added dropwise at −78 °C and the resulting solution was warmed to −45 °C and stirred for 
30 min. Dimethylsulfide (0.44 mL, 6.0 mmol) was added at −45 °C and the mixture was 
allowed to warm to room temperature and subsequently filtered through a short plug of SiO2 
washing with Et2O. The filtrate was concentrated under reduced pressure and the residue was 
purified by chromatography on SiO2 (hexane) to afford desired alkene (E)-400 (22 mg, 36%, 
>95:5 E:Z) as a colourless oil. 
1H NMR (CDCl3, 400 MHz) δ: 7.32–7.22 (m, 2H, Ar-H), 7.22–7.13 (m, 3H, Ar-H), 6.08 (dt, 
J1 = 18.5 Hz, J2 = 6.1 Hz, 1H, 2-H), 5.54 (dt, J1 = 18.6 Hz, J2 = 1.5 Hz, 1H, 1-H), 2.71 (t, 
J = 7.5 Hz, 2H, 4-H), 2.41 (m, 2H, 3-H), 0.04 (s, 9H, Si-CH3 × 3). 
13C NMR (CDCl3, 101 MHz) δ: 146.1 (2-C), 142.0 (Ar-C), 130.4 (Ar-C), 128.5 (2C, Ar-C × 2), 
128.2 (2C, Ar-C × 2), 125.7 (1-C), 38.5 (4-C), 35.2 (3-C), −1.0 (3C, CH3 × 3). 






Following a literature reported procedure,193 to a solution of molybdenum catalyst 
Mo(CO)2(allyl)Br(MeCN)2* (151 mg, 0.425 mmol) in THF (8.5 mL) at room temperature, was 
added 1-(trimethylsilyl)-1-propyne (983 mg, 8.76 mmol). Bu3SnH (2.3 mL, 8.5 mmol) was 
added dropwise over 2 min and the resulting dark reaction mixture was stirred for 1 h, then the 
solvent was removed under reduced pressure. The residue was taken up in hexane and filtered 
through a short plug of silica gel washing with hexane. The solvent was removed in vacuo to 
afford a mixture of the desired hydrostannylated product and Bu3SnH that was used directly in 
the next step without further purification. 
To a solution of the hydrostannylated product in CH2Cl2 (25 mL) at 0 °C was added a solution 
of I2 (2.2 g, 8.5 mmol) in CH2Cl2 (85 mL) dropwise via cannula until a dark purple colour 
persisted. The mixture was immediately quenched with sat. aq. Na2S2O3 (40 mL) and allowed 
to warm to room temperature. The layers were separated and the aqueous layer was extracted 
with CH2Cl2 (2 × 40 mL). The combined organic phases were dried over MgSO4, filtered and 
the solvent was removed under reduced pressure. Purification by flash column chromatography 
on SiO2 afforded alkene 403 (620 mg, 31%) as a colourless oil. 
1H NMR (CDCl3, 400 MHz) δ: 6.29 (q, J = 1.0 Hz, 1H, CH), 2.54 (d, J = 1.0 Hz, 3H, C-CH3), 
0.14 (s, 9H, Si-CH3 × 3). 
13C NMR (CDCl3, 101 MHz) δ: 144.2 (Si-CH), 110.0 (Cq), 34.7 (C-CH3), −0.2 (3C, Si-CH3 
× 3). 
All analytical data matched that previously reported in the literature.193 
* Mo(CO)2(allyl)Br(MeCN)2 was prepared as follows:
227 Mo(CO)6 (1.3 g, 5.0 mmol) was 
dissolved in a mixture of anhydrous benzene and CH3CN (1/1 v/v, 20 mL in total) and allyl 
bromide (0.65 mL, 7.5 mmol) was added. The resulting white suspension was heated at 80 °C 
for 4 h to give a yellow/orange solution. The reaction mixture was allowed to cool to room 
temperature and the resulting yellow precipitate was filtered and washed with benzene. IR 
spectrum recorded on the solid after drying in vacuo was found to be in agreement with the 




(E)-3-(Trimethylsilyl)allyl 2,4,6-triisopropylbenzoate (426) 
 
A solution of TIBOH (857 mg, 3.45 mmol), (E)-3-(trimethylsilyl)prop-2-en-1-ol (500 mg, 
3.84 mmol), and PPh3 (997 mg, 3.80 mmol) in anhydrous THF (14.0 mL) was cooled to −5 °C 
and DIAD (750 µL, 3.80 mmol) was added dropwise. The resulting mixture was stirred at 
−5 °C for 30 min, then it was warmed to room temperature and stirred overnight. Sat. aq. 
NaHCO3 (10 mL) and H2O (10 mL) were added, the phases were separated and the aqueous 
phase was extracted with Et2O (2 × 20 mL). The combined organic phases were dried over 
MgSO4, filtered and the solvent was removed under reduced pressure. The crude residue was 
dissolved in the minimum amount of hot CH2Cl2 and the resulting solution was poured into 
stirred cold pentane. The formed precipitate was filtered off and the solvent was removed in 
vacuo. Purification of the crude residue by flash column chromatography on silica gel 
(hexane:Et2O = 98:2) afforded benzoate 426 (1.05 g, 85%) as a colourless oil. 
Rf: 0.30 (hexane:CH2Cl2 = 90:10). 
1H NMR (CDCl3, 400 MHz) δ: 7.01 (s, 2H, Ar-H), 7.16 (dt, J1 = 18.7 Hz, J2 = 5.1 Hz, 1H, 
Si-CH), 6.06 (dt, J1 = 18.7 Hz, J2 = 1.2 Hz, 1H, CH2-CH), 4.82 (dd, J1 = 5.1 Hz, J2 = 1.2 Hz, 
2H, CH2), 2.88 (hept, J = 6.8 Hz, 3H, CH(CH3)2 × 3), 1.24 (d, J = 6.9 Hz, 18H, CH3 × 6), 0.08 
(s, 9H, Si-(CH3)3). 
13C NMR (CDCl3, 101 MHz) δ: 170.4 (CO), 150.2 (Ar-C), 144.8 (2C, Ar-C × 2), 138.9 
(CH2-CH), 134.8 (Si-CH), 130.3 (Ar-C), 120.9 (2C, Ar-C × 2), 67.2 (CH2), 34.4 (CH-(CH3)2), 
31.4 (2C, CH-(CH3)2 × 2), 24.1 (4C, CH3 × 4), 24.0 (2C, CH3 × 2), −1.5 (3C, Si-(CH3)3). 
IR (neat) νmax: 2959, 1728, 1247, 1069, 862, 837 cm
‒1. 
HRMS (ESI) calculated for C22H37O2Si (M+H)






Following a literature reported procedure,200 to a solution of benzyl propargyl ether (5.0 g, 
34 mmol) in anhydrous THF (20 mL) at room temperature was added t-BuOK (1.14 g, 
10.2 mmol). The resulting suspension was stirred at room temperature for 3 h and then filtered 
through a pad of celite washing with Et2O. The solvent was removed under reduced pressure 
and the crude residue was purified by chromatography on silica gel (hexane:Et2O = 98:2 with 
0.5% Et3N, silica gel was washed with 1% Et3N before running the column) to afford 
allene 318a (4.47 g, 89%) as a yellowish liquid. 
1H NMR (CDCl3, 400 MHz) δ: 7.40−7.27 (m, 5H, Ar-H), 6.84 (t, J = 5.9 Hz, 1H, CH), 5.48 
(d, J = 5.9 Hz, 2H, C-CH2), 4.62 (s, 2H, Ph-CH2). 
13C NMR (CDCl3, 101 MHz) δ: 201.3 (Cq), 137.3 (Ar-C), 128.4 (2C, Ar-C × 2), 127.8 (Ar-C), 
127.8 (2C, Ar-C × 2), 121.6 (CH), 91.1 (C-CH2), 70.6 (Ph-CH2). 






To a solution of allene 318a (53 mg, 0.36 mmol) in anhydrous Et2O (2.0 mL) at −42 °C was 
added n-BuLi (1.6 M in hexane, 225 µL, 0.360 mmol) dropwise. The reaction mixture was 
stirred at −42 °C for 30 min, warmed to 0 °C and stirred for additional 10 min. The mixture 
was cooled to −78 °C and a solution of phenethyl pinacol boronic ester 43 (70 mg, 0.30 mmol) 
in Et2O (0.50 mL) was added dropwise. The reaction was stirred at −78 °C for 30 min and at 
0 °C for further 30 min, then a suspension of NaOMe (49 mg, 0.90 mmol) in MeOH (0.50 mL) 
was added dropwise at −78 °C, immediately followed by the addition of a solution of I2 (91 mg, 
0.36 mmol) in MeOH (1.5 mL). The mixture was stirred at −78 °C for 1 h and at 0 °C for 
10 min. Sat. aq. Na2S2O3 (10 mL) and Et2O (10 mL) were added, the phases were separated 
and the aqueous phase was extracted with Et2O (2 × 10 mL). The combined organic phases 
were sequentially washed with sat. aq. NaHCO3 (20 mL), 1.0 M HCl (20 mL) and sat. aq. 
NaHCO3 (20 mL), dried over MgSO4, filtered and the solvent was removed under reduced 
pressure. Purification of the crude reaction mixture by flash column chromatography on silica 
gel (hexane:Et2O = 95:5) afforded enone 443 (21 mg, 44%) as a colourless oil. 
1H NMR (CDCl3, 400 MHz) δ: 7.37−7.08 (m, 5H, Ar-H), 6.36 (dd, J1 = 17.7 Hz, J2 = 10.5 Hz, 
1H, 2-H), 6.21 (dd, J1 = 17.7 Hz, J2 = 1.0 Hz, 1H, 1-Htrans), 5.83 (dd, J1 = 10.5 Hz, J2 = 1.0 Hz, 
1H, 1-Hcis),  3.04–2.84 (m, 4H, 3-H + 4-H). 
13C NMR (CDCl3, 101 MHz) δ: 199.7 (CO), 141.0 (Ar-C), 136.5 (2-C), 128.5 (2C, Ar-C × 2), 
128.3 (2C, Ar-C × 2), 128.2 (1-C), 126.1 (Ar-C), 41.2 (3-C), 29.8 (4-C). 






Following a modified literature reported procedure,229 to neat methyl propargyl ether (5.7 g, 
80 mmol) at room temperature was added t-BuOK (0.90 g, 8.0 mmol). The resulting 
suspension was heated at 65 °C for 3 h and then allowed to cool to room temperature. The 
condenser was removed and the reaction flask was connected to a receiving vessel cooled to 
−78 °C. Distillation under vacuum without heating afforded allene 318b (3.2 g, 56%) as a 
colourless liquid. 
1H NMR (CDCl3, 400 MHz) δ: 6.77 (t, J = 5.9 Hz, 1H, CH), 5.48 (d, J = 5.9 Hz, 2H, C-CH2), 
3.41 (s, 3H, Ph-CH2). 
13C NMR (CDCl3, 101 MHz) δ: 201.1 (Cq), 122.9 (CH), 91.3 (C-CH2), 55.9 (CH3). 





To a solution of allene 318b (34 mg, 0.48 mmol) in anhydrous Et2O (2.5 mL) at −42 °C was 
added n-BuLi (1.6 M in hexane, 300 µL, 0.480 mmol) dropwise. The reaction mixture was 
stirred at −42 °C for 30 min, warmed to 0 °C and stirred for additional 10 min. The mixture 
was cooled to −78 °C and a solution of phenethyl pinacol boronic ester 43 (93 mg, 0.40 mmol) 
in Et2O (0.50 mL) was added dropwise. The reaction was stirred at −78 °C for 30 min and at 
0 °C for further 30 min, then MeOH (3.0 mL) was added dropwise at 0 °C. The mixture was 
stirred at 0 °C for 30 min and at room temperature for 2 h before being quenched by addition 
of H2O (10 mL). Et2O (10 mL) was added, the phases were separated and the aqueous phase 
was extracted with Et2O (2 × 10 mL). The combined organic phases were dried over MgSO4, 
filtered and the solvent was removed under reduced pressure. The crude reaction mixture was 
dissolved in a mixture of THF:H2O (1:1 v/v, 10 mL) and NaBO34H2O (370 mg, 2.40 mmol) 
was added. The mixture was stirred at room temperature for 3 h, then H2O (5 mL) and Et2O 
(10 mL) were added. The phases were separated and the aqueous phase was extracted with 
Et2O (2 × 10 mL). The combined organic phases were dried over MgSO4, filtered and the 
solvent was removed under reduced pressure. Purification of the crude reaction mixture by 
flash column chromatography on silica gel (hexane:Et2O = 95:5) afforded enone 443 (37 mg, 
58%) as a colourless oil. 






(3-(Benzyloxy)-4-iodo-3-methoxypent-4-en-1-yl)benzene (442a)  
 
To a solution of allene 318a (53 mg, 0.36 mmol) in anhydrous Et2O (2.0 mL) at −42 °C was 
added n-BuLi (1.6 M in hexane, 225 µL, 0.360 mmol) dropwise. The reaction mixture was 
stirred at −42 °C for 30 min, warmed to 0 °C and stirred for additional 10 min. The mixture 
was cooled to −78 °C and a solution of phenethyl pinacol boronic ester 43 (70 mg, 0.30 mmol) 
in Et2O (0.50 mL) was added dropwise. The reaction was stirred at −78 °C for 30 min and at 
0 °C for further 30 min. A suspension of NaOMe (49 mg, 0.90 mmol) in MeOH (0.50 mL) was 
added dropwise at 0 °C, immediately followed by the addition of a solution of I2 (228 mg, 
0.90 mmol) in MeOH (1.5 mL). The mixture was stirred at 0 °C for 30 min and at room 
temperature for 2 h. Sat. aq. Na2S2O3 (10 mL) and Et2O (10 mL) were added, the phases were 
separated and the aqueous phase was extracted with Et2O (2 × 10 mL). The combined organic 
phases were dried over MgSO4, filtered and the solvent was removed under reduced pressure. 
Purification of the crude reaction mixture by flash column chromatography on silica gel 
(hexane:Et2O = 98:2) afforded vinyl iodide 442a (78 mg, 64%) as a colourless oil. 
Rf: 0.50 (hexane:Et2O = 95:5). 
1H NMR (CDCl3, 400 MHz) δ: 7.44−7.33 (m, 5H, Ar-H), 7.32–7.27 (m, 2H, Ar-H), 7.22−7.15 
(m, 3H, Ar-H),  6.87 (d, J = 1.3 Hz, 1H, 1-H), 6.25 (d, J = 1.2 Hz, 1H, 1-H), 4.53 (d, J = 11.5 Hz, 
1H, 6-H), 4.45 (d, J = 11.5 Hz, 1H, 6-H), 3.30 (s, 3H, CH3), 2.55–2.42 (m, 2H, 5-H), 2.31−2.16 
(m, 2H, 4-H). 
13C NMR (CDCl3, 101 MHz) δ: 141.3 (Ar-C), 138.0 (Ar-C), 131.5 (1-C), 128.4  (4C, 
Ar-C × 4), 128.2 (2C, Ar-C × 2), 127.5 (2C, Ar-C × 2), 127.5 (Ar-C), 125.9 (Ar-C), 111.1 
(3-C), 102.7 (2-C), 63.9 (6-C), 49.7 (CH3), 35.4 (4-C), 29.5 (5-C). 
IR (neat) νmax: 2960, 1609, 1497, 1453, 1147, 1070, 1040, 919, 732 cm
‒1. 
HRMS (ESI) calculated for C19H21NaO2 (M+Na)






Following a literature reported procedure,99 to a solution of vinyl iodide 442a (37 mg, 
0.091 mmol) in anhydrous DMF (1.2 mL) was added TBAF3H2O (145 mg, 0.455 mmol) at 
room temperature. The resulting reaction mixture was heated at 60 °C for 1 h, then cooled to 
room temperature. H2O (10 mL) was added, followed by Et2O (10 mL), the phases were 
separated and the aqueous phase was extracted with Et2O (2 × 10 mL). The combined organic 
phases were dried over MgSO4, filtered and the solvent was removed under reduced pressure. 
Purification of the crude reaction mixture by flash column chromatography on silica gel 
(hexane:Et2O = 97:3) afforded alkyne 447a (24 mg, 93%) as a colourless oil. 
Rf: 0.21 (hexane:Et2O = 98:2). 
1H NMR (CDCl3, 400 MHz) δ: 7.41−7.33 (m, 4H, Ar-H), 7.33–7.26 (m, 3H, Ar-H), 7.25−7.17 
(m, 3H, Ar-H), 4.76 (d, J = 11.5 Hz, 1H, 6-H), 4.63 (d, J = 11.4 Hz, 1H, 6-H), 3.41 (s, 3H, 
CH3), 2.91–2.87 (m, 2H, 5-H), 2.67 (s, 1H, 1-H), 2.29−2.14 (m, 2H, 4-H). 
13C NMR (CDCl3, 101 MHz) δ: 141.5 (Ar-C), 137.9 (Ar-C), 128.4 (2C, Ar-C × 2), 128.4 (4C, 
Ar-C × 4), 127.7 (Ar-C), 127.5 (Ar-C), 125.9 (2C, Ar-C × 2), 98.9 (3-C), 80.3 (2-C), 74.2 
(1-C), 65.2 (6-C), 50.2 (CH3), 39.4 (4-C), 30.5 (5-C). 
IR (neat) νmax: 3282, 2117, 1454, 1146, 1101, 1038, 1026, 731 cm
‒1. 
HRMS (ESI) calculated for C19H20NaO2 (M+Na)




(4-Iodo-3,3-dimethoxypent-4-en-1-yl)benzene (442b)  
 
To a solution of allene 318b (34 mg, 0.480 mmol) in anhydrous Et2O (2.5 mL) at −42 °C was 
added n-BuLi (1.6 M in hexane, 300 µL, 0.48 mmol) dropwise. The reaction mixture was stirred 
at −42 °C for 30 min, then warmed to 0 °C and stirred for additional 10 min. The mixture was 
cooled to −78 °C and a solution of phenethyl pinacol boronic ester 43 (93 mg, 0.40 mmol) in 
Et2O (0.50 mL) was added dropwise. The reaction was stirred at −78 °C for 30 min and at 0 °C 
for further 30 min. A suspension of NaOMe (65 mg, 1.2 mmol) in MeOH (0.50 mL) was added 
dropwise at 0 °C, immediately followed by the addition of a solution of I2 (305 mg, 1.20 mmol) 
in MeOH (2.0 mL). The mixture was stirred at 0 °C for 30 min and at room temperature for 
2 h. Sat. aq. Na2S2O3 (10 mL) and Et2O (10 mL) were added, the phases were separated and 
the aqueous phase was extracted with Et2O (2 × 10 mL). The combined organic phases were 
dried over MgSO4, filtered and the solvent was removed under reduced pressure. Purification 
of the crude reaction mixture by flash column chromatography on silica gel 
(hexane:Et2O = 98:2) afforded vinyl iodide 442b (81 mg, 61%) as a colourless oil. 
Rf: 0.50 (hexane:Et2O = 95:5). 
1H NMR (CDCl3, 400 MHz) δ: 7.33−7.23 (m, 2H, Ar-H), 7.23–7.14 (m, 3H, Ar-H),  6.75 (d, 
J = 1.1 Hz, 1H, 1-H), 6.20 (d, J = 1.2 Hz, 1H, 1-H), 3.24 (s, 6H, CH3 × 2), 2.52−2.38 (m, 2H, 
5-H), 2.17−2.07 (m, 2H, 4-H). 
13C NMR (CDCl3, 101 MHz) δ: 141.4 (Ar-C), 131.3 (1-C), 128.4  (2C, Ar-C × 2), 128.2 (2C, 
Ar-C × 2), 125.9 (Ar-C), 111.1 (3-C), 102.5 (2-C), 49.4 (2C, CH3 × 2), 34.8 (4-C), 29.5 (5-C). 
IR (neat) νmax: 2960, 1609, 1454, 1138, 1084, 1043, 918, 739 cm
‒1. 
HRMS (ESI) calculated for C13H17INaO2 (M+Na)




(1)  Brown, H.; Rao, B. C. J. Org. Chem. 1957, 22, 1136. 
(2)  Brown, H.; Rao, B. C. J. Org. Chem. 1957, 22, 1137. 
(3)  Brown, H. C. Tetrahedron 1961, 12, 117. 
(4)  Collins, B. S. L.; Wilson, C. M.; Myers, E. L.; Aggarwal, V. K. Angew. Chem. Int. Ed. 
2017, 56, 11700. 
(5)  Aggarwal, V. K.; Fang, G. Y.; Ginesta, X.; Howells, D. M.; Zaja, M. Pure Appl. Chem. 
2006, 78, 215. 
(6)  Bottoni, A.; Lombardo, M.; Neri, A.; Trombini, C. J. Org. Chem. 2003, 68, 3397. 
(7)  Thomas, S. P.; French, R. M.; Jheengut, V.; Aggarwal, V. K. Chem. Rec. 2009, 9, 24. 
(8)  Matteson, D. S.; Ray, R. J. Am. Chem. Soc. 1980, 102, 7590. 
(9)  Matteson, D. S.; Ray, R.; Rocks, R. R.; Tsai, D. J. S. Organometallics 1983, 2, 1536. 
(10)  Matteson, D. S. Acc. Chem. Res. 1988, 21, 294. 
(11)  Matteson, D. S. J. Org. Chem. 2013, 78, 10009. 
(12)  Matteson, D. S.; Sadhu, K. M. J. Am. Chem. Soc. 1983, 105, 2077. 
(13)  Corey, E. J.; Barnes-Seeman, D.; Lee, T. W. Tetrahedron: Asymmetry 1997, 8, 3711. 
(14)  Midland, M. M. J. Org. Chem. 1998, 63, 914. 
(15)  Matteson, D. S.; Man, H.-W.; Ho, O. C. J. Am. Chem. Soc. 1996, 118, 4560. 
(16)  Hiscox, W. C.; Matteson, D. S. J. Organomet. Chem. 2000, 614-615, 314. 
(17)  Matteson, D. S.; Singh, R. P.; Schafman, B.; Yang, J.-j. J. Org. Chem. 1998, 63, 4466. 
(18)  Tripathy, P. B.; Matteson, D. S. Synthesis 1990, 1990, 200. 
(19)  Matteson, D. S.; Hurst, G. D. Heteroat. Chem. 1990, 1, 65. 
(20)  Aggarwal, V. K.; Fang, G. Y.; Schmidt, A. T. J. Am. Chem. Soc. 2005, 127, 1642. 
(21)  Fang, G. Y.; Wallner, O. A.; Blasio, N. D.; Ginesta, X.; Harvey, J. N.; Aggarwal, V. K. 
J. Am. Chem. Soc. 2007, 129, 14632. 
(22)  Howells, D.; Robiette, R.; Fang, G. Y.; Knowles, L. S.; Woodrow, M. D.; Harvey, J. N.; 
Aggarwal, V. K. Org. Biomol. Chem. 2008, 6, 1185. 
(23)  Blakemore, P. R.; Burge, M. S.; Sephton, M. A. Tetrahedron Lett. 2007, 48, 3999. 
(24)  Durst, T.; LeBelle, M. J.; Elzen, R. V. d.; Tin, K. C. Can. J. Chem. 1974, 52, 761. 
(25)  Lockard, J. P.; Schroeck, C. W.; Johnson, C. R. Synthesis 1973, 1973, 485. 
(26)  Jacobus, J.; Mislow, K. J. Am. Chem. Soc. 1967, 89, 5228. 
(27)  Hoffmann, R. W.; Nell, P. G. Angew. Chem. Int. Ed. 1999, 38, 338. 
(28)  Hoffmann, R. W.; Nell, P. G.; Leo, R.; Harms, K. Chem. Eur. J. 2000, 6, 3359. 
 
291 
(29)  Blakemore, P. R.; Marsden, S. P.; Vater, H. D. Org. Lett. 2006, 8, 773. 
(30)  Blakemore, P. R.; Burge, M. S. J. Am. Chem. Soc. 2007, 129, 3068. 
(31)  Spande, T. F.; Garraffo, H. M.; Edwards, M. W.; Yeh, H. J. C.; Pannell, L.; Daly, J. W. 
J. Am. Chem. Soc. 1992, 114, 3475. 
(32)  Damaj, M. I.; Creasy, K. R.; Grove, A. D.; Rosecrans, J. A.; Martin, B. R. Brain Res. 
1994, 664, 34. 
(33)  Daly, J. W.; Tokuyama, T.; Fujiwara, T.; Highet, R. J.; Karle, I. L. J. Am. Chem. Soc. 
1980, 102, 830. 
(34)  Emerson, C. R.; Zakharov, L. N.; Blakemore, P. R. Org. Lett. 2011, 13, 1318. 
(35)  Emerson, C. R.; Zakharov, L. N.; Blakemore, P. R. Chem. Eur. J. 2013, 19, 16342. 
(36)  Drago, C.; Caggiano, L.; Jackson, R. F. W. Angew. Chem. Int. Ed. 2005, 44, 7221. 
(37)  Cogan, D. A.; Liu, G.; Kim, K.; Backes, B. J.; Ellman, J. A. J. Am. Chem. Soc. 1998, 120, 
8011. 
(38)  Bolm, C.; Bienewald, F. Angew. Chem. Int. Ed. Engl. 1996, 34, 2640. 
(39)  Satoh, T.; Oohara, T.; Ueda, Y.; Yamakawa, K. Tetrahedron Lett. 1988, 29, 313. 
(40)  Hoppe, D.; Hintze, F.; Tebben, P. Angew. Chem. Int. Ed. Engl. 1990, 29, 1422. 
(41)  Hoppe, D. Angew. Chem. Int. Ed. Engl. 1984, 23, 932. 
(42)  Herzogh, J. Ber. Dtsch. Chem. Ges. 1907, 40, 1831. 
(43)  Overman, L. E.; Campbell, C. B.; Knoll, F. M. J. Am. Chem. Soc. 1978, 100, 4822. 
(44)  Hoppe, D.; Hanko, R.; Brönneke, A.; Lichtenberg, F.; van Hülsen, E. Chem. Ber. 1985, 
118, 2822. 
(45)  Hoppe, D.; Hintze, F.; Tebben, P.; Paetow, M.; Ahrens, H.; Schwerdtfeger, J.; 
Sommerfeld, P.; Haller, J.; Guarnieri, W.; Kolczewski, S.; Hense, T.; Hoppe, I. Pure Appl. 
Chem. 1994, 66, 1479. 
(46)  Rondan, N. G.; Houk, K. N.; Beak, P.; Zajdel, W. J.; Chanrasekhar, J.; Schleyer, P. V. R. 
J. Org. Chem. 1981, 46, 4108. 
(47)  Sommerfeld, P.; Hoppe, D. Synlett 1992, 1992, 764. 
(48)  Würthwein, E.-U.; Hoppe, D. J. Org. Chem. 2005, 70, 4443. 
(49)  Genet, C.; McGrath, M. J.; O'Brien, P. Org. Biomol. Chem. 2006, 4, 1376. 
(50)  Hoppe, D.; Carstens, A.; Krámer, T. Angew. Chem. Int. Ed. Engl. 1990, 29, 1424. 
(51)  Carstens, A.; Hoppe, D. Tetrahedron 1994, 50, 6097. 
(52)  Lange, H.; Huenerbein, R.; Fröhlich, R.; Grimme, S.; Hoppe, D. Chem. Asian J. 2008, 3, 
78. 
(53)  Beckmann, E.; Desai, V.; Hoppe, D. Synlett 2004, 2004, 2275. 
 
292 
(54)  Stymiest, J. L.; Dutheuil, G.; Mahmood, A.; Aggarwal, V. K. Angew. Chem. Int. Ed. 2007, 
46, 7491. 
(55)  Dutheuil, G.; Webster, M. P.; Worthington, P. A.; Aggarwal, V. K. Angew. Chem. Int. 
Ed. 2009, 48, 6317. 
(56)  Stymiest, J. L.; Bagutski, V.; French, R. M.; Aggarwal, V. K. Nature 2008, 456, 778. 
(57)  Pu, L.; Yu, H.-B. Chem. Rev. 2001, 101, 757. 
(58)  Noyori, R.; Hashiguchi, S. Acc. Chem. Res. 1997, 30, 97. 
(59)  Riant, O.; Hannedouche, J. Org. Biomol. Chem. 2007, 5, 873. 
(60)  Shibasaki, M.; Kanai, M. Chem. Rev. 2008, 108, 2853. 
(61)  Corey, E. J.; Guzman-Perez, A. Angew. Chem. Int. Ed. 1998, 37, 388. 
(62)  Chen, C.-A.; Wu, K.-H.; Gau, H.-M. Angew. Chem. Int. Ed. 2007, 46, 5373. 
(63)  Ramón, D. J.; Yus, M. Tetrahedron Lett. 1998, 39, 1239. 
(64)  Betancort, J. M.; García, C.; Walsh, P. J. Synlett 2004, 2004, 0749. 
(65)  Fujii, A.; Hashiguchi, S.; Uematsu, N.; Ikariya, T.; Noyori, R. J. Am. Chem. Soc. 1996, 
118, 2521. 
(66)  Bagutski, V.; French, R. M.; Aggarwal, V. K. Angew. Chem. Int. Ed. 2010, 49, 5142. 
(67)  Larouche-Gauthier, R.; Fletcher, C. J.; Couto, I.; Aggarwal, V. K. Chem. Commun. 2011, 
47, 12592. 
(68)  Beak, P.; McKinnie, B. G. J. Am. Chem. Soc. 1977, 99, 5213. 
(69)  Beak, P.; Baillargeon, M.; Carter, L. G. J. Org. Chem. 1978, 43, 4255. 
(70)  Beak, P.; Carter, L. G. J. Org. Chem. 1981, 46, 2363. 
(71)  Kapeller, D. C.; Hammerschmidt, F. J. Org. Chem. 2009, 74, 2380. 
(72)  Pulis, A. P.; Blair, D. J.; Torres, E.; Aggarwal, V. K. J. Am. Chem. Soc. 2013, 135, 16054. 
(73)  Burns, M.; Essafi, S.; Bame, J. R.; Bull, S. P.; Webster, M. P.; Balieu, S.; Dale, J. W.; 
Butts, C. P.; Harvey, J. N.; Aggarwal, V. K. Nature 2014, 513, 183. 
(74)  Balieu, S.; Hallett, G. E.; Burns, M.; Bootwicha, T.; Studley, J.; Aggarwal, V. K. J. Am. 
Chem. Soc. 2015, 137, 4398. 
(75)  Brown, C. A.; Aggarwal, V. K. Chem. Eur. J. 2015, 21, 13900. 
(76)  Noble, A.; Roesner, S.; Aggarwal, V. K. Angew. Chem. Int. Ed. 2016, 55, 15920. 
(77)  Wu, J.; Lorenzo, P.; Zhong, S.; Ali, M.; Butts, C. P.; Myers, E. L.; Aggarwal, V. K. 
Nature 2017, 547, 436. 
(78)  Vigneron, J. P.; Dhaenens, M.; Horeau, A. Tetrahedron 1973, 29, 1055. 
(79)  Fleming, I.; Ghosh, S. K. J. Chem. Soc., Chem. Commun. 1994, 99. 
(80)  Rayner, P. J.; O’Brien, P.; Horan, R. A. J. J. Am. Chem. Soc. 2013, 135, 8071. 
 
293 
(81)  Sandford, C.; Aggarwal, V. K. Chem. Commun. 2017, 53, 5481. 
(82)  Scott, H. K.; Aggarwal, V. K. Chem. Eur. J. 2011, 17, 13124. 
(83)  Brown, H. C.; Zweifel, G. J. Am. Chem. Soc. 1961, 83, 2544. 
(84)  Kabalka, G. W.; Shoup, T. M.; Goudgaon, N. M. Tetrahedron Lett. 1989, 30, 1483. 
(85)  Webb, K. S.; Levy, D. Tetrahedron Lett. 1995, 36, 5117. 
(86)  Kabalka, G. W. J. Organomet. Chem. 1977, 125, 273. 
(87)  Mlynarski, S. N.; Karns, A. S.; Morken, J. P. J. Am. Chem. Soc. 2012, 134, 16449. 
(88)  Bagutski, V.; Elford, T. G.; Aggarwal, V. K. Angew. Chem. Int. Ed. 2011, 50, 1080. 
(89)  Bagutski, V.; Ros, A.; Aggarwal, V. K. Tetrahedron 2009, 65, 9956. 
(90)  Kim, B. J.; Matteson, D. S. Angew. Chem. Int. Ed. 2004, 43, 3056. 
(91)  Brown, H. C.; Midland, M. M.; Levy, A. B. J. Am. Chem. Soc. 1972, 94, 2114. 
(92)  Larouche-Gauthier, R.; Elford, T. G.; Aggarwal, V. K. J. Am. Chem. Soc. 2011, 133, 
16794. 
(93)  Sandford, C.; Rasappan, R.; Aggarwal, V. K. J. Am. Chem. Soc. 2015, 137, 10100. 
(94)  Nave, S.; Sonawane, R. P.; Elford, T. G.; Aggarwal, V. K. J. Am. Chem. Soc. 2010, 132, 
17096. 
(95)  Zweifel, G.; Arzoumanian, H.; Whitney, C. C. J. Am. Chem. Soc. 1967, 89, 3652. 
(96)  Evans, D. A.; Crawford, T. C.; Thomas, R. C.; Walker, J. A. J. Org. Chem. 1976, 41, 
3947. 
(97)  Sonawane, R. P.; Jheengut, V.; Rabalakos, C.; Larouche-Gauthier, R.; Scott, H. K.; 
Aggarwal, V. K. Angew. Chem. Int. Ed. 2011, 50, 3760. 
(98)  Armstrong, R. J.; García-Ruiz, C.; Myers, E. L.; Aggarwal, V. K. Angew. Chem. Int. Ed. 
2017, 56, 786. 
(99)  Wang, Y.; Noble, A.; Myers, E. L.; Aggarwal, V. K. Angew. Chem. Int. Ed. 2016, 55, 
4270. 
(100)  Imao, D.; Glasspoole, B. W.; Laberge, V. S.; Crudden, C. M. J. Am. Chem. Soc. 2009, 
131, 5024. 
(101)  Crudden, C. M.; Ziebenhaus, C.; Rygus, J. P. G.; Ghozati, K.; Unsworth, P. J.; Nambo, 
M.; Voth, S.; Hutchinson, M.; Laberge, V. S.; Maekawa, Y.; Imao, D. Nat. Commun. 2016, 
7, 11065. 
(102)  Matthew, S. C.; Glasspoole, B. W.; Eisenberger, P.; Crudden, C. M. J. Am. Chem. Soc. 
2014, 136, 5828. 




(104)  Li, L.; Zhao, S.; Joshi-Pangu, A.; Diane, M.; Biscoe, M. R. J. Am. Chem. Soc. 2014, 
136, 14027. 
(105)  Bonet, A.; Odachowski, M.; Leonori, D.; Essafi, S.; Aggarwal, V. K. Nat. Chem. 2014, 
6, 584. 
(106)  Odachowski, M.; Bonet, A.; Essafi, S.; Conti-Ramsden, P.; Harvey, J. N.; Leonori, D.; 
Aggarwal, V. K. J. Am. Chem. Soc. 2016, 138, 9521. 
(107)  Llaveria, J.; Leonori, D.; Aggarwal, V. K. J. Am. Chem. Soc. 2015, 137, 10958. 
(108)  Wilson, C. M.; Ganesh, V.; Noble, A.; Aggarwal, V. K. Angew. Chem. Int. Ed. 2017, 
56, 16318. 
(109)  Bigler, R.; Aggarwal, V. K. Angew. Chem. Int. Ed. 2018, 57, 1082. 
(110)  Sperber, N.; Papa, D.; Schwenk, E.; Sherlock, M.; Fricano, R. J. Am. Chem. Soc. 1951, 
73, 5752. 
(111)  Andries, K.; Verhasselt, P.; Guillemont, J.; Göhlmann, H. W. H.; Neefs, J.-M.; Winkler, 
H.; Van Gestel, J.; Timmerman, P.; Zhu, M.; Lee, E.; Williams, P.; de Chaffoy, D.; Huitric, 
E.; Hoffner, S.; Cambau, E.; Truffot-Pernot, C.; Lounis, N.; Jarlier, V. Science 2005, 307, 
223. 
(112)  Azzolina, O.; Collina, S.; Brusotti, G.; Loddo, G.; Linati, L.; Lanza, E.; Ghislandi, V. 
Tetrahedron: Asymmetry 2004, 15, 1651. 
(113)  Azzolina, O.; Collina, S.; Brusotti, G.; Rossi, D.; Linati, L.; Lanza, E.; Ghislandi, V. 
Tetrahedron Lett. 2004, 45, 1355. 
(114)  Burrows, J. N.; Cumming, J. G.; Fillery, S. M.; Hamlin, G. A.; Hudson, J. A.; Jackson, 
R. J.; McLaughlin, S.; Shaw, J. S. Bioorg. Med. Chem. Lett. 2005, 15, 25. 
(115)  Goehring, R. R.; Whitehead, J. F. W.; Brown, K.; Islam, K.; Wen, X.; Zhou, X.; Chen, 
Z.; Valenzano, K. J.; Miller, W. S.; Shan, S.; Kyle, D. J. Bioorg. Med. Chem. Lett. 2004, 
14, 5045. 
(116)  Chen, Z.; Miller, W. S.; Shan, S.; Valenzano, K. J. Bioorg. Med. Chem. Lett. 2003, 13, 
3247. 
(117)  Botteghi, C.; Chelucci, G.; Del Ponte, G.; Marchetti, M.; Paganelli, S. J. Org. Chem. 
1994, 59, 7125. 
(118)  Rische, T.; Eilbracht, P. Tetrahedron 1999, 55, 1915. 
(119)  Ahmed, M.; Seayad, A. M.; Jackstell, R.; Beller, M. J. Am. Chem. Soc. 2003, 125, 10311. 
(120)  Ahmed, M.; Buch, C.; Routaboul, L.; Jackstell, R.; Klein, H.; Spannenberg, A.; Beller, 
M. Chem. Eur. J. 2007, 13, 1594. 
 
295 
(121)  Hamid, M. H. S. A.; Allen, C. L.; Lamb, G. W.; Maxwell, A. C.; Maytum, H. C.; Watson, 
A. J. A.; Williams, J. M. J. J. Am. Chem. Soc. 2009, 131, 1766. 
(122)  Prediger, P.; da Silva, A. R.; Correia, C. R. D. Tetrahedron 2014, 70, 3333. 
(123)  Vedrenne, E.; Wallner, O. A.; Vitale, M.; Schmidt, F.; Aggarwal, V. K. Org. Lett. 2009, 
11, 165. 
(124)  Capriati, V.; Florio, S.; Luisi, R.; Salomone, A. Org. Lett. 2002, 4, 2445. 
(125)  Capriati, V.; Florio, S.; Luisi, R.; Nuzzo, I. J. Org. Chem. 2004, 69, 3330. 
(126)  Schmidt, F.; Keller, F.; Vedrenne, E.; Aggarwal, V. K. Angew. Chem. Int. Ed. 2009, 48, 
1149. 
(127)  Degennaro, L.; Zenzola, M.; Trinchera, P.; Carroccia, L.; Giovine, A.; Romanazzi, G.; 
Falcicchio, A.; Luisi, R. Chem. Commun. 2014, 50, 1698. 
(128)  Aggarwal, V. K.; Harvey, J. N.; Robiette, R. Angew. Chem. Int. Ed. 2005, 44, 5468. 
(129)  Alex, A.; Larmanjat, B.; Marrot, J.; Couty, F.; David, O. Chem. Commun. 2007, 2500. 
(130)  Couty, F.; David, O.; Larmanjat, B.; Marrot, J. J. Org. Chem. 2007, 72, 1058. 
(131)  Lo, C.; David, O.; Couty, F. Tetrahedron Lett. 2014, 55, 535. 
(132)  Park, J.-Y.; Kim, S.-W.; Lee, J.-K.; Im, W. B.; Jin, B. K.; Yoon, S.-H. Biol. Pharm. Bull. 
2011, 34, 538. 
(133)  Roesner, S.; Casatejada, J. M.; Elford, T. G.; Sonawane, R. P.; Aggarwal, V. K. Org. 
Lett. 2011, 13, 5740. 
(134)  Watson, C. G.; Balanta, A.; Elford, T. G.; Essafi, S.; Harvey, J. N.; Aggarwal, V. K. J. 
Am. Chem. Soc. 2014, 136, 17370. 
(135)  Toribatake, K.; Miyata, S.; Naganawa, Y.; Nishiyama, H. Tetrahedron 2015, 71, 3203. 
(136)  Sakae, R.; Hirano, K.; Satoh, T.; Miura, M. Angew. Chem. Int. Ed. 2015, 54, 613. 
(137)  Luisi, R.; Giovine, A.; Florio, S. Chem. Eur. J. 2010, 16, 2683. 
(138)  Köbrich, G.; Fischer, R. H. Tetrahedron 1968, 24, 4343. 
(139)  Tarhouni, R.; Kirschleger, B.; Rambaud, M.; Villieras, J. Tetrahedron Lett. 1984, 25, 
835. 
(140)  Dunsmore, C. J.; Carr, R.; Fleming, T.; Turner, N. J. J. Am. Chem. Soc. 2006, 128, 2224. 
(141)  Sumiya, F.; Shirai, N.; Sato, Y. Chem. Pharm. Bull. 1991, 39, 36. 
(142)  Zhou, J.-N.; Fang, Q.; Hu, Y.-H.; Yang, L.-Y.; Wu, F.-F.; Xie, L.-J.; Wu, J.; Li, S. Org. 
Biomol. Chem. 2014, 12, 1009. 
(143)  Lewis, E. S.; Boozer, C. E. J. Am. Chem. Soc. 1952, 74, 308. 
(144)  Capriati, V.; Florio, S. Chem. Eur. J. 2010, 16, 4152. 
(145)  Lovering, F.; Bikker, J.; Humblet, C. J. Med. Chem. 2009, 52, 6752. 
 
296 
(146)  Li, J.; Ballmer, S. G.; Gillis, E. P.; Fujii, S.; Schmidt, M. J.; Palazzolo, A. M. E.; 
Lehmann, J. W.; Morehouse, G. F.; Burke, M. D. Science 2015, 347, 1221. 
(147)  Satoh, T.; Oohara, T.; Ueda, Y.; Yamakawa, K. J. Org. Chem. 1989, 54, 3130. 
(148)  Rodriguez, R. A.; Pan, C.-M.; Yabe, Y.; Kawamata, Y.; Eastgate, M. D.; Baran, P. S. J. 
Am. Chem. Soc. 2014, 136, 6908. 
(149)  Maddox, S. M.; Nalbandian, C. J.; Smith, D. E.; Gustafson, J. L. Org. Lett. 2015, 17, 
1042. 
(150)  Samanta, R. C.; Yamamoto, H. Chem. Eur. J. 2015, 21, 11976. 
(151)  Bickart, P.; Carson, F. W.; Jacobus, J.; Miller, E. G.; Mislow, K. J. Am. Chem. Soc. 
1968, 90, 4869. 
(152)  Solladié, G. Synthesis 1981, 1981, 185. 
(153)  Andersen, K. K. Tetrahedron Lett. 1962, 3, 93. 
(154)  Cook, S.; Taylor, R. J. K. Tetrahedron Lett. 1981, 22, 5275. 
(155)  Quesnelle, C.; Iihama, T.; Aubert, T.; Perrier, H.; Snieckus, V. Tetrahedron Lett. 1992, 
33, 2625. 
(156)  Satoh, T.; Akita, K. Chem. Pharm. Bull. 2003, 51, 181. 
(157)  Hoffmann, R. W.; Ruhland, T.; Bewersdorf, M. J. Chem. Soc., Chem. Commun. 1991, 
195. 
(158)  Krasovskiy, A.; Knochel, P. Angew. Chem. Int. Ed. 2004, 43, 3333. 
(159)  Ren, H.; Krasovskiy, A.; Knochel, P. Org. Lett. 2004, 6, 4215. 
(160)  Biellmann, J. F.; Vicens, J. J. Tetrahedron Lett. 1978, 19, 467. 
(161)  Ludwig, G.; Ruffer, T.; Hoppe, A.; Walther, T.; Lang, H.; Ebbinghaus, S. G.; Steinborn, 
D. Dalton Trans. 2015, 44, 5323. 
(162)  Biellmann, J. F.; Vicens, J. J. Tetrahedron Lett. 1974, 15, 2915. 
(163)  Wang, C.; Glorius, F. Angew. Chem. Int. Ed. 2009, 48, 5240. 
(164)  Bootwicha, T.; Feilner, J. M.; Myers, E. L.; Aggarwal, V. K. Nat. Chem. 2017, 9, 896. 
(165)  Satoru, M.; William, C.; S., P. J.; R., S. L. Angew. Chem. Int. Ed. Engl. 1985, 24, 1. 
(166)  Rohr, J. Angew. Chem. Int. Ed. 2000, 39, 2847. 
(167)  Koskinen, A. M. P.; Karisalmi, K. Chem. Soc. Rev. 2005, 34, 677. 
(168)  Hertweck, C. Angew. Chem. Int. Ed. 2009, 48, 4688. 
(169)  Staunton, J.; Weissman, K. J. Nat. Prod. Rep. 2001, 18, 380. 
(170)  Reichle, M. A.; Breit, B. Angew. Chem. Int. Ed. 2012, 51, 5730. 
(171)  Haydl, A. M.; Breit, B. Chem. Eur. J. 2017, 23, 541. 
(172)  Lai, J.; Du, W.; Tian, L.; Zhao, C.; She, X.; Tang, S. Org. Lett. 2014, 16, 4396. 
 
297 
(173)  Kruse, C. G.; Wijsman, A.; Van der Gen, A. J. Org. Chem. 1979, 44, 1847. 
(174)  Walton, J. C.; Brahmi, M. M.; Fensterbank, L.; Lacôte, E.; Malacria, M.; Chu, Q.; Ueng, 
S.-H.; Solovyev, A.; Curran, D. P. J. Am. Chem. Soc. 2010, 132, 2350. 
(175)  Aichhorn, S.; Bigler, R.; Myers, E. L.; Aggarwal, V. K. J. Am. Chem. Soc. 2017, 139, 
9519. 
(176)  Carlson, B. A.; Brown, H. C. J. Am. Chem. Soc. 1973, 95, 6876. 
(177)  Brown, H. C.; Srebnik, M.; Bakshi, R. K.; Cole, T. E. J. Am. Chem. Soc. 1987, 109, 
5420. 
(178)  Bánhidai, B.; Schölikopf, U. Angew. Chem. 1973, 85, 861. 
(179)  Ragno, D.; Zaghi, A.; Di Carmine, G.; Giovannini, P. P.; Bortolini, O.; Fogagnolo, M.; 
Molinari, A.; Venturini, A.; Massi, A. Org. Biomol. Chem. 2016, 14, 9823. 
(180)  Reeves, J. T.; Tan, Z.; Herbage, M. A.; Han, Z. S.; Marsini, M. A.; Li, Z.; Li, G.; Xu, 
Y.; Fandrick, K. R.; Gonnella, N. C.; Campbell, S.; Ma, S.; Grinberg, N.; Lee, H.; Lu, B. 
Z.; Senanayake, C. H. J. Am. Chem. Soc. 2013, 135, 5565. 
(181)  Enders, D.; Seebach, D. Angew. Chem. Int. Ed. Engl. 1973, 12, 1014. 
(182)  Erős, G.; Kushida, Y.; Bode, J. W. Angew. Chem. Int. Ed. 2014, 53, 7604. 
(183)  Soderquist, J. A.; Ramos, J.; Matos, K. Tetrahedron Lett. 1997, 38, 6639. 
(184)  Hawkins, J. M.; Loren, S. D.; Kim, Y.-K. Tetrahedron Lett. 1991, 32, 1635. 
(185)  Grosso, A. D.; Helm, M. D.; Solomon, S. A.; Caras-Quintero, D.; Ingleson, M. J. Chem. 
Commun. 2011, 47, 12459. 
(186)  Bagutski, V.; Del Grosso, A.; Carrillo, J. A.; Cade, I. A.; Helm, M. D.; Lawson, J. R.; 
Singleton, P. J.; Solomon, S. A.; Marcelli, T.; Ingleson, M. J. J. Am. Chem. Soc. 2013, 
135, 474. 
(187)  Novikov, Y. Y.; Sampson, P. Org. Lett. 2003, 5, 2263. 
(188)  Novikov, Y. Y.; Sampson, P. J. Org. Chem. 2005, 70, 10247. 
(189)  Fournier, A. M.; Clayden, J. Org. Lett. 2012, 14, 142. 
(190)  Babudri, F.; Farinola, G. M.; Fiandanese, V.; Mazzone, L.; Naso, F. Tetrahedron 1998, 
54, 1085. 
(191)  Itami, K.; Kamei, T.; Yoshida, J.-i. J. Am. Chem. Soc. 2003, 125, 14670. 
(192)  Perrone, S.; Knochel, P. Org. Lett. 2007, 9, 1041. 
(193)  Frost, J. R.; Pearson, C. M.; Snaddon, T. N.; Booth, R. A.; Turner, R. M.; Gold, J.; Shaw, 
D. M.; Gaunt, M. J.; Ley, S. V. Chem. Eur. J. 2015, 21, 13261. 




(195)  Pulis, A. P.; Aggarwal, V. K. J. Am. Chem. Soc. 2012, 134, 7570. 
(196)  Zimmer, R. Synthesis 1993, 1993, 165. 
(197)  Zimmer, R.; Reissig, H.-U. Chem. Soc. Rev. 2014, 43, 2888. 
(198)  Hoff, S.; Brandsma, L.; Arens, J. F. Recl. Trav. Chim. Pays-Bas 1969, 88, 609. 
(199)  Hormuth, S.; Reissig, H. U.; Dorsch, D. Angew. Chem. Int. Ed. Engl. 1993, 32, 1449. 
(200)  Trost, B. M.; Xie, J. J. Am. Chem. Soc. 2006, 128, 6044. 
(201)  Miyaura, N.; Yoshinari, T.; Itoh, M.; Suzuki, A. Tetrahedron Lett. 1980, 21, 537. 
(202)  Matteson, D. S.; Majumdar, D. J. Am. Chem. Soc. 1980, 102, 7588. 
(203)  Tanaka, S.; Saito, Y.; Yamamoto, T.; Hattori, T. Org. Lett. 2018, 20, 1828. 
(204)  Kinumaki, A.; Suzuki, M. J. Chem. Soc., Chem. Commun. 1972, 744. 
(205)  Pilli, R. A.; de Andrade, C. K. Z.; Souto, C. R. O.; de Meijere, A. J. Org. Chem. 1998, 
63, 7811. 
(206)  Xuan, R.; Oh, H.-S.; Lee, Y.; Kang, H.-Y. J. Org. Chem. 2008, 73, 1456. 
(207)  Burchat, A. F.; Chong, J. M.; Nielsen, N. J. Organomet. Chem. 1997, 542, 281. 
(208)  Krasovskiy, A.; Knochel, P. Synthesis 2006, 890. 
(209)  Broussy, S.; Cheloha, R. W.; Berkowitz, D. B. Org. Lett. 2009, 11, 305. 
(210)  Varela, A.; Garve, L. K. B.; Leonori, D.; Aggarwal, V. K. Angew. Chem. Int. Ed. 2017, 
56, 2127. 
(211)  Dudley, G. B.; Takaki, K. S.; Cha, D. D.; Danheiser, R. L. Org. Lett. 2000, 2, 3407. 
(212)  Lujan-Montelongo, J. A.; Estevez, A. O.; Fleming, F. F. Eur. J. Org. Chem. 2015, 1602. 
(213)  García Ruano, J. L.; Alemán, J.; Belén Cid, M.; Parra, A. Org. Lett. 2005, 7, 179. 
(214)  O’Mahony, G. E.; Ford, A.; Maguire, A. R. J. Org. Chem. 2012, 77, 3288. 
(215)  Cooke, R. S.; Hammond, G. S. J. Am. Chem. Soc. 1970, 92, 2739. 
(216)  Hesse, M. J.; Butts, C. P.; Willis, C. L.; Aggarwal, V. K. Angew. Chem. Int. Ed. 2012, 
51, 12444. 
(217)  Smith, J. R.; Collins, B. S. L.; Hesse, M. J.; Graham, M. A.; Myers, E. L.; Aggarwal, V. 
K. J. Am. Chem. Soc. 2017, 139, 9148. 
(218)  Lee, J. C.; Oh, Y. S.; Cho, S. H.; Lee, J. D. Org. Prep. Proced. Int. 1996, 28, 480. 
(219)  Scharfbier, J.; Oestreich, M. Synlett 2016, 27, 1274. 
(220)  Corey, E. J.; Chaykovsky, M. J. Am. Chem. Soc. 1965, 87, 1345. 
(221)  Brondani, P. B.; Dudek, H.; Reis, J. S.; Fraaije, M. W.; Andrade, L. H. Tetrahedron: 
Asymmetry 2012, 23, 703. 
(222)  Tietze, L. F.; Schiemann, K.; Wegner, C.; Wulff, C. Chem. Eur. J. 1998, 4, 1862. 
 
299 
(223)  Chen, W.-C.; Lai, Y.-C.; Shih, W.-C.; Yu, M.-S.; Yap, G. P. A.; Ong, T.-G. Chem. Eur. 
J. 2014, 20, 8099. 
(224)  Benneche, T.; Strande, P.; Wiggen, U. Acta Chem. Scand. 1989, 43, 74. 
(225)  Kubota, K.; Yamamoto, E.; Ito, H. Adv. Synth. Catal. 2013, 355, 3527. 
(226)  Yamamoto, E.; Ukigai, S.; Ito, H. Chem. Sci. 2015, 6, 2943. 
(227)  Dieck, H. T.; Friedel, H. J. Organomet. Chem. 1968, 14, 375. 
(228)  Molander, G. A.; Jean-Gérard, L. J. Org. Chem. 2009, 74, 1297. 
(229)  Pérez, M.; Canoa, P.; Gómez, G.; Teijeira, M.; Fall, Y. Synthesis 2005, 2005, 411. 
 
